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training programme in order to achieve multiple training goals.  
 
Eccentric Muscle Contraction 
The phase of muscle contraction where the muscle is lengthening under tension. The actin 
and myosin filaments are being pulled away from the centre of the sarcomere. 
 
Gluconeogenesis 
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Abstract 
Title: The effectiveness of different lifestyle interventions on body composition, insulin 
sensitivity, and novel biomarkers of insulin resistance in obese individuals. 
Author: Diane Cooper. 
 
 Obesity is a serious global health problem (WHO, 2009) and an independent risk 
factor for a number of chronic diseases (Quilliot, Petit et al. 2002). Obesity is caused by a 
mismatch between energy intake and energy expenditure leading to storage of surplus 
energy and expansion of fat stores which causes metabolic disturbances (Speakman, 2004). 
Diet and exercise interventions remain the cornerstone of treatment for obesity but they 
have been largely ineffective (Franz et al. 2007). The purpose of this thesis was to identify 
components of a lifestyle intervention that are most likely to improve body composition, 
insulin sensitivity, and novel biomarkers of insulin resistance in obese individuals. This was 
achieved by investigating 4 different short term interventions. In study 1, isocaloric diet and 
exercise interventions were compared, while in study 2 concurrent training (regular 
resistance training combined with aerobic exercise) and concurrent training incorporating 
an eccentric component were compared.  
 
Briefly, the key findings of this PhD thesis were that isocaloric diet and exercise 
interventions lead to similar reductions in body weight, but exercise training may lead to 
greater improvements in body composition and metabolic health. Importantly, aerobic 
fitness was the single best predictor of improvements in metabolic health in this 
population. Resistance training is important for improving lean tissue mass, fat oxidation 
and resting metabolic rate. The novel biomarkers of insulin resistance are differentially 
regulated by diet, exercise and different modes of exercise training. Improvements in body 
composition and fitness drive improvements in insulin sensitivity and the circulating 
concentration of the biomarkers, and there is a cyclical relationship between the 
biomarkers and metabolic health. It is important to study the biomarkers for better 
understanding of metabolic processes but larger scale studies may be required to determine 
their role. A combination of calorie restriction, aerobic exercise and resistance training will 
optimise improvements in insulin resistance and body composition in obese individuals. 
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1. 1. Introduction 
There has been an exponential rise in the prevalence of overweight and obesity in recent 
years, which has reached epidemic proportions. In fact, the worldwide prevalence of 
obesity has almost doubled in the last 20 years and it is currently the fifth leading risk for 
global death (WHO 2010). Obesity is an independent risk factor for a number of chronic 
diseases including hypertension, cardiovascular disease, and diabetes. Obesity also increases 
the risk of developing certain cancers such as breast and colon cancer, in addition to 
respiratory disorders such as sleep apnea (Quilliot, Petit et al. 2002). An obese individual is 
also more likely to be depressed, suffer from joint problems, and suffer from skin disorders 
(Speakman 2004). The cost of treating obesity and its related complications puts 
considerable stress on the global economy. The direct costs of obesity include hospital 
admissions, medical consultations, and medications. In 2008, this amounted to $113.9 
billion in the USA, which accounted for almost 10% of health care spending (Tsai, 2011). 
In the UK the direct costs were £990-1225 million in 2004 and represented 2.3-2.6% of the 
National Health Service expenditure (HSMO 2004). In 2009, the direct cost of overweight 
and obesity was estimated at €399 million in the Republic of Ireland and €127 million in 
Northern Ireland (Safefood, 2012). This represented 2.7% and 2.8% of total health care 
costs in that year (Safefood, 2012). The indirect costs are more difficult to quantify but 
include absenteeism, disability and premature mortality and workers compensation 
(Trogdon, Finkelstein et al. 2008). These were estimated to be €729 million and €383 
million in the Republic of Ireland and Northern Ireland respectively in 2009 (Safefood, 
2012).  
 
The primary cause of obesity is a mismatch between energy intake and energy expenditure 
leading to storage of surplus energy. The industrialisation of food production has resulted 
in greater processing and preservation and a consequence of this is a dramatic increase in 
the availability of cheap foods that are energy dense, high in fat, sugar and salt (Ferder et al, 
2010). A growing number of individuals in Western society are increasing their 
consumption of these foods and this is occurring alongside an epidemic of physical 
inactivity, which is now the fourth leading risk factor for global mortality (WHO 2009). In 
addition to these behavioural factors, evidence is emerging to suggest that genetics also 
plays an important role, and it is the interaction between an individuals environment and 
their genetic composition that determines the extent of their obesity (Speakman and 
O'Rahilly 2012).  
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Over the last number of years a considerable amount of resources have been devoted to 
the development of therapies for the treatment of obesity. The most common include 
lifestyle intervention, consisting of dietary restriction and/or physical activity, weight loss 
promoting drugs such as Orlistat, and surgery in the case of the morbidly obese individual. 
Although these different treatment options are available, long term lifestyle intervention 
has been largely ineffective, surgery is impractical to implement at a population level and 
many of the pharmacological treatments have additional side effects.  There is a need to 
develop more innovative approaches to weight management and, in particular, to develop 
effective lifestyle intervention strategies.  
 
1. 2. Statement of the problem 
It is widely acknowledged that lifestyle interventions that promote healthy eating and daily 
physical activity effectively reduce fat mass in the obese population. However, translating 
research interventions into population based programmes has not been effective. One 
major challenge has been to identify the most effective intervention given the high degree 
of variability in study outcomes related to differences in study design. Interventions that 
have focused on dietary restriction differ with regard to the calorie deficit, the nutrient 
composition, and the quantification of nutrient intake (Franz, VanWormer et al. 2007). 
Similarly, exercise interventions vary in the number and intensity of sessions in addition to 
the mode of exercise (Franz, VanWormer et al. 2007). Both interventions vary in total 
duration and level of supervision and monitoring. The most effective interventions are 
those that are tightly controlled, heavily supervised, and of short duration (~12 weeks) 
(Tessier, Menard et al. 2000) with greater variation for studies lasting 6-24 months  (Franz, 
VanWormer et al. 2007).  
 
A second challenge is the perception that dietary restriction is superior to exercise training 
in treating obesity when weight loss is the primary outcome measure (Franz, VanWormer 
et al. 2007). However, it is difficult to accept this conclusion since the literature contains 
very few diet and exercise interventions that are isoclaoric (energy expended in exercise 
intervention is equal to energy restricted in dietary intervention) making a direct 
comparison impossible. The strategy most commonly prescribed in dietary interventions is 
a caloric restriction of 500kcal per day, which accumulates to an energy deficit of 3,500kcal 
per week (Franz, VanWormer et al. 2007). Assuming physical activity is controlled at pre 
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intervention levels; this calorie deficit would yield a weight loss of 0.39kg per week since 
there is approximately 9000 kcal in 1kg of body fat. On the other hand, many of the 
exercise interventions are based on the ACSM’s recommendations for health which is a 
minimum of 150 minutes per week of moderate intensity physical activity (Donnelly, Blair 
et al. 2009). The energy expenditure derived from this amount of physical activity depends 
on many factors including the perception of moderate intensity activity, their current level 
of fitness and body mass, but it generally yields an energy expenditure in the region of 
1,000kcal per week. This would result in a weight loss of approximately 0.11kg per week 
when energy intake is maintained at pre intervention caloric intake. Clearly there is a 
mismatch between the current design of diet and exercise interventions making it difficult 
to compare them.  
 
A third challenge is to devise physical activity recommendations for obesity and not just for 
health-enhancing benefits. The ACSM have recognised this and now state that a minimum 
of 250-300 minutes of moderate intensity physical activity per week is needed to produce 
clinically significant long term weight loss (Donnelly, Blair et al. 2009). The energy 
expenditure derived from this prescription is more in line with the caloric restriction 
currently used in diet interventions. This is also complicated by the failure to clearly 
differentiate between exercise and physical activity. One reason for suggesting the 
recommendations are unattainable is the perception that the targets must be met in 
structured exercise such as walking, running, cycling, etc. On the contrary, a shift is 
required to focus on total daily energy expenditure irrespective of how this is achieved but 
could include some structured exercise. 
 
1. 3. Significance of the study 
The literature reports that lifestyle interventions are successful in reducing fat mass in the 
obese population. However, translating research findings into successful population based 
programmes has not been effective. A change is required in our current approach and 3 
major challenges must be overcome to bring about this change. Firstly, the literature 
reports wide variation in the effectiveness of lifestyle interventions and this is due to the 
wide variation that exists in study design. There is a need to determine the study design that 
maximises fat loss and improvements in health in the obese population. Secondly, few 
isocaloric diet and exercise interventions exist making direct comparisons between them 
impossible. Isocaloric interventions must be designed and administered so that the 
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effectiveness of diet and exercise can be compared. Finally, the exercise prescription used 
in many training studies is based on the ACSM’s recommendations for health which does 
not lead to any meaningful energy expenditure or weight loss. These recommendations 
must be revised to promote significant fat mass loss for obese individuals. This PhD thesis 
addresses these 3 challenges and uses the findings to develop a revised lifestyle intervention 
that maximises improvements in fat mass and metabolic health in this population. 
  
1. 3. 1. Body composition or body weight change? 
A systematic review and meta-analysis of diet, exercise and combined lifestyle interventions 
shows that the success of most lifestyle interventions is based on body weight loss as the 
primary outcome variable (Franz et al, 2007). This is a crude descriptor of success and is 
not necessarily the best indicator of health enhancement (De Souza et al, 2012). Body 
weight can be compartmentalised into body fat mass and lean tissue but most interventions 
do not differentiate between the changes in each compartment. Lean tissue has high 
metabolic activity and accounts for the majority of resting energy expenditure (Poehlman 
1989). The metabolic activity of most tissues remains relatively stable to sustain life but 
skeletal muscle mass, which accounts for 60-75% of resting metabolic rate, can be 
influenced by physical activity and physical inactivity (Poehlman 1989). Caloric restriction, 
especially very low calorie diets, report significant weight loss but this often includes 
significant reductions in lean tissue. The loss of lean tissue consequently reduces metabolic 
rate and may have longer term implications for further weight loss and metabolic health 
(Martin, Heilbronn et al. 2007). The loss of lean tissue may even contribute to weight 
regain that is also often seen with these types of intervention over a 6 to 24 month period 
(Franz, VanWormer et al. 2007). Lifestyle interventions should ideally aim to reduce fat 
mass and maintain or increase skeletal muscle mass in obese individuals (Capurso and 
Capurso 2012). Exercise training is known to simultaneously reduce fat mass and maintain 
or increase lean tissue mass especially in previously sedentary individuals (Stewart, Bacher 
et al. 2005). The improvements in body composition with exercise training can be quite 
significant and carry a range of health benefits, but the net result is often only a minimal 
change in body weight, thus leading to a poor perception of success when weight loss is the 
primary outcome (Catenacci, 2007). Unrealistic expectations of the energy expenditure 
derived from exercise training, combined with poor weight loss outcomes and a poor 
understanding of the significance of favourable changes in body composition, can 
negatively affect adherence to such interventions (Foster, Wadden et al. 1997). It is 
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important that body composition is a primary outcome measure for diet and physical 
activity interventions and not body weight. 
 
1. 3. 2. Combining biology and physiology for individualised 
interventions. 
Another difficulty encountered is our incomplete understanding of the physiological 
regulation of energy balance. Even within tightly controlled and supervised programmes 
there is still a large variation in individual response to an intervention (Bouchard, Rankinen, 
2001). This is true for changes in body composition and body weight, improvements in 
fitness levels, rate of adaptation to training, and metabolic improvements (Bouchard, 
Rankinen, 2001). It is clear that one size does not fit all when it comes to exercise 
prescription for obese individuals and efforts must be made to consider a more 
individualised approach to intervention. The same is true for dietary interventions where 
nutrient composition may be need to be considered in conjunction with total caloric 
restriction due to the influence of different food types and fat content on metabolism 
(Astrup, Buemann et al. 2002).  
 
Our understanding of the biology of adipose tissue itself is also still incomplete. It is now 
recognised that adipose tissue is an important endocrine organ that produces and secretes a 
number of cytokines involved in glucose and lipid metabolism (Bays, Gonzalez-Campoy et 
al. 2008). Adipose tissue dysfunction is a key characteristic of obesity which results in 
increased production of disease promoting cytokines concomitant with a decreased 
production of health promoting cytokines (Arner, Pettersson et al. 2008). Leptin and 
Adiponectin were two of the first cytokines to be identified and have been studied 
extensively, but little is known about the effects of diet and exercise on novel cytokines that 
have recently been identified. A greater focus on the effects of diet and exercise 
interventions on the novel cytokines may assist in determining success of programmes 
from a metabolic perspective.  
 
In summary, more basic research is warranted to understand the impact of different 
nutrient intakes, and different physical activity interventions on the mechanisms at play in 
different types of body tissue, so that we may be better able to advise overweight and obese 
individuals. It is also important to investigate novel modes of exercise training that increase 
daily energy expenditure since it is difficult for obese, previously sedentary, individuals to 
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achieve and sustain the required amount of physical activity. For example, a single bout of 
eccentric exercise, where the muscle is lengthening under tension, has been shown to 
increase energy expenditure and fat oxidation in obese individuals (Dolezal, Potteiger et al. 
2000) but little is known about the effects of chronic eccentric training. It is also important 
that comparisons between dietary restriction and physical activity are based on isocaloric 
interventions, to assess the relative importance and contribution of both approaches. 
Finally, a re-evaluation of the criteria used to evaluate interventions is required and should 
focus more on the interface between physiological changes in body composition and 
biological regulation to maximise the chance of successful long term health outcomes. 
Therefore, the aims and objectives of this thesis are: 
  
1. 4. Aims 
The primary aim of this thesis is to identify components (calorie restriction or increased 
energy expenditure by exercise) of a lifestyle intervention that is most likely to improve 
weight loss, body composition, insulin sensitivity and biomarkers of insulin resistance in 
obese individuals. 
 
The second aim of this thesis is to identify the components of an exercise regime (aerobic 
versus resistance) that are most likely to improve weight loss, body composition, insulin 
sensitivity and biomarkers of insulin resistance in obese individuals. 
  
1. 5. Objectives 
1. To compare the effects of an isocaloric diet and aerobic exercise intervention on 
body composition, insulin sensitivity, and the circulating concentrations of novel 
biomarkers of insulin resistance. 
 
2. To measure the impact of eccentric exercise, as part of an aerobic and resistance 
training intervention, on body composition and biomarkers of insulin resistance in 
obese individuals.   
 
3. To compute the most effective combination of dietary restriction and physical 
activity based on improvements in body composition and changes in biomarker 
profile in the obese population. 
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1. 6. Hypothesis 
1. Dietary restriction and exercise interventions will result in distinctive physiological 
and biological profiles following a 12-week intervention in obese individuals. 
 
2. Exercise training will confer more favourable changes on body composition than 
dietary restriction with concurrent training being most effective. 
 
3. A combination of dietary restriction, aerobic exercise and resistance training will be 
necessary to maximise the impact on physiological variables and biomarkers of 
insulin resistance. 
 
1. 7. Thesis Overview 
In this thesis, two separate interventions were conducted to test our hypotheses. In both 
studies obese individuals volunteered to participate in a 12-week diet or exercise 
intervention. All interventions were isocaloric and comprised 2500 kcal/week dietary 
restriction or exercise.  
 
1. 7. 1. Intervention 1: Comparison of dietary restriction and aerobic 
exercise 
Subjects were randomised to a dietary restriction or exercise intervention for 12-weeks. 
Dietary restriction was monitored by food diaries completed every 2-weeks and evaluated 
by a dietician. The exercise programme consisted of supervised exercise in DCU Sport of 
60-75 minutes of aerobic exercise 4 times per week working at an intensity of 70% of 
O2max. Baseline measures of glucose tolerance, aerobic capacity and body composition and 
biomarker profiles were repeated at the end of the intervention and all programmes were 
updated at week 4 and week 8 to ensure continued adaptation and progression. 
 
1. 7. 2. Intervention 2: Eccentric exercise as a novel mode of increasing 
energy expenditure and fat oxidation 
All subjects performed aerobic exercise for 10-weeks and were randomised to complete a 
standard resistance training programme or an eccentric resistance training programme. The 
response to both inteventions was measured by changes in body composition, glucose 
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tolerance, resting energy expenditure, fat oxidation, and skeletal muscle cross sectional area 
and biomarker profiles.  
 
1. 7. 3. Study 3: Impact of exercise training on body composition and 
biomarker profile 
Exercise data from the two intervention studies was combined for a comprehensive 
statistical analysis to determine the effects of training on body composition and biomarker 
profile.  
 
1. 7. 4. Study 4: Comparison of 4 isocaloric interventions 
All data from the two intervention studies was combined for a comprehensive statistical 
analysis to determine the intervention or combination of interventions that resulted in the 
most favourable physiological and biological outcomes. 
 
1. 8. Delimitations 
 The subjects in all of the experiments were recruited exclusively from staff and 
students in Dublin City University due to ease of access to testing and training 
facilities. This group is only one sample of an obese population. 
 In the first study, the subjects recruited were delimited to being young (<30 years) 
or older (>50 years) due to original study design. 
 
1. 9. Limitations 
 With regard to intervention 1, the original study was a multi-centre cross-over 
experiment but the complexity of the design, analysis and the interaction effects led 
us to exclude the second phase of the intervention. The complex nature of this 
original design also resulted in a smaller sample size than originally anticipated. The 
data presented in this PhD thesis excluded a lot of the data that was actually 
collected as part of the original project but this allowed for more robust 
comparisons and conclusions. 
 We were not able to measure body composition on all subjects as the DEXA 
scanner was damaged in a flood during the first year of data collection. 
 For intervention 2, the original study design was a 12 week intervention. However, 
due to the time required to conduct the extensive baseline testing, the intervention 
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was reduced to 10 weeks to ensure that the post tests could be completed prior to 
end of semester.  
 The time commitment required for the training studies, in addition to the extensive 
pre and post tests that were carried out resulted in a smaller sample size than 
originally recruited. This limited the statistical power to detect change. 
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Chapter 2. Literature Review 
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This chapter will provide a focused review of the obesity related scientific literature. The 
overall body of knowledge is beyond the scope of a single review but the relevant literature 
across three key main sections will be critically appraised.  The first section will look at the 
factors that contribute to obesity, the health consequences associated with obesity, and the 
current modes of intervention used to treat and manage this condition. The second section 
will focus specifically on the physiological and metabolic adaptations that occur in response 
to exercise training and the role of these adaptations in treating obesity. The third and final 
section will begin with an overview of adipose tissue biology, and will subsequently focus 
on 6 novel biomarkers that are reported to play a role in obesity and insulin resistance. The 
known effects of lifestyle intervention on these biomarkers will also be presented.  
 
2. 1. Obesity - Cause, consequence and current modes of treatment. 
 
2. 1. 1. Introduction 
The prevalence of overweight and obesity has reached epidemic proportions in recent 
years. Overweight and obese individuals carry around excessive fat which is generally 
estimated by combining measures of height and weight, a method particularly relevant in 
the sedentary adults (Speakman, J.R, 2004). This is reflected in the Body Mass Index (BMI) 
measurement where weight (kg) is divided by height (m2) (Speakman, J.R, 2004). 
Overweight is defined as a BMI >25kg/m2 but <30kg/m2, obesity is defined as a BMI 
>30kg/m2 (Speakman, J.R, 2004). By the year 2000 obesity had grown to such as extent 
that the World Health Organisation declared it to be the greatest threat facing Western 
Society. In 2000, 300 million adults worldwide were classified as being obese but this figure 
has since increased to >520 million with an additional 1 billion adults classified as being 
overweight. The worldwide prevalence of obesity has almost doubled between the years 
1980 and 2008. In 1980 5% of men and 8% of women were classified as being obese 
compared to 10% of men and 14% of women in 2008. These figures are continuing to rise 
and it is predicted that by the year 2015, 2.3 billion adults worldwide will be overweight and 
700 million will be obese (WHO, 2009).    
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Figure 2.1 World Health Organisation global prevalence of obesity, ages 20+, both 
sexes, 2008 
 
The rise in the level of obesity over the last 20 years is particularly evident in the USA 
(Figure 2.2). Data from the National Health and Nutrition Examination Survey 2009-2010 
revealed that more than 2 in 3 or 68.8% of adults over the age of 20 in the US are 
overweight or obese. Furthermore, 1 in 20 adults or 6% are considered to have extreme 
obesity. This condition is not just confined to adults, alarmingly an estimated 33% of 
children aged 6 to 19 years are classified as being overweight or obese. It is predicted that 
by the year 2025 50% of the US population will be obese if these trends are maintained 
(NHANES, 2009-2010).  
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2000
2010
1990
No Data      <10%      10%-14%     15%-19%      20%-24%     25%-29%     ≥30%
 
Figure 2.2 Obesity trends in U.S. adults over a 20 year period from 1990 to 2010. 
BRFSS, 1990, 2000, 2010. The percentages refer to individuals with a BMI 30, or 
about 30 lbs overweight for 5’4” person. This figure has been adapted from the 
Center for Disease Control (2010). 
 
The latest available data from the Eurostat Statistics Database in 2012 revealed a similar 
picture in the EU. At least 52% of adults in all 27 member states were classified as 
overweight or obese, but this figure is even greater in 18 of the 27 member states (Eurostat 
Statistics Database, 2012). 
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Figure 2.3 Depicts the increasing obesity rates among adults in European countries over a 
20 year period from 1990 to 2000 to 2010 (or nearest years). Source: OECD Health 
Data 2012; Eurostat Statistics Database; WHO Global Infobase. 
 
Unfortunately, a similar trend is also evident in Ireland. In 1990 11% of the population 
were obese, this increased to 18% in 2000 and 25% in 2010. This was in addition to 39% of 
the population being classified as overweight at both of those time points. The most recent 
representative data for Ireland shows that 37% of the Irish adult population is overweight 
and a further 24% is obese (IUNA, 2010). By the year 2030 it is predicted that the 
prevalence of overweight and obesity in Irish adults will reach 89% and 85% in males and 
females respectively (Keaver et al. 2013). This issue is not exclusive to Irish adults. Recent 
research shows that 19% of 9 years olds are overweight and 7% are obese (Growing up in 
Ireland, 2011). This translates into a total of 30% of girls and 22% of boys being classified 
as either overweight or obese (Growing up in Ireland, 2011). The last prediction of 
childhood obesity in 2005, based in UK values, estimated the prevalence of obesity in Irish 
children is expected to rise by 10,000 per year (National Obesity Task Force, 2005). The 
rate of overweight and obesity in Ireland is greater than the EU average and creates an 
even stronger rationale for developing interventions to prevent and reduce excess fat 
accumulation. 
 
2. 1. 2. Health consequences of obesity 
Obesity, defined as a body mass index of >30kg/m2, is a serious global health issue. It is 
currently the fifth leading risk for global death, and at least 2.8 million adult deaths each 
year are a direct result of being overweight or obese (WHO, 2009). Mortality increases as 
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BMI increases above 25kg/m2. In the 1930’s, US life insurance companies analysed the 
factors that influenced the probability that someone would redeem a life insurance policy. 
Based on the redemption of 5,000,000 policies in that year, they deemed BMI to be the 
most effective predictor of mortality (Engeland et al., 2003). The reason for this was due to 
the direct link between body fatness and many chronic diseases. An individual with a BMI 
of 35kg/m2 is 40-90 times more likely to develop type 2 diabetes than an individual with a 
BMI of 22kg/m2 (Chan et al., 1994). Obesity is an independent risk factor for a number of 
chronic diseases including hypertension and cardiovascular disease. The risk of certain 
cancers such as breast and colon cancer are also increased with obesity (WHO, 2009), as is 
the risk of developing of clinical respiratory disorders such as sleep apnea (Quilliot et al., 
2002). The obese individual is also more likely to on anti-depressant medication, suffer 
from joint problems, and suffer from skin disorders (Speakman, 2004). Based on current 
trends, by the year 2020 non communicable chronic diseases are expected to account for 
70% of global deaths and 60% of the global disease burden (WHO, 2009).      
 
2. 1. 3. Economic cost of obesity 
The health consequences of obesity combined with the large number of people who are 
affected by it imposes significant costs to the economy both directly and indirectly. Firstly, 
the treatment of obesity and related morbidities impose direct medical costs on the health 
care system in terms of hospital admission, hospital days, patient care, medical 
consultations, drugs and other allied health care practitioners. In 2008, the direct cost of 
overweight and obesity per person in the USA was estimated at $266 and $1723 
respectively. This amounted to a total national cost of $113.9 billion in that year, which 
accounted for almost 10% of U.S. health care spending (Tsai, 2011). In 2009, the direct 
cost of overweight and obesity was estimated at €399 million in the Republic of Ireland 
and €127 million in Northern Ireland (Safefood, 2012). This represented 2.7% and 2.8% of 
total health care costs in that year (Safefood, 2012). It is estimated that over the next 20 
years non communicable disease will cost the global economy $30 trillion dollars 
representing 48% of the global Gross Domestic Product in 2010 (WHO, 2010b). Secondly, 
the indirect costs associated of obesity are those that are incurred through loss of 
productivity due to absenteeism, disability, and premature mortality. The evidence that is 
currently available suggests that obesity incurs high indirect costs but it is difficult to 
measure this and more research is required to determine the total spectrum of these costs 
(Trogdon et al., 2008). The indirect costs associated with overweight and obesity in the 
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Republic of Ireland and Northern Ireland was estimated at €729 million and €383 million 
respectively in 2009 (Safefood, 2012). It is likely that these costs will continue to rise in the 
absence of effective intervention. 
 
2. 1. 4. Risk factors for obesity 
Obesity has only become an epidemic in the past 50 years and a lot of research has been 
conducted to investigate why this is the case. The most significant contributing factors are 
thought to be changes that have occurred to our eating and physical activity habits, which 
ultimately favour the storage of excess energy. This excess energy is stored in the adipose 
tissue as fat, and chronic exposure to excess energy leads to an expansion of fat stores so 
that the person initially becomes overweight and eventually obese  (Speakman, 2004). 
Evidence has recently emerged to suggest that there may also be a genetic component to 
the development of obesity. The contribution of energy intake, energy expenditure, and 
genetics in the development of obesity is outlined below. 
  
2. 1. 4. 1. Trends in dietary intake and its contribution to obesity 
There is an ongoing debate as to whether chronic intake of excess energy, chronic physical 
inactivity, or a combination of both is the main contributor to energy storage and weight 
gain. Eating patterns have undoubtedly changed over the last 50 years. There has been a 
shift towards eating away from home (Binkley et al., 2000), and a marked increase in the 
consumption of energy dense convenience foods that are high in fat and added sugar. 
Fructose is a sugar that is added in the processing of convenience foods and is 
enzymatically produced from corn starch (Ferder et al, 2010). Unlike glucose, fructose is 
almost completely metabolised in the liver, does not stimulate insulin secretion or satiety, is 
more lipogenic than glucose and is associated with an adverse lipid profile and an 
accumulation of lipid in tissues of metabolic importance (Ferder et al, 2010). A positive 
relationship has been found between fructose ingestion, excess energy intake, body weight, 
T2DM and CVD (Tappy et al., 2010). This is coupled with a greater intake of saturated fat, 
predominantly from animal products, a reduced intake of complex carbohydrates and fiber, 
and a reduced intake of fruit and vegetables (Drewnowski and Popkin, 1997). The global 
availability of cheap vegetable oils and fats means that a high fat intake is particularly 
evident among low income nations (Drewnowski and Popkin, 1997). While it is widely 
accepted that patterns of dietary intake have changed over the past 30-50 years there is still 
debate about total energy intake as some report an increase (Nielsen et al., 2002), no 
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change (Alexy et al., 2002, Arnett et al., 2000) or a decrease (Popkin et al., 1989). However, 
this information must be interpreted with caution since the tools used to quantify food 
intake, such as dietary questionnaires and subject recall, are prone to misreporting (Black et 
al., 1993). There is more consensus with regard to the change that has occurred in 
macronutrient intake over the last 20 years with both the USA (Willett and Leibel, 2002) 
and Europe (Alexy et al., 2002) reporting a decrease in fat intake and an increase in the 
consumption of carbohydrate, particularly simple sugars (Alexy et al., 2002, Arnett et al., 
2000), which when not used for energy are stored as fat. 
 
The composition of food consumed in Ireland over the last number of years has also 
changed. The 2007 National Survey on Lifestyle, Attitudes and Nutrition reported that 
86% of respondents consumed greater than 3 servings per day of energy dense foods that 
are high in fat, salt and sugar, similar to reports in the years 1998 and 2002. There has been 
a reduction in the intake of complex carbohydrates over the past number of years with 
26% of respondents consuming the recommended 6 or more daily servings of cereals, 
breads and potatoes compared to 40% in 1998 and 36% in 2002.  Fruit and vegetable 
consumption has also changed as 65% of respondents met the recommended servings of 
fruit compared to 56% in 1998 and 68% in 2002. Half (48%) of the individuals snacked 
between meals mostly on carbohydrate based convenience snacks such as biscuits and 
cakes but there was no information available on total calorie intake or how this has 
changed since the previous survey in 2002 (SLAN, 2007).  
 
Dietary intake has changed over time in line with the rise in the prevalence of obesity. The 
literature suggests that total caloric intake may not have changed considerably but this 
finding must be interpreted with caution since it is based on self reported questionnaires 
that may be subject to underreporting. There is more consensus in the literature regarding 
the change in the composition of dietary intake over time which identifies a definite shift 
towards increased snacking between meals and increased consumption of energy dense, 
high fat, high processed food, all of which are linked to obesity and related health 
consequences (Tappy et al., 2010). 
 
2. 1. 4. 2. Trends in physical inactivity and its contribution to obesity 
On a global scale the literature suggests that calorie intake hasn’t increased significantly 
over the last 20 years (Willett and Leibel, 2002, Alexy et al., 2002), which implies that the 
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contribution of physical inactivity to obesity may be quite significant. Our environment has 
changed dramatically over the last 50 years to make daily tasks more efficient in terms of 
time required to complete them, but also in terms of the energy required to complete them. 
Advances in technology have significantly affected physical activity patterns. In the 1950’s 
the dominant mode of transport was walking. Most people in western society had no other 
option and walked to various small shops to do their weekly shopping and other tasks of 
daily life. In modern society the dominant mode of transport is by car and the numerous 
smaller shops have been replaced with larger hypermarket or convenience stores making 
weekly food shopping and general daily activities more energy conserved (Speakman, 
2004).  
 
Advances in household appliances have also had a significant impact on energy 
expenditure. The introduction of washing machines, dishwashers, vacuum cleaners and 
other appliances have made traditional domestic chores more time efficient but also more 
energy efficient since they were traditionally manual tasks. The appliance market has 
changed so dramatically over time that there are now electrical appliances for even the 
smallest of tasks such as cutting food with carving knives. All of these advances mean that 
daily energy expenditure is decreasing and daily sedentary time is increasing, contributing to 
positive energy balance (Speakman, 2004). 
 
One of the most significant factors linked to positive energy balance is an increase in the 
number of hours per day spent watching television (Dennison et al., 2002, Armstrong et al., 
1998, Salmon et al., 2000). In 1970, almost all households in the USA and in Europe 
possessed a television but the prevalence of obesity was much lower then. In the late 
1990’s it was estimated that 20% of children in the USA watched more than 6 hours of 
television per day and this was positively associated with BMI (Armstrong et al., 1998). 
Having a television in a child’s room significantly increases the risk of the child becoming 
obese (Dennison et al., 2002). A similar picture is also true for adults (Salmon et al., 2000). 
The increase in time spent watching television has brought about changes in behaviour. 
These individuals are less likely to be active (Eisenmann et al., 2002), and more likely to 
increase their consumption of snack foods. 
 
Finally, the time required for earning a living and domestic work has also declined over the 
last few decades in Western societies and this trend is associated with a marked decline in 
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energy spent on these activities. The reduction in work time means that more leisure time is 
available, but the majority of this time is spent on passive activities. Thus daily energy 
expenditure has fallen and lifestyles have become increasingly sedentary (Ferro-Luzzi and 
Martino, 1996).     
 
The epidemiological data that is available regarding the change in physical activity patterns 
over time shows that in the year 2000 only 26.2% of US adults engaged in enough physical 
activity to meet the basic ACSM guidelines for health, which is 30 minutes of moderate 
physical activity at least 5 times per week, or vigorous activity for 20 minutes at least 3 
times per week. The likelihood of reaching these recommendations was related to years 
spent in education where 14.5% of individuals with less than 12 years of education met the 
guidelines compared to 34.2% of  individuals with a college education (CDC, 1996). In the 
Irish context, the SLAN survey 2007 revealed that only 41% of Irish adults took part in 
moderate or vigorous activity for at least 20 minutes on 3 or more days per week (SLAN, 
2007). The 2008 report by the Health Behaviours in School Aged Children established that 
53% of Irish children were active for 60 minutes or more on 5 or more days of the week. 
The reported frequency of physical activity is 25% lower in children aged 15-17 years 
compared to children aged 10-11 years, indicating that children become less active in their 
teenage years, and girls consistently reported less activity than aged matched boys (HSBC, 
2008).  
 
Over the last number of decades our environment and our lifestyles have been engineered 
to favour increased sedentary time. Worldwide more than 60% of adults do not engage in 
sufficient levels of physical activity. Physical inactivity decreases with age and is more 
prevalent in women than men across all age groups. The rise in the prevalence of obesity is 
attributed to physical inactivity in leisure time combined with increased sedentary 
behaviour throughout the day. The health consequences of physical inactivity are 
significant (WHO, 2003). 
 
2. 1. 4. 3. The contribution of genetics to obesity 
It is clear that the changes in energy intake and energy expenditure over the last 50 have 
favoured positive energy balance which contributes to obesity. However, within all 
environments there is a mixture of lean and obese individuals indicating that the 
environment is not the only factor responsible for obesity. The possible genetic 
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contribution to obesity has received growing attention in recent years. Some rare cases have 
been reported where children were found to have defects in their Leptin genes (Farooqi et 
al., 1999). This meant that they did not produce Leptin, a hormone that would normally act 
to regulate appetite, and its absence meant that these children had ravenous, insatiable 
appetites resulting in extreme obesity at a very early age. Treatment with daily Leptin 
injections reversed their compulsive eating behaviour and dramatically reduced their weight 
(Farooqi et al., 1999). This is a rare genetic disorder but an example of the role of the 
interaction between genetics and the environment in the development of obesity. It is 
important to note that no direct causal link has been established between genes and 
obesity. Rather, some people develop obesity because their genetic makeup makes them 
more likely to adopt behaviours, such as over eating, or have physiological characteristics, 
such as low resting metabolic rates, that put them in positive energy balance. An individual 
does not develop excessive fat stores without consuming too much energy, expending too 
little energy, or a mixture of both, but genetic variation may explain the inter individual 
variation in the extent of obesity (Speakman, 2004). This is particularly evident in twin 
studies. Bouchard et al 1990 conducted a study to investigate the response of twins to long 
term overfeeding. The investigators took 12 pairs of young adult male identical twins and 
housed them in a closed section of a dormitory for 120 days with 24 hour supervision. The 
subjects were monitored over the first 14 days to establish baseline calorie intake. For the 
next 100 days, all individuals were fed 1,000kcal above their baseline intake for 6 days per 
week, and only their baseline intake on the last day of each week. Physical activity levels 
were tightly controlled. At the end of the study the weight gained within twin pairs was 
similar, but the weight gain between twin pairs varied greatly from 4.3kgs to 13.3kgs despite 
all of them being exposed to the same overfeeding conditions and the tight control of the 
study. Similar results were found for gains in fat mass. The authors concluded that the 
twins genetics may govern their tendency to store excess energy as fat mass or lean tissue, 
and may also influence various determinants of resting energy expenditure(Bouchard et al., 
1990). It is proposed that genetics may account for up to 65% of the variance in obesity 
(Speakman, 2004). 
 
The literature that is currently available regarding the genetics of obesity surmises that 
individuals do not become obese without consuming too many calories, being physically 
inactive, or a combination of both. Dietary intake patterns have changed over the last 
number of decades to favour increased snacking between meals and increased 
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consumption of energy dense foods. This has occurred alongside an epidemic of inactivity 
in leisure time and increased sedentary time throughout the day. Over a prolonged period 
of time this lifestyle favours energy storage which can accumulate to obesity. Only in very 
rare cases is genetics directly responsible for the development of obesity; however genetics 
may be responsible for individual variation in weight gain. The obesity epidemic is 
continuing to rise at an alarming rate and efforts must be made to treat and manage this 
condition. 
  
2. 1. 5. Treatment and management of obesity 
A considerable amount of resources have been devoted to the development of therapies 
for the treatment and management of obesity. The first mode of treatment is usually diet 
and exercise intervention, which is complimented with weight loss enhancing drugs such as 
Orlistat for some individuals. Bariatric surgery occurs in the morbidly obese after all other 
treatments have been administered (Franz et al, 2007). A review of the effectiveness of 
these therapies is presented below (Franz et al, 2007). 
 
 
Figure 2.4 Therapies currently used in the treatment and management of obesity.  
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2. 1. 5. 1. Bariatric Surgery 
Bariatric surgery includes a number of different procedures for obese individuals. The 
procedures include gastric banding, which involves reducing the size of the stomach with a 
gastric band, gastric bypass surgery which involves resecting and re-routing the small 
intestines to a small stomach pouch, and surgery to remove a portion of the stomach. 
These procedures were designed to cause weight loss by food restriction and nutrient 
malabsorption but there is evidence to suggest that they work by decreasing hunger, 
increasing satiation during a meal, changing food preferences and energy expenditure 
(Miras and le Roux, 2013). Bariatric surgery is recommended for individuals with a BMI of 
at least 40kg/m2, but if serious co-morbidities such as diabetes exist, the BMI criteria is 
>35kg/m2 (Robinson, 2009). Many studies report significant long term reductions in 
weight and mortality (Robinson, 2009). This treatment option is only considered when the 
patient has at least undergone a lifestyle intervention, in addition to pharmacological 
therapy in some cases (Maggard et al., 2005) but studies show that bariatric surgery is 
associated with substantial weight loss at 12-months. Schauer et al (2012) reported a weight 
loss of 29.4kgs+9kgs 12 months post Roux-en-Y gastric bypass (n=50) or sleeve 
gastrectomy (n=49), which was accompanied by significant metabolic and cardiovascular 
improvements. The drugs that were being used to control glucose, blood pressure and 
lipids in these subjects decreased significantly after both surgical procedures. Insulin 
resistance also improved significantly (Schauer et al., 2012) and these findings are 
supported by other studies (Guo et al., 2013). There were no deaths or life threatening 
complications in the Schauer (2012) study but other research shows that adverse events 
occur in approximately 20% of cases (Maggard et al., 2005). Bariatric surgery is 
undoubtedly very effective in producing weight loss in the obese population and studies 
show that this weight loss is highly correlated with improved quality of life as assessed by 
the Health Related Quality of Life Questionnaire (HRQOL) (Billy et al. 2014, Hansen et al. 
2014, Efthymiou et al. 2014) and the Obesity and Weight Loss Quality of Life 
questionnaire (OWLQOL) (Billy et al, 2014). Billy et al, 2014 reported a significant 
(p<0.0001 for both) improvement in OWLQOL scores in 174 patients within 6 months 
post implantation of the laparoscopic adjustable gastric band which continued to improve 
over a 3 year period. The mean improvement in quality of life from baseline scores was 
52%. Percent weight loss was maintained through the 3 years and the improvement in 
OWLQOL scores was associated with the percent weight loss at 3 years. The authors 
conclude there are meaningful improvements in quality of life following this type of surgery 
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(Billy et al, 2014). Many of the surgical interventions report weight loss at 12 to 36 months 
and so it is difficult to obtain results after only 12 weeks for comparison to common 
lifestyle interventions.  
 
2. 1. 5. 2. Weight loss promoting drugs 
In the USA in 2011, approximately 2.74 million patients were using some form of 
antiobesity drug (Hampp et al., 2013). These drugs are commonly used in conjunction with 
lifestyle intervention and have consistently shown a weight loss of 2-3kgs additional to that 
obtained by lifestyle intervention alone over a one year period (Rucker et al., 2007). A 
number of anti-obesity drugs have been developed. Some such as sibutramine and 
rimonabant work by acting centrally on the brain to suppress appetite, thereby reducing 
food intake and promoting weight loss (Akbas et al., 2009). However, their potentially 
severe side effects including psychiatric disorders with rimonabant and elevated blood 
pressure and insomnia with sibutramine, limit their clinical use (Akbas et al., 2009). 
Sibutramine has since been removed from the market due to these harmful side effects 
(FDA, 2010). Exenatide is a GLP-1 agonist prescribed to treat diabetes. It works by 
augmenting the insulin response to a glucose load, suppressing the glucagon response to a 
glucose load, delaying gastric emptying and thus the rate at which glucose appears in the 
blood stream, in addition to reducing appetite and promoting satiety (Bawa et al., 2013). 
When prescribed in addition to regular diabetic medications (insulin, metformin and 
sulphonylureas) the literature shows a significant improvement in glucose control in 
addition to a significant weight loss of 1.7+1.3kgs at one month, 3.8+2.5kgs at 3 months, 
6.3+3.4kgs at 6months and 8.3+4.3kgs at 12 months (Bawa et al., 2013). Currently, orlistat 
is the only registered drug for the pharmacotherapy of obesity in Europe (Avenell et al., 
2004). The drug works by inhibiting an enzyme in the intestine known as lipase, which 
would normally act to break down triglycerides into absorbable free fatty acids. Blocking 
this enzyme reduces the absorption of dietary fat, which is excreted undigested instead 
(Cahill and Lean, 1999). Orlistat therapy has been shown to reduce serum concentrations 
of lipid and glucose, as well as reducing blood pressure (Avenell et al., 2004, Cahill and 
Lean, 1999) but this may be due to weight lost. Franz et al 2007 carried out a systematic 
review on the effectiveness of orlistat combined with lifestyle intervention to assist weight 
loss and maintain it in the long term. Following a review of 13 studies, weight loss at 6 
months was 8.3kgs or 8%, and this was maintained at 8.2kgs or 8% at 12 months, 7.7kgs or 
7% at 24 months, 7.8kgs or 7% at 36 months, and 5.8kgs or 5% at 48 months (Franz et al., 
49 
 
2007). Weight loss achieved by orlistat combined with lifestyle intervention is reported to 
be significantly greater than lifestyle intervention alone (Olszanecka-Glinianowicz et al., 
2013) and may be beneficial in long term weight loss maintenance (Cahill and Lean, 1999).   
 
2. 1. 5. 3. Dietary interventions 
The general consensus in the literature is that caloric restriction is successful in the 
treatment of obesity and there appears to be a dose response relationship between the 
amount of calories restricted and the amount of weight lost (Franz et al., 2007). However a 
closer inspection of this body of work reveals that it is true in the short term but weight 
regain in common in the longer term, particularly following very low calorie diets (Franz et 
al., 2007). There is large variation in the reported success of dietary interventions, which is 
related to the wide variation in study design in terms of the number of calories restricted, 
the composition of the diets, and also the duration of the interventions and the level of 
supervision. Franz et al 2007 carried out a systematic review of 51 dietary interventions. 
The aim of this review was to evaluate the short term and long term success of the 
interventions, as measured by the amount of weight lost. The interventions reviewed 
included diet alone, meal replacements, and very low calorie diets (VLCD). All 51 studies 
were randomised clinical trials of different duration ranging from 6 weeks to 36 weeks with 
> 1 year follow up and contained > 50 subjects. Weight loss was measured at 6 months 
and again at 12, 18, 24, 36 and 48 months (Franz et al., 2007).  
 
The majority of the 51 interventions used a caloric deficit of 500kcal per day below that 
required by the individual as determined by a Resting Metabolic Rate (RMR) test. The 
mean weight loss at 6 months was 4.9kg (5%), which was maintained at 4.6kg (4.6%) at 12 
months, 4.4kg (4.4%) at 24 months, and 3.0kg (3%) at 48 months. The meal replacement 
studies (n=7) achieved a weight loss of 8.6kg (9.6%) at 6 months which was maintained at 
6.7kg (7.5%) at 12 months. Studies adopting a very low calorie diet (calorie intake 
<800kcal/day) achieved substantial weight loss at 6 months (17.9kg (16%)) that was not 
sustained at 12months (10.9 kg (10%)) or 36 months (5.6 kg (5%), even though the results 
are comparable or better than other dietary approaches. The authors concluded that caloric 
restriction was successful in initiating and maintaining weight loss (Franz et al., 2007).  
 
To limit the review, the primary outcome measure used to determine success was weight 
loss. No information was provided on the overall change in body composition of the 
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subjects and so it is unclear whether this weight loss was derived from body fat mass, lean 
tissue mass, or a mixture of both. Secondary outcome measures such as blood pressure, 
lipids, glucose, quality of life, and treatment satisfaction were not described. However there 
are a number of studies in the literature to support the observation that caloric restriction 
improves lipid profile, insulin sensitivity and cardiovascular risk in obese individuals 
(Brinkworth et al., 2004, Clifton et al., 2009, Lee et al., 2013b)Lee et al., 2009, Oberhauser 
et al., 2012).   
 
A number of short duration, carefully supervised studies have been conducted that report 
varying degrees of weight loss due to differences in study design. To follow is a discussion 
of the effectiveness of three typical study designs, a 30% reduction in calorie intake below 
daily requirements, a comparison of high protein to standard diets, and very low calorie 
diets. 
 
Klempel et al. (2012) conducted a 10 week intervention where subjects were randomly 
assigned to one of two groups, intermittent fasting (severe restriction one day per week) 
with calorie restriction using liquid meal replacements (IFCR-L), or intermittent fasting 
with calorie restriction based on food (IFCR-F). Each group was restricted by 
approximately 30% of their baseline caloric needs. They both consumed 240kcal for 
breakfast, 240kcal for lunch, and 400-600kcal for dinner 6 days per week, and on the last 
day of each week they fasted, which consisted of water consumption with 120kcal of juice 
powder only. The difference between groups was that the IFCR-L group consumed the 
calories in the form of liquid meal replacement supplements, but the IFCL-F consumed 
their calories in the form of food which was provided by the study. The first 2 weeks 
consisted of a weight maintenance period and the final 8 weeks involved calorie restriction. 
The post tests revealed that there was a significant decrease in weight in both groups, 
which was significantly greater in the IFCR-L group (3.9kgs or 4.1%) (p=0.04) compared 
to the IFCR-F group (2.5kgs or 2.6%). There was a significant decrease in fat mass post 
intervention in the IFCR-L group (2.8kgs) and in the IFCR-F group (1.9kgs) but there was 
no difference between groups in the amount of fat mass lost. Fat free mass decreased by an 
average of approximately 1.2kg in the IFCR-L group and 0.5kg in the IFCR-F group but 
this did not reach statistical significance and there was no difference between groups. The 
lipid profile of the subjects and risk factors for cardiovascular disease also improved post 
intervention (Klempel et al., 2012). The results of this study suggest that when calorie 
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restriction is similar, weight loss is augmented in those consuming a liquid diet compared to 
a solid food diet. However, Aslam et al 2009 conducted a 12 week solid food intervention 
also with a caloric restriction of 30% below actual daily requirements. The weight loss (-
7.86kgs) and fat mass loss (-5.22kgs) outcomes were approximately double that of the 
aforementioned study, but this was concomitant with a reduction of fat free mass in the 
region of 2.6kgs (Aslam et al., 2009).   
The use of high protein diets in weight loss interventions has become prominent in recent 
years. There is evidence in short term studies to suggest that a higher protein intake during 
feeding alters total energy intake via the feeling of satiety, and increases total energy 
expenditure by increasing thermogenesis. Additionally, higher protein intake has proven to 
lead to a reduction in subsequent energy intake compared lower protein diets. Thus high 
protein diets have reported greater weight and fat mass loss than lower protein 
conventional diets, but findings have not been consistent and further long term research is 
required (Eisenstein et al., 2002).  
Clifton et al. (2009) administered a 12 week intervention where subjects were randomised 
into one of two groups, a high protein (HP) diet, or a standard protein (SP) diet, with the 
energy allowance being 1300-1550kcal per day. Weight loss after 12 weeks was significant 
and comparable in both groups (-7.82kg in HP, -7.65kg in SP) as was total fat loss (-6.8kg 
in HP, -6.4kg in SP), with slight reductions in fat free mass (Clifton et al., 2009). Lee et al. 
(2009) also carried out a 12 week weight loss intervention comparing the effectiveness of a 
high protein diet to a conventional diet. Subjects were randomly assigned to one of two 
different groups, a low calorie diet with partial meal replacement and high protein content 
(HP), and a low calorie nutritionally balanced conventional plan (C). Weight loss was also 
comparable in both groups (-5kg in HP, -4.9kg in C) as was the total reduction in fat mass 
(-2.5kg in HP, -2.3kg in C). Both groups also experienced at least a 2kg reduction in fat free 
mass. When adherence to dietary intervention was greater then 70%, the HP group 
experienced greater success in total body fat reductions (Lee et al., 2009). The results of 
these studies indicate that both types of intervention yield similar weight loss and fat mass 
loss results. However, the high protein diets report other health outcomes including an 
improvement in lipid profile in obese subjects at risk for cardiovascular disease (Clifton et 
al., 2009)  
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Very low calorie diets have also received attention in the literature in recent years. The 
strategy often used in these types of interventions is a caloric intake of <800kcal per day 
and so the weight loss results, at least in the short term, have proven to be quite significant. 
Papadaki et al 2013 investigated the effects of an 8 week VLCD on obesity measures in 773 
overweight and obese subjects from eight European cities. The subjects were restricted to 
800kcal per day and all meals were replaced with supplements. The average weight loss was 
11.1 + 3.3kgs, which consisted of an average fat mass loss of 8.3 + 4.4kgs and an average 
lean tissue loss of 2.8 + 4.0kgs (Papadaki et al., 2013).  Foster et al. (1992) compared the 
effects of 3 different VLCD’s on body weight and body composition in obese subjects. 
The total calorie allowance for each of the 3 groups was 420kcal per day, 660kcal per day 
and 800kcal per day. After 12 weeks of intervention, subjects had an average weight loss of 
18.2kgs, 18.5kgs and 16.6kgs respectively. Fat mass accounted for 85.4% of the weight loss 
in the 420kcal/day group, 86.1% of the weight loss in the 660kcal/day group, and 88.2% of 
the weight loss in the 800kcal/day group, with the remainder derived from fat free mass. 
Weight loss was the single best predictor of changes in fat free mass, accounting for 42% 
of the variance, thus the subjects who lost the most weight also lost the most fat free mass 
(Foster et al., 1992). It is clear from these studies that VLCD’s lead to substantial weight 
loss and fat mass loss at least in the short term but this also occurs alongside a reduction in 
lean tissue mass.  
 
Novel types of diet intervention continue to emerge in the literature. The earliest work 
carried by Dr. Michelle Harvie shows intermittent fasting is as effective as continuous 
energy restriction with regard to weight loss and improvements in metabolic health, and 
may be offered as an alternative equivalent to continuous energy restriction for the 
overweight and obese population (Harvie, 2011). Intermittent fasting involves 2 days of 
restricted intake per week i.e. low calorie (~600kcal), high protein, low carbohydrate and 
limited dairy, and 5 days of normal eating per week based on a Mediterranean diet i.e. 
moderate calorie consumption, moderate protein, unprocessed carbohydrates, low fat, and 
limited dairy (Harvie, 2013). More recently, when intermittent energy and carbohydrate 
restriction (IECR) was compared to continuous daily energy restriction (DER) 
(1,500kcal/day) for a 3 month weight loss period in overweight women, the results showed 
that insulin resistance and body fat decreased in both groups but the improvement in 
insulin resistance was significantly greater in the IECR than the DER group despite both 
groups having an overall energy deficit of 25% per week. IECR may lead to greater positive 
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adaptations in metabolic characteristics of overweight and obese individuals but long term 
studies into the safety and effectiveness of IECR diets are warranted (Harvie et al, 2013).   
  
It is clear from the above research that calorie restriction is effective in reducing body 
weight in overweight and obese individuals. However, diet induced weight loss 
simultaneously reduces body fat and lean tissue mass in this population and few studies 
have investigated whether these changes are influenced by macronutrient composition of 
the diet intervention (de Souza et al, 2012). The POUNDS LOST trial was a 2 year study 
involving 811 overweight and obese adults, which investigated the effects of 4 diets with 
different macronutrient composition on fat mass, lean tissue mass, visceral adipose tissue, 
and hepatic fat in overweight and obese adults (de Souza et al, 2012). The subjects were 
randomly assigned to 1 of 4 diets (i) low-fat average-protein (20% fat, 15% protein, and 
65% carbohydrate), (ii) low-fat, high-protein (30% fat, 25% protein, and 55% 
carbohydrate), (iii) high-fat, average-protein (40% fat, 15% protein, and 45% carbohydrate), 
and (iv) high-fat, high-protein (40% fat, 25% protein, and 35% carbohydrate. For all diets, 
participants had caloric deficit of 750kcal/day below their energy requirements as 
determined by a resting metabolic rate test. At 6 months participants showed a significant 
reduction in fat (4.2±0.3kg or 12.4%) and lean tissue mass (2.1±0.3kg or 3.5%), there was 
no difference between diets. Abdominal fat (2.3 0.2kg or 13.8%), subcutaneous fat (1.5 
0.2kg or 13.6%) and visceral fat (0.9 0.1kg or 16.1%) also decreased significantly in all 
groups but there was no difference between diets. Participants regained 40% of these losses 
by the end of the 2 year period with no difference between groups. The key findings of this 
trial was that participants lost more fat mass than lean tissue mass in all groups and there 
was no difference between diets with regard to improvements in body composition, 
abdominal fat or hepatic fat. The authors concluded that total calorie restriction as opposed 
to macronutrient composition of the diet is the most important determinant of fat loss in 
this population (de Souza et al, 2012).      
 
An overview of the literature suggests that calorie restriction is effective in reducing body 
weight of obese individuals and this relationship is dose dependent. This is particularly true 
in the case of short term, structured and supervised interventions. Very low calorie diets 
(<800kcal per day) are associated with greater weight loss than diets using moderate calorie 
restriction (~500kcal per day), but the additional weight loss that occurs when calorie 
intake is less than 800kcal per day is minimal. Also, weight regain following very low calorie 
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interventions is common. This may be due to the fact that an individual cannot sustain an 
800kcal indefinitely and so calorie intake eventually increases resulting in an increase in 
body weight. It may also be related to the fact that caloric restriction, particularly severe 
caloric restriction, results in a loss of lean tissue mass concurrent with reductions in fat 
mass, which may reduce resting metabolic rate and thus daily energy expenditure, making it 
increasingly difficult to lose weight, or even maintain weight loss, in the longer term. The 
literature has reported reductions in fat free mass in the region of 17-25% after a low 
calorie diet intervention (Foster et al., 1990, Wadden et al., 1990, Barrows and Snook, 1987, 
Donnelly et al., 1991). 
 
In summary, caloric restriction is effect in reducing body weight in obese individuals and 
there appears to be a dose response relationship between the amount of calories restricted 
and the amount of weight lost, particularly in the short term (Franz et al., 2007). Numerous 
study designs are evident in the literature which explains the large variation in success of 
these interventions. More basic research is warranted to understand the impact of different 
nutrient intakes and caloric restriction on weight loss but also on the mechanisms at play in 
different types of body tissue so that we can determine the optimal intervention for this 
population. 
  
2. 1. 5. 4. Exercise Interventions 
Exercise training interventions are routinely used to treat obesity and improve metabolic 
health but controversy exists in the literature with regard to the effectiveness of these 
interventions particularly when weight loss is the primary outcome measure. Catenacci et al. 
(2007) investigated the effect of exercise on weight loss in obese individuals using 16 
randomized controlled trials ranging from 4 to 16 months in duration. The average BMI of 
the subjects was 25-30kg/m2. Eleven of the 16 studies reported significant reductions in 
body weight ranging from 0.1kg to 5.2kg with the average being 1-3kg. This is a modest 
weight loss and the results may be perceived to be unsuccessful. However, with closer 
investigation numerous limitations of the various studies were identified which greatly 
affect the interpretation of the results. In the majority of studies, exercise induced energy 
expenditure was not closely controlled or accurately measured. Also, the energy 
expenditure prescribed in the interventions was modest and not enough to result in 
substantial weight loss. Most of the interventions were designed based on the ACSM’s 
physical activity recommendations for health, which is 30 minutes of moderate physical 
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activity on 5 or more days of the week, and averaged 60-180 minutes per week (Catenacci 
and Wyatt, 2007). Energy expended per week based on this recommendation could be as 
little as 1000kcal which equates to a modest 0.11kg weight loss per week when energy 
intake is maintained at pre intervention caloric intake. Given the fact that there are 
9000kcal in 1kg of body fat, an energy expenditure of 1,000kcal per week is not sufficient 
to cause substantial weight loss. 
 
Franz et al. (2007) also carried out a review to establish the effectiveness of exercise 
training in treating obesity using weight loss as their primary outcome measure. The 
subjects in these studies were given recommendations for exercise and minimal or no 
advice on food or meal planning. Only 6 studies were included in this analysis. The mean 
weight loss at 6 months was 2.4kg (2.7%) maintained at 1.0kg (1%) at 24 months. The 
authors of the review concluded that exercise interventions are not successful in achieving 
weight loss in the obese population. However, there are also a number of limitations to this 
conclusion. Firstly, the review consisted of only 6 exercise interventions, the total treatment 
duration was 52 and 78 weeks , and the time spent exercising was as little as 90 minutes per 
week (Donnelly et al., 2000). This volume of exercise is less than the ACSM’s physical 
activity recommendations for health and so it is no surprise that weight loss was minimal 
(Irwin et al., 2003). Shorter term exercise training interventions based on more structured 
and supervised training have consistently reported significant changes in weight and 
physical characteristics in obese subjects (Donnelly et al., 2003, Tessier et al., 2000, Stewart 
et al., 2005). Secondly, weight loss as a primary measure of success does not reflect the 
changes that occur to body composition as a result of exercise training. Physical training 
over a number of weeks reduces body fat mass and concurrently increases lean tissue mass 
especially in previously sedentary individuals (Stewart et al., 2005). The change that occurs 
to body composition, especially over the first 10 weeks of training, means that the total net 
weight loss is often minimal over that time period because the weight gain in lean tissue 
negates the weight lost in fat mass. Therefore, it is more appropriate to use body 
composition as a primary measure of success following exercise training interventions. Also 
it is important to quantify changes in body composition since the literature consistently 
shows that fat accumulation in obese individuals is significantly inversely correlated with 
metabolic health (Capurso and Capurso, 2012) and so reductions in fat mass should be a 
primary outcome measure. Skeletal muscle mass in trained athletes is positively correlated 
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with metabolic health (Ebeling et al., 1993) and so it is important to quantify gains in lean 
tissue mass with exercise training in the obese population. 
  
Other reviews have demonstrated that exercise training is successful in the treatment of 
obesity. They report that the amount of weight loss is directly related to the amount of 
energy expended per week. Ross et al 2001 conducted a systematic review and meta 
analysis of the effects of physical activity on reducing obesity, with a particular focus on the 
influence of exercise induced weight loss on fat mass loss. Short term studies (<16 weeks) 
were tightly controlled and supervised, and used an energy expenditure target of 2,200kcal 
per week with an average weight loss and total fat loss of 0.18kg and 0.21kg respectively 
per week. Long term studies (<16 weeks) used an energy expenditure target of 1,100kcal 
per week, and yielded an average weight loss and total fat loss of 0.06kg and 0.06kg per 
week. The review of the short term training studies provide evidence that exercise induced 
weight loss correlates with fat loss in a dose response manner and that lean tissue mass is at 
least maintained with exercise training. This review also provides evidence that the amount 
of weight loss and fat loss achieved with exercise training is directly related to the energy 
expended throughout the intervention. Greater amounts of energy expenditure per week 
are associated with greater amounts of body weight and body fat mass loss (Ross and 
Janssen, 2001). 
 
Two uncontrolled short term randomised studies investigated the effects of higher 
amounts of exercise induced energy expenditure and reported much larger weight loss post 
intervention (Lee et al., 1994, Hadjiolova et al., 1982). Lee et al 1994 studied the impact of 
5 months of military training on 175 obese male recruits. The recruits exercised 5 days per 
week for 20 weeks and averaged 29 hours of training per week, 57% of which was deemed 
to be high intensity activity. No dietary restriction was imposed on the recruits. The 
average weight loss was 12.5kgs in 5 months or 0.63kg per week. The weight loss was 
attributed to loss of body fat determined by skin fold measurements (Lee et al., 1994). This 
study shows that even with substantial weight loss over a short period of time lean tissue 
mass is at least maintained with exercise training and the reduction in body weight 
completely accounted for by reductions in body fat mass. Hadjiolova et al 1982 studied the 
effects of 45 days of training 10 hours per day with an energy expenditure of 3,600-
3,700kcal per day. These subjects lost an average of 12.5kgs. Although these interventions 
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were relatively uncontrolled the findings demonstrate that substantial weight loss can be 
achieved with substantial energy expenditure (Hadjiolova et al., 1982).           
 
When assessing the effectiveness of exercise training with regard to improvements in body 
weight and body composition there is an additional difficulty to be considered in the 
interpretation of the results. In general the standard deviation is quite large indicating a 
high level of inter-individual variability even when energy expenditure and energy intake are 
tightly controlled. Thus, the mean result reported for weight loss or change in body 
composition can often mask the extent of the results achieved by some participants. King 
et al. (2008) attempted to identify and characterise the individual variability in response to 
an exercise intervention. The subjects performed supervised, aerobic exercise at 70% heart 
rate max until 500kcal were expended for 5 days per week. After 12 weeks of training there 
was a significant reduction in body weight (3.7 + 3.6kg), and fat mass (3.7 + 2.6kg), 
indicating again that lean tissue mass was maintained and all weight loss was derived from 
fat mass loss. However, the investigators reported that there was large individual variability 
in weight change (-14.7kg to +1.7kg) and the change to fat mass (-9.5kg to +2.6kg) despite 
the fact that the study was tightly controlled and supervised, and the subjects were deemed 
to be fully compliant. Due to the tight control and the large individual variation in results, 
the investigators further subdivided the participants into two groups, compensators and 
non compensators. Compensators were those whose weight loss was lower than predicted 
(-1.5+2.5kgs and -2.1+2.3kgs for body weight and body fat, respectively) and non 
compensators were those individuals who achieved or exceeded the predicted weight loss 
(6.3+3.2kg and 5.3+2.2kg for body weight and fat mass, respectively). Both groups had 
modest reductions in lean tissue mass (0.47±1.5 kg vs 0.89±2.1 kg for compensators and 
non-compensators, respectively) and so weight loss was mainly attributes to fat mass loss 
(King et al., 2008). This study highlights a number of important issues.  
 
Firstly, a mean outcome measure should be interpreted with caution since one size does 
not fit all and individuals respond differently to the same intervention with regard to 
changes in body weight and body composition. Secondly, it seems that either consciously 
or subconsciously some individuals compensate for energy expenditure even within tightly 
controlled interventions. This observation has been reported in other studies and possible 
explanations include variability in exercise compliance, compensation for energy 
expenditure with energy intake, and reduced energy expenditure in the non exercising 
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portion of the day (Bouchard and Rankinen, 2001, Hautala et al., 2006, Levine et al., 2005). 
Variability in exercise compliance was not an issue in the King et al. (2008) study since all 
of the sessions were individually designed and supervised and subjects were deemed to be 
compliant. It is possible that the subjects compensated for energy expenditure with an 
increase in energy intake or a reduction in total daily energy expenditure. This study 
highlights the need to educate subjects and make them aware of the effects of 
compensation either through increasing energy intake or reducing energy expenditure in 
non exercising time. It also highlights the need to treat obese individuals as individuals 
within a group in order to prescribe the most effective treatment for them. It is important 
to note that even the lowest responders exhibited significant improvements in health, 
characterised by decreased blood pressure, increased fitness and decreased waist 
circumference. These additional health benefits should be considered important outcome 
measures and participants should be educated in this regard so that success is not merely 
based on changes to physical characteristics  (King et al., 2008).     
 
A review of the current literature suggests that there is a dose dependent relationship 
between the amount of energy expended per week and the amount of weight loss achieved. 
Many exercise training interventions are based on the ACSM’s physical activity guidelines 
for health. These guidelines represent the minimal amount of physical activity required to 
obtain health benefits and are not sufficient for weight loss. Greater amounts of weekly 
energy expenditure are required to achieve more substantial weight loss. The dominant 
mode of exercise reported in the literature is aerobic exercise and / or resistance exercise. It 
is possible that other modes of training would augment the weight loss results and so more 
work needs to be carried out to investigate other possible modes or combinations of 
training. It must be highlighted that significant changes occur to body composition as a 
result of exercise training, particularly in previously sedentary individuals. Importantly, 
exercise induced weight loss is derived predominantly from fat mass, and lean tissue mass 
is at least maintained, if aerobic exercise is the only mode of training, or increased if 
resistance training is incorporated. Exercise induced changes in body composition have 
significant favourable implications for the health of this population. For these reasons it is 
more appropriate to focus on changes in body composition as a primary outcome measure 
of success in these types of intervention rather than weight loss.  
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In summary, exercise training is routinely used to treat obesity and improve metabolic 
health but controversy exists in the literature with regard to the effectiveness of these 
interventions. The majority of training studies are based on the ACSM’s physical activity 
recommendations for health (Catenacci and Wyatt, 2007) which are completely inadequate 
for meaningful weight loss. Weight loss is not the most appropriate measure of success of 
these interventions because exercise training results in reductions in fat mass concomitant 
with increases in lean tissue mass and the net effect is often minimal weight lost. More 
basic research is warranted to determine the energy expenditure required for significant 
improvements in body composition and body weight in this population, but also to 
investigate the effects of different types of physical activity on the mechanism at play in 
different types of body tissue so we can determine the optimal intervention for this 
population. 
 
2. 1. 5. 5. Comparison of diet and exercise interventions 
Diet and exercise interventions have been compared in the literature and the general 
consensus appears to lean towards diet being more effective when weight loss is the 
primary outcome measure (Franz et al., 2007). However, few isocaloric diet and exercise 
interventions exist making a direct comparison impossible. Both interventions have already 
been discussed in detail but a summary of the key differences between them is presented 
below. 
 
Firstly, the caloric restriction most commonly prescribed in dietary interventions is a 
minimum of 500kcal per day, which accumulates to an energy deficit of 3,500kcal per week, 
and a weight loss of ~0.39kgs per week when energy expenditure is controlled for (Franz et 
al., 2007). In contrast, the energy expenditure prescribed in many exercise interventions is 
approximately 1,000kcal per week (Donnelly et al., 2009), which yields a weight loss of 
~0.11kgs per week controlling for energy intake. Clearly there is a mismatch between the 
designs underpinning both interventions which is why weight loss is generally greater post 
diet intervention.  
 
Secondly, using weight loss as a primary measure of success poses an additional problem 
when comparing the effectiveness of diet and exercise interventions because it does not 
take into account the different changes that occur to body composition in response to both 
types of intervention. Exercise training simultaneously reduces fat mass and maintains or 
60 
 
increases lean tissue mass especially in previously sedentary individuals (Stewart et al., 
2005). The gains in lean tissue are associated with an increase in RMR which may facilitate 
weight loss in the longer term (Kirk et al., 2009, Byrne and Wilmore, 2001). The changes 
that occur to body composition with exercise training can be quite substantial but the net 
weight loss may be minimal. In contrast, the weight loss achieved by caloric restriction is 
directly proportional to the amount of calories restricted, but it is derived from reductions 
in fat mass combined with reductions in lean tissue mass. The loss of lean tissue is reported 
to be quite significant with very low calorie diets and it has been proposed that this may 
contribute to the weight regain that is often seen in these interventions over a 6 to 24 
month period (Franz et al., 2007).  
  
2. 1. 6. Obesity and poor fitness, an additional problem 
Extensive evidence exists to show that inactivity and poor fitness have serious implications 
for health. There is a strong, independent, inverse relationship between physical fitness and 
all cause mortality (Kampert et al., 1996, Blair et al., 1989,  Bronnum-Hansen et al., 2007, 
Mokdad et al., 2004) accounting for 3.2 millions deaths each year (WHO, 2010a). The 
World Health Organisation has declared physical inactivity to be the fourth leading risk 
factor for global mortality, to an even greater extent than obesity itself, which is currently 
the fifth leading risk factor (WHO, 2009). Physical inactivity is estimated to account for 21-
25% of breast and colon cancers, 27% of diabetes, and 30% of ischemic heart disease 
globally. When obesity and inactivity are combined the health consequences may be even 
more drastic than obesity alone.  
 
Individuals with a low fitness level and a diagnosed chronic disease have a higher rate of all 
cause mortality across all BMI categories after adjustment for age and baseline risk factors 
(McAuley et al., 2012). Individuals with higher levels of fitness are protected against 
mortality regardless of their BMI, waist circumference and percent body fat (Blair et al, 
1989). Therefore, when fitness is taken into account, the mortality risk associated with 
obesity is offset (McAuley and Blair, 2011) and, for this reason, obesity should not be used 
in isolation (McAuley et al., 2012). 
 
In a comparison of risk factors for all-cause mortality, Wei et al. (1999) examined the 
impact of BMI, aerobic fitness and established factors including baseline CVD, diabetes, 
cholesterol, hypertension and smoking status in 25,714 men. The key finding of this study 
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was that low fitness is a strong and independent predictor of all cause mortality but when 
coupled with obesity was much better than established risk factors and equivalent to having 
had a cardiovascular event (Wei et al., 1999). On average, physically active people live 5 
years longer than physically inactive people, and their expected lifetime without long-
standing illness is increased by approximately 8 years compared to inactive individuals 
(Bronnum-Hansen et al., 2007). The enormity of the health consequences of physical 
inactivity is such that Pedersen (2010) proposed the concept of the ‘diseasome of physical 
inactivity’. The theory behind this concept is that physical inactivity, which is associated 
with chronic systemic inflammation independent of obesity, leads to the accumulation of 
visceral fat and consequently the activation of inflammatory pathways, which promote the 
development of insulin resistance and type 2 diabetes, atherosclerosis and a cluster of 
diseases belonging to the ‘diseasome of physical inactivity’ (Pedersen, 2009).  
 
It is clear that physical activity and physical fitness may play a more important role in the 
health of the general population and the obese population than previously thought and for 
this reason the primary focus of this literature review and PhD thesis is the role of exercise 
training in the comprehensive treatment and management of obesity. To understand this 
role it is first necessary to understand metabolism in the normal weight healthy individual 
compared to the obese individual, and subsequently the physiological and metabolic 
adaptations that occur with acute and chronic exercise training.  
 
2. 1. 7. Metabolism – Normal vs Obese 
Blood glucose concentration is regulated by a number of organs and tissues in the body 
including the liver, skeletal muscle, brain, kidney, adipose tissue, pancreas and intestine 
(Groop et al., 1989). Of these tissues, skeletal muscle is the most important because it is 
responsible for almost 80% of insulin-mediated glucose uptake and disposal (Bonen et al., 
2004, Coort et al., 2004). The hormones released from the endocrine system play a major 
role in glucose homeostasis particularly insulin and glucagon, which are both released from 
the pancreas (Kang, 2008, Jones et al., 2012). 
 
62 
 
 
Figure 2.5 Glucose homeostasis requires coordinated interaction between various 
organs and tissues in the body. Glucose levels rise when absorbed from the 
intestine and also when released from the liver. The liver plays a key role in 
elevating glucose levels via glycogenolysis and gluconeogenesis, both of which are 
inhibited by insulin. Blood glucose levels are reduced by uptake by all cells in the 
body but predominantly skeletal muscle and adipose tissue. It has recently emerged 
that the CNS can also sense glucose and may affect glycemia by playing a role in 
the regulation of gluconeogenesis. Source: Nature 2006 December 14; 444(7121):847-
853.  
 
Insulin is produced by the β-cells of the pancreas and is secreted in response to elevated 
blood glucose levels. It acts on peripheral tissues to regulate both carbohydrate and lipid 
metabolism by oxidation to produce energy or stored as glycogen or intracellular lipid. In 
the adipose tissue, insulin suppresses lipolysis and insulin-mediated glucose uptake is used 
to re-esterify free fatty acids (FFA’s) as Triglycerides (TG’s). The liver does not require 
insulin to facilitate glucose uptake but insulin regulates hepatic glucose production by 
inhibiting gluconeogenesis and glycogenolysis. The kidney also plays an important role in 
glucose regulation. When blood glucose levels become excessively high, the kidney 
facilitates the excretion of glucose from the body in the urine. The combined actions of 
insulin on the muscle, liver and adipose tissue result in the appropriate control of blood 
glucose concentration (Ferrannini and Mari, 1998, Kang, 2008). Glucagon is produced in 
the α-cells of the pancreas and functions to oppose the action of insulin. It stimulates 
glycogenolysis and gluconeogenesis when blood glucose levels fall below the normal range 
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thus elevating blood glucose concentrations and returning them to normal circulating 
values (Jones et al., 2012). 
 
Obesity is characterised by an expansion of adipose tissue mass and ectopic fat storage in 
most tissues, including, the liver, heart and skeletal muscle (Capurso and Capurso, 2012). 
There is substantial evidence to suggest that the elevated concentrations of FFA’s and 
intracellular lipid in obese individuals induces insulin resistance by disrupting the normal 
insulin signalling cascade (Belfort and Mandarino 2005, Bevilacqua et al, 1987, DeFronzo, 
2004). Insulin stimulated glucose transport into target tissues such as the skeletal muscle, 
liver, intestine, pancreas, kidney, brain and adipose tissue is impaired (Petersen and 
Shulman, 2002, Shulman, 2000, Yu et al., 2002), resulting an elevation in blood glucose 
concentrations over time (Petersen and Shulman, 2006). The impaired suppression of 
lipolysis and hepatic glucose production further contribute to the metabolic stress of excess 
substrate availability in circulation (Rosen and Spiegelman, 2006).   
 
 
 
 
Figure 2.6 Obesity and insulin resistance are associated with increased lipolysis and 
elevated circulating concentrations of NEFA. NEFA inhibit the ability of insulin to 
promote glucose uptake in skeletal muscle and adipose tissue, and to suppress 
hepatic glucose production. Transiently elevated NEFA stimulate insulin release 
from the pancreas (e.g. after a meal) but chronically elevated NEFA reduce insulin 
secretion. Source: Nature 2006 December 14; 444(7121):847-853. 
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Skeletal muscle relies primarily on fat and carbohydrate as fuel for energy production. The 
contribution that fat or carbohydrate make to energy supply depends on a number of 
factors including the current metabolic demand, the amount of substrate available, and the 
ability of the muscle to transport and oxidise the fuel source. Metabolic flexibility in skeletal 
muscle refers to the ability of the muscle to adapt appropriately to changes in physiological 
condition by selecting the appropriate type and quantity of fuel for oxidation to meet 
particular energy demands. During fasting for example there is a greater reliance on fat for 
fuel. Oxidation of fat during fasting ensures that carbohydrate stores are preserved and 
available for use by the brain and skeletal muscle when required for energy. In contrast, 
after a meal there is a switch to glucose oxidation (Storlien et al., 2004). Physical activity 
also requires metabolic flexibility because skeletal muscle must be able increase glucose and 
fat oxidation in response to energy demand. The intensity and duration of physical activity 
determines the mix of substrate metabolised. Short duration higher intensity activities 
require a greater contribution from carbohydrate than from fat, where as the energy 
demands of longer duration lower intensity activities can be met by a greater contribution 
from fat than from carbohydrate, especially in trained individuals. Metabolic flexibility is 
evident in lean healthy individuals, particularly those who are trained, but metabolic 
inflexibility is a characteristic of obesity and insulin resistance (Brooks, 1997).  
 
2. 2. Physiological and metabolic responses to acute exercise, and 
adaptations to chronic exercise training. 
 
2. 2. 1. Physiological responses to acute exercise 
Aerobic fitness is measured by O2max which is the maximal amount of oxygen that an 
individual can take in and use to produce energy. O2max is a function of the ability of the 
cardiovascular system to deliver blood and oxygen to skeletal muscle, and the ability of 
skeletal muscle to extract this oxygen and use it to produce energy. At the onset of exercise 
the physiological systems respond, proportional to the intensity and duration of exercise, to 
maintain homeostasis. The cardiovascular system meets the increased demand of tissues 
for oxygen delivery and carbon dioxide removal by increasing heart rate and stroke volume. 
As stroke volume reaches its maximal capacity at exercise intensities between 40-60% of 
O2max in untrained individuals, further increases in cardiac output are met by increasing 
heart rate. The increase in cardiac output can reach 5 times the resting levels and leads to (i) 
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an increase in mean arterial pressure, mainly due to increased systolic pressure, despite 
intrinsic (active hyperemia, chemical messengers) and extrinsic (neural and endocrine) 
promotion of vasodilation and (ii) a redistribution of blood to the working muscle and to 
the skin for dissipation of heat (Hughson and Tschakovsky, 1999). In skeletal muscle there 
is a greater demand for energy to fuel actin-myosin cross-bridging in muscle contraction 
and the reploarisation of muscle cells. Both glucose and lipids are used as substrates in the 
mitochondria but carbohydrate is preferentially used with higher intensity exercise, 
although it has a limited availability relative to fat (Hultman, 1995). The availability and 
utilisation of substrates for metabolic processes is also regulated by the sympathetic 
nervous system and the endocrine system with increases in pituitary (growth hormone, 
adrenocorticotrophin hormone, thyroid stimulating hormone), adrenal (catecholamines, 
cortisol, aldosterone), thyroid and pancreatic (glucagon) hormones (Richter, 1994).  
 
2. 2. 2. Metabolic responses to acute exercise 
A single bout of aerobic exercise has many benefits with regard to glucose and lipid 
regulation. During exercise there is an increased demand for metabolic substrates in the 
active muscles, with a 10-20 fold increase in glucose uptake evident during moderate to 
high intensity exercise (Wahren et al., 1971). The glucose is supplied via increased 
glycogenolysis in the active muscles as well as increased uptake of glucose from circulation 
into the working muscles. In this way exercise plays a key role in increasing the usage of 
circulating blood glucose and well as stored glucose (Hayashi et al., 1997). The hours 
following an exercise bout is characterised by an increase in insulin sensitivity. The 
expression of the glucose transporter isoform 4 (GLUT4) remains elevated and so a lower 
concentration of insulin is required to exert its maximal effect on glucose transport. 
Glycogen synthase activity, the enzyme responsible for the synthesis of glycogen, is also 
elevated following exercise, which increases the rate of glucose uptake in to the skeletal 
muscle in order to replenish depleted glycogen stores (Holloszy, 2005). Evidence in 
support of this increased insulin sensitivity post exercise is provided by numerous studies 
that found increased sensitivity post exercise in an exercising leg but not in the resting 
control limb (Richter et al., 1989). 
  
2. 2. 3. Physiological adaptations to aerobic exercise training 
Aerobic exercise leads to significant improvements in aerobic fitness, which in turn is 
positively associated with metabolic health and reduced risk of all cause mortality (Blair et 
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al., 1989, Kampert et al., 1996). The improvement in O2max and thus fitness that occurs 
with aerobic exercise training is due to a combination of adaptations that occur to the 
cardiovascular system to facilitate greater oxygen delivery, and the muscles themselves to 
facilitate greater oxygen use. With regard to the cardiovascular system there are exercise 
induced adaptations to the heart, blood and blood vessels. The left ventricle hypertrophies 
and this increase in wall thickness allows for greater force of contraction. With training, 
heart rate decreases during submaximal exercise which extends ventricular filling time and 
plasma volume increases due to increased protein content and up regulation of the fluid 
conservation hormones. As the ventricles stretch in response to the elevated blood volume 
the heart muscle responds by generating a more forceful contraction, known as the Frank-
Starling mechanism, with the result being an increase in stroke volume. Aerobic training is 
associated with an increase in the number of capillaries infiltrating muscle tissue and an 
increase in the recruitment of currently available capillaries. Blood flow redistribution is 
more effective and all of these adaptations combine to facilitate increased blood flow to the 
metabolically active tissues Red blood cell volume and thus oxygen carrying capacity also 
increase with training. Once the blood reaches the active muscles oxygen must be extracted 
for energy production. Oxygen extraction, represented by the a-vO2diff, is augmented with 
exercise training, which increases energy production and functional capacity. There is an 
increase in the size of type 1 muscle fibers, which are characterised by having a high 
aerobic oxidative capacity. Myoglobin content, the oxygen transporter molecule, increases 
in the region of 75-80% which augments the oxygen carrying capacity of the muscle. 
Training results is marked improvements in the functionality of the mitochondria, which 
increase in size and number. In addition, the activity of the oxidative enzymes in the 
muscle also increases.  All of these adaptations combine to increase the extent to which an 
individual can use oxygen to produce energy (Blomqvist and Saltin, 1983). An increase in 
blood flow to exercising tissue combined with an increase in the ability of the tissues to 
extract oxygen from the blood and remove waste products, results in increased energy 
production represented by an increase in fitness or O2max. 
 
2. 2. 4. Metabolic adaptations to aerobic exercise training 
In addition, aerobic training increases the expression of GLUT4, which facilitates greater 
uptake of blood glucose into skeletal muscle (Kim et al., 2004). Glycogen synthase 
expression and activity is augmented, which leads to increased storage of glucose in the 
form of glycogen (Ebeling et al., 1993). Whether the increased insulin sensitivity results 
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from exercise training or the previous exercise session has been debated but athletes 
experience a lower insulin response to a glucose load in comparison to untrained 
individuals (Horton, 1986) suggesting that these adaptations are due to chronic training and 
not just a single bout of exercise (Ebeling et al., 1993). The same adaptations are also true 
for master athletes (King et al., 1987), which has important implications for ameliorating 
age related insulin resistance in inactive older individuals. 
 
The literature shows that aerobic exercise training augments lipid oxidation and reduces fat 
stores in the body (Carey et al., 1996). Of particular importance is the reduction in 
abdominal fat stores associated with aerobic exercise training. This reduces the availability 
of free fatty acids in circulation (Roden, 2005), which in turn reduces intramuscular 
triglycerides (O'Leary et al., 2006). Low intensity aerobic exercise training increases the 
oxidation of intramyocellular lipids. These small lipid droplets lie adjacent to mitochondria 
and it appears that exercise facilitates the delivery of these droplets to the mitochondria for 
oxidation (Goodpaster et al., 2001). The expression and activity of enzymes involved in 
lipid oxidation also increases with training (Kim et al., 2004). This is particularly evident in 
highly trained endurance athletes, who paradoxically have elevated intra muscular lipid 
content, but their skeletal muscle is markedly insulin sensitive due to the higher oxidative 
capacity and a high rates of fat turnover (Goodpaster et al., 2001). Given the adverse 
relationship between fat accumulation and insulin resistance in obese sedentary individuals, 
an increased ability to oxidise fat is important in the prevention or treatment of insulin 
resistance in the obese population. It may also contribute to greater loss of fat mass over 
time. 
 
2. 2. 5. Physiological adaptations to resistance training 
Prior to discussing the physiological adaptations to resistance training, it is important to 
understand that there are two main types of muscle contraction, concentric and eccentric, 
and the adaptations that occur are specific to the type of contraction performed. When a 
muscle is contracted concentrically it is shortening under tension. In physiological terms, 
the thin filaments of the sarcomere are being pulled towards the centre of the sarcomere, 
thus shortening the length of the sarcomere. An example of this type of contraction in the 
context of resistance training is the lift phase of a bicep curl (Figure 2.7). When a muscle is 
contracted eccentrically it is lengthening under tension. In this case the thin filaments of 
the sarcomere are being pulled away from the centre of the sarcomere, thus elongating it 
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but still developing force (Figure 2.7). This type of contraction is the lowering phase of a 
bicep curl. Most actions whether they are aerobic or resistance type exercise require both 
types of contraction (McArdle, 2011).  
 
  
 
Figure 2.7 Depicts concentric muscle contraction (shortening of the sarcomere 
under tension) and eccentric muscle contraction (lengthening of the sarcomere 
under tension). 
 
Resistance training lasting 3-6 months can improve strength in previously untrained 
individuals by as much as 25-100%. The neuromuscular system is very responsive to 
training and up to 50% of initial strength gains in untrained individuals can be accounted 
for by neuromuscular efficiency commonly referred to as the learning effect (Baechle, 
2000). In line with this learning effect, the largest gains in strength occur within the first 8-
10 weeks of training. Longer term strength gains occur mostly as a result of adaptations to 
the physical structure of the muscle such as hypertrophy, which means an increase in the 
size of the muscle (Staron et al., 1994). 
 
For many years the increase in strength that occurs with resistance training was attributed 
mostly to muscle hypertrophy. While there is a relationship between muscle size and 
muscle strength, this theory does not explain increased strength in the absence of 
hypertrophy. The literature reports that neural adaptations account for strength gains in the 
absence of hypertrophy (Enoka, 1988). The neural adaptations to resistance training 
include (i) improved synchronization of motor units, which improves the rate of force 
development and the capability of the muscle to exert steady forces (Duchateau and 
Enoka, 2002), (ii) increased number of motor units recruited thus leading to greater force 
production, (iii) increased frequency of stimulation of the muscle fibers with electrical 
69 
 
impulses that summate to produce a greater amount of force (Enoka, 1997), (iv) a 
reduction in autogenic inhibition allowing muscles to produce greater amounts of force and 
reach greater levels of strength before they are inhibited to prevent injury (Aagaard et al., 
2000), and a reduction in coactivation of antagonist muscles which may allow for greater 
force generation in the agonist or working muscles (Enoka, 1997).  
 
 
 
 
 
 
 
 
Figure 2.8 Increased frequency of stimulation of motor units initiates greater 
contractile response. G.A. Brooks, et al., 2005, Exercise Physiology: Human 
bioenergetics and its applications, 4th ed. (New York: McGraw-Hill), 388. 
 
Chronic resistance training leads to structural adaptations in the muscle which increases the 
size of the muscle, this is known as hypertrophy. Hypertrophy occurs due to (i) an increase 
in the size of the existing muscle fibers (Figure 2.9) (ii) an increase in the number of muscle 
fibers known as hyperplasia, or (iii) a combination of both. Hyperplasia is the term given to 
the splitting of the original muscle fiber and the growth of each of these fibers to the size 
of the original parent fiber (McCall et al., 1996). Resistance training causes trauma or injury 
to the muscle fibers, which stimulates the activation of satellite cells. The satellite cells 
proliferate fuse to existing muscle fibers to repair them (hypertrophy) or fuse with each 
other to form a new myofibril (hypertrophy) (Hawke and Garry, 2001).  
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Figure 2.9 Microscopic view of muscle cross section of the vastus lateralis (a) before 
and (b) after 6 months of resistance training. Adapted from Wilmore, J.H., Costill, 
D.L., and Kenney W.L (2008) Physiology of Sport and Exercise (pg 207) Human 
Kinetics. 
 
Hypertrophy is often initiated by the structural redevelopment following muscle damage 
(Figure 2.10). The eccentric phase of muscle contraction during resistance training is 
reported to be responsible for muscle damage, thus it is this type of contractions that is 
responsible for stimulating the increase in the cross sectional area of muscle (Shepstone et 
al., 2005). The muscle damage is evident 24-48 hours after the exercise bout and thus is 
termed delayed onset muscle soreness or DOMS (Evans and Cannon, 1991). In 1984, 
Armstrong proposed the following sequence of DOMS. Eccentric exercises causes high 
tension in the contractile-elastic system of skeletal muscle and results in damage to the 
physical structure of the muscle, and its cell membrane. This damage disturbs the calcium 
homeostasis in the injured fiber(s) leading to cell death that peaks at 48 hours post exercise. 
The products of macrophage activity in addition to intracellular contents e.g. histamines, 
kinnis, and K+, accumulate outside the cell. These substances stimulate free nerve endings 
in the muscle causing pain. Muscle strength is initially reduced in injured muscle fibers. 
This may be due to physical disruption of the muscle, failure of the excitation-contraction 
coupling process, and loss of contractile protein. In the days following an eccentric bout 
the muscle adapts, become stronger and more resilient to further damage (Warren et al., 
2001).    
 
 
 
 
   
(a) (b) 
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Figure 2.10 Electron micrograph showing normal arrangement of the actin and 
myosin filaments and Z-disk (a) before and (b) after exhaustive exercise. After 
exhaustive exercise there is moderate Z disk streaming and major disruption of the 
thick and thin filaments in a parallel group of sarcomeres as a result of the force of 
eccentric actions. Taken from From R.C. Hagerman et al., 1984, "Muscle damage 
in marathon runners," Physician and Sportsmedicine 12: 39-48. 
 
2. 2. 6. Metabolic adaptations to resistance training 
Resistance training improves insulin sensitivity and glucose tolerance (Fenicchia et al., 
2004). One legged training studies report increased blood flow and glucose clearance in the 
exercise trained limb in comparison to the untrained control limb (Holten et al., 2004). The 
muscles of the trained limb exhibit an increase in GLUT4 content, an increase in the 
activity of glycogen synthase, and an increase in the expression and activity of various 
proteins involved in the insulin receptor and insulin signalling (Holten et al., 2004). 
Increased muscle mass resulting from resistance training may improve glycemic control 
(Eriksson et al., 1997) by increasing the storage space available for glucose. The area under 
the curve for glucose (Fenicchia et al., 2004) and insulin (Jones et al., 2009) have both been 
shown to decrease with resistance training. 
 
Importantly, resistance training significantly increases lean tissue mass which has the 
strongest positive influence on and correlation with resting metabolic rate (Poehlman, 
1989). Resting metabolic rate is the amount of energy that a person expends at rest. It 
represents 60-70% of an individuals total daily energy expenditure, with the remainder 
attributed to the thermic effect of food and physical activity (Levine et al., 2001). Increasing 
an individuals BMR and thus total daily energy expenditure, may contribute greatly to 
weight loss over time. Resistance training is also associated with augmented fat oxidation, 
an adaptation that improves insulin sensitivity in the obese population but also may help to 
reduce fat stores over time (Kirk et al., 2009). 
(b) (a) 
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Other health benefits associated with resistance training include maintenance of functional 
ability, prevents osteoporosis, sarcopenia, lower back pain, and other disabilities (Winett 
and Carpinelli, 2001).  
The responses to exercise training thus far have focused predominantly on general 
physiological adaptations in addition to alterations in the structure and function of skeletal 
muscle. Exercise training also has important implications for the biology of tissues of 
metabolic importance which will be discussed in detail below. 
 
2. 3. Tissues of metabolic importance and their biomarkers 
The customary research approach to obesity has been to address individual organ 
systems and not the interaction between different systems that affect whole body function. 
Therefore, a scientific challenge would be to adopt an integrated physiological approach to 
disease monitoring and prevention. One strategy could be to identify “universal/general” 
biomarkers that integrate the responses to weight gain and responsiveness to lifestyle 
interventions. A biomarker can be defined as "a characteristic that is objectively measured 
and evaluated as an indicator of normal biologic processes, pathogenic processes, or 
pharmacologic responses to a therapeutic intervention" (Atkinson et al. 2001). There is 
emerging evidence of an extensive communication network between all of the major organ 
systems whereby hormones released from the muscle, fat, gut, bone, brain, vasculature and 
liver have physiological influence on other organ systems (Jazet and Pijl, 2003, Pedersen, 
2011, Tan and Bloom, 2013). The measurement of a cascade of one or a combination of 
these new proteins could provide a ‘real-time’ assessment of overall physiological function 
and allow for effective and individualised lifestyle intervention strategies. This section will 
review established and novel biomarkers that could become potential candidates for an 
integrated and personalised response to lifestyle intervention in obese individuals. 
 
2. 3. 1. Adipose tissue as an endocrine organ 
It is now widely accepted that adipose tissue is an important endocrine organ that not only 
functions to store energy but is also involved in the regulation of energy homeostasis and 
metabolism (Bays et al., 2008). Adipose tissue produces and secretes a number of 
hormones or adipokines that communicate with tissues of metabolic importance such as 
the liver, muscle and brain and play a role in the regulation of glucose and lipid metabolism 
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(Kahn and Flier, 2000), blood pressure, inflammation and atherosclerosis (Rabe et al., 
2008). The level of adiposity of an individual greatly affects the production and circulating 
concentration of these adipokines (Cianflone et al., 2005). Obesity is a chronic 
inflammatory disorder (Wellen and Hotamisligil, 2005), which is characterised by the 
accumulation of macrophages in adipose tissue. As adipose tissue expands with obesity 
there is initial local inflammation induced by macrophage infiltration, which eventually 
becomes systemic low grade inflammation. By the time insulin resistance is present, most 
tissues in the body display activation of inflammatory signalling pathways (Murdolo and 
Smith, 2006). Macrophages infiltrate the adipose tissue and are involved in the production 
of proinflammatory factors such as cytokines, chemokines, and nitric oxide. This leads to 
further monocyte infiltration in adipose tissue, greater production of proinflammatory 
mediators, and the start of the acute phase response (Shi et al., 2006). When this response 
is activated the liver produces complement factors, cytokines, coagulation proteins, CRP 
and serum amyloid A among other agents, all of which are required for proper immune 
function (Gabay and Kushner, 1999). This response is normal and necessary for the 
control of acute inflammation, however, if this response is chronically activated, as with 
obesity, circulating concentrations of acute-phase reactants such as CRP are associated with 
biomarkers of metabolic disease. Thus the adipocytes in obese individuals exhibit altered 
metabolic and endocrine function, which leads to an increase in the production and 
secretion of proinflammatory adipokines and a reduction in the secretion of anti-
inflammatory adipokines (Arner, 2001). These proinflammatory adipokines affect insulin 
sensitivity of the adipocytes in a paracrine fashion, and also affect insulin sensitivity of 
other tissues such as skeletal muscle and the liver in an endocrine fashion (Rosen and 
Spiegelman, 2006). Leptin and Adiponectin were two of the first hormones to be identified 
and investigated. Their role in metabolism led to the conclusion that cytokines may provide 
a link between obesity, insulin resistance and type 2 diabetes (Wellen and Hotamisligil, 
2005).  However, more than 300 adipokines have now been identified and the function of 
many of these chemical messengers is poorly understood. The remainder of this review will 
focus on some of the more established adipokines in addition to the novel biomarkers of 
insulin resistance that have recently been identified to better understand if they have a role 
in physiological consequences of fat accumulation and if they have the potential to respond 
to lifestyle intervention. 
 
74 
 
2. 3. 2. Established Biomarkers: Leptin and Adiponectin 
 
2. 3. 2. 1. Leptin  
Leptin was the first fat cell-derived hormone to be discovered. It was first identified in 
mice in 1950 at the Jackson Laboratory (Halaas et al., 1995). Mice homozygous for the ob 
mutation (ob/ob) ate ravenously and were massively obese. In 1994, the ob gene was 
isolated and the name given to this new hormone was Leptin (Halaas et al., 1995). Leptin is 
produced predominantly in the adipose tissue and plays a major role in the regulation of 
energy homeostasis by influencing food intake and energy expenditure. More specifically it 
acts on receptors in the hypothalamus of the brain to regulate appetite, hunger, metabolism 
and behaviour and thus body weight (Brennan and Mantzoros, 2006). It is considered to 
play a crucial role in defending against the excessive accumulation of body fat. Under 
normal conditions increased energy consumption and accumulation of body fat stores leads 
to elevated circulating concentrations of Leptin. Leptin ultimately suppresses appetite until 
fat is lost. In contrast, under conditions of starvation and loss of body fat, circulating 
concentrations of Leptin decrease resulting in an increase in food intake concomitant with 
a decrease in energy expenditure in an effort to conserve energy (Brennan and Mantzoros, 
2006). It has been reported that Leptin concentrations also decrease in response to fasting 
or following very low calorie diets (Dubuc et al., 1998). Rare cases of complete Leptin 
deficiency due to mutations in the Leptin gene have been reported (Brennan and 
Mantzoros, 2006). Relative Leptin deficiency (lower levels than normal) has also been 
reported in individuals who have lipoatrophy and some forms of hypothalamic amenorrhea 
(Brennan and Mantzoros, 2006). These defects lead to a constant desire for food and 
consequently severe obesity (Brennan and Mantzoros, 2006). Research has shown that the 
administration of Leptin to these individuals, in replacement doses, normalises 
neuroendocrine, metabolic and immune function, but more clinical studies are required to 
determine its long term efficacy and safety (Brennan and Mantzoros, 2006).  
 
In obese individuals, the enlarged adipose tissue releases larger quantities of Leptin. 
Although Leptin normally reduces appetite, these beneficial effects are not evident in obese 
individuals indicating that they are resistant to the action of Leptin (Considine et al., 1996). 
It is possible that chronically elevated serum Leptin in obesity may result in desensitization 
and resistance to the action of the hormone (Brennan and Mantzoros, 2006). Research has 
been conducted to investigate the potential role of Leptin administration in the treatment 
75 
 
of obesity (Heymsfield et al, 1999). Seventy three obese subjects were randomly assigned to 
one of two groups, Leptin or placebo. All subject self administrated recombinant human 
Leptin or the placebo subcutaneously once per day for 24 weeks. The Leptin dose was 
increased progressively over time. All subjects were also encouraged to walk for 20-30 
minutes 3-5 times per week and adopt a calorie restriction of 500kcal per day. The caloric 
deficit should have lead to an average weight loss of 0.5kg per week for 24 weeks. The 
mean weight loss in the control group was 1.7kg which suggests that compliance to the 
dietary intervention was poor and thus the authors concluded that the effect of the diet in 
this study was minimal. The key finding was that there was a dose response relationship 
between Leptin administration and weight loss and fat mass loss. Weight loss at 4 weeks 
was 0.4±2.0kg in the placebo group and 1.9±1.6kg in the Leptin group. At 24 weeks this 
increased to 0.7±5.4kg in the placebo group and 7.1±8.5kg in the Leptin group. Fat loss 
accounted for greater than 95% of weight lost. Lowest energy intake was recorded when 
the highest dose of Leptin was being administered suggesting weight loss may be due to 
reduced food consumption. The authors presumed that weight loss in this group of 
subjects was related to increased central nervous system exposure to exogenous Leptin. 
However, there was wide variation between individuals in the amount of energy restricted 
and the 48 hour recall used to measure this is relatively insensitive. Adverse reactions 
occurred at the injection site in 71% of those administering the placebo and 62% of those 
administering Leptin. It appears from the results of this study that obese individuals with 
high endogenous levels of Leptin do not have absolute resistance to this hormone. High 
doses of Leptin may be required to provide enough of a stimulus for weight loss in this 
population. Further research is required to determine the potential role of Leptin in the 
treatment of obesity (Heymsfield et al, 1999).       
 
2. 3. 2. 2. Adiponectin 
Adiponectin is an insulin sensitizing, anti-inflammatory and anti-atherogenic hormone 
produced exclusively by the adipocytes. Weight loss significantly increases the expression 
of Adiponectin (Kopp et al., 2005) but weight gain suppresses its expression and thus its 
health promoting properties (Weyer et al., 2001). The circulating concentration of the 
hormone is inversely correlated with total body fat but the distribution of body fat also has 
an important influence. High levels of abdominal body fat are associated with a lower 
concentration of Adiponectin, but if body fat is mostly distributed in the lower body, the 
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circulating concentrations of Adiponectin isn’t suppressed to the same extent independent 
of total body fat (Cnop et al., 2003).  
 
Adiponectin is proposed to have a role in carbohydrate and fat metabolism. Adiponectin 
lowers circulating concentrations of FFA in addition to stimulating the oxidation of 
intramyocellular fat, leading to improvements in insulin signalling and insulin sensitivity 
(Carey et al., 1996). Adiponectin activated AMPK in the liver reduces the expression of 
enzymes involved in gluconeogenesis such as glucose-6-phosphatase and consequently 
hepatic glucose production (Trujillo and Scherer, 2005). It has been reported that 
Adiponectin may also act on the brain to decrease body weight. When the hormone was 
injected into the lateral cerebral ventricles of mice they experienced a dose dependent 
decrease in body weight. Food intake was not inhibited in these mice which suggest that 
the reduction in body weight occurred via increased energy expenditure (Qi et al., 2004). 
Circulating concentrations of Adiponectin are reduced in obese subjects but increase 
significantly after weight loss (Monzillo et al., 2003). Numerous studies have been carried 
out to investigate the effects of exercise on Adiponectin with and without weight loss. It 
appears that Adiponectin concentrations do not change after a single bout of exercise 
(Jamurtas et al., 2006) or exercise training (Yatagai et al., 2003, Hulver et al., 2002) in the 
absence of weight loss despite increases in insulin sensitivity and glucose tolerance. 
Circulating concentrations of Adiponectin are reported to increase following exercise 
training when weight and body composition are improved (Monzillo et al., 2003, Fatouros 
et al., 2005).  
 
2. 3. 3. Novel biomarkers of insulin resistance  
It is clear that the adipokines Leptin and Adiponectin play a crucial role in carbohydrate 
and lipid metabolism and in the maintenance of metabolic homeostasis. Novel adipokines, 
cytokines, hepatokines and myokines are continuing to emerge and their potential role in 
obesity and metabolic health is currently under investigation. Six novel biomarkers 
including Fibroblast Growth Factor 21 (FGF21), Chemerin, Omentin, Fetuin-A, Visfatin 
and Interleukin-13 (IL-13) have recently been identified. The tissues that produce these 
hormones and their primary metabolic function is depicted in Figure 2.11. To follow is a 
review of emerging biomarkers of insulin resistance and our current knowledge of their 
role in obesity in addition to their response to exercise training and lifestyle intervention. 
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Figure 2.11 Summary of the origin of the novel biomarkers of insulin resistance and 
their primary metabolic function. The biomarkers are produced by a number of 
metabolically active tissues in the body. FGF21, IL-13, Visfatin and Omentin 
promote insulin sensitivity. Chemerin and Fetuin-A promote insulin resistance. 
 
2. 3. 3. 1. Fibroblast Growth Factor 21 
 
FGF21 is an endocrine hormone which is thought to enhance the action of insulin and 
thus play a role in improving glucose tolerance and lipid metabolism (Long and 
Kharitonenkov, 2011). FGF21 exerts many important metabolic effects that are initiated 
when the hormone binds to and activates its receptor, which is found on metabolically 
active organs such as the liver, white adipose tissue and the pancreas (Zhang et al., 2006). 
The hormone itself is expressed in the liver, but also in adipose tissue, skeletal muscle and 
the pancreas (Nishimura et al., 2000).  
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FGF21
- Produced in liver, adipose tissue, skeletal muscle and pancreas
- ↑ insulin sensitivity
- inhibits lipolysis
- inhibits hepatic glucose production
 
Figure 2.12 FGF21 is produced in the liver, adipose tissue, skeletal muscle and 
pancreas. It increases insulin sensitivity and stimulates the uptake of glucose into 
adipocytes and skeletal muscle. It also acts to inhibit hepatic glucose production 
and inhibit lipolysis. 
 
Much of what is currently known about the beneficial effects of FGF21 has been derived 
from animal studies. These studies have reported that FGF21 increases insulin sensitivity 
by stimulating the translocation of GLUT1 thus increasing glucose uptake into the 
adipocytes, and also by decreasing glucose production by the liver (Coskun et al., 2008). 
This is an insulin independent action and is additive to the effects of insulin. FGF21 also 
helps to preserve b-cell function in diabetic mice and decreases the secretion of glucagon, 
which results in decreased hepatic glucose production and improved insulin sensitivity 
(Coskun et al., 2008). In fact, administration of FGF21 to diabetic mice causes a reduction 
in plasma glucose to near normal levels (Kharitonenkov et al., 2005), and improves the 
lipid profile by decreasing circulating concentrations of FFA’s and TG’s, in addition to 
increasing the oxidation of lipids (Kharitonenkov et al., 2005, Badman et al., 2007). FGF21 
may have a therapeutic role in the treatment of obesity in ob/ob mice. Administration of 
the hormone to diet induced obese and ob/ob mice for two weeks resulted in a 20% 
reduction in mean body weight predominantly due to a reduction in adiposity. These mice 
did not decrease their calorie intake or increase their energy expenditure during this time 
and so the effects can be attributed to the administration of FGF21 alone. The mice 
showed increase energy expenditure, increase utilisation of fat, reduced liver fat content, 
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suppression of lipogenesis in the liver, and improved glycaemia and insulin resistance 
(Coskun et al., 2008).  
 
In humans, the circulating concentration of FGF21 is elevated in obesity, insulin resistance, 
impaired glucose tolerance, type 2 diabetes, the metabolic syndrome and non-alcoholic 
fatty liver disease (Semba et al., 2012, Chavez et al., 2009). However, the expected positive 
effects of the hormone on glucose and lipid metabolism are absent in obesity and related 
conditions (Fisher et al., 2010). FGF21 concentrations are also elevated in situations of 
starvation (Mai et al., 2010), indicating that the hormone is responsive to extreme 
metabolic states. Positive correlations have been found between FGF21 and fat mass, liver 
fat, triglycerides, insulin, insulin resistance as measured by HOMA, area under the glucose 
curve, LDL cholesterol (Tyynismaa et al., 2011) and FFA’s (Mai et al., 2009). FFA’s have 
recently been proposed to be regulators of FGF21, as increased concentrations of FFA’s 
promote increased concentrations of FGF21. This may in part explain the elevated 
circulating concentrations of FGF21 seen in obese and insulin resistant states, and also in 
starvation (Mai et al., 2010). To test this hypothesis, Mai et al, 2010 carried out a study to 
investigate the effects of moderate lipid infusion on serum FGF21 in lean healthy men. 
The lipid infusion replicated the physiological rise in FFA’s seen in obesity. In this study 
FGF21 increased linearly with increases in FFA’s (Mai et al., 2010). There also appears to 
be a significant relationship between FGF21 and cardiovascular disease in humans. 
Circulating concentrations of FGF21 are significantly higher in patients with CVD than in 
controls. If the CVD patients also have diabetes, hypertension or both, the circulating 
concentrations of FGF21 are even higher again. FGF21 is positively correlated with an 
adverse lipid profile in these patients (Lin et al., 2010). 
 
However, there is some research to show that the beneficial metabolic effects of FGF21 
reported in animal models are also evident in humans. FGF21 has been shown to enhance 
glucose uptake in skeletal muscle and inhibit lipolysis in adipocytes of humans both of 
which contribute to increased insulin sensitivity (Arner et al., 2008). Administration of 
antidiabetic drugs to patients with type 2 diabetes and subsequent improvements in insulin 
sensitivity results in a decrease in circulating FGF21. This suggests that improvements in 
insulin sensitivity affect the production of the FGF21in humans (Li et al., 2009, Samson et 
al., 2011).  
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2. 3. 3. 1. 1 . The effects of lifestyle intervention on circulating 
concentrations of FGF21 
The research that has been conducted to date investigating the effects of lifestyle 
intervention on circulating concentrations of FGF21 has produced conflicting results. An 
acute bout of exercise appears to have no effect on serum FGF21 in the 4 hours following 
exercise (Cuevas-Ramos et al., 2012). The effects of exercise training on serum FGF21 is 
unclear. One study found that 2 weeks of daily exercise carried out by young, lean, healthy, 
sedentary women resulted in a significant increase in serum FGF21 but no change in 
anthropometric characteristics including body weight and body fat. The authors proposed 
that the exercise induced increase in FFA’s may have been the main stimulus for increasing 
the serum concentrations of FGF21. They also proposed that FGF21 probably increases in 
obesity to counteract chronic exposure to elevated FFA’s and lipotoxicity. Exercise may 
reinforce this compensatory pathway (Cuevas-Ramos et al., 2012).   
 
In contrast, a concurrent exercise training study reported that the circulating concentration 
of FGF21 decreased moderately post intervention. Obese subjects in this study trained 5 
days per week for 3 months, which consisted of 45 minutes of aerobic exercise working at 
60-70% age-predicted hear rate maximum combined with 20 minutes of resistance training 
equating to 100kcal per session. Post intervention BMI, waist circumference, blood 
pressure, and TG levels decreased significantly, which was accompanied by a modest 
decrease in FGF21 levels (Yang et al., 2011).   
 
Weight loss induced by bariatric surgery also yields conflicting results. Some studies show 
an increase in circulating FGF21 following substantial weight loss and this was 
accompanied with a significant improvement in insulin sensitivity and decreased hepatic fat 
content (Jansen et al., 2011). However, other studies report no change in circulating FGF21 
despite significant reductions in body weight and insulin resistance, normalisation of lipid 
profile and resolution of the metabolic syndrome (Woelnerhanssen et al., 2011). 
 
Similar controversies exist when investigating the effects of caloric restriction on circulating 
FGF21. Weight loss (~4kgs) induced by 6 months of calorie restriction significantly 
improved glucose and lipid metabolism but had no effect on serum FGF21. FGF21 was 
associated with markers of lipid metabolism and an estimate of abdominal adiposity (Mai et 
al., 2011). Although FGF21 expression does not increase with dietary restriction it does 
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increase during short term starvation in rodents. This protocol is a critical element in 
alternate day fasting and may possibly exert beneficial effects on serum FGF21 in humans 
(Mendelsohn, 2012). 
 
The literature regarding the effects of diet, exercise, surgery and weight loss on circulating 
concentrations of FGF21 has produced conflicting results. Further research is required to 
determine the factors that regulate FGF21 and its response to intervention.  
 
2. 3. 3. 2. Interleukin 13  
IL-13 is an anti-inflammatory myokine, which is synthesized and released by skeletal 
muscle. It is proposed to suppress the secretion of inflammatory cytokines which in turn 
counteracts several cytokines linked to the development of insulin resistance and type 2 
diabetes (Cannon and St Pierre, 1998). It is thought that myokine production may be 
altered in obese and insulin resistant states but there is limited information available on 
this. Myokines are reported to contribute to whole body metabolism by signally directly to 
distant organs including the liver and adipose tissue and regulating metabolic processes in 
these tissues (Pedersen, 2011). Since skeletal muscle is one of the largest organs in the 
body, a modest change in the secretion of myokines may have substantial metabolic effects. 
Exercise is associated with increased secretion of several cytokines from skeletal muscle, 
which may promote a transient increase in glucose uptake and metabolism (Febbraio and 
Pedersen, 2005). IL-13 may prevent inflammation induced insulin resistance in adipose 
tissue indirectly due to a suppressive effect on macrophage activity, and thereby attenuate 
the release of pro-inflammatory cytokines (Febbraio and Pedersen, 2005).  
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IL-13
- Produced exclusively in skeletal muscle 
- Inhibits the secretion of inflammatory cytokines
- May ameliorate insulin resistance
 
Figure 2.13 IL-13 is produced exclusively in skeletal muscle. It inhibits the secretion 
of inflammatory cytokines and thus counteracts several cytokines linked to the 
development of insulin resistance. It may regulate metabolic processes in other 
tissues including the liver and adipose tissue. 
 
2. 3. 3. 2. 1 . Effects of lifestyle intervention on circulating 
concentrations of IL-13 
There is very limited information available about the effects of lifestyle intervention on the 
production and secretion of IL-13. A single aerobic exercise session consisting of one hour 
of cycling at 70% O2max improved the inflammatory response in sedentary women but 
there was no change in the circulating concentration of IL-13 (Garcia et al., 2011). 
 
Peake et al. (2005) investigated the effects of different modes and intensity of aerobic 
exercise on plasma cytokine changes including IL-13. After 60 minutes of level treadmill 
running at 60% O2max  there was no effect on IL-13. The same was also true for 60 
minutes of level treadmill running at 85% O2max, and 45 minutes of downhill running at 
60% O2max  with a -10% gradient. It appears that a single bout of exercise has no effect on 
circulating concentrations of IL-13 but the effects of aerobic exercise training on 
circulating concentrations of IL-13 are unknown. 
 
Resistance training has been shown to significantly increase the expression of IL-13 in 
skeletal muscle. Prokopchuk et al (2007) investigated the effects of 6 weeks of resistance 
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training on IL-13 expression. 24 collegiate males with resistance training experience ranging 
from 3 months to 5 years were divided into 2 groups. Group one (n=12) performed 
maximal contractions on the bench press (5 sets * 3 rep max) 3 days per week. Group 2 
(n=12) performed 3 different workouts per week ranging from maximal contractions to 
submaximal contractions (30% 1RM) to body resistance loads. A muscle biopsy taken from 
the triceps brachii revealed that IL-13 expression increased significantly post intervention 
in both groups. This was the first time that IL-13 expression was shown to be up-regulated 
in skeletal muscle in response to strength training. Higher training loads (group one) 
produced a greater expression of IL-13 but this did not reach statistical significance 
between groups. The mechanisms behind this response remain to be established but the 
authors speculate that IL-13 is involved in muscle hypertrophy in addition to anti 
inflammatory damage control that occurs during strength training (Prokopchuk, 2007). 
 
A recent personal communication suggests that IL-13 is particularly sensitive to freeze 
thaw cycles and that it may be necessary to measure using a sample that had not previously 
been thawed. This may explain some of the variance in the literature.  
 
2. 3. 3. 3. Visfatin 
Visfatin has been identified as a novel adipokine that is up regulated in visceral fat, hence 
the name (Fukuhara et al., 2005). It is also expressed in the liver, muscle and macrophages 
(Samal et al., 1994). Visfatin is reported to mimic the action of insulin and thus plays a role 
in increasing glucose uptake in adipose tissue and skeletal muscle (Fukuhara et al., 2005). 
The literature available to date suggests that Visfatin is involved in the pathogenesis of 
obesity, insulin resistance and type 2 diabetes, but controversy exists with regard to its role 
(Fukuhara et al., 2005).  
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VISFATIN
- Produced predominantly in visceral fat but also in the liver, 
muscle and macrophages
- Mimics the actions of insulin
- ↑ glucose uptake in adipose tissue and skeletal muscle
 
Figure 2.14 Visfatin is produced predominantly in visceral adipose tissue but it also 
produced in the liver, skeletal muscle and macrophages. It is reported to mimic the 
action of insulin and plays a role in increasing glucose uptake in adipose tissue and 
skeletal muscle.  
 
Some studies report that the circulating concentration of Visfatin is significantly increased 
in patients with insulin resistance and diabetes (Esteghamati et al., 2011), which is true in 
the presence (Chen et al., 2006) and absence (Dogru et al., 2007) of obesity. The increase in 
Visfatin concentration appears to become more pronounced with greater levels of glucose 
intolerance (Dogru et al., 2007). This indicates that there is a relationship between Visfatin 
and insulin sensitivity independent to that of adiposity, which is supported by other studies 
(Yildiz et al., 2010). However, the literature also reports no relationship between Visfatin 
and markers of insulin sensitivity such as fasting insulin, fasting plasma glucose or glucose 
infusion rate during the euglycaemic-hyperinsulinemic clamp (Berndt et al., 2005). It is 
proposed that obese, insulin resistant, and type 2 diabetic subjects who have elevated levels 
of Visfatin may be resistant to the action of the hormone, and the increased production of 
Visfatin may be a compensatory response to diminished insulin function in these 
individuals (Sun et al., 2007).  
 
The relationship between Visfatin and obesity is even more controversial with some studies 
showing a positive relationship (Berndt et al., 2005), some showing a negative relationship 
(Pagano et al., 2006) and others showing no relationship (Dogru et al., 2007). Visfatin is 
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positively correlated with BMI and waist hip ratio in obese children and adolescents 
(Taskesen et al., 2012). A similar finding has been reported in adults (Olszanecka-
Glinianowicz et al., 2011). 
  
The inconsistency in the relationship between Visfatin and obesity and insulin resistance 
may be due to limitations in the detection of serum Visfatin by different immunoassays. 
The literature recognises that a variety of immunoassays are currently being used to 
quantify circulating Visfatin and they do not consistently yield comparable results. This 
finding must be considered when interpreting data from clinical studies (Korner et al., 
2007). 
 
2. 3. 3. 3. 1 . The effects of lifestyle intervention on circulating 
concentrations of Visfatin 
Changes in nutritional status such as over or under feeding, or changes in energy 
expenditure as with exercise, has significant effects on adipose tissue, gene expression and 
insulin sensitivity and may also effect on serum Visfatin.  
 
The circulating concentration of Visfatin appears to be differentially influenced by an acute 
bout of exercise and exercise training. A single bout of high intensity exercise in lean fit 
men leads to an increase in plasma Visfatin immediately after the exercise bout. This 
occurred together with an increase in plasma glucose and insulin concentrations. After 45 
minutes of recovery all of the physiological changes returned to baseline values. The 
authors concluded that plasma Visfatin may increase immediately after exercise to assist 
glucose uptake and glycogen restoration (Ghanbari-Niaki et al., 2010). 
 
In contrast, 12 weeks of exercise training results in a significant decrease in the circulating 
concentration of Visfatin. Forty eight Korean women completed a 12 week concurrent 
training intervention where they exercised progressively for 5 days per week. The training 
sessions consisted of 45 minutes (~300kcal) of aerobic exercise working at 60-70% age 
predicted heart rate maximum, and 20 minutes (~100kcal) of resistance training. The 
resistance training programme began at 40% of heart rate maximum and progressed to 65-
70% throughout the 12 weeks. Plasma Visfatin levels were elevated in the obese subjects at 
baseline compared to lean subjects. After 12 weeks of training, body weight, BMI, waist 
circumference, percent fat mass, blood pressure, fasting glucose levels, and insulin 
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resistance all decreased significantly in the subjects and this was accompanied by a 
significant decrease in plasma Visfatin (Choi et al., 2007). This study shows that exercise 
training in the presence of weight loss significantly reduces circulating Visfatin.  
 
Twelve weeks of aerobic exercise training also resulted in a significant reduction in 
circulating Visfatin. The subjects in this study were obese (BMI 33.4+1.5kg/m2) at baseline 
and completed 5 training sessions per week for 12 weeks working at an intensity of 85% of 
heart rate maximum. After 12 weeks of training there was a significant increase in fitness, in 
addition to a significant reduction in body weight, visceral adipose tissue, subcutaneous 
adipose tissue, area under the glucose curve and area under the insulin curve. The decrease 
in circulating Visfatin was significantly correlated with the decrease in the area under the 
glucose and insulin curves. The authors concluded that the reduction in circulating Visfatin 
was most likely due to changes in body composition and weight (Haus et al., 2009). These 
findings are supported by other 12 week aerobic exercise training studies (Lee et al., 
2010b). 
 
The above studies show that the circulating concentration of Visfatin decreases in response 
to exercise induced favourable changes in physical and metabolic characteristics of obese 
individuals. This outcome is also evident in some diet induced weight loss interventions but 
not all. De Luis et al. (2008) reported that serum Visfatin decreased in obese subjects who 
lost weight following 3 months of a hypocaloric diet  (de Luis et al., 2008). This finding is 
supported by some diet interventions (Lee et al., 2010a), but others report no change in 
circulating Visfatin despite a 4.4% reduction in body weight over a 2 month period (De 
Luis et al., 2010).  
 
The effect of lifestyle intervention on the circulating concentration of Visfatin is unclear at 
present as is the mechanism behind any changes that do occur. A meta analysis of the 
literature available to date suggests that Visfatin concentration is increased in overweight 
and obese individuals, in addition to those with insulin resistance, type 2 diabetes, the 
metabolic syndrome and cardiovascular disease. For this reason the circulating levels of 
Visfatin may be a potential predictor of these metabolic conditions (Chang et al., 2011). 
Interventions that improve insulin resistance may improve the circulating concentration of 
this hormone. 
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2. 3. 3. 4. Omentin 
Omentin is synthesised by visceral stromal vascular cells and not adipocytes. It is expressed 
abundantly in visceral adipose tissue and barely detectable in subcutaneous adipose tissue. 
Omentin is a secreted protein and is therefore detectable in serum (Yang et al., 2006). The 
circulating concentration of Omentin differs according to body weight and metabolic status 
(Akbarzadeh et al., 2012, Cai et al., 2009, Tan et al., 2010, Yan et al., 2011). Omentin is 
negatively correlated with HOMA-IR, body weight, body mass index, waist to hip ratio, 
triglycerides, and fasting insulin. Its expression is positively correlated with serum 
concentrations of HDL cholesterol and adiponectin (Cai et al., 2009). These findings are 
supported by other studies (Yan et al., 2011, Zhou et al., 2012).   
 
 
OMENTIN
- Produced in omental adipose tissue (lean > obese > T2)
- ↑ insulin sensitivity
- ↑ insulin action →↑ glucose uptake  
 
Figure 2.15 Omentin is expressed abundantly in visceral adipose tissue of lean 
individuals. It is reported to play a role in insulin sensitivity by enhancing the 
action of insulin. Its circulating concentration is suppressed in obese individuals, 
and even more so when obesity is combined with insulin resistance or T2DM. 
 
Omentin appears to play a role in insulin sensitivity by enhancing the action of insulin. 
Addition of recombinant Omentin in vitro significantly increases insulin stimulated glucose 
uptake by ~47% in subcutaneous adipose tissue, and by ~30% in omental adipocytes 
(Yang et al., 2006). In contrast, administration of insulin and glucose to omental adipose 
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tissue significantly decreases the expression of Omentin in this tissue in a dose dependent 
manner (Tan et al., 2008). It is important to note that omentin enhances insulin action by 
augmenting insulin stimulated glucose transport but it does not cause glucose transport by 
itself. Omentin increases Akt phosphorylation transiently in the presence and absence of 
insulin. It may act in an autocrine and paracrine fashion to increase insulin sensitivity in 
visceral fat, but since it also circulates in the blood it may work in an endocrine fashion to 
increase insulin sensitivity and glucose metabolism in other tissues such as the liver, muscle 
and subcutaneous adipose tissue (Yang et al., 2006). This hormone is also involved in the 
regulation of vascular tone since it has been shown to vasodilate blood vessels (Tan et al., 
2010, Zhou et al., 2012, Maenhaut and Van de Voorde, 2011). 
 
The ability of Omentin to increase insulin sensitivity, as well as its anti-inflammatory and 
anti-atherogenic properties, means that it may have therapeutic effects on insulin resistance 
and the metabolic syndrome (Zhou et al., 2012). It could be a promising therapeutic target 
for this condition. Further research is required to determine the Omentin receptor, target 
tissue and signal transduction pathways as well as the exact physiological role of the 
hormone in glucose metabolism. (Rabe et al., 2008).  
 
2. 3. 3. 4. 1 . The effects of lifestyle intervention on circulating 
concentrations of Omentin 
There is limited information available with regard to the effects of lifestyle intervention on 
serum Omentin. The research that is available suggests that the circulating concentration of 
Omentin increases in response to reductions in body weight and this is true for diet 
induced (Moreno-Navarrete et al., 2010) and exercise induced (Saremi et al., 2010a) weight 
loss.     
 
Caloric restriction of 500-1,000kcal per day for 4 months produced a weight loss of 0.5-
1.0kg per week in obese individuals. Serum Omentin increased significantly post 
intervention in this group which was associated with a significant decrease in BMI, insulin 
resistance and fasting insulin (Moreno-Navarrete et al., 2010).  
 
Twelve weeks of aerobic exercise training also significantly increased serum Omentin 
concentrations. Normal weight, over weight and obese subjects took part in a 12 week 
exercise intervention where they trained progressively 5 days per week for the 12 weeks. 
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The post intervention analysis revealed that there was a significant decrease in waist 
circumference, body fat, insulin resistance, fasting glucose, triglycerides, total cholesterol, 
LDL cholesterol, and systolic blood pressure in these individuals and this was accompanied 
by a significant increase in circulating Omentin. The change in Omentin was significantly 
correlated with changes in aerobic fitness, waist circumference and insulin resistance 
(Saremi et al., 2010a). The circulating concentration of Omentin increases with diet and 
exercise induced improvements in body weight and insulin resistance. Aerobic fitness may 
also influence the production of this hormone but further research is required. 
 
2. 3. 3. 5. Chemerin 
Chemerin has recently been identified as a novel adipokine and chemokine, which is 
expressed predominantly in the adipose tissue along with its receptor, chemokine-like 
receptor 1 (CMKLR1, or ChemR23), both of which have been found to play a key role in 
adipogenesis and adipocyte metabolism. It is also reported to be expressed in the lungs, 
liver and kidneys (Bozaoglu et al., 2007, Stejskal et al., 2008). Chemerin is a 
proinflammatory cytokine that activates immune cells by recruiting macrophages (Saremi et 
al., 2010b). Chemerin expression is increased in adipose tissue of obese subjects but not in 
the liver (Stejskal et al., 2008). It is possible that adipocytes of obese individuals are 
responsible for the elevated serum concentrations found in this population (Wang et al., 
2009). Chemerin is positively correlated with BMI, insulin resistance, body fat, blood 
pressure, triglycerides and age (Bozaoglu et al., 2007). Research shows that Chemerin 
induces insulin resistance in skeletal muscle at the level of the insulin receptor substrate 1, 
protein kinase B, glycogen synthase 3 phosphorylation, and glucose uptake (Sell et al., 
2009). These associations remain even after adjustment for age, gender and BMI. Chemerin 
is inversely associated with adiponectin (Chu et al., 2012) and it may be a valuable 
biomarker for the metabolic syndrome (Stejskal et al., 2008).  
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CHEMERIN
- Produced predominantly in adipose tissue, also produced in    
the liver, lungs and kidneys 
- Pro inflammatory cytokine that promotes insulin resistance
-↑ recruitment of macrophages into adipose tissue
 
Figure 2.16 Chemerin is produced predominantly in the adipose tissue of obese 
individuals but is also produced in the liver, lungs and kidney. It is a 
proinflammatory cytokine that promotes the recruitment of macrophages into 
adipose tissue which further stimulates the production of pro inflammatory 
cytokines. 
 
2. 3. 3. 5. 1 . The effects of lifestyle intervention on circulating 
concentrations of Chemerin 
Saremi et al (2010) carried out the first study to investigate the effects of aerobic exercise 
training on circulating concentrations of Chemerin. In this study, subjects engaged in 
aerobic exercise 5 days per week for 12 weeks. The duration and intensity of training was 
increased progressively from 15-20 minutes working at an intensity of 60-65% of heart rate 
maximum in week 1, to 45-50 minutes working at an intensity of 80-85% heart rate 
maximum in week 12. Dietary intake was monitored throughout the intervention to ensure 
that it did not change from baseline intake. The exercise training led to significant decreases 
in waist circumference, percent body fat, visceral fat, subcutaneous fat, fasting glucose, 
insulin resistance, triglycerides, total cholesterol, LDL cholesterol, systolic blood pressure 
and serum Chemerin. The primary finding of this study was that the change in Chemerin 
was significantly correlated with changes in visceral and subcutaneous fat, HOMA-IR, 
glucose, waist circumference and O 2peak (Saremi et al., 2010b). Other 12 week aerobic 
exercise training studies support the finding that serum Chemerin concentrations decrease 
post intervention (Kim et al., 2013, Venojarvi et al., 2013).  
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Concurrent training studies also report reductions in circulating concentrations of 
Chemerin post intervention. This particular intervention was 6 months in duration and 
included 98 subjects across a wide range of age and BMI categories. Serum Chemerin was 
positively associated with total cholesterol, TG’s, fasting insulin, HOMA-IR, systolic blood 
pressure and CRP independently of BMI. Multiple regression analysis revealed that 
Chemerin was an independent predictor of insulin resistance measured by HOMA-IR. The 
circulating concentration of Chemerin decreased significantly post intervention and this 
was associated with the change in HOMA-IR even after adjustment for waist 
circumference (Stefanov et al., 2013).   
 
Exercise training without weight loss may also exert favourable effects on Chemerin 
induced insulin resistance. To test this hypothesis skeletal muscle cells were incubated in 
monocyte chemotactic protein (MCP)-1 and Chemerin, which induced insulin resistance by 
significantly reducing the insulin-stimulated phosphorylation of Akt. These cells were then 
contracted by applying electrical impulse stimulation. Contraction of the skeletal muscle 
cells resulted in increased glucose uptake in comparison to controls, and abrogation of the 
conditioned medium induced insulin resistance (Lambernd et al., 2012). 
 
Chakaroun et al. (2011) investigated the effects of various weight loss interventions on 
serum Chemerin with the hypothesis that decreased body fat would lead to decreased 
concentrations of Chemerin. The interventions included a 12 week exercise intervention, a 
6 month diet intervention, or a 12 month follow up post bariatric surgery. All interventions 
led to significant reductions in weight and Chemerin, and this was associated with 
improved glucose infusion rate. (Chakaroun et al., 2012). 
 
All of the above findings suggest that improvements in physical characteristics, insulin 
resistance and glucose tolerance are associated with improvements in the circulating 
concentration of the pro-inflammatory cytokine Chemerin independently of the 
mechanism by which these improvements were achieved.  
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2. 3. 3. 6. Fetuin-A 
Fetuin-A is a protein secreted mostly by hepatocytes in the liver, but also by the tongue and 
placenta. Circulating concentrations of Fetuin-A are elevated in individuals who are obese, 
and in those who have the metabolic syndrome, insulin resistance and impaired glucose 
tolerance. Fetuin-A has been shown to be an independent predictor of diabetes, and is 
associated with atherosclerosis (Brix et al., 2010).  
FETUIN-A
- Produced predominantly in the liver but is also expressed in 
the tongue and placenta 
- ↓ insulin sensitivity
 
Figure 2.17 Fetuin-A is produced predominantly in the liver but is also thought to 
be expressed in the tongue and placenta. It is thought to promote insulin 
resistance. 
 
The circulating concentrations of Fetuin-A is associated with visceral adiposity (Ix et al., 
2009), the accumulation of fat in the liver, and the metabolic syndrome (Stefan et al., 2006). 
Fatty liver is strongly associated with the metabolic syndrome and also strongly predicts 
type 2 diabetes (Shibata et al., 2007). Based on these findings it has been proposed that 
increased liver fat, as seen in obesity, is the link between obesity and elevated Fetuin-A 
levels in this population (Stefan et al., 2008). In support of this, Fetuin-A concentrations 
decrease linearly with decreases in liver fat (Stefan et al., 2008).  Fetuin-A may play an 
important role in fatty liver induced type 2 diabetes (Stefan et al., 2008). It is reported to 
suppress the production of the insulin sensitizing hormone Adiponectin (Hennige et al., 
2008). It has also been shown to exert pro-inflammatory effects and provoke cytokine 
expression in monocytes (Hennige et al., 2008), which infiltrate adipose tissue and 
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contribute to inflammation of the adipose tissue leading to the expression and secretion of 
other pro-inflammatory adipokines (Weisberg et al., 2003). However, not all obese 
individuals have fatty liver disease and elevated circulating Fetuin-A and so further 
investigation is required.  
 
The mechanism behind the disproportionate association of Fetuin-A with lipids is not 
certain. The leading hypothesis is that Fetuin-A inhibits tyrosine kinase activity of the 
insulin receptor and this directly or indirectly inhibits insulin action. Insulin would normally 
act to suppress lipolysis in adipose tissue (Jensen et al., 1989), which may be negated by 
high concentrations of Fetuin-A and result in an influx of fatty acids from adipose tissue 
that increase VLDL production (Lewis et al., 1995) and HDL cholesterol (Brinton et al., 
1991) but further research is required in this area (Ix et al., 2006).  
 
Circulating Fetuin-A is elevated in insulin resistance and type 2 diabetes and appears to play 
a significant role in the development of both (Stefan et al., 2008). In an examination of a 
large random sample of subjects (2,500 of 27,548 subjects) from the European Prospective 
Investigation into Cancer and Nutrition (EPIC)-Potsdam Study, Fetuin-A was reported to 
be an independent risk factor for type 2 diabetes. This finding remained even after 
adjustment for the established risk factors of this metabolic condition including age, body 
mass index, waist circumference, glucose, triglycerides, HDL cholesterol and A1C. These 
findings strongly suggest that Fetuin-A is an independent predictor for the risk of 
developing type 2 diabetes (Stefan et al., 2008). 
 
2. 3. 3. 6. 1 . Effects of lifestyle intervention on circulating concentration 
of Fetuin-A 
The research available to date investigating the effects of exercise training on serum Fetuin-
A has reported varying results. Six weeks of aerobic exercise training in 14 non-diabetic 
obese women had no effect on Fetuin-A despite significant reductions in waist 
circumference and body fat mass (Schultes et al., 2010). Three months of concurrent 
training also had no effect on Fetuin-A in normal glucose tolerant obese women (n=40) 
despite significant reductions in BMI, waist circumference, blood pressure, and triglycerides 
post intervention (Yang et al., 2011).  
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Longer term exercise training may be required to positively influence serum Fetuin-A. 
Jenkins et al. (2011) investigated the effects of chronic exercise on serum Fetuin-A 
concentrations in young and older men with high activity levels compared to age and BMI 
matched less active controls. The investigators found that circulating Fetuin-A was 
significantly higher in the low activity groups (~20%) and was inversely related to fitness. 
The investigators also reported that Fetuin-A was related to cardiovascular and metabolic 
disease risk factors. Chronic exercise training exerted favourable effects on these risk 
factors, which was associated with the lower levels of Fetuin-A evident in the highly active 
groups (Jenkins et al., 2011). 
 
There is no data currently available regarding the effects of short term dietary interventions 
on circulating concentrations of Fetuin-A. However, a longer term (2 year) diet study 
shows that serum Fetuin-A decreases significantly in obese adults following diet induced 
weight los, and this trend continues even with weight regain. This may be due to either a 
delayed response to the initial weight loss or a continued benefit to adopting a healthier 
diet. The results suggest that Fetuin-A concentration may be influenced by factors other 
than just changes in body weight (Bluher et al, 2012). The finding that diet induced weight 
loss is associated with reduced circulating concentrations of Fetuin-A is supported by a 12 
month study in obese children. In this study the reduction in Fetuin-A was significantly 
related to the change in HOMA-IR, waist circumference and blood pressure in this group 
(Reinehr and Roth, 2008). 
 
There is no established pattern with regard to the effects of lifestyle intervention on the 
circulating concentration of Fetuin-A. This hormone is elevated in obese insulin resistant 
individuals and is also positively associated with NAFLD, diabetes and cardiovascular 
disease. Interventions that reduce adiposity and liver fat, and improve insulin resistance 
may decrease the production of Fetuin-A. Further research is required in this area. 
 
2. 3. 3. 7. Biomarker Summary 
It is clear that the circulating concentrations of the novel biomarkers are very much 
influenced by level of obesity and metabolic status. Research investigating the effects of 
exercise training and dietary restriction on these biomarkers has produced conflicting 
results but it appears that favourable alterations in body weight, body composition and 
metabolic health are associated with favourable changes in the production of these 
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biomarkers. The mechanisms underpinning these adaptations remain to be elucidated.  
Also, for the most part these biomarkers have been studied in isolation which may not be a 
true reflection of the integrated response from the body. Therefore there is a need to study 
the interaction between these biomarkers and their integrated response to lifestyle 
intervention. These biomarkers may prove to be useful independent predictors of 
metabolic status but further research is required.  
 
2. 3. 4. Summary 
Obesity is a serious global health issue which has currently reached epidemic proportions. 
When obesity is combined with low fitness levels the health consequences may be even 
more drastic (Kampert et al., 1996, Blair et al., 1989). It is widely acknowledged that diet 
and exercise interventions are effective in reducing obesity. The effectiveness of both has 
been compared in the literature but few isocaloric diet and exercise interventions exist 
making a direct comparison impossible. Also, there are a number fundamental differences 
in the response to both of these interventions. Firstly, exercise training alone significantly 
improves cardiovascular fitness which reduces the risk of all cause mortality in this 
population in a dose dependant manner (Blair et al., 1989, Kampert et al., 1996). Secondly, 
the changes that occur to body composition in response to both interventions are very 
different and can not be determined by a measurement of body weight. Weight loss post 
diet intervention is proportional to calories restricted but is often derived from a 
combination of reductions in fat and lean tissue mass. This is particularly true with very low 
calorie diets. Weight loss post exercise intervention is not proportional to calories 
expended in training because exercise training in previously sedentary individuals increases 
lean tissue mass. Importantly, weight loss post exercise intervention may be minimal but 
the changes that occur to body composition are often quite substantial. Finally, the 
literature reports that both interventions successfully improve metabolic health in this 
population but they may do so via different mechanisms. Their effect on the novel 
biomarkers of insulin resistance is not conclusive and limited information is available to 
date.  Further research is required in this area. 
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Chapter 3. The effects of isocaloric diet 
and exercise interventions on body 
composition and metabolic health in 
obese individuals. 
97 
 
3. 1. Rationale 
Obesity is a serious global health problem which has reached epidemic proportions (WHO, 
2009). The primary cause of obesity is a mismatch between energy intake and energy 
expenditure resulting in a surplus of energy, which is predominantly stored as fat in the 
adipose tissue. Chronic exposure to excess energy leads to an expansion of fat stores so 
that the person initially becomes overweight and eventually obese  (Speakman, 2004). Diet 
and exercise interventions remain the cornerstone of treatment for obesity. Both 
interventions have been compared in the literature and the general consensus appears to 
lean towards diet being more effective when weight loss is the primary outcome measure 
(Franz et al., 2007). However, few isocaloric diet and exercise interventions exist making a 
direct comparison impossible. The caloric restriction most commonly prescribed in dietary 
interventions is 3,500kcal per week, which accumulates to a weight loss of ~0.39kgs per 
week when energy expenditure is controlled for (Franz et al., 2007). In contrast, the energy 
expenditure prescribed in many exercise interventions is approximately 1,000kcal per week 
(Donnelly et al., 2009), which yields a weight loss of ~0.11kgs per week controlling for 
energy intake. An additional challenge that exists when comparing the effectiveness of both 
interventions is that they are both associated with very different changes in body 
composition, which may have important implications for metabolic health. Exercise 
training reduces fat mass and simultaneously maintains or increases lean tissue mass 
especially in previously sedentary individuals (Stewart et al., 2005). For this reason net 
weight loss post exercise training is often minimal but the changes that occur to body 
composition can be quite substantial. In contrast, the weight loss achieved by caloric 
restriction is directly proportional to the amount of calories restricted, but it is often 
derived from reductions in fat mass concurrent with reductions in lean tissue mass (Franz 
et al., 2007). The differential changes in body composition in response to both 
interventions may also influence the production and thus circulating concentrations of 
novel biomarkers of insulin resistance. A comparison of iocaloric diet and exercise 
interventions is essential to determine their effects on the physical characteristics, metabolic 
characteristics and biomarker profile of obese individuals.  
 
3. 2. Aim 
The aim of this study was to compare the physiological responses and biomarker profiles 
of insulin resistance and body composition following an isocaloric diet or exercise 
interventions. 
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3. 3. Objective 
 To assess changes in body composition, insulin resistance and aerobic fitness 
following a 12 week isocaloric dietary restriction or exercise intervention. 
 To measure novel biomarkers responses to the intervention and create biomarker 
profiles. 
 
3. 4. Hypothesis 
Dietary restriction and exercise training will result in distinctive physiological and biological 
profiles following a 12 week intervention in obese individuals. Exercise training will confer 
more favourable changes on body composition than dietary restriction. 
  
3. 5. Overview of Original Study Design 
This was originally designed as a cross-over study following a successful European 
Foundation for the Study of Diabetes award to Prof. John Nolan in St. James’s Hospital. In 
DCU, young (18-30yrs) and older (50-70yrs) obese but normal glucose tolerant individuals 
were to undertake a 3-month isocaloric diet or exercise intervention in random order. 
These subjects were matched for age and BMI with a group of young and old type 2 
diabetic subjects recruited in St. James’s Hospital. The original design is depicted in Figure 
3.1. This study was a major undertaking as part of a PhD and the design was too complex 
to allow for meaningful comparisons. The data used in the analysis of this chapter was a 
subset of the overall cohort that allowed for unbiased group comparisons.  
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Diet Intervention
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Intervention
Visit 1
-Medical exam,  VO2max test + 
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12 Week
Exercise 
Intervention
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Diet Intervention
Visit 2
Repeat visit 1 
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Visit 3
Repeat visit 1 
tests
 
Figure 3.1 Overview of original study design which was decided before this PhD 
began. 
 
3. 6. Overview of Actual Study Design 
The physical and metabolic responses of obese subjects to a 12-week isocaoloric diet 
restriction or exercise intervention were compared.  The complexity of the analysis of the 
original cross over design and the interaction effects led us to exclude the second phase of 
the intervention. The complex nature of this original design also resulted in a smaller 
sample size than originally anticipated. While a larger number of subjects were recruited to 
the study, the data presented in this chapter, refers to those that successfully completed.  
  
Subjects were recruited from staff and students in Dublin City University. Following a 
health screening and medical exam, subjects were randomly assigned to either a 12 week 
diet intervention or a 12 week exercise intervention. A number of tests were completed at 
baseline and repeated after the 12 week intervention. The tests and procedures are 
explained in detail below. 
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12 week exercise intervention
(expend 2,500kcal/wk)
Start date: Sept 2008
End date: Jan 2011
(data collection ongoing for 2yrs)
Pre Tests
-Medical exam,  VO2max 
test + ECG,  OGTT, Biopsy, 
DEXA, food diary
Subject
Recruitment
Post Tests
Repeat Pre Tests
12 week diet intervention
(2,500kcal deficit/wk)
Start date: Sept 2008
End date: Jan 2011
(data collection ongoing for 2yrs)
 
Figure 3.2 Overview of the actual study design that was conducted for this PhD 
thesis. 
 
3. 7. Test Procedures 
To follow is a detailed explanation of the tests outlined in Figure 3.2. 
 
3. 7. 1. Subject recruitment 
An email was sent to all staff and students in DCU briefly outlining the nature of the study 
(Appendix 3). All individuals who responded to the email received a copy of the plain 
language statement (Appendix 4), which explained the study in great detail. A private 
meeting was then arranged with each potential participant and all elements of the study 
were discussed in detail including the nature of the study, the tests involved, the 
interventions involved, and all risks and benefits associated with the study. The informed 
consent form (Appendix 5) was explained to the potential participant at this time and they 
were also given an opportunity to ask any questions they had. Potential participants were 
advised to re read the informed consent form in their own time and return a signed copy if 
they wished to take part in the study.  
 
Upon receiving the informed consent form, each participant then completed a health 
history questionnaire (Appendix 6), which was reviewed by the study physician, and they 
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underwent a medical examination to confirm their suitability for the study. Subjects were 
excluded at this point if they had uncontrolled hypertension, unstable cardiovascular 
disease, hepatic or renal disease, active cancer, HIV infection, previous thyroid surgery or 
hyperthyroidism, chronic diarrhoea, were pregnant, or unable to stay in the same 
geographic location for the duration of the study. Twenty five subjects originally 
volunteered for the study. Of these individuals, one subject completed baseline testing 
only, two subjects dropped out of the study due to work commitments, three subjects 
dropped out of the study due to the development of medical conditions including 
appendicitis, pregnancy and stress induced high blood pressure (work related), and two 
subjects were non compliant with the interventions. The remaining seventeen subjects were 
randomly assigned to complete either a 12 week diet intervention or a 12 week exercise 
intervention in addition to a number of baseline and post intervention tests. One additional 
obese non diabetic subject was tested and trained in St James Hospital due to its proximity 
to their home, giving a total of eighteen subjects who completed the study. Ten subjects 
were randomly assigned to the exercise intervention of which 5 were male and 5 were 
female. Eight subjects were randomly assigned to the diet intervention of which 4 were 
male and 4 were female. This study was approved by the DCU Research Ethics Committee 
and conformed to the Declaration of Helsinki.  
 
3. 7. 2. Anthropometric measurements 
Height and body mass were measured to the nearest 0.1 cm and 0.1 kg respectively (SECA, 
Hamburg, Germany). Subjects were weighed barefoot and with minimal clothing. They 
were advised to keep their food and fluid intake similar on the day of the weight 
measurement. This measurement was taken at the same of the same day each week where 
possible. 
 
3. 7. 3. Body composition analysis / DEXA Scan 
Body composition was measured in the Exwell Medical Clinic, Ballymun, Dublin 9 using a 
Dual Energy X-Ray Absorptiometry (DEXA) scan. This technique is commonly used to 
measure bone mineral density but has become a standard technique for determining body 
composition (Putz et al, 2004; Azuma et al., 2007, Stefan N. et al, 2004). Subjects were 
required to sign an informed consent form (Appendix 7) prior to undertaking this scan due 
to exposure to a minimal amount of radiation. Subjects were instructed to remove shoes, 
socks, jewellery, as much clothing as possible, and lay flat on the bench with their eyes 
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closed or protected by goggles. The full body scan took 7 minutes after which a report was 
generated which detailed the body mass of the subject in addition to their percent body fat, 
percent lean tissue and percent bone mass (Figure 3.3). This technology was unavailable in 
the first year of data collection as it had been damaged by flooding. For this reason body 
composition analysis is only available for year 2 of data collection. 
  
Note: The radiation exposure from a whole body DEXA is approximately 1.0-3.6 μSv 
(Njeh et al., 1999), in comparison to a standard chest X-ray of approximately 100 μSV. On 
an annual basis we are exposed to approximately 2400 μSv (Thorne MC, 2003). Therefore, 
the DEXA is equivalent to no more than 1-3 days of background exposure.  
 
        
 
Figure 3.3 Shows the DEXA scan and the body composition output derived from 
this scan. 
 
3. 7. 4. O2max test with Electrocardiogram (ECG) 
All subjects performed an incremental exercise test to volitional fatigue on an electrically 
braked cycle ergometer (Ergoline 900, SensorMedics, Yorba, Linda, CA) to determine 
maximal oxygen consumption ( O2max). A number of the subjects recruited for this 
intervention were older adults (>60yrs) and so it was determined that a stationary bicycle 
would be more appropriate for this population as it reduced impact and the risk of falling. 
Both male and female subjects underwent a 3 minute incremental protocol but the starting 
wattage and incremental increase in wattage was greater for males than for females. Briefly, 
male subjects began cycling at 80W for a five minute warm up, and the power output was 
increased by 50W every three minutes thereafter until volitional fatigue. Female subjects 
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performed the warm up at 50W and the power output increased by 35W thereafter every 
three minutes.  
 
All exercise tests took place under standard laboratory conditions (19-21°C, 40-55% 
relative humidity) and in the presence of the study physician. Expired oxygen, carbon 
dioxide, ventilatory volume, respiratory exchange ratios and O2max were determined by 
indirect calorimetry using the Innocor (INN00010 – Innocor® CPX System). Systolic and 
diastolic blood pressure was measured by the physician at rest and during the last minute of 
each stage of exercise. Rate of perceived exertion was taken during the last ten seconds of 
each stage using the 6-20 point Borg scale (Appendix 8). Electrical activity of the heart was 
recorded at rest and at the end of each stage using 12 lead ECG. Heart rate was recorded in 
the last 10 seconds of each stage. Subjects exercised until reaching volitional fatigue. 
Oxygen uptake was deemed to have peaked if two or more of the following criteria were 
satisfied (i) plateau of oxygen consumption with increasing power output (increase of less 
than 2 ml/kg/min), (ii) heart rate within 10 beats of the subjects’ age predicted maximum 
heart rate (220bpm – age in years) and (iii) respiratory exchange ratio >1.10. O2max was 
determined as the highest minute average recorded for oxygen uptake during the test.  
 
3. 7. 5. Glucose Tolerance and Insulin Sensitivity 
In order to rule out previously undiagnosed type 2 diabetes, impaired fasting glucose or 
impaired glucose tolerance, subjects underwent a standard 3 hour Oral Glucose Tolerance 
Test (OGTT) (Reinauer et al., 2002). In preparation for the test subjects were required to 
adhere to the following criteria (i) no exercise the day before the test (ii) consume adequate 
carbohydrate in the 3 days leading up to the test to avoid low glycogen levels (iii) refrain 
from taking medication the morning of the test (iv) fast for 10 hours prior to the test. On 
the morning of the test, the 75 g (113 ml) anhydrous glucose equivalent (Polycal; Nutricia 
Clinical, Trowbridge, United Kingdom) was consumed in 300 ml of water within 5 
minutes. Blood samples were taken 10 minutes prior to consuming the glucose load, and 
also at 30, 60, 90, 120 and 180 minutes after ingesting the glucose load. Total area under 
glucose curve (AUCG) and insulin curve (AUCI) was determined by the trapezoidal 
method as presented in Equations 3.1 and 3.2 respectively (Tai, 1994, Psyrogiannis, 2003). 
HOMA-B (Equation 3.3) was used as an indicator of fasting insulin secretion (Song, 2007). 
The AUCG/AUCI index (Penesova, 2004), Matsuda model (Matsuda, 1999) and Stumvoll 
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model (Stumvoll, 2000) (Kanauchi, 2003) were also used an indices of insulin sensitivity 
(Equations 3.4, 3.5 and 3.6 respectively). 
 
 
Equation 3.1 Area under the glucose curve 
AUCG = 0.25 x (fasting glucose) + 0.5 x (glucose at 30 minutes) + 0.75 x (glucose 
at 60 minutes) + 0.5 x (glucose at 120 minutes)  
 
Equation 3.2 Area under the insulin curve 
AUCI = 0.25 x (fasting insulin) + 0.5 x (insulin value at 30 minutes) + 0.75 x 
(insulin value at 60 minutes) + 0.5 x (insulin value at 120 minutes)  
 
Equation 3.3 HOMA-B 
20 x fasting insulin (μIU/ml) / fasting glucose (mmol/ml) – 3.5  
 
Equation 3.4 Area under the glucose curve / area under the insulin curve 
 AUCG (Equation 3.1) / AUCI (Equation 3.2) 
 
Equation 3.5 Matsuda index of insulin sensitivity 
(10,000/square root of [fasting glucose x fasting insulin] x [mean glucose x mean 
insulin during OGTT])  
 
Equation 3.6 Stumvoll index of insulin sensitivity 
0.226 – (0.032 x BMI) – (0.0000645 x Insulin at 120 minutes pmol/L) – (0.00374 x 
Glucose at 90 minutes mmol/L) 
 
3. 7. 6. Collection, handling and storage of Blood Samples 
Prior to the OGTT subjects had a 20 or 22 GA indwelling cannula (BD VialonTM, 
Biomaterial, Spain) placed into a prominent forearm vein for blood sampling. Samples for 
glucose analysis were collected in grey top plasma tubes (BD Vacutainer®, 10 mg sodium 
fluoride, 8 mg potassium oxalate). Samples for insulin determination and other biomarkers 
were collected in red top serum tubes (BD Vacutainer®). Blood samples were collected 10 
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minutes before the oral glucose load and, 30, 60, 90, 120 and 180 minutes after the glucose 
load. Lines were flushed with saline solution after each blood draw. Approximately 2.5 ml 
of blood was evacuated as waste at each time point prior to the sample to be analysed 
being collected. The grey top vaccutainers for glucose analysis were immediately stored on 
ice. The red top vaccutainers were allowed to stand for 30 minutes at room temperature 
before centrifugation at 3000 r.p.m-1 (Dovio et al., 2007) for 15 min at 4ºC. Following this 
process aliquots were stored at -80○C for further analysis. 
 
3. 7. 7. Biochemical Analysis and Assays 
Plasma glucose was measured using the glucose oxidase method (YSI 2300 Stat Plus, 
Yellow Springs, Ohio). Serum insulin was measured initially in St. James Hospital 
biochemistry laboratory using hospital using a commercially available flouroimmunassay. 
 
FGF21 was measured using a commercially available ELISA kit (R&D Systems, UK), as 
was IL-13 (R&D Systems, UK), Chemerin (BioVendor, Germany), Omentin (BioVendor, 
Germany), Fetuin-A (R&D Systems, UK) and Visfatin (Phoenix Pharmaceuticals, Inc., 
CA). 
 
Free Fatty Acids, plasma triglycerides, total cholesterol, LDL cholesterol and HDL 
cholesterol were measured with Randox reagents on the Randox-Daytona automated 
analyser using a spectro-photometric method (Randox, Antrim, Northern Ireland). 
 
3. 7. 8. Muscle Biopsy 
The muscle biopsies were performed by the study physician under sterile conditions. 
Skeletal muscle specimens were taken by muscle biopsy from the m. vastus lateralis under 
local anaesthesia. An area of skin, subcutaneous tissue, and fascia was anaesthetized with 
2% w/v Lidocaine HCl and a small (0.5 cm) incision made. The biopsy needle was inserted 
into the muscle and approximately 100-200 mg of tissue removed using the percutaneous 
muscle biopsy technique with suction applied. Muscle samples were snap-frozen in liquid 
nitrogen and stored at –80°C until analysis. Muscle biopsies were taken in all subjects pre 
and post intervention. A fresh incision was made for each biopsy, at least 2 cm from a 
previous biopsy site. Subjects were provided with post biopsy care and treatment 
instructions (Appendix 12). The study investigator called all subjects on the evening of the 
day they had their biopsy and again the following morning to follow up. These biopsies are 
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currently being analysed as part of other projects and will not be reported as part of this 
PhD thesis. 
 
3. 7. 9. Aerobic Exercise Prescription Using Metabolic Equations 
A baseline O2max test was conducted for all subjects. This data was used to individually 
prescribe aerobic exercise training for those who were randomly assigned to the exercise 
intervention. Subjects were required to exercise at 70% of their O2max. The ACSM 
metabolic equations (ACSM, 2010 pp158) were used to calculate the speed and grade on 
the treadmill, and the wattage on the cycle ergometer that corresponded to 70% of their 
O2max.. These equations were also used to calculate the total exercise time required to 
expend 625kcal per session or 2,500kcal per week. A pilot study was conducted to confirm 
the accuracy and consistency of this approach (see 3.7.13). The subjects adapted to this 
workload quite quickly and so to ensure that the desired exercise intensity was maintained 
throughout the entire intervention, a O2max test was conducted again in weeks 4 and 8 and 
the equations were recalculated to determine the new workloads for each subject.  
 
Equation 3.7 ACSM Metabolic Equation for Walking 
O2 (ml/kg/min) = 0.1 (speed in meters per min) + 1.8 (speed in meters per min) 
(grade in decimal form) + 3.5 
    
Equation 3.8 ACSM Metabolic Equation for Jogging 
O2 (ml/kg/min) = 0.2 (speed in meters per min) + 0.9 (speed in meters per min) 
(grade in decimal form) + 3.5 
 
Equation 3.9 ACSM Metabolic Equation for cycling 
O2 (ml/kg/min) = 7.0 + 1.8 (work rate in kgm/min) / (body weight in kgs) 
 
Equation 3.10 Calculation of Energy Expenditure from O2 
To convert O2 (l/min) to kcal/min = O2 (l/min) * (5kcal/min) 
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3. 7. 10. Data collection / record sheets / monitoring of subjects 
All exercise sessions for all subjects were monitored by the study investigator. Record 
sheets were devised for all subjects and the information recorded during the sessions 
included (i) heart rate, (ii) rate of perceived exertion, (iii) exercise intensity (speed, grade, 
level, RPM, Watts), and (iv) additional comments / events relevant to the particular 
exercise session.  
 
3. 7. 11. Polar Heart Rate Monitors 
When a special circumstance arose where a subject could not attend all 4 GYM based 
sessions per week, they were given a recordable polar heart rate monitor and a home based 
exercise session (based on walking or cycling) to complete to compensate for the missed 
GYM session. This monitor recorded heart rate throughout the entire session and this data 
was then downloaded by the study investigator and analysed to ensure the correct intensity 
and calorie expenditure was achieved 
 
3. 7. 12. Food Diary Analysis 
All subjects completed a 7 day food diary at baseline which was analysed by a clinical 
dietician in St. James Hospital. In order to simplify the completion of the food diary and 
improve adherence to this aspect of the intervention, subjects were not required to weigh 
their food intake. Instead, they estimated their intake based on pictures provided (Figure 
3.4 (a)) and household measures. A sample one day food diary is also presented in Figure 
3.4 (b). The clinical dietician converted these estimates into weights with the assistance of a 
food portion size converter reference manual (FSA, 2002). The weights were then entered 
into the WISP analysis package to determine food and nutrient intake. In the diet 
intervention, subjects also completed a 3 day food diary for analysis every two weeks. In 
the exercise intervention subjects completed a 3 day food diary every 4 weeks for analysis.  
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(a) 
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Figure 3.4 (a) demonstrates the method used to determine food portion size, (b) is a 
sample one day food diary. Nelson, M., Atkinson, M., and Myer, J. (1997). Food 
Portion Sizes : A Photographic Atlas. MAFF publications. 
 
 
 
 
 
 
 
(b) 
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3. 7. 13. Pilot Investigations 
In order to validate the methodology for this intervention, 4 weeks of pilot work was 
carried out prior to subject recruitment. Two individuals consented to take part in this pilot 
work. A O2max test was conducted at baseline for both subjects. The ACSM equations 
were used to determine the speed and grade on the treadmill and the wattage on the bike 
that the subjects needed to work at to exercise at an intensity of 70% O2max. These 
training sessions took place in the human performance laboratory in the school of health 
and human performance in Dublin City University where indirect calorimetry was also used 
to calculate the energy expenditure derived from the exercise bouts. This data was 
compared to the estimated energy expenditure calculated using the ACSM metabolic 
equations. The energy expenditure derived from actual and estimated measurements was 
comparable confirming that the ACSM equations could be used to prescribe exercise at the 
correct intensity and caloric expenditure for the obese subjects. The subjects completed 4 
exercise sessions per week for 4 weeks to investigate how quickly they adapted to exercise 
training and when programme updates would be required. Pilot work was also carried out 
on procedures including the OGTT, muscle biopsy and DEXA scan prior to subject 
recruitment. A number of ELISA kits were also run at this time to ensure that the 
investigator was proficient in this technique prior to the analysis of the novel biomarkers of 
insulin resistance. 
 
3. 8. Exercise intervention study design 
On the first day of testing subjects completed a O2max test with ECG on a cycle 
ergometer, as per detailed protocol in section They were also given a 7 day food diary to 
complete and return to the clinical dietician in St. James Hospital who performed the 
analysis. On the second day of testing they underwent a muscle biopsy and a 3 hour 
OGTT. This was followed by a DEXA scan in the ExWell medical clinic, Ballymun, to 
determine body composition. Please refer back to section 3.7 for details of these test 
procedures.  
 
For the exercise intervention, subjects trained in the fitness centre in Dublin City 
University 4 days per week for 12 weeks, working at an intensity of 70% O2max and 
expending 625kcal per session. The ACSM metabolic equations were used to determine the 
speed, grade, and length of time that the subjects would need to walk on the treadmill for 
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and the level and revolutions per minute that they would need to cycle for to expend 
625kcal per session. This was verified by the pilot work that was carried out prior to subject 
recruitment which is detailed in section 3.7.13. The subjects level of fitness, determined by 
the O2max test, in addition to their current weight, influenced the total time required to 
expend 625kcal. The average exercise session duration was 60-75 minutes. O2max testing 
was repeated for all subjects in weeks 4 and 8. The ACSM metabolic equations were 
recalculated using the new fitness levels and body weights and programmes for all subjects 
were updated to ensure that the desired energy expenditure and intensity of exercise was 
continuously achieved. To include variety and enhance motivation to train, other aerobic 
exercise equipment were incorporated into the sessions in week 6 including the cross 
trainer and the rowing machine. There are no metabolic equations for these pieces of 
equipment and so the subjects were given a target heart rate to work at on these pieces of 
equipment that corresponded to 70% O2max. The subjects also completed a 3 day food 
diary in week 4 and week 8, which was submitted to the clinical dietician and analysed to 
ensure that dietary intake did not change from baseline throughout the intervention. All 
subjects were weighed by the study investigator each week at the same time of the day and 
under the same conditions as much as possible. All training session for all subjects were 
supervised by the study investigator for the 2 years of data collection. The baseline tests 
were repeated upon completion of the intervention. 
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Figure 3.5 Schematic representation of the exercise intervention 
 
3. 9. Diet intervention study design 
The method used to recruit subjects to the dietary arm of this intervention was the same as 
that used for the exercise arm of the intervention. In order to avoid repetition the reader is 
asked to please refer to section 3.7.1 for details on recruitment. The tests and procedures 
outlined in figure 3.4 are common with the exercise intervention and so to avoid repetition 
the reader is asked to refer to sections 3.7.2 to 3.7.8 and 3.7.12.  At the beginning of the 
diet intervention, the subjects attended St. James Hospital for a consultation with the 
clinical dietician associated with the study. During this time the analysis from their baseline 
7 day food diary was discussed. The subjects were instructed to adopt a lower fat diet with 
a caloric deficit of ~365kcal per day or 2,500kcal per week. To help them achieve this the 
clinical dietician taught the subjects how to read food labels so that they could determine 
the calorie content and fat content of their portion sizes and calculate their total calorie 
intake each day. This was supported with handouts. The dietician also gave them extensive 
handouts which detailed the calorie and fat content of many common foods including a 
variety of fruits, vegetables, meats, carbohydrates and alcohol. The clinical dietician also 
Pre test 
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provided on going support in the form of weekly emails and phone calls to the subjects. In 
order to monitor compliance to the dietary intervention a 3 day food diary was completed 
by each subject every 2 weeks and submitted to the clinical dietician for analysis. Also to 
monitor compliance, the study investigator weighed all of the subjects every week at the 
same time of the day and under the same conditions. The weight loss target was 0.35kg 
every week. If the weight loss target was achieved the subjects were deemed to be 
compliant. If the weight loss target was either not achieved or was too great the clinical 
dietician arranged a phone based consultation with the subject to discuss compliance, give 
advice and modified their diet as necessary. 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
Figure 3.6 Schematic representation of diet intervention 
 
3. 10. Statistical Analyses 
Experimental data is presented as mean ± standard deviation. Data was evaluated using the 
Sigmaplot 12 statistical package (Systat Software, Inc. Chicago, IL). Statistical significance 
was set as p<0.05. To follow is a description of the statistical tests that were used in the 
analysis of the data in this chapter. 
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3. 10. 1. Dependent t-test 
A paired or dependent samples t-test was used to compare mean values of a dependent 
variable pre and post intervention for the same group. Statistical significance was set at 
p<0.05. 
 
3. 10. 2. Independent t-test 
An unpaired or independent samples t-test was used to compare the change (mean change) 
in a dependent variable in one group to the change (mean change) in the same dependent 
variable in another group post intervention. Statistical significance was set at p<0.05. 
 
3. 10. 3. Pearson correlation 
Pearson correlations were used to measure the strength of association between two 
variables. The correlation coefficient is represented by r. An r value of 1.0 indicates a 
perfect positive relationship between two variables. An r value of -1.0 indicates a perfect 
negative relationship between two variables. Statistical significance was set at p<0.05. 
 
3. 10. 4. Stepwise linear regression (backwards stepwise regression) 
Stepwise linear regression is used to predict the value in one variable from the value in one 
or more other variables. This test can determine the independent variable (s) that best 
predict the dependent variable. For the analysis in this chapter, a backwards stepwise 
regression test was used to identify the change in the independent variable (s) that best 
predicted the change in the dependent variable post intervention. Prior to performing 
backwards regression, pearson regression analysis was run to identify the independent 
variables that were significantly correlated with the dependent variable. These independent 
variables were entered into the backwards regression model and were eliminated one by 
one until the independent variable (s) that best predict the change in the dependent variable 
were identified. Multicollinearity exists when independent variables are highly correlated 
(r=.9 and above). To avoid multicollinearity only one of the related variables were entered 
into the regression analysis. An R2 of 1.0 indicates a perfect prediction model. Statistical 
significance was set at p<0.05.   
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3. 11. Results 
The data was analysed in a number of sequential steps. Firstly, a comparison of the physical 
and metabolic raw data was performed. Secondly, we studied a number of novel 
biomarkers that were identified as mainly, though not exclusively, secreted from adipose 
tissue to determine if the diet and exercise interventions differentially regulated their 
circulating concentration. Finally, physiological and biological changes associated with the 
diet and exercise interventions were identified using a linear regression analysis to establish 
the relationship between changes in variables and then by backward stepwise regression 
analysis to identify those that best predicted the changes. 
 
All subjects who took part in this study were obese at baseline and had been inactive for a 
minimum of 6 months prior to enrolling in the study. Inactive was defined as not meeting 
the ACSM’s recommendations for health which is a minimum of 150 minutes of moderate 
intensity physical activity per week (Donnelly, Blair et al. 2009). The baseline values for the 
physical characteristics, metabolic characteristics, and biomarker profile are presented in 
table 3.1, 3.2 and 3.3 respectively. Intervention groups were matched for age, weight and 
BMI but there were still some baseline differences, despite randomisation, in fat mass 
(p=0.03), AUCI (p=0.01), AUCG/AUCI (p=0.002), Matsuda (p=0.01) and Omentin 
(p=0.04).  The differences in insulin were most surprising and despite having analysed 
them a number of times, in different centres, the difference can only be explained by 
random variation. 
 
3. 11. 1. Physical Characteristics 
Following both interventions there was a significant reduction in body weight (p=0.01), 
BMI (p=0.01) and fat mass (kg) (p=0.05). An unpaired t-test revealed that there was no 
difference between groups in the percent change in these variables. Although the weight 
lost in each group was similar, it is important to note that the exercise group achieved a 
12.2% reduction in fat mass compared to a 5.8% reduction in the diet group. There was an 
11% or 3kg increase in lean tissue following the exercise intervention but there were no 
statistically significant changes in either group, or between groups post intervention. Total 
percent body fat and total percent lean tissue determined by the DEXA scan did not 
change significantly in either group post intervention. In all future analysis, fat mass (kg) 
and lean tissue mass (kg) are used instead of percent body fat and percent lean tissue in 
order to avoid multicolinearity. Aerobic fitness, measured by O2max (ml/kg/min) 
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increased significantly post exercise intervention (p<0.001) but did not change post diet 
intervention (p=0.22). The smaller than anticipated sample size limited the depth of 
statistical analysis and meant a paired samples t-test was used to examine the extent of 
changes following the intervention rather than the preferred option of a 2-way ANOVA. 
 
Table 3.1 Pre and post values for the physical characteristics of the subjects in the 
exercise and diet group. The percent change in each variable that occurred post 
intervention is also presented. 
 Exercise Diet % change 
Variable Pre Post Pre Post Exercise Diet 
 (n=10) (n=8)   
Age (yr) 45 ± 14 
 
 45 ± 16    
Weight (kg) 98.6 ± 20.7 96.0 ± 20.0* 99.3 ± 15.5 96.3 ±15.3* 
 
-2.6 ± 2.5 -3.1 ± 2.9 
BMI (kg/m2) 34.8 ± 5.2 33.9 ± 5.3* 32.7 ± 4.0 31.7 ± 4.1* 
 
-2.6 ± 2.5 -3.1 ± 2.9 
Fat mass (kg) 46.8 ± 21.9 40.9 ± 19.1* 45. ± 6.5  43.0 ± 5.2* 
 
-12.2 ± 11.0 -5.8 ± 5.1 
% body fat 
 
47.0 ± 13.6  42.3 ± 12.0٢ 46.2 ± 5.9  44.4 ± 5.11 -9.8 ± 9.1 -3.7 ± 4.4 
Lean tissue 
(kg) 
47.6 ± 12.6 50.8 ± 11.1 52.1 ± 13.1 52.5 ± 12.3 8.6 ± 14.2 1.4 ± 6.3 
% Lean 
Tissue 
50.3 ± 13.3 54.8 ± 11.6٢ 51.5 ± 6.0 53.3 ± 5.5 11.0 ± 12.6 3.6 ± 5.1 
O2max 
(ml/kg/min) 
22.7 ± 5.6 29.3 ± 8.5* 21.8 ± 6.1 23.5 ± 6.3 29.3 ± 20.7 10.1±20.8 
O2max 
(L/min) 
2.3 ± 0.7 2.9 ± 0.8* 2.2 ± 0.9 2.3 ± 0.9 28.3 ± 18.3 8.3±21.6 
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change in 
the variable post intervention. Note: n=5 for fat mass, % body fat, lean tissue mass and % 
lean tissue in both groups. ٢p<0.09 is trending towards a significant change post 
intervention.   
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Figure 3.7 Percent change in weight (kg), fat mass (kg) and fitness ( O2max 
ml/kg/min) post intervention presented as mean ± SD. *p<0.05 represents a 
significant change in the variable post intervention.  
 
3. 11. 2. Metabolic characteristics 
The changes that occurred in the metabolic characteristics post intervention are presented 
in Table 3.2. There was a significant decrease in insulin secretion and increased insulin 
sensitivity in the exercise group but not in the diet group. In the exercise group, this was 
evident as a significant reduction in AUCI (p=0.01) and HOMA-B (p=0.04), in addition to 
a significant increase in the AUCG/AUCI index (p=0.02). These findings are supported by 
trending changes in the Stumvoll (p=0.06) and Matsuda (p=0.08) predictors of insulin 
sensitivity. Following the diet intervention, there was no change in AUCG (p=0.71), AUCI 
(p=0.12), AUCG/AUCI (p=0.10), HOMA-B (p=0.18), Stumvoll (p=0.71), or Matsuda 
(p=0.54).  
 
The lipid profile of the subjects was also measured pre and post intervention. These values 
in addition to the percent change that occurred to the lipids are presented in Table 3.2. 
There was no significant change in the lipid profile of the subjects following the diet or 
exercise intervention.  
 
 
* 
* * 
* 
* 
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Table 3.2 Pre and post values for the metabolic characteristics of the subjects in the 
exercise and diet group. The percent change that occurred to each of the variables 
post intervention is also presented. 
 Exercise Diet % change 
Variable Pre Post Pre Post Exercise Diet 
 (n=10) (n=8)   
AUCG 1092 ± 189 109 ± 197 1166 ± 
157 
1142 ± 
135 
1.1 ± 14.8 -0.9 ± 14.6 
 
AUCI 21020 ± 
8850 
15373±9031* 9332 ± 
6274 
7494 ± 
4666 
-27.4 ± 21.3 -12.4 ± 
26.0 
AUCG 
/AUCI 
0.06  ± 0.02 0.09 ± 0.05 * 0.17 ± 
0.09 
0.19 ± 0.08 50.3 ± 46.3 19.0 ± 
25.2 
HOMA-B 58.3 ± 25.8 51.5 ± 28.5 *  35.6 ± 
24.9 
23.8 ± 13.0 
 
-14.1 ± 17.9 -14.9 ± 
39.4 
Stumvoll 0.136 ± 
0.043 
0.125±0.031٢ 0.118 ± 
0.015 
0.116 ± 
0.013 
-7.02 ± 7.53 -0.7 ± 7.0 
Matsuda 7.7 ± 3.5 10.2 ± 4.7٢ 18.1 ± 
10.0 
19.6 ± 7.9 34.8 ± 49.1 21.2 ± 
44.3 
FFA’s 0.60 ± 0.12 0.62 ± 0.16 0.60 ± 
0.30 
0.51 ± 0.17 4.52 ± 
19.42 
4.51 ± 
55.60 
TG’s 1.77 ± 1.07 1.40 ± 0.66 1.25 ± 
0.31 
1.16 ± 0.30 -10.1 ± 32.6 -6.6 ± 11.2 
 
TC 5.11 ± 1.64 5.00 ± 1.54 5.20 ± 
0.41 
5.20 ± 0.35 1.96 ± 
31.15 
0.19 ± 
6.56 
LDL 3.52 ± 1.49 3.21 ± 1.23 3.18 ± 
0.74 
3.41 ±0.50 -1.4 ± 32.9 10.1 ± 
18.7 
HDL 1.08 ± 0.20 1.08 ± 0.31 1.31 ± 
0.37 
1.23 ± 0.22 4.8 ± 26.8 -3.6 ± 15.3 
 
Data is presented as mean ± standard deviation. *p<0.05 represents significant change pre 
and post intervention. ٢p<0.09 is trending towards a significant change post intervention. 
Note: AUCG = Area Under the Glucose Curve, AUCI = Area Under the Insulin Curve, 
AUCG/AUCI = Area Under the Glucose Curve / Area Under the Insulin Curve (index of 
insulin sensitivity), HOMA-B is an index of fasting insulin secretion, Stumvoll and 
Matsuda are indexes of insulin sensitivity, FFA’s = Free Fatty Acids, TG’s = Triglycerides, 
TC = Total Cholesterol, LDL = Low Density Lipoprotein Cholesterol, HDL = High 
Density Lipoprotein Cholesterol.  
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An unpaired samples t-test revealed that there was no difference between groups in the 
percent change that occurred to AUCI (p=0.21), AUCG/AUCI (p=0.11), or HOMA-B 
(p=0.96) post intervention. 
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Figure 3.8 Percent change in the area under the insulin curve (AUCI), the area 
under the glucose curve / area under the insulin curve (AUCG/AUCI) and HOMA-
B which is a measure of fasting insulin secretion post intervention in the exercise 
and diet group. Data is presented as mean percent change ± standard deviation. 
*p<0.05 represents a significant change post intervention.  
 
3. 11. 3. Biomarker Profile 
A number of novel biomarkers related to insulin resistance and metabolic health were 
measured pre and post intervention. The circulating concentrations of these biomarkers as 
well as the percent change that occurred to the concentrations of these biomarkers post 
intervention are presented in Table 3.3. There was a lot of inter-individual variation for all 
of the biomarkers and the paired samples t-tests showed that there was no significant 
change in the circulating concentration of FGF21 (p=0.99), IL-13 (p=0.95), Chemerin 
(p=0.33), Omentin (p=0.87) or Visfatin (p=0.86) post exercise intervention, but there was 
a significant reduction in Fetuin-A (p=0.02). Following the diet intervention, there was no 
change in any of the biomarkers but there was a trend toward a change in Omentin 
(p=0.06). The percent change in Chemerin was significantly greater following the diet than 
the exercise intervention (p=0.05). While the individual variation makes it difficult to 
* 
* 
* 
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determine if changes in these biomarkers have any role, there is some evidence of 
biomarker specific responses to diet or exercise. Therefore, the next stage was to conduct 
correlation and regression analysis of the data to examine association between the variables. 
 
Table 3.3 Pre and post values for the novel biomarkers. The percent changes that 
occurred post intervention are also presented. 
 Exercise Diet % change 
Variable Pre Post Pre Post Exercise Diet 
 (n=10) (n=8)   
FGF21 222.3 ± 
124.1 
223.0 ± 79.0 382.8 ± 
241.7 
256.4 ± 118.7 28.5 ± 85.9 -1.1 ± 
81.4 
IL-13 106.6 ± 
33.4 
105.8 ± 30.4 98.3 ± 
19.9 
94.1 ± 13.5 3.1 ± 23.8 -3.2 ± 9.4 
 
Chemerin 224.1 ± 
39.0 
216.2 ± 38.4 278.0 ± 
106.6 
216.4 ± 65.1 -3.2 ± 11.9 -19.2 ± 
16.2 
Omentin 279.0 ± 
133.9 
271.5 ± 
118.8 
424.9 ± 
114.6 
374.3±134.8٢ 7.1 ± 37.0 -12.4 ± 
13.9 
Visfatin 16.0 ± 4.3 16.2 ± 5.6 14.4 ± 2.9 14.9 ± 3.1 0.2 ± 3.4 6.0 ± 23.7 
 
Fetuin-A 578.5 ± 
141.2 
464.9±76.1* 561.5 ± 
78.0 
530.31 ± 
163.5 
-19.8 ± 13.1 -4.1 ± 
32.1 
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change 
post intervention.  ٢p<0.09 is trending towards a significant change post intervention. 
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Figure 3.9 Percent change in the biomarkers post intervention. Data is presented as 
mean ± SD.         *p<0.05 represents a significant change post intervention, ٢p<0.09 
represents a trend towards a significant change post intervention. †p<0.05 
represents a significant difference between groups in the percent change the 
occurred to the biomarker post intervention. 
 
3. 11. 4. Pearson correlation and backwards stepwise regression analysis 
The pearson correlation analysis for the physical characteristics, as presented in Table 3.4. 
showed that the percent change in weight following the exercise and diet interventions did 
not relate to any of the metabolic adaptations and it was only correlated with the percent 
change in BMI and the Matsuda insulin sensitivity index for the diet intervention. 
 
On the other hand, the percent change in fat mass appeared to correlate better with 
metabolic adaptations following the exercise intervention and was positively related to the 
percent change in AUCG and total cholesterol, with a trend for HOMA-B. In the diet 
group, the percent change in fat mass was only significantly correlated with the percent 
change in another predictor of insulin sensitivity, Stumvoll. 
 
The percent change in fitness following the exercise intervention was significantly 
positively correlated with indicators of insulin sensitivity and lipid metabolism including the 
percent change in Matsuda, AUCG, AUCI, HOMA-B, triglycerides, total cholesterol, and 
LDL cholesterol, with a trending relation with the AUCG/AUCI index. In the diet group, 
* ٢ † 
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the percent change that occurred to fitness, although not statistically significant, was 
significantly correlated with the percent change in fat mass and FFA’s, with a trending 
relation with HOMA-B. 
 
The change that occurred in percent lean tissue (%) was correlated with the percent change 
in IL-13 (p=0.03) in the exercise group. 
 
Backwards stepwise regression was not carried out on the physical characteristics because 
the percent change that occurred to these variables post intervention was directly predicted 
by the actual physical exercise training that was carried out, in addition to the calories 
expended during the exercise sessions or the calories restricted during the dietary 
intervention. 
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Table 3.4 Summary of pearson correlations for the physical characteristics for the 
exercise and diet groups. 
 
Independent 
Weight (kg) Fat Mass (kg) Fitness (ml/kg/min) 
Variables Exercise Diet Exercise Diet Exercise Diet 
Body Mass 
Index 
 r=1.000 * 
p<0.001 
   
 
 
Fat Mass 
 
     r=0.979 * 
p=0.004 
AUCG   r=0.873 * 
p=0.05  
 r=-0.665 * 
p=0.05 
 
AUCI     r=-0.813 * 
p=0.01 
 
AUCG/AUCI     r=0.635 ٢ 
p=0.07 
 
HOMA-B   r=0.869 ٢ 
p=0.06 
 r=-0.755 * 
p=0.01 
r=0.690 ٢ 
p=0.06 
Stumvoll    r=-0.907 * 
p=0.03 
 
 
 
Matsuda  r=-0.700 * 
p=0.05 
  r=0.841 * 
p=0.001 
 
TC   r=0.952 * 
p=0.05  
 r=-0.789 * 
p=0.02 
 
TG’s     r=-0.708 * 
p=0.05 
 
LDL     r=-0.655 * 
p=0.04 
 
FFA’s 
 
     r=0.925 * 
p=0.003 
r represents the strength of the correlation between two variables, *p< 0.05 is significant. 
٢p<0.09 is trending towards significance. Note: AUCG = Area Under the Glucose Curve, 
AUCI = Area Under the Insulin Curve, AUCG/AUCI = Area Under the Glucose Curve / 
Area Under the Insulin Curve (index of insulin sensitivity), HOMA-B is an index of fasting 
insulin secretion, Stumvoll and Matsuda are indexes of insulin sensitivity, FFA’s = Free 
Fatty Acids, TG’s = Triglycerides, TC = Total Cholesterol, LDL = Low Density 
Lipoprotein Cholesterol.  
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Pearson correlations were run to investigate whether the change that occurred to AUCI, 
HOMA-B and AUCG/AUCI post intervention, was related to, or associated with, the 
change that occurred to any of the other measured variables. This data is presented in 
Table 3.5. In the exercise group, the percent change in AUCI was significantly positively 
correlated with the percent change in TG’s and total cholesterol, and inversely correlated 
with the percent change in O2max (ml/kg/min). These variables were entered into a 
backwards stepwise regression model, which eliminates each independent variable one by 
one until it ultimately determines the independent variable that most significantly predicts 
the percent change in the dependent variable. In this case the percent change in AUCI was 
most significantly predicted by the percent change in TG’s, which accounted for 70.6% of 
the variance in AUCI post intervention. Further backwards regression analysis revealed that 
the percent change in fitness best predicted the percent change in TG’s. This data is 
presented in Table 3.6. 
 
The percent change in AUCG/AUCI was inversely correlated with the percent change in 
TG’s and LDL cholesterol. It was trending towards a positive correlation with O2max 
(ml/kg/min). Backwards stepwise regression revealed that the percent change in TG’s was 
the most significant contributor to the percent change in AUCG/AUCI and accounted for 
64.9% of the variance as presented in Table 3.6. The percent change in fitness once again 
best predicted the percent change in TG’s as shown in Table 3.6. 
 
The percent change in HOMA-B was positively correlated with the percent change in 
FFA’s and AUCG. It was inversely correlated with the percent change in O2max 
(ml/kg/min). When backwards stepwise regression was performed, it revealed that the 
percent change in HOMA-B was most significantly predicted by the percent change in 
fitness, which accounted for 50.2% of the variance in HOMA-B post intervention as 
presented in Table 3.6. 
 
With regard to the diet intervention, the percent change in AUCI was only correlated with 
the percent change in AUCG. The percent change in AUCG/AUCI was only correlated 
with the percent change in total cholesterol. The percent change in HOMA-B was only 
correlated with the percent change in FFA’s and so backwards regression could not be run 
for these variables.  
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Table 3.5 Summary of pearson correlations for the metabolic characteristics in the 
exercise and diet groups. 
 
Independent  
AUCI AUCG/AUCI HOMA-B 
Variables Exercise Diet Exercise Diet Exercise Diet 
O2max 
(ml/kg/min) 
r=-0.813 * 
p=0.01 
 r=0.635 ٢ 
p=0.07 
 r=-0.755 * 
p=0.01 
 
AUCG 
 
 R=0.806 * 
p=0.02 
  r=0.735 * 
p=0.03 
 
TG’s 
 
r=0.840 * 
p=0.01 
 r=-0.806 * 
p=0.02 
   
FFA’s 
 
    r=0.660 * 
p=0.05 
r=0.799 * 
p=0.03 
TC 
 
r=0.802 * 
p=0.02 
  r=0.835 * 
p=0.02 
  
LDL 
 
  r=-0.761 * 
p=0.03 
   
r represents the strength of the correlation between two variables, *p< 0.05 represents a 
significant correlation between two variables. ٢p<0.09 represents a trend towards a 
significant relationship. Note: AUCI = Area Under the Insulin Curve, AUCG/AUCI = Area 
Under the Glucose Curve / Area Under the Insulin Curve, HOMA-B is a measure of 
fasting insulin secretion, AUCG = Area Under the Glucose Curve, FFA’s = Free Fatty 
Acids, TG’s = Triglycerides, TC = Total Cholesterol, LDL = Low Density Lipoprotein 
Cholesterol.  
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Table 3.6 Backwards stepwise regression analysis to predict the percent change in 
AUCI, AUCG/AUCI, and HOMA-B in the exercise group post intervention. 
Dependant 
variable 
Indep. 
variables in 
model 
Coef. Std. 
Coeff. 
Std. Error F-to-
Remove 
P 
% change in 
AUCI 
(R2=0.706) 
Constant -23.53  4.748   
 
% change in 
TG’s 
0.565 0.840 0.149 14.43 0.009 
% change in 
AUCG/AUCI 
(R2=0.649) 
 
Constant 45.44  10.740 
 
  
% change in 
TG’s 
-1.114 -0.806 0.334 11.11 0.016 
% change in 
HOMA-B 
(R2=0.891) 
 
Constant -2.196  5.124   
% change in 
O2max 
(ml/kg/min) 
-0.700 -0.944 0.141 24.61 0.016 
% change in 
TG’s 
(R2=0.502) 
 
Constant 21.798  15.678   
% change in 
O2max 
(ml/kg/min) 
-1.091 -0.708 0.444 6.068 0.049 
R2 represents the extent to which the change in the independent variable predicts the 
percent change in the dependent variable. p<0.05 is significant. Note: AUCI = Area Under 
the Insulin Curve, AUCG/AUCI = Area Under the Glucose Curve / Area Under the Insulin 
Curve (index of insulin sensitivity), HOMA-B is an index of fasting insulin secretion, TG’s 
= Triglycerides, O2max = aerobic fitness.  
 
Pearson correlations were run on the biomarkers to investigate if the percent change that 
occurred to these biomarkers post exercise or post diet, was significantly correlated with 
the percent change in any other variable. This data is presented in Table 3.7. 
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Table 3.7 Summary of pearson correlations between the percent change in the 
biomarkers and the percent change in all other measured variables for both the 
exercise and diet group.  
Variable Group Correlations with Independent Variables 
 
 
% change in 
FGF21 
Ex Not correlated with the percent change in any other measured 
variable 
Diet TC  
(r=0.767, p=0.04) * 
HDL 
(r=0.799, p=0.03) * 
 
 
% change in 
IL-13 
Ex Lean Tissue (kg) 
(r=0.907, p=0.03) * 
  
Diet Visfatin 
(r=0.934, p=0.07) ٢  
  
 
% change in 
Chemerin 
 
Ex O2max (L/min) 
(r=-0.716, p=0.05) * 
  
Diet Not correlated with the percent change in any other measured 
variable 
 
% change in 
Omentin 
 
Ex Stumvoll 
(r=-0.666, p=0.07) ٢  
  
Diet LDL 
(r=-0.851, 0.02) * 
IL-13 
(r=0.835, p=0.03) * 
 
 
% change in 
Visfatin 
 
Ex Not correlated with the percent change in any other measured 
variable 
Diet IL-13 
(r=0.934, p=0.07) ٢ 
Delta % LT 
(r=0.967, p=0.03) * 
Delta % BF 
(r=-0.968,p=0.03) * 
 
% change in 
Fetuin-A 
 
Ex FFA’s 
(r=0.684, p=0.08) ٢ 
  
Diet 
 
Not correlated with the percent change in any other measured 
variable 
r represents the strength of the correlation between variables. *p<0.05 is significant. 
٢p<0.09 is trending towards significance. Note: TC = Total Cholesterol, HDL = High 
Density Lipoprotein Cholesterol, LDL = Low Density Lipoprotein Cholesterol, Delta % LT 
= the actual change in % lean tissue, Delta % BF = the actual change in % body fat, FFA’s 
= Free Fatty Acids. 
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Backwards stepwise regression requires numerous significantly correlated independent 
variables to be entered into the model to determine those that best predict that change in 
the dependent variable. The number of significant correlations with the biomarkers that 
were identified by the pearson correlation analysis was limited. When these variables were 
entered into the backwards regression models they only accounted for approximately 10% 
of the variance in each particular biomarker in the exercise and diet group. In an attempt to 
better understand the variables that predicted the change in the biomarkers in both groups 
post intervention, backwards regression was run using the variables in Table 3.7 in addition 
to various combinations of other physical and metabolic variables. These combinations 
were determined based on the relationships that were identified in the literature.  
 
This backwards regression analysis presented in Table 3.8 revealed a number of similarities 
and differences between groups in terms of the independent variables that best predicted 
the percent change in the biomarkers post intervention. In the exercise group the percent 
change in lean tissue mass and fitness accounted for 93% of the variance in FGF21. In the 
diet group the percent change in HDL cholesterol accounted for 63.8% of the variance in 
FGF21. 
 
The percent change in IL-13 was best predicted by the percent change in lean tissue mass 
in the exercise group, which accounted for 82.4% of the variance, compared to the percent 
change in Visfatin, which accounted for 87.2% of the variance in the diet group post 
intervention. 
 
The single best predictor of the percent change in Chemerin post exercise intervention was 
the percent change in fitness, which accounted for 93.4% of the variance. Interestingly no 
measured variable predicted the percent change in Chemerin in the diet group. 
  
Indicators of insulin sensitivity predicted the percent change in Omentin in both groups 
post intervention. The percent change in Stumvoll accounted for 44.3% of the variance in 
Omentin in the exercise group. The percent change in AUCI accounted for 94% of the 
variance in Omentin in the diet group. 
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None of the measured variables predicted the percent change in Visfatin in the exercise 
group. The percent change in IL-13 was the best single predictor of the percent change in 
Visfatin in the diet group, accounting for 87.2% of the variance post intervention. 
 
Finally, 42% of the variance in Fetuin-A in the exercise group was predicted by the percent 
change in FFA’s. However none of the measured variables predicted the percent change in 
Fetuin-A post intervention in the diet group. 
 
 
 
 
 
Table 3.8 Backwards stepwise regression analysis to predict the percent change in 
the biomarkers in the exercise and diet groups post intervention. 
Study Dependant 
variable 
Indep. 
variables in 
model 
Coef. Std. 
Coeff. 
Std. 
Error 
F-to-
Remove 
P 
 
 
 
% change 
in  
FGF21 
 
 
Exercise 
(R2=0.930) 
Constant 1.553  8.055   
% change in 
LT (kgs) 
-1.599 -0.911 0.344 21.65 0.043 
% change in 
O2max 
(ml/kg/min) 
0.820 0.693 0.231 12.558 0.071 
Diet 
(R2=0.638) 
Constant 14.293  20.924   
% change in 
HDL 
4.251 0.799 1.432 8.815 0.031 
 
 
 
% change 
in  
IL-13 
 
 
Ex 
(R2=0.824) 
Constant 1.082 
 
 2.357   
% change in 
LT (kgs) 
0.299 0.907 0.080 14.003 0.033 
 
Diet 
(R2=0.872) 
Constant -6.768  2.606   
% change in 
Visfatin 
0.389 0.934 0.106 13.619 0.066 
Note: the % change in LT perfectly predicted the percent change in IL-
13 
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% change 
in 
Chemerin 
 
 
Ex 
(R2=0.934) 
Constant 35.59  8.081   
% change in 
O2max 
(L/min) 
-1.190 -0.967 0.223 28.42 0.033 
Diet 
 
None of the measured variables predicted the percent change in 
Chemerin post intervention in the diet group 
 
 
% change 
in 
Omentin 
 
Ex 
(R2=0.443) 
Constant -16.41  15.044   
% change in 
Stumvoll 
-3.107 -0.666 1.422 4.777 0.072 
Diet 
(R2=0.940) 
Constant -4.401  1.434   
% change 
AUCI 
0.701 0.970 0.125 31.418 0.03 
 
 
% change 
in  
Visfatin 
 
Ex 
 
None of the measured variables predicted the percent change in 
Visfatin in the exercise group post intervention 
 
Diet 
(R2=0.872) 
Constant 16.884  5.312   
% change in 
IL-13 
2.239 0.934 0.607 13.619 0.066 
 
% change 
in  
Fetuin-A 
Ex 
(R2=0.420) 
Constant -21.551  3.896   
% change in 
FFA’s 
0.409 0.648 0.196 4.349 0.082 
Diet None of the measured variables predicted the percent change in 
Fetuin-A post intervention in the diet group 
R2 represents the extent to which the change in the independent variable predicts the 
percent change in the dependent variable. p<0.05 is significant. p<0.09 is trending towards 
significance. Note: LT = Lean Tissue, O2max = aerobic fitness, AUCI = Area Under the 
Insulin Curve, FFA’s = Free Fatty Acids. 
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3. 12. Discussion 
The main findings of the current study were that both the diet and the exercise 
intervention were equally effective in reducing body weight and body fat mass, but the 
exercise group showed a trend towards greater improvements in body composition. Fitness 
and metabolic profile improved significantly in the exercise group only, with the increase in 
fitness accounting for the improvements in metabolic health in this group. Importantly the 
percent change in body weight did not relate to any of the metabolic adaptations post 
intervention in either group, but the percent change in fat mass did. The results also 
indicate that the biomarkers of insulin resistance may be differentially regulated by exercise 
and diet. Fetuin-A was the only biomarker to decrease significantly post intervention, 
which occurred in the exercise group, but there was a trend towards a change in Omentin 
in the diet group. The changes that did occur to the other biomarkers in both groups, 
although non significant, were associated with improvements in lean tissue and fitness and 
metabolic profile so they may be useful independent predictors in larger scale studies.   
 
Exercise training and/or dietary restriction continues to be the focus of weight loss 
interventions for obese individuals. Numerous studies have been conducted to investigate 
the effects of diet or exercise on weight loss and metabolic health in this population, but a 
review of this literature shows varying degrees of effectiveness (Franz et al., 2007). The 
difficulty in reviewing this data is that the designs underpinning the exercise interventions 
often differ greatly in terms of the number of exercise session per week, the intensity of 
exercise, the mode of exercise used in the intervention, and the total duration of the study 
(Franz et al., 2007). A similar picture is true for the diet interventions that have been 
reported in the literature since there is extensive variation between studies with regard to 
the amount of calories restricted, in addition to the nutritional composition of the diets 
(Franz et al., 2007). It is unclear whether one type of intervention is superior to the other in 
terms of the magnitude of metabolic benefits that they produce in this population. 
 
The purpose of this study was to compare the effectiveness of an isocaloric diet or 
exercise intervention on body composition and metabolic health in an obese population. 
The results show that both interventions were successful in reducing body weight and body 
fat mass. It is worthy to note that the actual change in fat mass was a 12% or 5.9kg 
reduction in the exercise group compared to a 6% or 2.8kg reduction in the diet group, but 
the difference between groups did not reach statistical significance because of the small 
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sample size. The literature supports the finding that 12 weeks of diet or exercise 
successfully reduces body weight and body fat mass in obese individuals, but there is large 
variability in the magnitude of change due to differences that exist in the exercise and 
dietary protocols. The main criteria for the dietary intervention in this current study, was to 
adopt a lower fat diet with a total calorie deficit of approximately 350kcal per day. This 
yielded an average weight loss of 3.1kgs or 3.1% of total body weight, and an average fat 
loss of 2.8kgs or 5.9% of total body fat. One other study in the literature that used a similar 
calorie deficit and intervention duration, reported a similar weight loss of 2.7%, but an 
average fat loss of 8.2% (Lee et al., 2013a). The difference in fat loss between the two 
studies may be a reflection of the small sample size for body composition in this current 
study. A review of short term dietary interventions surmises that there is a dose response 
relationship between the amount of fat restricted in the diet, and the amount of weight loss 
achieved. A modest 10% reduction in daily dietary fat intake in obese individuals, similar to 
the guidelines in the present study, produces a 4-5kg reduction in body weight (Astrup et 
al., 2002), which is a similar reduction to that found in the present study. The literature also 
indicates that in general, weight loss and fat loss results may be augmented when the 
protein content of the diet is greater than that of a regular balanced diet, in addition to 
modest decreases in total fat intake (Noakes et al., 2005, Clifton et al., 2009, Lee et al., 
2009).  
 
A review of short term (<16 weeks) exercise training studies indicates that the amount of 
body weight and fat mass lost is directly related to the amount of calories expended in 
training. The studies with an energy expenditure of 1,100kcal per week obtained an average 
weight loss of 0.06kg per week, and an average fat mass loss of 0.06kg per week. Exercise 
interventions based on an energy expenditure of 2,200kcal per week obtained an average 
weight loss of 0.18kg, and an average fat mass loss of 0.21kg per week (Ross and Janssen, 
2001). In the higher energy expenditure interventions this yielded an estimated weight loss 
of 2.2kgs over a 12 week period concomitant with a 2.5kg reduction in fat mass. The 
energy expenditure in the current study was 2,500kcal per week which yielded an average 
weight loss of 2.6kgs and an average fat loss of 5.9kgs in 12 weeks or a 12% reduction in 
fat mass from baseline values. The difference in the magnitude of fat loss between this 
current study and the studies included in the review may be due to differences in the 
intensity of exercise training or the mode of aerobic exercise used. 
 
133 
 
There was no statistical change in lean tissue mass in either group post intervention 
but there was a tendency for increased lean tissue in the exercise group compared to the 
diet group. The exercise group exhibited a 3.2kg or 8.6% increase in lean tissue mass 
compared to a 0.45kg or 1.36% increase in the diet group. This is clinically important 
because weight loss, particularly when achieved by caloric restriction alone, can be 
associated with a decline in fat free mass, and consequently a decline in resting metabolic 
rate, which is a major contributor to total daily energy expenditure. This may ultimately 
hinder the progress of weight loss in the future in addition to having deleterious effects on 
carbohydrate and lipid metabolism in this population (Stiegler and Cunliffe, 2006). Weight 
loss through calorie restriction alone has been reported to reduce metabolic rate in the long 
term (Martin et al., 2007), and so exercise training may be important to prevent a decline in 
lean tissue and metabolic rate during a period of weight loss (Broeder et al., 1992). The 
small sample size for body composition measurements in both groups may mask the extent 
of the actual changes that occurred post intervention.   
 
Clearly weight loss can be achieved by both interventions but their effects on other 
aspects of health must also be considered. It is interesting to note that the change in total 
body weight in both groups was not correlated with the change in any of the metabolic 
variables. The change in fat mass however was significantly correlated with improvements 
in fasting insulin secretion, insulin sensitivity and glucose tolerance in the exercise group, 
and Stumvoll, a predictor of insulin sensitivity, in the diet group. Also, the change in lean 
tissue was significantly correlated with improvements in the insulin sensitizing hormone IL-
13 in the exercise group, and TG’s and LDL in the diet group. These are important 
findings and worth some consideration since the primary outcome measure of many 
lifestyle interventions is weight loss, when in fact it is more appropriate to focus changes in 
body composition due to its relationship with metabolic health in this population. It has 
been well established that fat mass, visceral fat mass in particular, is associated with 
metabolic dysfunction in obese individuals  (Capurso and Capurso, 2012). It has also been 
well established that lean tissue mass is highly metabolically active and confers a range of 
metabolic benefits for the obese population (Ebeling et al., 1993). Weight loss induced by 
lifestyle intervention should ideally be derived from fat loss only. A simple measurement of 
body weight can not possibly give an insight into the composition of weight lost. It is 
therefore essential for researchers and clinicians to shift their focus from weight loss as an 
outcome measure for these individuals, to changes in body composition. The results of the 
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present study indicate that favourable changes in body composition must be a primary 
outcome measure in interventions of this nature.  
 
Interestingly, the metabolic profile of the subjects improved significantly in the 
exercise group but not in the diet group, despite statistically similar reductions in weight, 
BMI and fat mass. This was evident as a significant decrease in HOMA-B and AUCI, and 
an increase in AUCG/AUCI. The best single predictor for the percent change in AUCI in 
the exercise group was the percent change in TG’s, which accounted for 70.6% of the 
variance in AUCI Table 3.6. The percent change in TG’s also accounted for 64.9% of the 
variance in AUCG/AUCI post intervention Table 4.6. Further analysis revealed that the 
percent change in fitness was the best single predictor of the percent change in TG’s Table 
3.6. The percent change in fitness was also the best single predictor of the reduction in 
HOMA-B in this group, which accounted for 89.1% of the variance in HOMA-B Table 
3.6. Fitness improved significantly in the exercise group post intervention, but did not 
change in the diet group, which may account for the lack of improvement in metabolic 
profile of the subjects in the diet group. It could also possibly be related to the fact that the 
insulin values were significantly greater in the exercise group than in the diet group at 
baseline. The increase in fitness in the aerobic group was highly correlated with 
improvements in insulin secretion and insulin sensitivity as mentioned above, but it was 
also correlated with an improved lipid profile in these subjects. This is a clinically 
significant finding given the positive relationship between lipid accumulation and the 
development of insulin resistance in obese individuals (Belfort et al., 2005, Petersen and 
Shulman, 2006). The results indicate that exercise training and increased fitness, 
independent of weight loss, improves metabolic profile in obese individuals. 
 
The positive effects of exercise on the lipid profile and metabolic health of this population 
have been widely reported. O’Leary et al. 2006 carried out a 12 week aerobic exercise 
intervention in obese elderly individuals and reported that exercise training significantly 
reduced visceral fat and the availability of fat in circulation, in addition to improving 
glucose metabolism. Exercise training and fitness was also associated with the reversal of 
insulin resistance in these subjects (O'Leary et al., 2006). Other 12 week aerobic exercise 
training studies have found that exercise training significantly improves insulin sensitivity 
and glucose metabolism (Kadoglou et al., 2012), which is true in the presence (O'Leary et 
al., 2006) and absence (Nassis et al., 2005) of weight loss and fat mass loss. Even an acute 
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bout of exercise has been shown to enhance insulin sensitivity (O'Gorman et al., 2006). 
This is particularly evident in one legged training studies where glucose uptake increases in 
the exercising leg during and after the training bout, but not in the non exercising leg of the 
same individual (Richter et al., 1989). In fact as exercise intensity increases in the exercising 
limb, so too does the magnitude of glucose uptake (Wahren et al., 1971).  
 
It appears from the results of the current study that improvements in insulin 
secretion and insulin sensitivity were due to exercise induced improvements in lipid profile. 
It is likely that exercise training reduced the availability of lipids by reducing total body fat 
mass, but it may also have improved the oxidative capacity of skeletal muscle leading to 
improvements in lipid oxidation, thus correcting the mitochondrial dysfunction that is 
often present in this population (Kelley et al., 2002). These findings emphasise the 
importance of aerobic fitness in improving metabolic health. This is further supported by 
the enhanced fat oxidation and insulin sensitivity that is evident in athletes (Ebeling et al., 
1993). It is therefore necessary to focus on fitness as an outcome measure of interventions 
of this nature, in addition to changes in body composition. 
  
Although there were no significant metabolic adaptations to the diet intervention in 
this current study, calorie restriction is proposed to improve insulin sensitivity. This is true 
even in the initial stages of calorie restriction before there is any major effect on obesity 
(Arciero et al., 1999). A 10 day low calorie diet consisting of 50% of the calories required to 
maintain energy balance, reduced insulin concentrations during hyperglycemia by 40% in 
obese individuals (Arciero et al., 1999). A 12 week diet intervention with similar caloric 
restriction to this current study revealed a 2.7% decrease in body weight of the obese 
women, which was associated with a significant decrease in insulin resistance measured by 
HOMA-IR (Lee et al., 2013a). Diet interventions using various nutrient compositions have 
also proved to enhance insulin sensitivity. Noakes et al. 2005 investigated the effects of two 
different types of diet on metabolic status. An energy restricted high protein/low 
carbohydrate diet, and a high carbohydrate/low protein diet both produced a weight loss 
of 7.3kgs in a 12 week period and this was associated with a decrease in fasting insulin 
(Noakes et al., 2005). The mechanism responsible for the diet induced increase in insulin 
sensitivity is proposed to be as follows. In the immediate response to reduced calorie intake 
and reduced glucose levels, the restricted individual starts to break down muscle glycogen 
stores. Over an extended period of time as the glycogen stores become depleted, the body 
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must rely on fat for energy and as a consequence of this, reduction in fat mass occurs 
(Barzilai and Gabriely, 2001). The liver is thought to up regulate the expression of enzymes 
involved in gluconeogenesis and suppresses the expression of the enzymes involved in 
glycolysis (Dhahbi et al., 1999). The liver also produces ketones from the breakdown of fat 
and protein, which help to meet energy demands and so blood glucose remains lower than 
baseline values during this phase (Greene et al., 2001). The beta cells of the pancreas sense 
lower glucose levels and produce less insulin. Insulin levels remain lower than that at 
baseline, thus improving insulin sensitivity (Dhahbi et al., 2001). The results of this study 
confirm that diet and exercise interventions are both important in the fight against obesity, 
but increasing physical activity in this population is likely to have a greater impact on 
metabolic health mediated by increased fitness and possibly better changes in body 
composition.  
 
The alterations in adiposity that occur with calorie restriction and exercise training 
may have additional important benefits for obese individuals. In recent years, adipose tissue 
has been identified as an important endocrine organ that produces and secretes a number 
of adipokines involved in glucose and lipid metabolism (Jazet et al., 2003). Some of these 
adipokines, Omentin for example, promote insulin sensitivity and their circulating 
concentration is down regulated in obesity (de Souza Batista et al., 2007). Other adipokines, 
including FGF21 and Visfatin, enhance insulin sensitivity but their circulating 
concentration is elevated in obesity without the beneficial effects, possibly showing 
resistance to the action of the hormones. The overproduction of these hormones may be in 
compensation for the poor action of insulin (Fisher et al., 2010, Beltowski, 2006). There are 
a number of other adipokines that promote insulin resistance, such as Chemerin, whose 
circulating concentration increases with increases in fat mass (Catalan et al., 2011). 
Research shows that the serum concentration of these biomarkers is very much related to 
the physical and metabolic characteristics of obese individuals, and they are generally 
improved with improvements in body composition and metabolic status (Brix et al., 2010, 
Cuevas-Ramos et al., 2012, Moreno-Navarrete et al., 2010, Chakaroun et al., 2012, Choi et 
al., 2007). These cytokines in addition to IL-13 and Fetuin-A were analysed pre and post 
intervention in both groups. The reduction in fat mass that occurred in the exercise and 
diet group may have altered the expression and secretion of these biomarkers, which in 
turn may have influenced or been associated with the metabolic health of the subjects. It is 
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possible that the circulating concentration of these hormones could be a useful indicator of 
metabolic status in the obese population.  
 
The lack of significant change in the biomarkers in either group post intervention 
may be due to the large variability that existed between subjects in the baseline 
concentrations of the hormones. The large variability in the individual response (Figure 3.9) 
to caloric restriction and exercise training may also be a factor. Many of these novel 
cytokines are produced in adipose tissue but they are also produced in other tissues 
throughout the body such as skeletal muscle and the liver, and so changes in fat mass may 
not be the only regulator of their circulating concentration. It may also be the case that the 
biomarkers are differentially regulated by diet or exercise.  
 
The significant decrease in Fetuin-A in the exercise group is supported by some but 
not all studies in the literature. Some aerobic training studies have found no change in this 
hormone post intervention despite significant reductions in waist circumference and body 
fat content (Schultes et al., 2010). Other concurrent training studies incorporating aerobic 
and resistance exercise have also found no change in Fetuin-A post intervention (Yang et 
al., 2011). However, weight loss induced by a combination of diet and exercise resulted in a 
decrease in circulating Fetuin-A (Reinehr and Roth, 2008). Also, a study comparing young 
and older high and low active men reported that Fetuin-A was inversely related to fitness 
and concluded that regular exercise may be important in maintaining low levels of Fetuin-A 
(Jenkins et al., 2011). It is difficult to determine the mechanism behind the effects of 
exercise training on Fetuin-A. In the current study, the percent change in FFA’s best 
predicted the percent change in Fetuin-A but this did not reach significance (p=0.08). The 
reduction in the circulating concentrations of this hormone is likely explained by the 
significant reduction in fat mass combined with the significant increase in fitness that 
occurred in this group, since an equal reduction in fat mass in the diet group had no effect 
on serum concentrations. The literature has reported that the circulating concentration of 
this insulin resistance promoting hormone is greater in obese individuals, particularly those 
with high liver fat content (Ix and Sharma, 2010). The liver fat content of the subjects in 
the present study was not measured but obesity is associated with excess fat in the liver 
(Tominaga et al., 1995), primarily because excess availability of fatty acids in addition to the 
presence of insulin resistance fuels the synthesis of triglycerides in the liver (Reinehr and 
Roth, 2008, Ix and Sharma, 2010). Excess liver fat has been proposed to stimulate the 
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production of Fetuin-A (Ix and Sharma, 2010). The results of this study suggest that 
exercise training reduced total fat mass, which may possibly also have reduced fat mass in 
the liver, and this in turn may have suppressed the production of Fetuin-A resulting in 
lower circulating concentrations of this hepatokine post intervention. The results also 
suggest that Fetuin-A may be an indicator of liver fat mass in obese individuals.   
 
There was no significant change in the circulating concentration of the other 
biomarkers in the exercise group, but the changes that did occur provided an insight into 
the possible mechanisms by which they may be regulated, and their potential relationship 
with metabolic health. The exercise induced increase in lean tissue mass and aerobic fitness 
accounted for 93% of the variance in FGF21, 82.4% of the variance in IL-13, and 93.4% of 
the variance in Chemerin post intervention. These adaptations are specific to exercise 
training and show the potential role of exercise in the regulation of the production of these 
biomarkers. IL-13 is an anti-inflammatory insulin sensitizing cytokine that is secreted 
exclusively by skeletal muscle (Cannon and St Pierre, 1998). Its circulating concentration 
increased by 3% after exercise training, which was predicted by gains in lean tissue. This 
suggests that the exercise induced increase in lean tissue, although not significant, 
augmented the production of IL-13. Therefore, modes of exercise that promote greater 
gains in lean tissue, resistance training for example, may lead to more significant increases 
in the production of this hormone, which may in turn contribute to improved insulin 
sensitivity. In contrast, the circulating concentration of IL-13 decreased by 3% in the diet 
group, and this was mostly accounted for by the percent change in Visfatin, possibly 
demonstrating a regulatory role between both of these hormones. FGF21, an insulin 
sensitizing hormone, is also produced in skeletal muscle, in addition to the liver, adipose 
tissue and thymus (Zhang et al., 2008). Its circulating concentration increased by 28% in 
the exercise group compared to a 1% reduction in the diet group. The increase in fitness 
and lean tissue in the exercise group predicted the increase in FGF21. Exercise training that 
promotes greater increases in muscle mass may also stimulate greater production of this 
hormone. Chemerin is a proinflammatory cytokine predominantly secreted from adipose 
tissue, but is also produced in the lungs, liver and kidney (Goralski et al., 2007). Its 
circulating concentration decreased by 19% in the diet group which was significantly 
greater than the 3% reduction in the exercise group. Surprisingly no measured variable was 
found to predict the change in Chemerin in the diet group, whereas increased fitness 
accounted for the change in Chemerin in the exercise group. Many 12 week aerobic and / 
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or resistance training studies have reported a decrease in serum Chemerin post 
intervention, independent of change in body mass or body fat mass (Chakaroun et al., 
2012, Venojarvi et al., 2013). This suggests that Chemerin is influenced by muscle 
contraction and not just changes in body weight and body fat. However, it is likely that the 
change in Chemerin in the diet group was partly due to the reductions in fat mass but must 
also be influenced by other variables since the reductions in fat mass was similar in both 
groups.  
 
Visfatin is another insulin sensitizing hormone produced in skeletal muscle. It is 
also produced in the liver and macrophages but is predominantly released from visceral 
adipose tissue (Dogru et al., 2007). Controversy exists in the literature regarding Visfatin 
concentrations and its association with obesity and metabolic disease (Chang et al., 2011). 
Visfatin did not change in the exercise group but increased by 6% in the diet group post 
intervention. An overview of the current literature suggests that circulating concentrations 
of Visfatin should decrease post lifestyle intervention, thus ameliorating the resistance to 
the insulin sensitizing action of this hormone. This is true following 12 weeks of aerobic 
exercise training intervention (Choi et al., 2007, Haus et al., 2009, Lee et al., 2010b), and 
caloric restriction (Kovacikova et al., 2008, de Luis et al., 2008). In all of these studies the 
reduction in Visfatin was correlated with markers of insulin sensitivity independent of 
weight loss. Other interventions have found no relationship between fat mass and Visfatin 
but have found an inverse relationship between Visfatin and lean tissue mass suggesting 
that lean tissue could influence its circulating concentrations (Agueda et al., 2012). In fact 
12 weeks of concurrent exercise training incorporating aerobic and resistance training 
(300kcal/day aerobic, and 100kcal/day resistance training / 60mins per day) significantly 
reduced circulating Visfatin (Choi et al., 2007). Lean tissue mass was not measured in the 
aforementioned study but it is known to increase with resistance training. In the present 
study, the percent change in Visfatin in the diet group was best predicted by the percent 
change in the myokine IL-13, which further supports the hypothesis that lean tissue mass 
might regulate the production of Visfatin. Thus exercise training that augments gains in 
lean tissue mass might also be associated with significant reductions in Visfatin.  
 
The percent change in Omentin in both groups was influenced by the percent 
change in insulin sensitivity. Omentin is a cytokine secreted exclusively from visceral 
stromal vascular cells and is reported to enhance the action of insulin by augmenting 
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glucose uptake (Moreno-Navarrete et al., 2010). Interestingly its circulating concentration 
increased by 7% in the exercise group, which was best predicted by the percent change in 
the Stumvoll index of insulin sensitivity, but its circulating concentrations decreased by 
12% in the diet group and this was predicted by the percent change in AUCI. The 
circulating concentration of Omentin is reduced in obese individuals compared to lean 
insulin sensitive individuals, and further reductions are evident in obese individuals with 
insulin resistance or type 2 diabetes (Akbarzadeh et al., 2012, An et al., 2012). Other 12 
week aerobic exercise studies reported an increase in circulating Omentin post training, and 
this was significantly inversely correlated with improvements in insulin resistance, glucose 
tolerance, waist circumference and fitness (Saremi et al., 2010a). Dietary interventions using 
a caloric restriction of 500-1,000kcal per day less than RMR also reported a significant 
increase in Omentin post intervention and this was associated with a significant reduction 
in BMI in addition to a significant improvement in insulin sensitivity (Moreno-Navarrete et 
al., 2010).  Since body weight and body fat mass improved to a similar degree in both 
groups, it appears that the additional improvements in the metabolic status of the subjects 
in the exercise group was associated with the increase in Omentin in this group. 
Chemerin 
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IL-13
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Fetuin-A
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Visfatin
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Figure 3.10 Schematic illustrating the percent change in the independent variables 
that best predict the percent change in the biomarkers post (a) diet intervention 
and (b) exercise intervention. Note: AUCI = Area Under the Insulin Curve, HDL-C 
= High Density Protein Cholesterol, LT = Lean Tissue, FFA’s = Free Fatty Acids. 
(a) (b) 
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The response of the novel biomarkers to exercise training and caloric restriction is 
very interesting. Both interventions produced a similar energy deficit per week, but it 
appears that both modes of intervention differentially regulated the production and 
circulating concentration of the biomarkers. It is clear from the results that improvements 
in fitness, lean tissue mass, and insulin sensitivity accounted for the variance in many of the 
biomarkers which highlights the role of exercise training in the regulation of the 
biomarkers, and also suggests that greater improvements in lean tissue, such as that seen 
with resistance training, may lead to more substantial alterations in the circulating 
concentration of the biomarkers.  
 
3. 13. Study limitations 
The smaller than anticipated sample size in both groups limited the dept of the statistical 
analysis and meant that t-tests were used instead of the preferred option of a 2 way 
ANOVA. The small sample size for body composition limited the dept and interpretation 
of statistical analysis. A final limitation was the statistical difference in the baseline insulin 
values. Higher baseline insulin values in the exercise group may account for some of the 
metabolic differences between both groups, although the literature in addition to the 
research presented above consistently shows that both acute and chronic exercise improves 
insulin sensitivity in obese individuals. 
 
3. 14. Conclusions and future recommendations 
The literature suggests that both caloric restriction and exercise training are beneficial in 
reducing body weight and body fat mass in obese individuals (Franz et al., 2007). The 
extensive variation in the design of diet and exercise interventions makes it difficult to 
determine whether one intervention is superior to the other with regard to improving body 
composition and metabolic health of obese individuals. A comparison of an isocaloric diet 
and exercise intervention in this study revealed that both interventions were statistically 
equally successful in reducing body weight and body fat mass in these subjects. However, 
exercise training may lead to greater improvements in metabolic health mediated by 
increases in fitness and possibly greater improvements in body composition. It appears that 
exercise and diet interventions differentially regulate the circulating concentration of the 
novel biomarkers of insulin resistance. Interestingly, improvements in insulin sensitivity, 
fitness, and lean tissue mass significantly influenced the circulating concentration of many 
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of the biomarkers. It is possible that exercise training that significantly increases lean tissue 
mass, such as resistance training, may also significantly favourably affect the circulating 
concentration of the biomarkers. Future studies must investigate the effects of combined 
aerobic and resistance training on the metabolic health of these individuals. This type of 
training, also known as concurrent training, may provide all of the improvements in body 
composition, aerobic fitness, and insulin sensitivity evident in the aerobic group in the 
current study, but may additionally improve lean tissue mass, potentially resulting in a more 
substantial impact on the circulating concentrations of the biomarkers and improved 
metabolic health.    
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4. The impact of concurrent 
exercise training incorporating an 
eccentric component on energy 
expenditure and metabolism in obese 
individuals.  
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4. 1. Rationale 
Concurrent training has emerged in the literature as a potential weight loss therapy for 
obese individuals. A review of the acute and chronic effects of concurrent training in obese 
individuals concludes that this type of training enhances energy expenditure both during 
and after the training sessions, and also positively alters body composition in these 
individuals (Vilaca et al., 2011). This may contribute to greater weight loss in the obese 
population than either aerobic or resistance training alone (Vilaca et al., 2011).  
 
The vast majority of the literature to date focuses on the combination of aerobic exercise 
and regular resistance training, which incorporates an eccentric and concentric component.  
However, a greater contribution of eccentric exercise may prove to be a novel way of 
augmenting energy expenditure and fat oxidation thus potentially augmenting loss of fat 
mass in these individuals. Eccentric exercise reduces cardiovascular stress and perceived 
exertion but can illicit the same rate of energy expenditure as concentric contraction, which 
may also improve adherence (Minetti et al., 2002). The muscle damage caused by eccentric 
exercise is quite extensive and is energy expensive during the repair period which may 
contribute to increased energy expenditure and increased metabolic rate in the hours and 
days post training (Welle and Nair, 1990). Resting metabolic rate has been shown to be 
elevated at 24 and 48 hours following a bout of eccentric resistance exercise, and this 
elevation appears to be greater in sedentary untrained individuals than in trained individuals 
(Dolezal et al., 2000). Also, following a bout of eccentric exercise the muscle adapts and 
becomes stronger and more resilient to damage (Friden et al., 1983). Over time this may 
allow the individual to perform more work and thus expend more energy in the same time 
frame thus expending more calories during training sessions. A small number of studies 
have been conducted to investigate the effects of concurrent training incorporating an 
eccentric resistance component on energy expenditure and fat oxidation, but these are 
mainly acute studies (Burt et al., 2013, Dolezal et al., 2000, Paschalis et al., 2010). There is 
little research available to show the effects of chronic eccentric training on energy 
expenditure and fat oxidation in obese individuals.  
 
4. 2. Aim 
The aim of this study was to investigate the effects of concurrent training on fat oxidation, 
energy expenditure and metabolic health in obese individuals, and to determine whether an 
eccentric component leads to augmented fat loss and health benefits in this population. 
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4. 3. Objective 
 To measure the impact of eccentric exercise, as part of an aerobic and resistance 
training intervention, on body composition and insulin resistance in obese 
individuals. 
 To identify a biomarker profile of concurrent exercise training. 
 
4. 4. Hypothesis 
Both interventions will result in distinctive physiological and biological profiles following 
10 weeks of exercise training but eccentric exercise will confer more favourable changes 
resting metabolic rate and fat oxidation in obese subjects.  
 
4. 5. Overview of Original Study Design 
Subjects were recruited from staff and students in DCU. Following the initial screening and 
medical examination, eligible participants were randomly assigned to begin either a 10-12 
week exercise training programme consisting of (i) concurrent exercise training 
intervention incorporating aerobic exercise and regular resistance training (REG) or (ii) 
aerobic exercise and eccentric resistance training (ECC). A number of tests were carried 
out at baseline and repeated after 12 weeks of training.   
ECC
12 weeks
n = 8
Pre Tests
VO2max + ECG, DEXA, OGTT, 
muscle biopsy, RMR, MRI, 3RM
Subject
Recruitment
Post Tests
Repeat baseline tests
REG
12 weeks
n = 7
 
Figure 4.1 Overview of Original Study Design 
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4. 6. Test Procedures 
Some of the tests that were carried out in this intervention were the same of those already 
outlined in chapter 3. Please refer to section 3.7.2 for details of anthropometric assessment, 
3.7.3 for details of the DEXA scan and body composition assessment, 3.7.5 for details of 
the measurement and assessment of glucose tolerance and insulin sensitivity, 3.7.6 for 
details regarding the collection of blood samples, 3.7.7 for details of biochemical analysis 
and assays, and 3.7.8 for details regarding the muscle biopsy. Aerobic exercise prescription 
using the ACSM metabolic equations is detailed in section 3.7.9. Data collection and 
monitoring of the subjects exercise sessions is details in section 3.7.10. Additional tests 
were performed that were unique to this intervention are explained in detail to follow. 
  
4. 6. 1. Subject Recruitment 
An email was sent to all staff and students in DCU briefly outlining the nature of the study 
(Appendix 9). All individuals who responded to the email received a copy of the plain 
language statement (Appendix 10), which explained the study in great detail. A private 
meeting was then arranged with each potential participant and all elements of the study 
were discussed in detail including the nature of the study, the tests involved, the 
interventions involved, and all risks and benefits associated with the study. The informed 
consent form (Appendix 11) was explained to the potential participant at this time and they 
were also given an opportunity to ask any questions they had. Potential participants were 
advised to re read the informed consent form in their own time and return a signed copy if 
they wished to take part in the study.  
 
Upon receiving the informed consent form, each participant then completed a health 
history questionnaire (Appendix 6), which was reviewed by the study physician, and they 
underwent a medical examination to confirm their suitability for the study. Subjects were 
excluded at this point if they had uncontrolled hypertension, unstable cardiovascular 
disease, hepatic or renal disease, active cancer, HIV infection, previous thyroid surgery or 
hyperthyroidism, chronic diarrhoea, were pregnant, or unable to stay in the same 
geographic location for the duration of the study. 
 
Of the twenty five subjects who volunteered for the study, one subject was excluded after 
baseline screening due to the detection of T2DM during the OGTT and the detection of 
resting hypertension. This subject was referred to St. James Hospital for further tests. Two 
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subjects completed baseline testing in addition to 10 week exercise intervention but could 
not be contacted for the final testing period. Four subjects averaged 2 training sessions per 
week and so were excluded for non compliance. One subject moved to France in week 5 of 
the study. Finally, 2 subjects dropped out of the training study after 6 weeks due to work 
commitments. Of the remaining 15 subjects, 7 were randomly assigned to the ‘ECC’ 
training programme and 8 were randomly assigned to ‘REG’ training programme. The 
study was approved by the Dublin City University Research Ethics Committee and 
conformed to the Declaration of Helsinki.   
 
4. 6. 2. O2max with Electrocardiogram (ECG) 
For this intervention all subjects performed an incremental exercise test to volitional 
fatigue on a treadmill (HaB h/p/cosmos quasar) to determine O2max. The data collection 
for this study occurred alongside the final phase of data collection for intervention 1, which 
was on going for two years, and so availability of equipment dictated that the treadmills be 
used for testing in this intervention. Both male and female subjects underwent a 3 minute 
incremental protocol, but the speed and grade for the warm up, as well as the speed and 
grade for the stage increments were greater for males than for females. Briefly all subjects 
started with a walking warm up of 6.5km/hr. Every 3 minutes the speed was increased by 
1km/hr for all subjects until they reached their maximum walking speed. After this time 
the grade was increased by 2% every 3 minutes. If the subject continued to exercise for 
longer than 12 minutes, the grade remained the same but the speed was increased to 
jogging pace.   
 
All exercise tests took place under standard laboratory conditions (19-21°C, 40-55% 
relative humidity) and in the presence of the study physician. Expired oxygen, carbon 
dioxide, ventilatory volume, respiratory exchange ratios and O2max were determined by 
indirect calorimetry the Sensormedics metabolic system (Sensormedics Vmax 229, 
Sensormedics Corp., Yorba Linda CA). Systolic and diastolic blood pressure was measured 
by the physician at rest and during the last minute of each stage of exercise. Rate of 
perceived exertion was taken during the last ten seconds of each stage using the 6-20 point 
Borg scale (Appendix 8). Electrical activity of the heart was recorded at rest and at the end 
of each stage using 12 lead ECG. Heart rate was recorded in the last 10 seconds of each 
stage. Subjects exercised until reaching volitional fatigue. Oxygen uptake was deemed to 
have peaked if two or more of the following criteria were satisfied (i) plateau of oxygen 
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consumption with increasing power output (increase of less than 2 ml/kg/min), (ii) heart 
rate within 10 beats of the subjects’ age predicted maximum heart rate (220bpm – age in 
years) and (iii) respiratory exchange ratio >1.10. O2max was determined as the highest 
minute average recorded for oxygen uptake during the test.  
 
4. 6. 3. Resting Metabolic Rate (RMR) 
To determine energy expenditure and fat oxidation at rest, subjects underwent an RMR test 
in the human performance laboratory, DCU. Subjects reported to the laboratory after an 
overnight fast and they rested in a quiet, dark room for 60 minutes. During the last 30 
minutes a metabolic hood was placed over the subjects head and O2, ventilation, 
respiratory exchange ratio, fraction of inspired oxygen and carbondioxide, and fraction of 
expired oxygen and carbondioxide was measured by indirect calorimetry using the 
sensormedics metabolic system (Sensormedics Vmax 229, Sensormedics Corp., Yorba 
Linda CA). The hood was ventilated by 50 litres of air per minute. The subject was 
monitored throughout the test to ensure that steady state was reached for at least 15 
minutes. RMR was calculated for each subject using the Weir equation (Weir, 1949). This 
test was conducted on the ECC group and the REG group only. 
 
 
 
Figure 4.2 Resting metabolic rate procedure 
  
 Equation 11 The Weir equation to estimate energy expenditure per minute 
 ((1.1 * RQ) + 3.9) * O (l/min)  
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4. 6. 4. Magnetic Resonance Imaging (MRI) Scan 
An MRI scan was used to determine any exercise induced change to the total cross 
sectional area of the thigh (total CSA), the total cross sectional area of fat in the thigh (fat 
CSA), and the total cross sectional area of muscle in the thigh (muscle CSA). This scan was 
carried out in Cappagh Hospital, Finglas, Dublin. All subjects were transported to and 
from the hospital by the study investigator. The subjects completed a screening form in the 
reception area which was revised by a radiological nurse prior to the scan. The subjects 
were then guided to a private room, instructed to remove clothing, metal piercings and 
jewellery, and wear a gown for the scan. The entire process took 20 minutes per subject. 
The output from the scan was an image of the cross sectional area of the thigh (Figure 4.4). 
Total CSA, fat CSA and muscle CSA of both thighs for all subjects pre and post 
intervention was manually calculated by the study investigator. These areas were traced 
individually using specialized image analysis software (Image J version 1.34) and the total 
area of each of these components was computed. 
  
 
 
Figure 4.3 Sample image output from the MRI scan. The total CSA, fat CSA and 
muscle CSA was traced from the scan and calculated manually using Image J 
analysis software. 
 
4. 6. 5. Protocol for 3 Repetition Maximum Testing (3RM) 
1. Instruct the individual to warm up with a light resistance that easily allows 5-10 
repetitions of the exercise. 
2. Provide 1 minute rest. 
3. Estimate a warm up load that allows the individual to complete 5-7 repetitions of 
the exercise.  
4. Provide 2 minutes rest.  
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5. Estimate a near maximum load that allows the individual to complete 4-5 
repetitions of the exercise. 
6. Provide 2-4 minutes rest.  
7. Increase the load to maximum 
o If the individual can lift >3 repetitions, repeat steps 6 and 7 until the 3RM 
is determined 
o Continue increasing or decreasing the load until the individual can complete 
only 3 repetitions with correct execution. Ideally this is achieved within 5 
testing sets. 
o This procedure was conducted for the (1) Chest Press (Figure 4.6b) (2) Lat 
Pull Down (Figure 4.6c) and (3) Leg Extension (Figure 4.6a) exercises at 
baseline for all subjects in the REG and ECC groups.  
 
4. 6. 6. Resistance Training Programme Design and Update 
Once the 3RM was determined for all 3 exercises for all subjects, their 1RM was estimated 
using a conversion table (Figure 4.5). The 1RM is the preferred test to conduct but due to 
the subjects in this study being obese and untrained it was decided to perform the less 
aggressive 3RM test and use the conversion tables to convert their 3RM score to an 
estimated 1RM. 
 
Once the 1RM’s were determined, the ECC group completed 6 sets of 10 repetitions of all 
3 exercises working at an intensity of 110% of their 1RM. The REG group completed 3 
sets of 10 repetitions of all 3 exercises working at an intensity of 80% of their 1RM. 
 
The 3RM test is very time consuming and was impractical to repeat with all subjects 
throughout the intervention. When the subjects adapted to training, which was evident by 
them being able to perform 12 repetitions of any exercise with appropriate technique, the 
load was increased by 2.5kgs. This process occurred continuously over the 10 week period 
in both groups to ensure continued adaptation and progression. 
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Figure 4.4 This table was adapted from Baechle, T.R., and Earle, R.W. (2000). 
Essentials of Strength Training and Conditioning, Human Kinetics.  
 
4. 6. 7. Spotter Protocol for the Eccentric Resistance Exercises  
Two spotters were required to perform the concentric phase for all exercises for all 
subjects in the ECC group. In the leg extension exercise (Figure 4.6a) the spotters lifted the 
weight from the starting position (1) to the end position (2) and the subject lowered it 
slowly and in a controlled manner back to the starting position (1). In the chest press 
exercise (Figure 4.6b) the spotters pushed the weight forward from the starting position (2) 
until the subjects arms were fully expended (1) and the subject then lowered the weight 
back to the starting position (2) in a slow and controlled manner. For the lat pull down 
(Figure 4.6c), the spotters pulled the weight from the starting position (1) towards the 
ground until the subjects hands (and the bar) were in line with their chest (2). The subject 
then returned the weight to the starting position (1) in a slow and controlled manner.  
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Figure 4.5 (a) The leg extension exercise, (b) the chest press exercise, and (c) the 
lat pull down exercise. 
 
4. 6. 8. Pilot Investigations 
In order to validate the methodology for this study, 4 weeks of pilot investigations were 
carried out. Four subjects consented to take part in a 4 week training programme. Each 
subject underwent a O2max test at baseline test in addition to a 3RM test on the leg 
extension, lat pull down and chest press exercises. Two subjects completed 4 weeks of the 
ECC interventions detailed in section 4.7.17, and two subjects completed 4 weeks of the 
REG intervention detailed in section 4.7.18. The study investigator and another trained 
instructor completed the concentric phase of the leg extension, lat pull down and chest 
press exercise for the subjects in the ECC group.  
 
(c) 
(a) (b) 
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4. 6. 9. Details of the ECC study design 
The ECC study design is depicted in Figure 4.6. Eight subjects were randomly assigned to 
the ECC group. The pre tests included a O2max test with ECG on day one. The subjects 
underwent an RMR test, a muscle biopsy, and an OGTT on day two. On a third day the 
subjects had their body composition analysed in the ExWell Medical Clinic, Ballymun, 
using a DEXA scan, and this was followed by a visit to Cappagh Hospital for an MRI scan 
of their thighs. The 3RM test was completed in the fitness centre in DCU as part of their 
first day of training. 
 
All subjects completed 4 exercise sessions per week for 10 weeks, which were supervised 
by the study investigator. Two of the weekly sessions consisted of 60 minutes of aerobic 
exercise working at 70% O2max. The other two training sessions consisted of 15 minutes of 
aerobic exercise followed by 45 minutes of eccentric resistance training. In each of the 
resistance training sessions, the subjects completed 6 sets of 10 repetitions of the chest 
press, lat pull down and leg extension exercises, which totalled 180 repetitions per session, 
or 360 repetitions per week. Each subject was instructed on correct technique for the 
resistance exercises and monitored throughout their session. Two individuals (spotters) 
performed the concentric phase of the repetition (lift or push phase of the exercise), as 
outlined in Figure 4.6. Once this phase was complete the subjects assumed the correct 
position and returned the weight to the starting position in a slow and controlled manner. 
Sixty seconds recovery time was allowed between sets. Only 4 lifters / spotters were 
available for this study and so while one subject was resting between sets the spotters 
moved on to the next subject to begin their set. Tightly controlled scheduling of subjects 
and timing of sets was required in each session. The resistance element of the programme 
was continuously updated as progressed as outlined in section 4.7.14.  
 
O2max testing was repeated in week 5 for all subjects to determine their new fitness levels 
and update their training programmes using the ACSM’s metabolic equations. This ensured 
that the subject exercised at the desired intensity for the duration of the intervention and 
that they continued to adapt accordingly. Body weight was also recorded for all subjects 
every week. The baseline tests were repeated in week 10. 
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4. 6. 10. REG Intervention Study Design 
The study design for the regular (REG) exercise group is depicted in Figure 4.6. Seven 
subjects were randomly assigned to the REG group. The tests that were completed at 
baseline were the same as those completed in the ECC intervention. Two of the weekly 
sessions consisted of 60 minutes of aerobic exercise working at 70% O2max. The other two 
training sessions consisted of 45 minutes of aerobic exercise working at 70% O2max 
followed by 15 minutes of regular resistance training incorporating a concentric and 
eccentric component.  
 
The weight for the chest press, lat pull down and leg extension was set at 80% of their 
1RM, which was estimated from their 3RM scores. In each session, the subjects completed 
3 sets of 10 repetitions of the 3 exercises, which totalled 180 repetitions per session 
(counting concentric and eccentric movements), or 360 repetitions per week, which 
matched the repetitions performed by the ECC group. Each subject was instructed on 
correct technique for the resistance exercises and monitored throughout their session. The 
resistance was increased by 2.5kgs each time the subject could perform 12 repetitions of 
any exercise. 
 
O2max testing was repeated in week 5 for all subjects to determine their new fitness levels 
and update their training programmes using the ACSM’s metabolic equations. This ensured 
that the subject exercised at the desired intensity for the duration of the intervention and 
that they continued to adapt accordingly. Body weight was also recorded for all subjects 
every week. The baseline tests were repeated on completion of the 10 week intervention. 
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Figure 4.6 Schematic representation of the ECC and REG interventions 
 
4. 7. Statistical Analyses 
Experimental data is presented as mean ± standard deviation. Data was evaluated using the 
Sigmaplot 12 statistical package (Systat Software, Inc. Chicago, IL). Statistical significance 
was set as p<0.05. The statistical tests used to perform the analysis of the data in this 
chapter included a dependent t-test, an independent t-test, pearson correlation analysis and 
backwards stepwise regression. These tests are explained in detail in sections 3.10.1, 3.10.2, 
3.10.3, and 3.10.4 respectively. 
 
4. 8. Results 
The data is analysed in a number of sequential steps. Firstly, a comparison of the physical 
and metabolic raw data was performed. Secondly, we studied a number of novel 
biomarkers that were identified as mainly, though not exclusively, secreted from adipose 
tissue to determine if the diet and exercise interventions differentially regulated their 
circulating concentration. Finally, physiological and biological changes associated with the 
diet and exercise interventions were identified using a linear regression analysis to establish 
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the relationship between changes in variables and then by backward stepwise regression 
analysis to identify those that best predicted the changes. 
 
All subjects who took part in this study were obese at baseline and had been sedentary for a 
minimum of 6 months prior to enrolling in the study. The baseline values for the physical 
characteristics, metabolic characteristics, and biomarker profile are presented in Table 4.1, 
Table 4.2 and Table 4.3 respectively. Intervention groups were matched at baseline for 
physical and metabolic characteristics. 
 
 
4. 8. 1. Physical Characteristics 
The smaller than anticipated sample size limited the power of statistical analysis and meant 
a paired samples t-test was used to examine the extent of changes following the 
intervention rather than the preferred option of a 2-way ANOVA. Following both 
interventions there was a significant reduction in percent body fat (p=0.05 for ECC, 
p=0.01 for REG), and a significant increase in percent lean tissue (p=0.05 for ECC, 
p=0.01 for REG). Fat mass (kg) was significantly reduced in the REG group (p=0.03) but 
not in the ECC group (p=0.11). In contrast, lean tissue mass (kg) increased significantly in 
the ECC group (p=0.04) but not in the REG group (p=0.09). In all future analysis in this 
chapter, fat mass (kg) and lean tissue mass (kg) are used instead of percent body fat and 
percent lean tissue in order to avoid multicolinearity. Aerobic fitness ( O2max ml/kg/min) 
improved significantly in the ECC group (p<0.001) but not in the REG group (p=0.26). 
There was no change in weight or BMI in either group, but the REG group trended 
towards a change in both (p=0.07 for weight, p=0.07 for BMI). The weight loss achieved 
post intervention was 0.4kg in the ECC group compared to 3.3kg in the REG group. Fat 
mass was reduced by 2.2kg in the ECC group compared to 4.2kg in the REG group. An 
unpaired samples t-test confirmed that there was no difference between groups in the 
changes that occurred to any of the variables post intervention.  
 
Muscle strength measured by the 3RM test increased significantly in both groups for all 3 
resistance exercises. The strength gains achieved post intervention were significantly greater 
in the ECC group compared to the REG group for the lat pull down (p=0.01), chest press 
(p<0.001), and leg extension (p<0.001) exercises. An analysis of the MRI scans showed 
that the cross sectional area of fat in the thigh decreased significantly in the REG group 
(p=0.03) but not in the ECC group (p=0.35). The total cross sectional area of the thigh 
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also decreased significantly in the REG group (p=0.05) but not in the ECC group 
(p=0.26). There was no change in the cross sectional area of muscle in the thigh in either 
group (p=0.74 for ECC, p=0.75 for REG) post intervention.   
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Table 4.1  Pre and post values for the physical characteristics of the subjects in the 
REG and ECC groups. The percent change that occurred in each variable post 
intervention is also presented. 
 ECC REG % change 
Variable Pre Post Pre Post ECC REG 
 (n=7) (n=8)   
Age (yr) 29 ± 10  36 ± 9    
Weight (kg) 83.3± 12.1 82.9 ± 12.9 97.7± 22.1 94.4±20.3٢ -0.6 ± 2.8 -3.1 ± 3.8 
BMI (kg/m2) 30.0 ± 3.5 29.8 ± 4.1 33.7 ± 4.8 32.6 ± 4.4٢ -0.6 ± 2.8 -3.1 ± 3.8 
Fat mass (kg) 39.3 ± 11.6 37.1 ± 12.6 45.4 ± 15.3 41.2 ± 14.6* -6.2 ± 8.1 -9.3 ± 8.4  
% body fat 46.6 ± 8.3  44.0 ± 9.3* 46.0 ± 8.7 43.2 ± 9.4* -5.8 ± 6.1 -6.5 ± 5.47 
Lean tissue 
(kg) 
41.4 ± 5.9 43.2 ± 6.8* 49.5 ± 12.8 50.4 ± 12.7٢ 4.2 ±  4.5  2.0 ± 3.2  
% Lean 
Tissue 
50.3 ± 8.1 52.9 ± 9.1* 51.0 ± 8.5 53.8 ± 9.2* 4.9 ± 5.8   5.4 ± 4.6  
O2max 
(ml/kg/min) 
31.8 ± 5.3 35.0 ± 5.9* 29.6 ± 6.3 31.6 ± 6.1 10.1 ± 5.5 9.0 ± 17.1 
O2max 
(L/min) 
2.7 ± 0.5 2.9 ± 0.5 * 2.9 ± 0.9 3.0 ± 0.9 8.7 ± 6.2 7.1 ± 11.4 
3RM LPD 
(kgs) 
51.8 ± 8.8 90.0± 12.4* 52.8 ± 17.7 62.8 ± 19.3* 75.1±14.5† 19.8 ± 4.1 
3RM CP (kgs) 40.4 ± 8.1 70.7± 11.7* 46.6 ± 19.3 56.9 ± 21.3* 77.8 ± 27.7† 24.1 ± 7.7 
3RM LE (kgs) 85.4 ±  22.2 124.3±20.1* 84.1 ± 34.9 96.9 ± 37.6* 51.2 ± 30.7† 17.1 ± 9.2 
Muscle CSA 7395 ± 
1100 
7352 ± 975 8813 ± 
1443 
8847 ± 1430 -0.2 ± 6.1 0.5 ± 4.7 
Fat CSA 9598 ± 
3651 
9380 ± 3958 11005 ± 
4229 
10028 ± 4449 
* 
-3.0 ± 8.0 -9.6 ± 14.8 
Thigh CSA 17350 ± 
3275 
17189 ± 3548 20297 ± 
4393 
19355 ± 4547 
* 
-1.7 ± 4.5 -4.7 ± 8.7 
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change 
post intervention. †p<0.05 represents a significant difference between groups in the percent 
change that occurred to the variable post intervention. ٢p<0.09 represents a trend towards a 
change post intervention. Note: BMI = Body Mass Index, O2max = aerobic fitness, 3RM 
LPD = 3 Repetition Maximum on the Lat Pull Down, 3RM CP = 3 Repetition Maximum 
on the Chest Press, 3RM LE = 3 Repetition Maximum, Muscle CSA = Muscle Cross 
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Sectional Area, Fat CSA = Fat Cross Sectional Area, Thigh CSA = Total Cross Sectional 
Area of the Thigh.  
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Figure 4.7 Percent change in weight (kg), fat mass (kg) and fitness ( O2max 
ml/kg/min) post intervention presented as mean ± SD. *p<0.05 represents a 
significant change post intervention. ٢p<0.09 represents a trend towards a 
significant change post intervention. 
 
4. 8. 2. Metabolic characteristics 
The metabolic adaptations to training are presented in Table 4.2 for both groups. There 
was no change in AUCG, AUCI, AUCG/AUCI or HOMA-B in either group post 
intervention. The Stumvoll and Matsuda indices of insulin sensitivity also did not change in 
either group, but the REG group experienced a 23% increase in the Matsuda predictor of 
insulin sensitivity compared to a 14% increase in the ECC group. There was no change in 
RMR in either group but it increased by 6.9% in the ECC group compared to 2.9% in the 
REG group. There was a significant increase in fat oxidation in both groups represented by 
a significant reduction in RQ (p=0.01 for ECC, p<0.001 for REG) post intervention. 
 
The lipid profile of the subjects was also measured pre and post intervention. These values 
in addition to the percent change that occurred to the lipids are presented in Table 4.2. 
There was no significant change in the lipid profile of the subjects in the ECC or REG 
group post intervention. Also there was no difference between groups in the percent 
change that occurred to the metabolic variables.  
* 
* 
* 
٢ 
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Table 4.2 Pre and post values for the metabolic characteristics of the subjects in the 
ECC and REG groups. The percent change that occurred to each of the variables 
post intervention is also presented. 
 ECC REG % change 
Variable Pre Post Pre Post ECC REG 
 (n=7) (n=8)   
AUCG 1081 ± 232 1052 ± 126 1089 ± 260 1033 ± 200 -0.4 ± 16.1 -3.3 ± 18.7 
AUCI 10531 ± 
6742 
9541± 
6698 
8844 ± 
4064 
8101 ± 
4229 
-8.5 ± 14.4 -9.1 ± 23.5 
AUCG/AUCI 0.14 ± 0.08 0.16 ± 0.11 0.17 ± 0.14 0.19 ± 0.18 10.5 ± 20.0 10.9 ± 24.8 
 
HOMA-B 45.2 ± 2.7 40.2 ± 24.4 39.9 ± 30.8 28.6 ± 11.2 -6.4 ± 28.5 -8.9 ± 97.6 
 
Stumvoll 0.128 ± 
0.014 
0.131 ± 
0.018 
0.116 ± 
0.024 
0.117 ± 
0.022 
3.7 ± 13.7 1.7 ± 11.4 
Matsuda 18.1 ± 15.8 18.4 ± 12.7 20.3 ± 16.5 26.7 ± 32.6 14.3 ± 19.6 23.7 ± 52.8 
 
RMR 1409 ± 133 1508 ± 211 1640 ± 433 1670 ± 401 7.0 ± 9.7 2.9 ± 8.9 
 
RQ 0.89 ± 0.04 0.82±0.02* 0.88 ± 0.06 0.79±0.03* -7.6 ± 5.3 -9.3 ± 5.2 
 
FFA’s 0.51 ± 0.23 0.47 ± 0.27 0.54 ± 0.10 0.50 ± 
0.184 
7.7 ± 77.9 -7.0 ± 32.3 
 
TG’s 1.04 ± 0.37 1.17 ± 0.49 1.31 ± 0.98 1.33 ± 0.96 25.5 ± 32.5 -11.9 ± 
46.8 
TC 4.99 ± 0.81 4.78 ± 1.10 4.91 ±1.92 5.23 ± 0.95 4.4 ± 18.4 -8.9 ± 32.0 
LDL 2.69 ± 0.33 2.52 ± 0.44 3.13 ±1.71 3.22 ± 0.57 2.9 ± 12.2 26.1 ± 57.7 
HDL 1.38 ± 0.38 1.55 ± 0.51 1.08 ± 0.24 1.30 ± 0.42 1.1 ± 15.7 30.3 ± 76.5 
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change 
post intervention. Note: AUCG = Area Under the Glucose Curve, AUCI = Area Under the 
Insulin Curve, AUCG/AUCI = Area Under the Glucose Curve / Area Under the Insulin 
Curve (index of insulin sensitivity), HOMA-B is an index of fasting insulin secretion, 
Stumvoll and Matsuda are indexes of insulin sensitivity, RMR = Resting Metabolic Rate, 
RQ = Respiratory Quotient, FFA’s = Free Fatty Acids, TG’s = Triglycerides, TC = Total 
Cholesterol, LDL = Low Density Lipoprotein Cholesterol, HDL = High Density 
Lipoprotein Cholesterol.  
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Figure 4.8 Percent change in the area under the insulin curve (AUCI), the area 
under the glucose curve / the area under the insulin curve (AUCG/AUCI), fasting 
insulin secretion (HOMA-B) and respiratory quotient (RQ) post intervention in the 
ECC and REG groups. Data is presented as mean percent change ± standard 
deviation. *p<0.05 represents a significant change post intervention.  
 
4. 8. 3. Biomarker Profile 
A number of novel biomarkers related to insulin resistance and metabolic health were 
measured pre and post intervention. The circulating concentrations of these biomarkers in 
addition to the percent change that occurred to the concentration of these biomarkers post 
intervention are presented in Table 4.3. The individual variation in the baseline values of 
the biomarkers was quite large and the same was true for the individual response to 
exercise training as presented in Table 4.3. Following the ECC intervention, there was a 
significant decrease in the circulating concentration of Visfatin (p=0.05). There was no 
change in circulating concentrations of FGF21 (p=0.82), IL-13 (p=0.87), Chemerin 
(p=0.34) or Omentin (p=0.77). There was no change in the circulating concentration of 
FGF21 (p=0.38), IL-13 (p=0.95), Chemerin (p=0.76), Omentin (p=0.23) or Visfatin 
(p=0.64) in the REG group post intervention. While the individual variation makes it 
difficult to determine if changes in these biomarkers have any role, there is some evidence 
of biomarker specific responses to different types of exercise training. Therefore, the next 
stage was to conduct correlation and regression analysis of the data to examine association 
between the variables. 
* * 
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Table 4.3 Pre and post values for the novel biomarkers in the ECC and REG 
groups. The percent changes that occurred to the biomarkers post intervention are 
also presented. 
 ECC REG % change 
Variable Pre Post Pre Post ECC REG 
 (n=7) 
 
(n=8)   
FGF21 303.7 ± 
129.7 
324.9 ± 
241.8 
383.4 ± 
108.3 
326.4 ± 
131.1 
12.3 ± 68.1 -9.8 ± 39.6 
IL-13 152.3 ± 
36.6 
154.9 ± 
23.4 
213.2 ± 
175.4 
214.1 ± 
153.9 
7.9 ± 30.8 5.2 ± 22.7 
Chemerin 234.2 ± 
35.2 
196.2 ± 
64.9 
194.0 ± 
53.1 
183.3 ± 
54.1 
-11.4 ± 
40.7 
2.9 ± 41.6 
 
Omentin 378.4 ± 
183.5 
397.0 ± 
90.9 
374.6 ± 
153.0 
442.1 ± 
156.8 
21.0 ± 55.9 25.7 ± 56.1 
Visfatin 18.5 ± 4.5 16.8 ± 3.6 * 16.5 ± 3.3 15.9 ± 4.1 -8.1 ± 8.2 -2.9 ± 22.9 
 
Data is presented as mean ± standard deviation.  * p<0.05 represents a significant change 
post intervention. 
 
-80
-60
-40
-20
0
20
40
60
80
100
FGF21 IL-13 Chemerin Omentin Visfatin
%
 
c
h
a
n
g
e
ECC
REG
 
Figure 4.9 Percent change in the biomarkers post intervention in both groups. Data 
is presented as mean ± SD. *p<0.05 represents a significant change post 
intervention.  
 
* 
 163 
 
4. 8. 4. Pearson correlations and backwards stepwise regression analysis 
The pearson correlation analysis for the physical characteristics, as presented in Table 4.4, 
show that the percent change in weight in both groups did not relate to any of the 
metabolic adaptations, but was significantly correlated with the percent change in IL-13 
and trending towards a correlation with the percent change in FGF21, Chemerin and LDL 
cholesterol in the ECC group. In the REG group, the percent change in weight was 
trending towards a correlation with the percent change in RMR. 
 
On the other hand, the percent change in fat mass appeared to correlate better with 
metabolic adaptations in the REG group, which was positively related to the percent 
change in AUCI, in addition to the percent change in circulating Chemerin. The percent 
change in fat mass in the ECC group did not reach significance post intervention and was 
not correlated with the percent change in any other variable.  
 
In the ECC group, the percent change in lean tissue was positively correlated with 
adaptations in insulin secretion and insulin sensitivity represented by AUCI. It was 
inversely correlated with the percent change in circulating Omentin. In addition, it was 
trending towards an inverse correlation with circulating FGF21. In the REG group, the 
percent change in lean tissue mass, although not significant, was positively correlated with 
strength gained in the chest press exercise, and trending towards a correlation with 
increased fat oxidation represented by a reduction in RQ. 
 
The percent change in fitness following the ECC intervention was significantly positively 
correlated with the Matsuda indicator of insulin sensitivity and trending towards a 
correlation with AUCG. In the REG group, the non significant percent change in fitness, 
was significantly correlated with the percent change in circulating concentrations of IL-13. 
 
Backwards stepwise regression was not run for the physical characteristics because all 
changes that occurred to body composition, fitness and strength were a direct result of the 
actual physical training in addition to the energy expended in the exercise sessions. 
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Table 4.4 Pearson correlations for weight, body composition and fitness in the ECC 
and REG group. 
 
Variable 
% change  
weight (kgs) 
% change  
 FM (kgs) 
% change  
 LT (kgs) 
% change  
 O2max 
(ml/kg/min) 
 ECC REG ECC REG ECC REG ECC REG 
% chg. 
RMR 
r=0.723٢ 
p=0.07 
       
% chg. 
AUCG 
      r=0.801٢ 
p=0.06 
 
% chg. 
Matsuda 
      r=-0.99* 
p=0.001 
 
% chg. 
AUCI 
   r=0.755* 
p=0.05 
r=0.827* 
p=0.04 
   
% chg. 
Omentin 
    r=-0.80* 
p=0.03 
   
% chg. 
FGF21 
 r=-0.68٢ 
p=0.06 
  r=-0.73٢ 
P=0.06 
   
% chg. 
Chemerin 
 r=0.681٢ 
p=0.09 
 r=0.702* 
p=0.05 
    
% chg. 
IL-13 
 r=0.823* 
p=0.01 
     r=-
0.73* 
p=0.01 
% chg. 
LDL 
 r=0.721٢ 
p=0.07 
      
% chg. 
CP 
     r=0.781* 
p=0.02 
  
% chg. 
RQ 
     r=0.636٢ 
p=0.09 
  
r represents the strength of the relationship between two variables. *p<0.05 is significant. 
٢p<0.09 is trending towards significance. Note: FM = Fat Mass, LT = Lean Tissue, RMR 
= Resting Metabolic Rate, AUCG = Area Under the Glucose Curve, AUCI = Area Under 
the Insulin Curve, FGF21 = Fibroblast Growth Factor 21, IL-13 = Interleukin-13, LDL = 
Low Density Lipoprotein Cholesterol, CP = Chest Press, RQ = Respiratory Quotient. 
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The pearson correlations for the percent change in AUCI, HOMA-B, RQ and RMR in 
both groups is presented in Table 4.5. The percent change in AUCI in the ECC group was 
significantly positively correlated with the percent change in lean tissue mass and 
significantly inversely correlated with the percent change in Visfatin. It was trending 
towards being positively correlated with Chemerin, and inversely correlated with FGF21. 
In contrast, the percent change in AUCI in the REG group was significantly correlated 
with the percent change in fat mass and the fat derived hormone Omentin.  
 
The percent change in HOMA-B was positively correlated with the percent change in 
Chemerin in the ECC group, and with the percent change in lean tissue mass, RQ and 
strength gained in the chest press exercise in the REG group.  
 
The percent change in RQ was correlated with metabolic adaptations in both groups. It 
was trending towards a correlation with the percent change in the Matsuda predictor of 
insulin sensitivity in the ECC group, and significantly correlated with the percent change in 
HOMA-B in the REG group. Additionally in the REG group, it was correlated with the 
percent change in RMR and inversely correlated with the percent change in serum Visfatin.   
 
In the ECC group, the percent change in RMR was trending towards a correlation with 
body weight only. While in the REG group, the percent change in RMR was inversely 
correlated with the lipid profile of the subjects including total cholesterol, LDL cholesterol 
and HDL cholesterol, in addition to being positively correlated with fat oxidation or RQ. It 
was also positively correlated with the percent change in the Stumvoll index of insulin 
sensitivity, the percent change in the cross sectional area of muscle in the thigh. It was 
inversely correlated with the percent change in the circulating concentrations of Omentin 
and Visfatin.   
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Table 4.5 Pearson correlations for the percent change in AUCI, HOMA-B, RQ and 
RMR post intervention in the ECC and REG group.  
 
Variable 
% change  
AUCI 
% change  
 HOMA-B 
% change  
 RQ 
% change  
 RMR 
 ECC REG ECC REG ECC REG ECC REG 
% change 
weight 
      R=0.723٢ 
P=0.07 
 
% change 
LT 
r=0.827* 
p=0.04 
  r=0.850* 
p=0.01 
    
% change 
FGF21 
r=-0.791 
p=0.06٢ 
       
% change 
Chemerin 
r=0.773٢ 
p=0.07 
 r=0.760* 
r=0.05 
     
% change 
Visfatin 
r=-0.82 * 
p=0.04 
    r=-0.65* 
p=0.01 
 r=-0.90* 
p=0.002 
% change 
in BF 
 r=0.73* 
p=0.05 
      
% change 
Omentin 
 r=-0.77* 
p=0.03 
     r=-0.665 
p=0.07٢ 
% change 
in RQ 
   r=0.856* 
p=0.01 
   r=0.712* 
p=0.04 
% change 
CP 
   r=0.873* 
p=0.001 
    
% change 
RMR 
     r=0.712* 
p=0.05 
  
% change 
HOMA-B 
     r=0.856* 
p=0.01 
  
% change 
Matsuda 
    r=0.858 
p=0.06٢ 
   
% change 
Stumvoll 
       r=0.727* 
p=0.04 
% change 
Muscle 
CSA 
       r=0.874* 
p=0.002 
% change 
TC 
       r=-0.97* 
p=0.03 
% change 
HDL 
       r=-0.95* 
p=0.05 
% change        r=-0.97* 
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LDL p=0.03 
r represents the strength of the relationship between two variables. *p<0.05 is significant. 
٢p<0.09 is trending towards significance. Note: AUCI = Area Under the Curve for Insulin, 
HOMA-B = fasting insulin secretion, RQ = Respiratory Quotient, RMR = Resting 
Metabolic Rate, LT = Lean Tissue, BF = Body Fat, CP = Chest Press, Muscle CSA = 
Cross Sectional Area of Muscle, TC = Total Cholesterol, HDL = High Density Lipoprotein 
Cholesterol, LDL = Low Density Lipoprotein Cholesterol. 
 
The backwards regression analysis for AUCI, HOMA-B, RQ and RMR in both groups is 
presented in Table 4.6. The results of this analysis showed that 99.9% of the variance in 
AUCI was predicted by the percent change in FGF21, Chemerin and Visfatin in the ECC 
group. In the REG group, 59% of the variance in AUCI was predicted by the percent 
change in Omentin.  
 
Backwards stepwise regression was not run for HOMA-B in the ECC group as this was 
only correlated with one variable. Simple linear regression revealed that the percent change 
in Chemerin accounted for 57.8% of the percent change in HOMA-B in this group. In the 
REG group, the percent change in lean tissue and RQ accounted for 88.9% of the variance 
in HOMA-B post intervention. 
 
Backwards stepwise regression was not run for RQ in the ECC group as this was only 
correlated with one variable. Simple linear regression revealed that the percent change in 
Matsuda accounted for 73.6% of the variance in RQ. In the REG group, the percent 
change in RMR and HOMA-B accounted for 94% of the variance in RQ. 
 
In the ECC group, the percent change in strength gained in the chest press predicted 
85.5% of the variance in RMR post intervention. In the REG group, the percent change in 
the cross sectional area of muscle in the thigh, in addition to the percent change in 
Omentin, predicted 90.5% of the change in RMR post intervention.  
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Table 4.6 Backwards stepwise regression analysis to predict the change in AUCI, 
AUCG/AUCI, and HOMA-B post exercise intervention. 
Study Dependant 
variable 
Indep. 
variables in 
model 
Coef. Std. 
Coeff. 
Std. 
Error 
F-to-
Remove 
P 
 
 
 
 
% change 
AUCI 
ECC 
(R2=0.999) 
 
 
Constant  -13.380  0.403   
% chg. 
FGF21 
-0.073 -0.358 0.005 213.25 0.005 
% chg. 
Chemerin 
0.162 0.435 0.008 370.03 0.003 
% chg. 
Visfatin 
-0.886 -0.462 0.046 371.50 0.003 
REG 
(R2=0.592) 
Constant -0.769  6.390   
% chg. 
Omentin 
-0.323 -0.769 0.109 8.703 0.026 
 
 
 
% change 
HOMA-B 
 
 
ECC Note: Backwards regression could not be performed for HOMA-B in the ECC group. 
Simple linear regression revealed that the percent change in Chemerin accounted for 
57.8% of the variance in HOMA-B post intervention  
REG 
(R2=0.889) 
Constant 69.683  44.63   
% change LT 15.867 0.514 5.948 7.117 0.044 
% change 
RQ 
9.982 0.529 3.636 7.538 0.041 
 
 
 
% change 
RQ 
ECC Note: Backwards regression could not be performed for RQ in the ECC group. Simple 
linear regression revealed that the percent change in Matsuda accounted for 73.6% of 
the variance in RQ post intervention 
REG 
(R2=0.940) 
Constant -10.448  0.560   
%change 
RMR 
0.297 0.483 0.067 17.390 0.09 
% change 
HOMA-B 
0.037 0.697 0.006 36.196 0.002 
 
 
 
% change 
RMR 
 
ECC 
(R2=0.855) 
Constant 32.055  4.868   
% change 
Chest press 
-0.323 -0.925 0.059 29.492 0.003 
REG 
(R2=0.905) 
Constant 3.886  1.332   
% change 
Omentin 
-0.064 -0.402 0.023 7.398 0.042 
% change 
Muscle CSA 
1.395 0.729 0.283 24.303 0.004 
R2 represents the extent to which the change in the independent variable predicted the change in the 
dependent variable.  p<0.05 is significant. Note: AUCI = Area Under the Curve for Insulin, HOMA-
B = fasting insulin secretion, RQ = Respiratory Quotient, LT = Lean Tissue, RMR = Resting 
Metabolic Rate, HOMA-B = Fasting Insulin Secretion, Muscle CSA = Cross Sectional Area of 
Muscle. 
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The pearson correlations for the percent change in the biomarkers post intervention in 
both groups are presented in Table 4.7. 
 
Table 4.7 Pearson correlations for selected biomarkers for the ECC and REG 
groups 
Variable Group Correlations with the % change in Independent Variables 
 
 
% change in 
FGF21 
ECC LT 
(r=-0.730, p=0.06) ٢ 
Omentin 
(r=0.805, p=0.03) * 
AUCI 
(r=-0.791, p=0.06)٢ 
REG  Weight 
(r=-0.682, p=0.06) ٢ 
Stumvoll 
(r=0.731, p=0.04) * 
 
 
% change in 
IL-13 
ECC  Chemerin 
(r=-0.821, p=0.05) * 
TG’s 
(r=-0.961, p=0.04) * 
 
REG  Weight 
(r=0.823, p=0.01) * 
 O2max (ml/kg/min) 
(r=-0.730, p=0.04) * 
Matsuda 
(r=-0.707, p=0.05)* 
 
% change in 
Chemerin 
 
ECC IL-13 
(r=-0.821, p=0.05) * 
HOMA-B 
(r=0.760, p=0.05) * 
AUCI 
(r=0.773, p=0.07) ٢ 
REG Fat Mass 
(r=0.755, p=0.05) * 
LDL 
(r=0.855, p=0.03) * 
 
 
% change in 
Omentin 
 
ECC Lean Tissue 
(r=-0.802, p=0.03) * 
FGF21 
(r=0.804, p=0.03) * 
Lat Pull Down 
(r=-0.777, p=0.04)* 
REG AUCG 
(r=-0.749, 0.05) * 
RMR 
(r=-0.665, p=0.07) ٢ 
 
 
% change in 
Visfatin 
 
ECC AUCI 
(r=-0.822, p=0.05) * 
LDL 
(r=0.927, p=0.07) ٢ 
 
REG RQ 
(r=-0.858, p=0.01) * 
RMR 
(r=-0.904, p=0.002) * 
Muscle CSA 
(r=-0.790, p=0.02)* 
r represents the strength of the correlation between variables. *p<0.05 is significant. 
٢p<0.09 is trending towards significance. Note: LT = Lean Tissue, AUCI = Area Under the 
Curve for Insulin, TG = Triglycerides, O2max = aerobic fitness, HOMA-B = Fasting 
Insulin Secretion, LDL = Low Density Lipoprotein Cholesterol, AUCG = Area Under the 
Curve for Glucose, RMR = Resting Metabolic Rate, RQ = Respiratory Quotient, Muscle 
CSA = Cross Sectional Area of Muscle. 
 
 
 170 
 
The backwards regression analysis for the biomarkers is presented in Table 4.8. This 
analysis revealed that the percent change in FGF21 was mostly predicted by the percent 
change in Omentin in the ECC group, which accounted for 70% of the variance in FGF21. 
In the REG group the percent change in the Stumvoll predictor of insulin sensitivity 
accounted for 53.4% of the variance in FGF21 post intervention. 
 
The percent change in IL-13 was mostly predicted by the percent change in TG’s in the 
ECC group, which accounted for 92.4% of the variance in IL-13. The percent change in 
weight and fitness accounted for 86.3% of the variance in IL-13 in the REG group. 
 
In the ECC group, the percent change in IL-13 predicted 67.4% of the percent change in 
Chemerin, while the percent change in LDL cholesterol accounted for 73% of the variance 
in Chemerin in the REG group.  
 
The best single predictor of the percent change in Omentin in the ECC group was the 
percent change in FGF21, which accounted for 64.6% of the variance in Omentin. The 
percent change in AUCG accounted for 56.1% of the variance in Omentin in the REG 
group.  
 
The percent change in RQ and RMR predicted 91% of the variance in Visfatin in the ECC 
group. The percent change in AUCI accounted for 67.6% of the variance in Visfatin in the 
REG group. 
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Table 4.8 Backwards stepwise regression analysis to predict the change in the biomarkers 
post ECC intervention and REG intervention. 
Study Dependant 
variable 
Indep. 
variables in 
model 
Coef. Std. 
Coeff. 
Std. 
Error 
F-to-
Remove 
P 
 
 
% change in  
FGF21 
ECC 
(R2=0.702) 
 
Constant  -15.667  18.473   
% change  
Omentin 
0.958 0.838 0.312 9.424 0.037 
REG 
(R2=0.534) 
Constant -14.196  10.443   
% change 
Stumvoll 
2.546 0.731 0.970 6.886 0.039 
 
 
 
% change in  
IL-13 
 
ECC 
(R2=0.924) 
Constant 39.371  7.350   
% change in 
TG’s 
-0.957 -0.961 0.194 24.401 0.039 
 
REG 
 (R2=0.863) 
Constant 22.349  4.713   
% change 
weight 
3.724 0.629 1.074 12.021 0.018 
% change 
fitness 
-0.627 -0.472 0.241 6.772 0.048 
 
 
% change in 
Chemerin 
ECC 
(R2=0.674) 
Constant 1.142  11.752   
% change in 
IL-13 
-1.158 -0.821 0.402 8.289 0.045 
REG 
(R2=0.730) 
Constant -17.245  12.435   
%change 
LDL 
0.638 0.855 0.194 10.830 0.030 
 
 
% change in 
Omentin 
ECC 
(R2=0.646) 
Constant 12.895  14.022   
% change in 
FGF21 
0.659 0.804 0.218 9.129 0.029 
REG 
(R2=0.561) 
Constant 22.457  16.473   
% change in 
AUCG 
-2.367 -0.749 0.937 6.381 0.053 
 
 
% change in  
Visfatin 
ECC 
(R2=0.676) 
Constant -10.066  2.311   
% change in 
AUCI 
-0.429 -0.822 0.148 8.365 0.044 
 
REG 
(R2=0.910) 
Constant -16.451  9.375   
% change in 
RQ 
-1.927 -0.435 0.844 5.208 0.071 
% change in 
RMR 
-1.520 -0.594 0.488 9.701 0.026 
R2 represents the extent to which the change in the independent variable predicts the change in the 
dependent variable. p<0.05 is significant. Note: TG’s = Triglycerides, IL-13 = Interleukin-13, LDL = 
Lipoprotein Cholesterol, AUCG = Area Under the Curve for Insulin, AUCG = Area Under the Curve 
for Insulin, RQ = Respiratory Quotient, RMR = Resting Metabolic Rate. 
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4. 9. Discussion  
The main findings of this study were that the changes that occurred to body composition 
were highly specific to the mode of exercise undertaken, and not simply due to total energy 
expenditure which was matched in both interventions. The ECC group demonstrated 
significant gains in fitness and lean tissue mass, while the REG group displayed significant 
reductions in fat mass. There was no change in insulin secretion or insulin sensitivity in 
either group post intervention, however both groups demonstrated a significantly greater 
capacity to oxidise fat post intervention, which has important implications for insulin 
sensitivity and possibly augmented reductions in fat mass in the long term in this 
population. Muscle strength improved significantly in both groups which confer numerous 
health benefits for these subjects, and the strength gains were significantly greater in the 
ECC group compared to the REG group for all resistance exercises. There was no 
significant change in RMR post intervention, but the modest increase that occurred in the 
ECC group may still have important benefits for longer term weight loss. Finally, there was 
no change in the circulating concentrations of the novel biomarkers of insulin resistance in 
either group, with the exception of Visfatin which decreased significantly in the ECC group 
post intervention. In this study it appears that the production of the biomarkers is 
differentially influenced by the mode of exercise training. The biomarkers themselves 
appear to be inter-dependent, and markers of metabolic health are also associated with the 
changes in the biomarkers. The biomarkers may be a useful indicator of metabolic health in 
larger scale studies. 
 
 Concurrent training has emerged in the literature as an interesting therapy for obese 
individuals. A review of the acute and chronic effects of concurrent training in obese 
individuals concludes that this type of training enhances energy expenditure both during 
and after the training sessions, and also positively alters body composition in these 
individuals (Vilaca et al., 2011). This may contribute to greater weight loss in the obese 
population than either aerobic or resistance training alone (Vilaca et al., 2011). Concurrent 
training incorporating an eccentric component may augment energy expenditure and fat 
oxidation in obese individuals and thus may potentially lead to greater loss of fat mass and 
greater improvements in metabolic health (Burt et al., 2013, Dolezal et al., 2000, Paschalis 
et al., 2010). Many of the studies incorporating eccentric exercise are acute bouts, little is 
known about the effects of chronic eccentric exercise training. 
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In the present study, the changes that occurred to the physical characteristics of the 
subjects post intervention appeared to be highly influenced by the training mode 
undertaken. The 3RM scores for the lat pull down, chest press, and leg extension resistance 
exercises increased significantly in both groups post intervention. These results were 
expected and indicate that the subjects responded as expected to the training stimulus 
(Guilhem et al., 2010, Reeves et al., 2009, Roig et al., 2009). This increase in strength is 
clinically important because it confers numerous health benefits for these individuals. It is 
proven to contribute to the maintenance of functional ability that would otherwise decline 
with age, prevent osteoporosis by increasing bone density, prevent sarcopenia or muscle 
wasting that is also evident with age, and improve lower back pain among other age and 
inactivity related disabilities (Winett and Carpinelli, 2001).  
 
For many years the strength gains that accompany resistance training were mostly 
attributed to hypertrophy, or increased size of the trained muscles. While there is a 
relationship between muscle size and muscle strength, this theory does not explain the 
increased strength that is evident with resistance training in the absence of hypertrophy. 
Research shows that the neuromuscular system is very responsive to resistance training. 
The largest strength gains occur within the first 8-10 weeks of training and for the most 
part these gains are attributed to neural adaptations (Staron et al., 1994). Longer term 
strength gains occur as a result of adaptations to the physical structure of the muscle 
including hypertrophy (Staron et al., 1994). The neural adaptations to resistance training are 
numerous and include improved synchronization of motor units, which improves the rate 
of force development and the capability of the muscle to exert steady forces (Duchateau 
and Enoka, 2002). There may be increased recruitment of additional motor units, which 
would also lead to greater force production (Duchateau and Enoka, 2002). An increase in 
the frequency of stimulation of the muscle fibers has also been observed, which ultimately 
results in a state of tetanus and peak force development in the muscle fibers (Enoka, 1997). 
Other adaptations include reduced autogenic inhibition allowing the working muscles to 
produce greater amounts of force and reach greater levels of strength before they are 
inhibited (Aagaard et al., 2000). Finally, a reduction in coactivation of the antagonist 
muscles have been observed allowing for greater strength generation in the agonist or 
working muscles (Enoka, 1997). These neural adaptations explain the increase in strength 
in both groups, even in the absence of a significant increase in lean tissue mass in the REG 
group.  
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The literature reports that strength can increase by as much as 25-100% above 
baseline values in untrained subjects. The average increase in the 3RM scores in the ECC 
group was 68.1%, which was significantly greater than 20.3% observed in the REG group. 
The increase in strength in the ECC group was accompanied by a significant increase in 
lean tissue mass post intervention. This indicates that hypertrophy occurred in the ECC 
group in addition to the neuromuscular adaptations, possibly accounting for the magnitude 
of the change in strength in this group.  
 
The eccentric component of resistance training is reported to be the most important factor 
responsible for the increase in the cross sectional area of muscle following training 
(Shepstone et al., 2005). A number of studies have reported greater hypertrophy with 
eccentric training compared to concentric training or combination training (Shepstone et 
al., 2005). The results are augmented further when the eccentric movements are performed 
with high velocity (Shepstone et al., 2005). Eccentric exercise is thought to stimulate 
hypertrophy in the muscles being used because it causes extensive damage to these muscles 
compared to concentric actions, and muscle damage is the precursor to hypertrophy. The 
muscle damage creates muscle soreness which peaks at 24-48 hours after the eccentric 
exercise bout and this is termed delayed onset muscle soreness or DOMS (Miles and 
Clarkson, 1994). In 1984, Armstrong proposed the following sequence of DOMS. 
Eccentric exercises causes high tension in the contractile-elastic system of skeletal muscle 
and results in damage to the physical structure of the muscle, and its cell membrane. This 
damage disturbs the calcium homeostasis in the injured fiber(s) leading to cell death that 
peaks at 48 hours post exercise. The products of macrophage activity and intracellular 
contents e.g. histamines, kinnis, and K+, accumulate outside the cell. These substances 
stimulate free nerve endings in the muscle causing pain. Muscle strength is initially reduced 
in injured muscle fibers. This may be due to physical disruption of the muscle, failure of 
the excitation-contraction coupling process, and loss of contractile protein. In the days 
following an eccentric bout the muscle adapts, become stronger and more resilient to 
further damage (Warren et al., 2001).  
 
The increase in strength and size following eccentric training may have important 
implications for the obese population. The ability to lift a greater amount of weight over 
time means that work rate, and thus energy expenditure, increases per session over time. 
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The increase in lean tissue may also increase resting metabolic rate (Dolezal and Potteiger, 
1998), which accounts for 60-75% of total daily energy expenditure, thus a small increase in 
RMR can have a substantial effect on a persons total daily energy expenditure (Broeder et 
al., 1992). These adaptations may accumulate to greater energy expenditure and weight loss 
in obese individuals in the long term, above that induced by regular concurrent training. 
Resistance training is also proposed to augment fat oxidation. This is attributed to 
increased energy expenditure and improved body composition, in addition to enhanced 
lipolysis in abdominal subcutaneous adipose tissue (Ormsbee et al., 2007). Since there is a 
causative relationship between fat accumulation and insulin resistance (Petersen and 
Shulman, 2002, Shulman, 2000, Yu et al., 2002), increased fat oxidation may have 
significant implications for improving insulin sensitivity and metabolic health in obese 
individuals. 
 
There was no statistically significant change in RMR in either group post 
intervention in the present study. Lean tissue mass increased significantly in the ECC 
group, but it may not have been sufficient to stimulate a significant elevation in RMR. 
There was an increase in percent lean tissue in the REG group but no significant change in 
lean tissue mass which might explain the lack of change in RMR in this group. Is it possible 
that an interference effect occurred between the aerobic training and the strength training 
in the REG group. The larger volume of aerobic training in the REG intervention may 
have negated the gains in lean tissue that generally result from resistance training. Babcock 
et al. (2012), reported that the physiological environment created by endurance training 
appears to negatively affect the satellite cells usual response to resistance training, ultimately 
compromising muscle fiber growth post training (Babcock et al., 2012). The exact 
mechanism behind this interference effect is unclear and research continues to be carried 
out in this area. This finding is supported by the fact that many studies investigating the 
effects of endurance training on RMR have reported no change post intervention 
(Tagliaferro et al., 1986, Bingham et al., 1989, Tremblay et al., 1990). The sequence of 
training may also have affected muscle growth in the REG group. In the present study and 
on 2 days per week, 45 minutes of aerobic exercise was performed first, followed by 15 
minutes of resistance training. Cadore et al. (2012) suggest that strength training 
immediately prior to endurance training has no influence on maximal endurance power 
adaptation, but aerobic exercise immediately prior to strength training reduces the force 
that can be produced per unit of muscle mass thus influencing the quality of the training 
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session and the magnitude of adaptation that could potentially occur from resistance 
training (Cadore et al., 2012). It is possible that a greater volume of resistance training is 
required as part of a concurrent training programme. The REG intervention in the current 
study incorporated only two 15 minutes bouts of resistance training per week. A more 
intense resistance training component may be necessary to ensure that participants obtain 
the reported benefits of fat loss that are associated with aerobic exercise and resistance 
training, in addition to the increases in metabolically active lean tissue and RMR that are 
associated with resistance training (Byrne and Wilmore, 2001).  
 
Although RMR did not change significantly in either group post intervention, it is clinically 
important to note that RMR increased by an average of 100kcal per day in the ECC group. 
Hill et al (2003) estimated that an “energy gap” of only 100kcal per day may over time be 
responsible for the weight gain in 90% of the American population. Therefore, a reduction 
or elimination of this energy gap could prevent or reduce body fat gain in the majority of 
American people (Hill et al., 2003). An increase in energy expenditure of 100kcal per day in 
the subjects in the present study equates to 700kcal per week or approximately 1lb 
(3500kcal) of body fat in 35 days. Over time, and with continued training, this could 
accumulate to significant fat loss in this population. The small numbers in this study may 
mask the implications of these findings. 
  
Importantly, there was a significant decrease in RQ in both groups post 
intervention confirming that the subjects had a greater ability to oxidise fat for fuel after a 
period of exercise training. This finding has also been reported in the literature even after 
an acute bout of resistance training (Ormsbee et al., 2007). This is a key finding with 
clinical significance because there is substantial evidence to show that elevated 
concentrations of intracellular lipids in obese individuals contribute to the development of 
insulin resistance by inhibiting insulin stimulated glucose transport into target tissues 
(Petersen and Shulman, 2002, Shulman, 2000, Yu et al., 2002). The increase in fat oxidation 
may be due in part to a training induced conversion of type IIx muscle fibers to type IIa 
muscle fibers which have greater oxidative properties (Staron et al., 1990). It may also be 
due to the adaptations that occur in response to the aerobic endurance training that formed 
part of each intervention. Endurance training is known to increase the number and 
function of type I fibers in skeletal muscle, which have a high oxidative capacity and a 
greater ability to oxidise fat for fuel (Costill et al., 1976). This is particularly evident in 
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highly trained endurance athletes, who paradoxically have elevated intra muscular lipid 
content, but their skeletal muscle is markedly insulin sensitive, has a very high oxidative 
capacity and thus a high fat turnover (Goodpaster et al., 2001). Given the adverse 
relationship between fat accumulation and insulin resistance in obese sedentary individuals, 
an increased ability to oxidise fat may be important in the prevention or amelioration of 
insulin resistance in the obese population. It may also contribute to greater loss of fat mass 
over time. 
 
Surprisingly there was no change in body weight or BMI in either group post 
intervention. Subjects were instructed to maintain their pre intervention energy intake for 
the duration of the study. If this was achieved then the energy expended in the exercise 
sessions should have been sufficient to cause a reduction in fat mass and body weight in 
this previously sedentary group, as it did in the aerobic exercise group in chapter 3 of this 
thesis. In the present study, weight loss may have been offset by gains in lean tissue that 
were acquired with resistance training. This may be particularly true for the ECC group 
who experienced a significant increase in percent lean tissue and lean tissue mass. This 
group also achieved a significant reduction in percent body fat and a non statistically 
significant decrease in fat mass. This finding is supported by other studies (Dolezal and 
Potteiger, 1998). The REG group achieved a significant reduction in percent body fat and 
fat mass in addition to a significant increase in percent lean tissue but a non statistically 
significant increase in lean tissue mass. These changes in body composition may have 
ultimately resulted in no net change in body weight or BMI. A more detailed discussion of 
the similarities and differences between the outcome measures in the 3 exercise 
interventions will be discussed in detail in the next chapter. An alternative explanation is 
that it is quite possible that either consciously or subconsciously the subjects in this study 
partly compensated for the energy expended in the weekly exercise training sessions. Other 
studies have reported that when compliance to supervised exercise training interventions is 
near perfect, which it was in the present study, the effectiveness of exercise may be 
undermined by compensatory responses that negate the energy deficit caused by exercise 
training (King et al., 2008). Compensatory responses include increased energy intake 
(Stubbs et al., 2004) and / or reduced daily physical activity and energy expenditure in non 
exercising time (Donnelly et al., 2003). The latter may be an attempt to recover from the 
exercise session. Other compensatory responses include a reduction in RMR. Weight loss 
in obese individuals, particularly substantial weight loss, has been associated with decreases 
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in RMR, even when exercise is the mode of intervention (Leibel et al., 1995). RMR was 
maintained in this study and so this theory is not relevant to this particular situation.  
 
The finding that fat mass reduced in the REG group after 10 weeks of training, and 
not in the ECC group, was surprising but percent body fat did decrease significantly in 
both groups after training. Both groups completed 4 hours of exercise training per week. 
Within the 4 hours of training per week, the REG group performed two 15 minute bouts 
of resistance training, where as the ECC group performed two 45 minutes bouts of 
resistance training. The remainder of the exercise time consisted of aerobic exercise. It is 
possible that the aerobic exercise stimulus in the ECC group was not sufficient to induce 
significant fat loss. The literature suggests that aerobic training is superior to resistance 
training with regard to decreasing fat mass, but resistance training is superior to aerobic 
exercise in terms of increasing lean tissue mass (Dolezal and Potteiger, 1998). This would 
explain the greater reduction in fat mass found in the REG group, and the greater increase 
in lean tissue mass found in the ECC group. The combination of both modes of training 
provide all of these benefits just to a lesser extent than either mode of exercise alone 
(Dolezal and Potteiger, 1998). It is possible that a better balance between aerobic exercise 
and resistance training in both groups is required to achieve significant reductions in fat 
mass concomitant with significant gains in lean tissue mass. 
 
Interestingly, there was no change in insulin secretion or insulin sensitivity in either 
group post intervention. This was a surprising finding that lies in direct contrast to the 
metabolic adaptations that occurred in response to the exercise intervention in study one of 
this thesis. A comparison of the metabolic adaptations to each of the three exercise 
interventions will be discussed in detail in the chapter to follow. Given the well 
documented inverse relationship between insulin sensitivity and body weight and body fat 
mass (Carey et al., 1996, Redinger, 2007), the lack of improvement in the metabolic status 
of the subjects in the present study might be explained by the fact that there was no 
significant change in body weight in the REG group, and no significant change in body 
weight or body fat mass in the ECC group post. A limited number of studies have reported 
no change in insulin sensitivity with exercise training even in the presence of significant 
reductions in body weight and body fat mass (Short et al., 2003). However this is very 
unlikely because the literature overwhelmingly and consistently supports the fact that 
exercise training even in the absence of weight loss improves insulin sensitivity (Holloszy, 
 179 
 
2005). Some theories have been proposed as to why insulin sensitivity may not improve 
with exercise training. A greater duration, intensity or frequency of exercise may be 
required in some individuals to improve insulin sensitivity (Short et al., 2003). The 
beneficial effects of exercise on insulin sensitivity may be lost quicker in some individuals 
and so the timing of the post training OGTT could be important (Short et al., 2003). 
Insulin mediated trafficking of GLUT4 may be impaired in some individuals but the 
mechanism behind this remains to be elucidated (Short et al., 2003). Specific to the ECC 
group, a single bout of eccentric resistance training has been reported to impair insulin 
sensitivity immediately after the training session and so the timing of the post intervention 
OGTT could again be crucial. This is thought to be due to the muscle damage that occurs 
with this type of training. The muscle damage may impair insulin stimulation of IRS-1, PI3 
kinase and Akt kinase, which may inhibit insulin stimulated glucose disposal (Marcus et al., 
2009, Kirwan et al., 1992, Del Aguila et al., 2000). Study one of this PhD thesis established 
a positive causative relationship between aerobic fitness and insulin sensitivity, in addition 
to an inverse relationship between fat mass and insulin sensitivity. It is possible that greater 
improvements in fat mass and fitness were required in the REG and ECC group to result 
in significant improvements in the metabolic status of these subjects.   
 
Although insulin secretion, insulin sensitivity and the indices of insulin sensitivity did not 
change significantly post intervention, the non significant changes that did occur appeared 
to play a role in the increase in fat oxidation that was evident in both groups post 
intervention. The percent change in RQ in the ECC group was positively correlated with 
the percent change in the Matsuda index of insulin sensitivity (r=0.858, p=0.06). Also, 94% 
of the percent change in RQ in the REG group was predicted by the percent change in 
RMR and the percent change in HOMA-B. These findings indicate that even small 
improvements in insulin secretion and insulin sensitivity can have important implications 
for overall metabolic health in this population.  
 
The novel biomarkers of insulin resistance that were referred to in study one of this 
thesis were also analysed pre and post the ECC and REG interventions in an attempt to 
further investigate the possible relationships between the biomarkers and the physical and 
metabolic characteristics. It appeared from the analysis of the results in study one that 
significant increases in insulin sensitivity, fitness, and lean tissue mass influenced the 
production of these hormones. The gains in lean tissue mass did not reach statistical 
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significance in the aerobic exercise group and so it is possible that a significant increase in 
lean tissue mass, such as that seen in the ECC group, might have a significant impact on 
the circulating concentration of many of the biomarkers. This may be particularly true for 
the biomarkers that are secreted from lean tissue such as FGF21, IL-13 and Visfatin. The 
circulating concentration of Visfatin decreased significantly in the ECC group. There was 
no significant change in the circulating concentration of the other biomarkers in either 
group post intervention. However, the non statistically significant changes that did occur to 
the biomarkers in each group yielded some very interesting findings.  
 
 
The results of the present study indicate that different modes of exercise training may 
differentially regulate the circulating concentrations of the biomarkers, in addition to the 
relationship between the biomarkers and all other physical and metabolic variables. With 
the ECC group, the percent change in FGF21 and Omentin was positively correlated with 
the percent change in each other. In fact the percent change in Omentin accounted for 
70% of the percent change in FGF21, and the percent change in FGF21 accounted for 
64.6% of the percent change in Omentin. This suggests a regulatory role between both of 
these biomarkers. The pearson correlation analysis revealed that the percent change in IL-
13 and Chemerin were inversely correlated with the percent change in each other. The 
backwards regression analysis showed that the percent change in IL-13 accounted for 
67.4% of the percent change in Chemerin, and the percent change in TG’s accounted for 
92.4% of the variance in IL-13. These findings indicate that Chemerin and IL-13 may have 
a role in the regulation of each other. The correlations that appear in the ECC group are 
not evident in the REG group, which suggests that the biomarkers may be differentially 
regulated by various modes of exercise training. However, some of the results of the REG 
intervention including no change in fitness or lean tissue mass after 10 weeks of exercise 
training were not typical or expected and may mask the changes that should occur to the 
biomarkers in response to this type of exercise training.  
 
The main differences in the outcome measures between both groups were that fitness and 
lean tissue mass increased in the ECC group only, where as fat mass decreased in the REG 
group only. In addition, the strength gains achieved in the ECC group post intervention 
were significantly greater than those achieved by the REG group. The final difference in 
outcome measures between groups was that Visfatin decreased significantly in the ECC 
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group but not in the REG group post intervention. The percent change in Visfatin in the 
ECC group was correlated with the percent change in lean tissue mass, which also actually 
predicted its variance in study one of this thesis. In the current study, the single best 
predictor of the percent decrease in circulating Visfatin was the percent decrease in AUCI, 
which accounted for 67.7% of the variance in Visfatin post intervention. Further analysis 
revealed that 99.9% of the percent change in AUCI was attributed to the percent change in 
FGF21, Chemerin and Visfatin. These are important findings because they show the 
changes that occurred to the biomarker profile of the subjects post intervention almost 
completely accounted for the improvements in insulin secretion and insulin sensitivity in 
these subjects. In turn, the decrease in AUCI mostly accounted for the significant 
reduction in circulating Visfatin in these subjects. These results indicate a possible cyclical 
relationship between the biomarkers and insulin secretion and insulin sensitivity. In appears 
that the increase in fitness and lean tissue mass in the ECC group was responsible for the 
changes that occurred to the biomarkers and metabolic status in these subjects. However, it 
is unclear whether the improvements in insulin secretion and insulin sensitivity regulate the 
secretion of the biomarkers, or if changes in the circulating concentrations of the 
biomarkers regulate the improvement in insulin secretion and insulin sensitivity. It is also 
possible that both of these responses occur simultaneously. Interestingly in the REG 
group, none of the biomarkers accounted for the percent change in each other. The change 
in Stumvoll, AUCG and AUCI were the best predictors of the change in FGF21, Omentin 
and Visfatin respectively supporting the relationship between the biomarkers and insulin 
sensitivity and glucose tolerance. The percent change in weight and fitness were the best 
predictors of the change in IL-13. Finally, the percent change in LDL was the best 
predictor of the percent change in Chemerin.  
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Figure 4.10 Schematic illustrating the percent change in the independent variables 
that best predicted the percent change in the biomarkers post (a) ECC and (b) 
REG interventions. Note: IL-13 = Interleukin-13, FGF21 = Fibroblast Growth 
Factor 21, TG’s = Triglycerides, LDL-C = Low Density Lipoprotein Cholesterol, 
AUCG = Area Under the Curve for Glucose, RMR = Resting Metabolic Rate. 
 
4. 10. Limitations 
The smaller than anticipated sample size in both groups limited the dept of the statistical 
analysis which meant that t-tests were used instead of the preferred option of a 2 way 
ANOVA. Also, Fetuin-A data was not available for the subjects in either group due to a 
technical error that occurred in the final stages of the analysis of those ELISA kits. 
 
The ECC intervention was very time intensive to operate. It was very physically demanding 
for the small number of spotters / lifters and could not be sustained long terms despite its 
effectiveness. The strength of the spotters could be a limiting factor in longer term studies. 
Also, the improvements in eccentric ability over time were quite large and so a limiting 
factor for one subject was that the weight available on the leg extension was less than that 
required. It would be quite difficult to administer this intervention on a population based 
level without the development of specialised equipment to complete the concentric phase 
of contraction.  
(a) (b) 
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4. 11. Summary, conclusion and future recommendations 
It appears that the changes that occurred to body composition, metabolic health, and the 
biomarker profile in the obese individuals in this study were specific to the mode of 
exercise undertaken. The concurrent intervention incorporating an eccentric component 
(ECC) showed promising potential to augment fat mass loss and improve metabolic health 
in the longer term in obese subjects. This was evident by the significant increase in fitness, 
lean tissue mass and fat oxidation, and the clinically important but non statistically 
significant increase in RMR post intervention. The potential regulatory relationship 
between fitness, lean tissue mass and the biomarkers identified in study one was further 
supported in this ECC group with a significant decrease in circulating Visfatin.  
 
However, there are practical implications for conducting this type of intervention. 
Eccentric resistance training is extremely demanding of time and human resources. Two 
lifters were required per subject to complete the concentric phase of every repetition, 
which in this study equated to 180 lifts per subject, two days per week, for 10 weeks. 
Therefore there was a total of 2,520 lifts per week for the 7 subjects in the ECC group, 
which was very challenging with a small team of 4 lifters including the study investigator. It 
would be very difficult to implement this type of intervention on a larger scale. Also, 
subjects can tolerate much higher loads eccentrically than they can with regular resistance 
training and so in many cases, particularly with the leg extension exercise, the lifters were 
required to lift or push loads ranging from 150-250kgs with every repetition. This was 
achieved in the current study but in the longer term as subjects continue to adapt to 
training, greater loads would need to be lifted to ensure the stimulus is sufficient to 
maintain the desired intensity and induce the appropriate adaptations to training. The 
strength of the lifters could be a limiting factor in this situation. It may not be practical to 
continue with this type of intervention in the long term. For this mode of training to be 
available routinely for obese individuals and on a large scale, specialised equipment must be 
designed specifically for this purpose.   
 
The results of the REG intervention were surprising and unexpected, particularly the 
findings that there were no changes in fitness or lean tissue mass after 10 weeks of exercise 
training. Also there was no change in insulin secretion or insulin sensitivity despite 
progressive exercise training, and a significant reduction in fat mass, both of which should 
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improve insulin sensitivity. For this reason it is difficult to interpret the effects that this 
type of intervention should have on the novel biomarkers. However, the results did 
support a link between the biomarkers and metabolic health in obese individuals. The 
significant reduction in fat mass in the REG group supports the findings of the aerobic 
exercise intervention in study one of this thesis, indicating that aerobic exercise is 
important for reducing fat mass in this population. It is possible that the volume of 
resistance training in this intervention was insufficient to stimulate the expected changes in 
lean tissue mass, although significant improvements in fat oxidation were observed 
indicating that the subjects did respond in some way to the training stimulus. Future 
concurrent training studies incorporating a greater volume and intensity of regular 
resistance exercises may provide all of the benefits associated with aerobic exercise and 
resistance training, which may lead to greater improvements in energy expenditure, fat 
mass loss, and metabolic health of obese individuals.  
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Chapter 5. Integration of results from 
studies 1 and 2 and secondary analysis.  
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5. 1. Rationale 
It is clear from chapters 3 and 4 of this PhD thesis that exercise training favourably 
influences the physical and metabolic characteristics of obese individuals, and plays a role 
in the regulation of the circulating concentration of the novel biomarkers of insulin 
resistance. The adaptations that occur may be specific to the mode of exercise undertaken. 
One limitation that exists when interpreting the results of the three exercise interventions is 
that the number of subjects in each intervention was smaller than originally anticipated 
which limited the depth of the statistical analysis and the interpretation of the findings. 
Also, there was wide variation in the baseline values for insulin and the novel biomarkers 
of insulin resistance, in addition to the individual response to exercise training. In an 
attempt to address the issue of the small sample size in the 3 exercise interventions, the 
subject data from the aerobic exercise group, the ECC group and the REG group was 
combined and a pre post analysis was carried out. These interventions did not use exactly 
the same mode of exercise training but it was broadly similar in terms of the frequency of 
training per week, the intensity of the aerobic exercise, the duration of the session and the 
energy expenditure derived from each bout. Combining the data increased the power thus 
enhancing the dept of statistical analysis which may enhance the interpretation of the 
findings. 
 
5. 2. Aim 
The aim of this analysis was to increase statistical power and investigate the effects of 10-12 
weeks of exercise training on body composition, metabolic health, and novel biomarkers of 
insulin resistance in obese subjects. 
 
5. 3. Objectives 
To measure the impact of exercise training on body composition and metabolic health in 
obese individuals. 
 
To investigate the relationship between body composition, insulin sensitivity and the 
circulating concentrations of the novel biomarkers of insulin resistance.  
 
5. 4. Hypothesis 
Exercise training will significantly reduce fat mass, increase lean tissue mass and improve 
insulin sensitivity in obese subjects. 
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Improved body composition and fitness will predict the improvements in insulin 
sensitivity. There will be a cyclical relationship between the biomarker profile of the obese 
subjects and their metabolic health. 
    
5. 5. Study Design 
Twenty five subjects were included in this analysis. 10 of these subjects completed the 
aerobic exercise intervention detailed in chapter 3, 7 completed the eccentric intervention 
detailed in chapter 4, and 8 completed the aerobic and resistance training intervention 
detailed in chapter 4. Please refer to the relevant chapters for a detailed explanation of 
these 3 interventions. A pre post analysis was carried out to determine the effects of 10-12 
weeks of exercise training on body composition, insulin sensitivity, and the novel 
biomarkers of insulin resistance in obese subjects. 
Pre Tests
VO2max + ECG
Muscle Biopsy + OGTT
DEXA Scan
(n = 25)
• 10-12 weeks of exercise training
• 4 * 60 minutes exercise per week 
Post Tests
VO2max + ECG
Muscle Biopsy + OGTT
DEXA Scan
 
Figure 5.1 Schematic representation of study design.  
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5. 6. Methods 
Please refer to chapters 3 and 4 for a detailed explanation of the tests and procedures 
outlined in Figure 5.1.  
 
5. 7. Statistical analysis  
Experimental data is presented as mean ± standard deviation. Data was evaluated using the 
Sigmaplot 12 statistical package (Systat Software, Inc. Chicago, IL). Statistical significance 
was set as p<0.05. The statistical tests used to perform the analysis of the data in this 
chapter included a dependent t-test, pearson correlation analysis and backwards stepwise 
regression. These tests are explained in detail in sections 3.10.1, 3.10.3, and 3.10.4 
respectively.  
Best subsets regression was also used in this analysis. Best Subsets Regression is a 
technique for selecting variables in a multiple linear regression by systematically searching 
through different combinations of independent variables and selecting the subsets of 
variables that best contribute to predicting the dependent variable. It is important to avoid 
multicolinearity and so where two independent variables are highly correlated only one of 
those variables can be entered into the best subsets regression model. The output from this 
analysis details all possible prediction models ranging from the lowest prediction to the 
highest prediction. The predictive ability of the model is reflected by the R2 value which is a 
measure of how well the model describes the data. The larger the R2 value, the better the 
model predicts the dependent variable. The R2 value does not take in to account the 
number of variables used in the equation. More variables result in higher R2 values and so it 
is necessary to interpret the data and choose the model with the lowest number of 
independent variables that best predict the dependent variable.  
Note: There is a subtle difference between a backwards stepwise regression and best 
subsets regression. Backwards stepwise regression is used when a number of independent 
variables are known to predict a dependent variable and you are interested in systematically 
removing the independent variables to determine those that best predict the dependent 
variable. In contrast, best subsets regression is best used when you are not sure which 
independent variables best predict the dependent variables and want to consider various 
possible combinations to determine that independent variables that best predict the 
dependent variable (Sigmaplot 12, Systat Software Inc., 2012). 
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5. 8. Results 
All 25 subjects included in this study were obese at baseline and had been sedentary for a 
minimum of 6 months prior to enrolment.  
 
5. 8. 1. Physical Characteristics 
The pre and post values for the physical characteristics in addition to the percent change 
that occurred to these variables after exercise training are presented in Table 5.1. A paired 
samples t-test revealed that there was a significant reduction in weight (p=0.003), BMI 
(p=0.003), fat mass (p=0.001) and percent body fat (p=0.001) post intervention. This was 
accompanied by a significant increase in lean tissue mass (p=0.022), percent lean tissue 
(p=0.001) and fitness ( O2max ml/kg/min) (p<0.001).  
 
Table 5.1 All measured physical characteristics pre and post intervention in addition 
to the percent change that occurred to each variable. 
 Pre Post % change 
 
 (n=25)  
Age (yr) 38 ± 13   
Weight (kg) 94.1 ± 19.7 91.8 ± 18.6 * -2.3 ± 3.1  
BMI (kg/m2) 33.07 ± 4.90 32.32 ± 4.79 * -2.30 ± 3.13 
Fat mass (kg) 43.61 ± 15.53 39.70 ± 14.46 * -8.92 ± 8.82  
% body fat 46.47 ± 9.41 43.28 ± 9.53 * -7.08 ± 6.55  
Lean tissue (kg) 46.19 ± 10.89 47.98 ± 10.61 * 4.44 ± 7.72  
% lean tissue 50.59 ± 9.20 53.72 ± 9.28 *  6.63 ± 7.67  
O2max (ml/kg/min) 27.47 ± 6.84 31.64 ± 7.19 * 17.43 ± 18.77  
O2max (L/min) 2.56 ± 0.75 2.9 ± 0.75 * 16.01 ± 16.67  
Data is presented as mean ± standard deviation. * p<0.05 represents a significant change 
post intervention. Note: BMI = Body Mass Index, = O2max aerobic fitness. 
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Figure 5.2 Percent change in weight (kg), fat mass (kg), lean tissue mass (kg) and 
aerobic fitness ( O2max ml/kg/min) post intervention. Data is presented as the 
mean percent change ± standard deviation.  * p<0.05 represents a significant 
change post intervention. 
 
5. 8. 2. Metabolic characteristics 
The baseline and post intervention values for the metabolic characteristics are presented in 
Table 5.2, in addition to the percent change that occurred to these variables post 
intervention. A paired samples t-test identified a significant reduction in HOMA-B 
(p=0.04) which was accompanied by a significant increase in the AUCG/AUCI index 
(p=0.03). AUCI decreased significantly (p=0.01) but there was no change in AUCG 
(p=0.52) or the Stumvoll (p=0.133) and Matsuda (p=0.166) indexes of insulin sensitivity. 
  
The lipid profile of the subjects was also measured pre and post intervention. These results 
in addition to the percent change that occurred to the lipids after exercise training is 
presented under in Table 5.2. There was no change in free fatty acids (p=0.93), triglycerides 
(p=0.57), total cholesterol (p=0.65), LDL cholesterol (p=0.82) or HDL cholesterol 
(p=0.22) post intervention. Pearson correlation and backwards stepwise regression analysis 
was not carried out for these variables. 
 
 
* 
* 
* 
* 
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Table 5.2 All measured metabolic characteristics pre and post intervention in 
addition to the percent change that occurred to each variable. 
 Pre Post % change 
 
 (n=25)  
AUCG 1088.43 ± 216.73 1064.33 ± 177.34 -0.73 ± 15.77 
AUCI 14049 ± 8785 11322 ± 7543 -16.09 ± 21.75 * 
AUCG/AUCI 0.117 ± 0.099 0.144 ± 0.127 26.21 ± 38.15 * 
HOMA-B 48.70 ± 26.91 40.99 ± 24.25 -4.60 ± 56.55 * 
Stumvoll 0.127 ± 0.030 0.124 ± 0.025 -1.186 ± 11.315 
Matsuda 14.80 ± 13.50 18.07 ± 20.86 26.09 ± 44.59 
FFA’s 0.56 ± 0.15 0.54 ± 0.21 4.52 ± 19.42 
TG’s 1.43 ± 0.92 1.32 ± 0.72 -3.27 ± 39.39 
TC 5.01 ± 1.52 5.04 ± 1.21 -1.52 ± 29.23 
LDL 3.18 ± 1.37 3.05 ± 0.90 9.65 ± 41.55 
HDL 1.15 ± 0.28 1.27 ± 0.42 13.41 ± 49.48 
Data is presented as mean ± standard deviation. * p<0.05 represents a significant change 
in the variable post intervention. Note: AUCG = Area Under the Glucose Curve, AUCI = 
Area Under the Insulin Curve, AUCG/AUCI = Area Under the Glucose Curve / Area 
Under the Insulin Curve (index of insulin sensitivity), HOMA-B is an index of fasting 
insulin secretion, Stumvoll and Matsuda are indexes of insulin sensitivity, FFA’s = Free 
Fatty Acids, TG’s = Triglycerides, TC = Total Cholesterol, LDL = Low Density 
Lipoprotein Cholesterol, HDL = High Density Lipoprotein Cholesterol.  
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Figure 5.3 Percent change in the area under the curve for insulin (AUCI), the area 
under the curve for glucose / the area under the curve for insulin (AUCG/AUCI), 
and fasting insulin secretion (HOMA-B) post intervention. Data is presented as the 
mean percent change ± standard deviation.   * p<0.05 represents a significant 
change post intervention. 
 
5. 8. 3. Novel Biomarkers of Insulin Resistance 
The circulating concentration of the selected biomarkers pre and post intervention is 
presented in Table 5.3. The percent change that occurred in the biomarkers post 
intervention is also included. A paired samples t-test revealed that there was a significant 
decrease in Fetuin-A post intervention (p=0.02). However, Fetuin-A was only measured in 
a subgroup of the subjects (n=9) because of a technical error that occurred during the 
analysis of the other Fetuin-A kits containing samples for the remainder of the subjects. 
There was no change in the circulating concentration of FGF21 (p=0.77), IL-13 (p=0.87), 
Chemerin (p=0.35), Omentin (p=0.45), or Visfatin (p=0.58) post intervention.  
 
 
 
 
 
* 
* 
* 
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Table 5.3 All measured biomarkers pre and post intervention in addition to the 
percent change that occurred to each variable. 
 Pre Post % change 
 
 (n=25)  
FGF21 296.81 ± 134.92 284.62 ± 156.85 11.69 ± 68.20 
IL-13 155.46 ± 110.42 156.22 ± 99.19 5.05 ± 24.30 
Chemerin 218.82 ± 44.07 200.11 ± 51.82 -3.88 ± 32.41 
Omentin 339.85 ± 156.40 364.98 ± 142.68 17.78 ± 48.54 
Visfatin 16.90 ± 4.17 16.23 ± 4.44 -3.42 ± 14.16 
Fetuin-A 578.49 ± 141.23 464.89 ± 76.12  -19.79 ± 13.08 * 
Data is presented as mean ± standard deviation. * p<0.05 represents a significant change 
post intervention.  Note: n=9 for the Fetuin-A data (aerobic exercise subjects only) 
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Figure 5.4 Percent change in selected biomarkers post intervention. Data is 
presented as the mean percent change ± standard deviation from the mean. 
*p<0.05 represents a significant change post intervention. 
 
5. 8. 4. Pearson correlation analysis for the physical characteristics 
Pearson correlations revealed that the percent change in weight post intervention was 
significantly positively correlated with the percent change in AUCI (r=0.433, p=0.04), and 
* 
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LDL cholesterol (r=0.478, p=0.04), and significantly inversely correlated with the percent 
change in the Matsuda index of insulin sensitivity (r=-0.431, p=0.05). 
 
The percent change in fat mass was significantly positively correlated with the percent 
change in AUCI (r=0.524, p=0.02) as shown in Figure 5.5, and significantly inversely 
correlated with the percent change in Matsuda (r=-0.547, p=0.02) and O2max (ml/kg/min) 
(r=-0.433, p=0.05), the latter relationship is also presented in Figure 5.5.    
 
The percent change in lean tissue mass (kg) post intervention was not correlated with the 
percent change in any other variable. The percent change in fitness ( O2max ml/kg/min) 
was significantly positively correlated with the percent change in the AUCG/AUCI index 
(r=0.662, p<0.001). It was significantly inversely related to the percent change in fat mass 
(r=-0.443, p=0.05), AUCI (r=-0.665, p<0.001), LDL cholesterol (r=-0.491, p=0.03) and 
trending towards an inverse correlation with HOMA-B (r=-0.377, p=0.06). 
 
Figure 5.5 (a) Depicts the positive relationship between the percent change in fat 
mass (kgs) and the percent change in the area under the curve for insulin (AUCI) 
post intervention (r=0.524, p=0.02).    (b) Depicts the inverse relationship between 
the percent change in fat mass (kgs) and the percent change in aerobic fitness 
( O2max ml/kg/min) post intervention (r=0.443, p=0.05). 
 
Backwards stepwise regression was not run on the physical characteristics because the 
percent change that occurred to these variables post intervention was completely due to the 
actual exercise training that was undertaken, in addition to the calories expended during the 
exercise sessions. 
 
(a) (b) 
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5. 8. 5. Pearson correlation and backwards stepwise regression analysis 
for the metabolic characteristics 
Pearson correlations revealed that the percent change in AUCI was significantly positively 
correlated with the percent change in weight (r=0.433, p=0.04), BMI (r=0.434, p=0.04), fat 
mass (kg) (r=0.524, p=0.02), serum Chemerin (r=0.469, p=0.03), HDL cholesterol 
(r=0.557, p=0.02), and LDL (r=0.693, p<0.001). It was significantly inversely correlated 
with the percent change in Omentin (r=-0.453, p=0.003) and fitness (r=-0.665, p<0.001). 
Backwards stepwise regression presented in Table 5.4 illustrates that the percent change in 
AUCI was most significantly predicted by the percent change in fitness ( O2max 
ml/kg/min) and HDL cholesterol, which accounted for 74.7% of the variance in AUCI 
post intervention.  
 
The percent change in AUCG/AUCI was significantly positively correlated with the 
percent change in fitness ( O2max ml/kg/min) (r=0.662, p<0.001), and significantly 
inversely correlated with the percent change in LDL cholesterol (r=-0.574, p=0.01). 
Backwards stepwise regression presented in Table 5.4 shows that the percent change in 
AUCG/AUCI was most significantly predicted by the percent change in fitness, which 
accounted for 74.7% of the variance in AUCG/AUCI post intervention. 
 
Following exercise training, the percent change in HOMA-B was trending towards a 
significant inverse correlation with the percent change in fitness ( O2max ml/kg/min) (r=-
0.377, p=0.06). It was significantly inversely correlated with the percent change in the 
circulating concentration of Visfatin (r=-0.506, p=0.01), and positively correlated with the 
percent change in FFA’s (r=0.689, p=0.04). Backwards stepwise regression revealed that 
the percent change in fitness accounted for 71.6% of the variance in HOMA-B post 
intervention. This data is presented in Table 5.4.  
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Table 5.4 Backwards stepwise regression analysis showing the independent 
variables that best predict the change in the dependent variables AUCI, 
AUCG/AUCI, and HOMA-B post exercise training. 
Dependant 
variable 
Indep. 
variables in 
model 
Coef. Std. 
Coeff. 
Std. Error F-to-
Remove 
P 
 
 
AUCI 
(R2=0.740) 
Constant -6.313  5.216   
% change in 
O2max 
ml/kg/min 
-0.803 -0.646 0.181 19.593 <0.001 
% change in 
HDL 
0.199 0.417 0.0696 8.165 0.013 
 
AUCG/AUCI 
(R2=0.747) 
 
Constant 4.261  10.812   
% change in 
O2max 
ml/kg/min  
1.399 0.660 0.398 12.337 0.003 
 
HOMA-B 
(R2=0.716) 
 
Constant 8.787  7.324   
% change in 
O2max 
ml/kg/min 
-0.807 -0.846 0.207 15.112 0.008 
R2 represents the extent to which the percent change in the independent variable (s) 
contribute to the percent change in the dependent variable. p<0.05 is significant. Note: 
AUCI = Area Under the Curve for Insulin, AUCG/AUCI = area under the curve for glucose 
/ area under the curve for insulin, HOMA-B = fasting insulin secretion, HDL = High 
Density Lipoprotein Cholesterol, = O2max  aerobic fitness. 
 
5. 8. 6. Pearson correlation and backwards stepwise regression analysis 
for the biomarkers. 
Pearson correlations for all of the biomarkers are presented in Table 5.5. The percent 
change in IL-13 was not correlated with the percent change in any other variable post 
intervention but was trending towards a positive correlation with the percent change in 
body weight (p=0.07). The percent change in Fetuin-A was not significantly correlated with 
the percent change in any other variable post intervention but was trending towards a 
correlation with the percent change in free fatty acids (p=0.08).  
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Table 5.5 Pearson correlations for selected biomarkers. 
 % change 
in FGF21 
% change 
Chemerin 
% change 
Omentin 
% change  
Fetuin-A 
% change 
in Visfatin 
% change 
in IL-13 
% change 
in FGF21 
 r=-0.438 * 
p=0.04 
    
% change 
in 
Chemerin 
r=-0.438 * 
p=0.04 
 r=-0.563 * 
p=0.01 
   
% change 
in Omentin 
 r=-0.563 * 
p=0.01 
    
% change 
in AUCG 
  r=-0.618 * 
p=0.003 
 r=-0.407 
p=0.70 
 
% change 
in AUCI 
 r=0.469 * 
p=0.03 
r=-0.453 * 
p=0.03 
   
% change 
in Matsuda 
  r=0.409 ٢ 
p=0.07 
 r=0.507 * 
p=0.02 
 
% change 
in Stumvoll 
    r=-0.440 * 
p=0.04 
 
% change 
in HOMA-
B 
    r=-0.506 
p=0.01 * 
 
% change 
in LDL 
r=-0.424 ٢ 
p=0.07 
r=0.643 * 
p=0.004 
    
% change 
in HDL 
 r=0.526 * 
p=0.03 
    
% change 
in FFA’s 
   r=0.648٢ 
p=0.08 
  
% change 
In weight 
     r=0.391٢ 
p=0.07 
r represents the strength of the correlation between two variables. * p<0.05 is significant.  
٢p<0.09 is trending towards significance. Note: AUCG = Area Under the Curve for 
Glucose, AUCI = Area Under the Curve for Insulin, HOMA-B = Fasting Insulin Secretion, 
LDL = Low Density Lipoprotein Cholesterol, HDL = High Density Lipoprotein 
Cholesterol, FFA’s = Free Fatty Acids, FGF21 = Fibroblast Growth Factor 21, IL-13 = 
Interleukin-13.  
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The change that occurred to IL-13 post intervention was not significantly correlated with 
the percent change in any other variable, thus backwards stepwise regression was run using 
a combination of variables identified in the literature as having an important influence on 
the circulating concentration of this biomarker. The only independent variable that was not 
removed from the model was body weight. The change in body weight predicted 22% of 
the change in IL-13 post intervention.  
 
The percent change in FGF21 also was not significantly correlated with the percent change 
in any other variable post intervention. A combination of variables identified in the 
literature as having an important influence on the production of FGF21 was entered into 
the backwards stepwise regression. The only independent variable that was not removed 
from the model was Chemerin. The percent change in Chemerin accounted for 19.2% of 
the variance in FGF21 post intervention.  
 
Only 9 data points were available for Fetuin-A, which represented the subjects who 
undertook the aerobic exercise intervention. Backwards stepwise regression was conducted 
on Fetuin-A in study one of this PhD thesis and these results are included in the current 
chapter presented in Table 5.6 below. The findings show that 42% of the variance in 
Fetuin-A in the aerobic exercise group was predicted by the percent change in FFA’s. This 
data analysis can not be applied to the entire group in the current study. 
 
The percent change in Chemerin was mostly predicted by the percent change in Omentin 
and AUCI, which accounted for 55.4% of the variance in Chemerin post intervention. 
Similarly, when backwards regression analysis was performed on Omentin, the percent 
change in Omentin was mostly predicted by the percent change in Chemerin and AUCG, 
which accounted for 61% of the variance in Omentin post intervention. This data is 
presented in Table 5.6. 
 
Finally, Table 5.6 shows that the percent change in Visfatin post intervention was mostly 
predicted by the percent change in AUCG and HOMA-B, which accounted for 49.4% of 
the variance in Visfatin. 
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Table 5.6 Backwards stepwise regression analysis illustrating the percent change in 
the independent variable (s) that best predicted the percent change in the 
dependent variables post intervention. 
Dependant 
variable 
Indep. 
variables in 
model 
Coef. Std. Coeff. Std. Error F-to-
Remove 
P 
% change in  
FGF21 
(R2=0.192) 
Constant         -1.345                                  9.972 
% change in    -0.681            -0.438            0.313             4.749               0.041 
Chemerin 
 
% change in 
Chemerin 
(R2=0.554) 
Constant 15.338  6.230   
% change in 
Omentin 
-0.289 -0.495 0.106 7.400 0.015 
% change in 
AUCI 
0.499 0.372 0.244 4.181 0.057 
 
% change in 
Omentin 
(R2=0.610) 
Constant 19.008  7.642   
% change in 
Chemerin 
-0.875 -0.511 0.275 10.147 0.005 
% change in  
AUCG 
-1.437 -0.446 0.517 7.734 0.013 
 
% change in 
Visfatin 
(R2=0.494) 
Constant -1.563  2.357   
% change in 
AUCG 
-0.309 -0.360 0.149 4.278 0.054 
% change in 
HOMA-B 
-0.126 -0.559 0.039 10.333 0.005 
 
% change in 
Fetuin-A 
(R2=0.420) 
Constant -21.551  3.896   
% change in 
FFA’s 
0.409 0.648 0.196 4.349 0.082 
 
% change in 
IL-13 
(R2=0.220) 
Constant 11.90  6.036   
 
% change in 
weight 
3.575 0.469 1.546 5.346 0.03 
R2 represents the extent to which the percent change in the independent variable predicted 
the percent change in the dependent variable.  p<0.05 is significant. Note: FGF21 = 
Fibroblast Growth Factor 21, AUCI = Area Under the Curve for Insulin, AUCG = Area 
Under the Curve for Glucose, HOMA-B = Fasting Insulin Secretion, FFA’s = Free Fatty 
Acids, IL-13 = Interleukin-13. 
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The backwards regression analysis presented in Table 5.6 identified independent variables 
that predicted only 19-61% of the variance in any biomarker post intervention. In an 
attempt to identify other variables that might influence the production of the biomarkers, 
best subsets regression analysis was performed. This analysis looks at every possible 
combination of selected variables and identifies all possible models ranging from the 
smallest to the largest predictive ability. The output from this analysis revealed that 
combining the variables originally identified in the pearson correlation analysis presented in 
Table 5.5, with other combinations of measured variables deemed to be important by the 
literature, had very little additional impact on the predictive ability of the backwards 
regression models presented in Table 5.6. Also, the only independent variables to 
significantly contribute to the change in any particular biomarkers post intervention were 
those that were originally identified in the backwards stepwise regression in Table 5.6.   
 
 
5. 9. Discussion 
There are 3 key findings to the current analysis. Firstly, exercise training significantly 
improved body weight, all components of body composition, and fitness in obese, 
previously sedentary subjects. The 3 individual interventions demonstrated adaptations in 
the physical characteristics that were specific to the mode of exercise undertaken including 
greater reductions in body weight and body fat when aerobic exercise was the predominant 
mode of training (aerobic and REG groups), and greater increases in lean tissue mass when 
a greater volume of resistance training was combined with aerobic exercise (REG and ECC 
groups). The current analysis supports these findings and suggests that with general 
exercise and with a greater sample size all physical characteristics respond favourably and 
significantly to training. Secondly, insulin secretion and insulin sensitivity improved 
significantly post training which was evident as a significant reduction in HOMA-B and 
AUCI in addition to a significant increase in the AUCG/AUCI index. These findings 
support those of the aerobic intervention. HOMA-B, AUCI and the AUCG/AUCI index 
also improved in the ECC and REG groups post training and although these 
improvements did not reach statistical significance, fat oxidation improved significantly 
which has important implications for metabolic health in obese individuals. The larger 
number of subjects in the current analysis shows that exercise training improves insulin 
sensitivity and insulin secretion in obese previously sedentary subjects. These findings add 
further support to the previous chapters of this thesis and the current literature that 
exercise training improves metabolic health in obese individuals. Importantly, the current 
analysis identified that increased aerobic fitness post training was the single best predictor 
of the improvements in metabolic health in these subjects, supporting the findings of the 
aerobic exercise intervention. In the ECC and REG group that improvements in metabolic 
health was mostly attributed to improvements in the circulating concentrations of the 
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biomarkers suggesting that they also play a role, but overall and with greater numbers of 
subjects increased fitness was the best predictor of metabolic health. Finally, the results of 
the 3 individual interventions in addition to the current analysis indicate a cyclical 
relationship between metabolic health and the circulating concentrations of the biomarkers 
as opposed to a causative relationship. It also appears that the biomarkers play a role in the 
regulation of each other.  
 
Ten to twelve weeks of exercise training is associated with significant 
improvements in body weight, body composition and aerobic fitness in obese individuals. 
Overall there was a 2.3% or 2.2kg reduction in body weight, which is supported by a 
review of numerous other training studies of similar duration and energy expenditure (Ross 
and Janssen, 2001). The subjects in the current group expended approximately 2,500kcal 
per week which equated to approximately 25,000 - 30,000kcal over 10-12 weeks. The 
subjects were required to maintain their pre intervention energy intake and so the total 
caloric deficit caused by exercise training should have accumulated to a total weight loss of 
approximately 2.8 - 3.3kg post intervention since there are approximately 9,000kcal in 1kg 
of body fat. However, this simplistic calculation does not take into account the changes 
that occurred to body composition as a result of physical training. The subjects in the 
current analysis achieved an 8.9% or 3.9kg reduction in fat mass, which is greater than a 
2.5kg reduction reported in a review of exercise training studies of similar duration and 
energy expenditure (Ross and Janssen, 2001). This difference may be due to variations in 
the mode and intensity of exercise training in the present study. The loss in fat mass was 
accompanied by a 4.4% or 1.8kg increase in lean tissue mass, in addition to a 17.4% 
increase in aerobic fitness. These findings were an expected consequence of exercise 
training and are supported by numerous other training studies in the literature (O'Leary et 
al., 2006, Haus et al., 2009, Saremi et al., 2010a).  
 
The adaptations that occurred to the physical characteristics in response to exercise training 
in the current analysis support those identified in the aerobic, REG and ECC groups 
detailed in chapters 3 and 4 adding support to the less powered interventions. In the 
aerobic exercise intervention, body weight, BMI, fat mass and fitness all improved 
significantly. Lean tissue mass increased by 8.6+14.2% and although this did not reach 
statistical significance the change in percent lean tissue trended towards significance 
(p=0.09). Body composition data was only available for 5 subjects in the aerobic 
intervention and the current analysis suggests that greater power in the aerobic intervention 
may have led to significant increases in lean tissue mass post intervention. The adaptations 
that occurred to the physical characteristics of the subjects in the ECC and REG groups 
appeared to be very specific to the mode of exercise training undertaken. There were 
greater reductions in fat mass in the REG group (-9.3+8.4%) compared to the ECC group     
(-6.2+8.1%). The difference between groups, although not statistically significant, was 
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possibly due to the greater contribution of aerobic exercise in the REG intervention. In 
contrast, there were greater gains in lean tissue mass in the ECC group (4.2+4.5%) 
compared to the REG group (2.0+3.2%). The difference between groups, although not 
significant, was most likely due to the greater volume of resistance training in the ECC 
group (45mins twice per week) compared to the REG group (15mins twice per week), in 
addition to the fact that muscle damage such as that evident post eccentric training often 
stimulates hypertrophy (Shepstone et al., 2005). The greater reductions in fat mass 
combined with smaller increases in lean tissue mass in the REG group explains why body 
weight and BMI trended towards a decrease (p=0.07) in the REG group but did not 
change in the ECC group post intervention. However, in general and when the data from 
all 3 interventions are combined it is clear that exercise training is associated with 
significant weight loss in addition to significant improvements in body composition.  
 
Aerobic fitness increased significantly in the aerobic exercise group and in the ECC group 
post intervention but surprisingly did not change in the REG group. The average increase 
in fitness was 22.7+5.6%, 10.1+5.5% and 9.0+17.1% in the aerobic, ECC and REG groups 
respectively. These findings clearly indicate that the greatest gains in fitness were evident 
following aerobic exercise training only. The average change in fitness was similar between 
the ECC and REG groups but the large standard deviation in the REG group might 
explain why the increase in fitness in this group did not reach statistical significance. It also 
highlights the potential for wide variation in individual response to exercise training which 
may have masked the true changes in aerobic fitness in the REG group. When all data is 
combined and the sample size is larger it is clear that exercise training significantly increases 
aerobic fitness. The physical characteristics of the obese subjects in the 3 individual 
interventions demonstrated adaptations that were specific to the mode of exercise 
undertaken but overall it is clear from the current analysis that exercise training significantly 
improves the physical characteristics of obese subjects including body weight, body 
composition and aerobic fitness. Any deviations from these findings are most likely 
explained by the varying modes of exercise in addition to small sample sizes. 
 
The metabolic profile of the subjects improved significantly following exercise 
training. This was evident as a significant reduction in insulin secretion and insulin 
sensitivity measured by HOMA-B, AUCI and the AUCG/AUCI index. These findings 
support those of the aerobic exercise intervention and are well documented by numerous 
other exercise training studies (Duncan et al., 2003, Hayashi et al., 1997, Holloszy, 2005). 
HOMA-B (-6.4+28.5% in ECC and -8.9+97.6% in REG), AUCI (-8.5+14.4% in ECC and 
-9.1+23.5% in REG), and the AUCG/AUCI index (10.5+20.0 in ECC and 10.9+24.8% in 
REG) all improved in the ECC and REG groups post intervention but did not reach 
statistical significance. This was an unexpected finding given the well established 
relationship between exercise training, improved body composition and insulin sensitivity 
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(Carey et al., 1996, Redinger, 2007) and possible explanations for these findings are detailed 
in Chapter 4. Importantly, both groups demonstrated a significant increase in fat oxidation 
post intervention which has important implications for enhanced insulin sensitivity in an 
obese population (Petersen and Shulman, 2002, Shulman, 2000, Yu et al., 2002). These 
adaptations confirm that the subjects did respond metabolically to exercise training, and the 
findings from the current analysis suggest that the other measures of insulin sensitivity may 
have increased significantly with a greater sample size. Similar to the findings of the 3 
individual interventions, the Stumvoll and Matsuda indices of insulin sensitivity did not 
change significantly following exercise training demonstrating that a greater sample size still 
had no effect on these predictive models of insulin sensitivity. This may be due to the large 
variability that existed between the subjects in their baseline fasting insulin values, in 
addition to the variability in their insulin response to a glucose load. These findings suggest 
that the use of the Stumvoll and Matsuda models alone may not be the most 
comprehensive predictors of insulin sensitivity in an obese population, and may need to be 
supported by other indicators. Finally, the circulating concentration of the lipids did not 
change in any of the 3 interventions post training, or in the current analysis even with a 
larger sample size. However, RQ did improve significantly following the ECC and REG 
intervention demonstrating that fat oxidation improved in these groups with exercise 
training which in the longer term could ameliorate insulin resistance. The subjects in the 
aerobic group did not undergo an RMR and so data pertaining to fat oxidation is not 
available. These findings indicate that it is important to measure fat oxidation in this 
population to show improvements in fuel utilization and metabolism that may not be 
evident in measures of circulating lipids. 
  
In the current analysis, the improvement in the metabolic health of the subjects 
post intervention was highly correlated with the favourable changes that occurred to their 
physical characteristics. The reduction in body weight and body fat mass were both 
significantly positively correlated with the reduction in AUCI. The increase in aerobic 
fitness in particular was associated with improvements in all indices of metabolic health 
with the exception of the Stumvoll predictor of insulin sensitivity. In fact, the increase in 
fitness was the single best predictor of the improvements in insulin secretion and insulin 
sensitivity in these subjects. The backwards regression analysis revealed that the percent 
increase in fitness accounted for 71.7% of the reduction in HOMA-B, 74.7% of the 
increase in the AUCG/AUCI index of insulin sensitivity, and 74.7% of the decrease in 
AUCI post intervention (Table 5.4). These results support those of the aerobic exercise 
intervention, which also revealed that the percent change in fitness best predicted the 
favourable percent change in HOMA-B, AUCI and the AUCG/AUCI index (Table 3.6). 
For the ECC and REG group, the best predictors of the change in these measures were the 
percent changes that occurred to the circulating concentration of the biomarkers in 
addition to the percent increase in lean tissue mass (Table 4.6). All 3 interventions led to 
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improvements in these variables and it is possible that the improvements were regulated by 
the differential changes in body composition in response to different modes of training. 
Overall, when all data is combined, it is clear that aerobic fitness is the best predictor of 
insulin resistance and insulin sensitivity in an obese population. There is an abundance of 
literature to support this finding (Duncan et al., 2003) which is true in the presence (Saremi 
et al., 2010b) and absence (Nassis et al., 2005) of weight loss. Exercise training has even 
been reported to reverse insulin resistance in overweight subjects (O'Leary et al., 2006). As 
little as one bout of exercise has been shown to enhance insulin sensitivity in this 
population (O'Gorman et al., 2006). These results illustrate the crucial role of exercise and 
aerobic fitness in improving the metabolic health of obese individuals, and support the 
recommendation that aerobic fitness must be a primary outcome measure in interventions 
of this nature. 
 
The literature that is currently available suggests that significant improvements in 
body composition, fitness and insulin sensitivity lead to significant favourable changes in 
the circulating concentration of the novel biomarkers of insulin resistance (Brix et al., 2010, 
Cuevas-Ramos et al., 2012, Moreno-Navarrete et al., 2010, Chakaroun et al., 2012, Choi et 
al., 2007). The results of the current analysis confirms that exercise training significantly 
improves body composition, fitness and insulin sensitivity, but there was no significant 
change in the circulating concentration of any of the biomarkers. The large variation in the 
individual response of the biomarkers to exercise training suggests that larger scale studies 
may be required to determine the effects of exercise on the biomarkers. Chapters 3 and 4 
of this thesis also suggest that the circulating concentration of the biomarkers may be 
differentially regulated by different modes of exercise training since Fetuin-A decreased 
significantly following aerobic exercise only, and Visfatin increased significantly following 
the ECC intervention only.  
 
Although the serum concentration of the biomarkers did not change significantly post 
intervention, the changes that did occur provide further support to the results of the 
previous studies, along with some additional interesting findings. The pearson correlations 
in the current analysis revealed that there was no relationship between the percent change 
in any of the biomarkers and the percent change in any of the physical characteristics. 
Instead, the percent change in the circulating concentrations of the biomarkers was 
significantly correlated with the percent change in each other, the lipids, and various 
parameters of insulin secretion and insulin sensitivity. The backwards regression analysis in 
the current chapter showed that the best predictor of the percent change in Chemerin was 
the percent change in Omentin and AUCI, which accounted for 44.5% of the variance in 
Chemerin. The literature supports a significant inverse relationship between the pro-
inflammatory cytokine Chemerin and the anti-inflammatory cytokine Omentin (El-
Mesallamy et al., 2011). It has been suggested that the adipocytes of obese individuals are 
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responsible for the elevated concentration of Chemerin (Stejskal et al., 2008), and that 
Chemerin induces insulin resistance at the level of the insulin receptor, thus inhibiting 
glucose uptake (Lambernd et al., 2012). The results of the current study suggest that 
exercise induced improvements in fat mass and thus circulating Omentin, down regulated 
the production of Chemerin by 3.9% in this population. Other exercise training 
interventions of similar duration support these findings (Saremi et al., 2010b, Chakaroun et 
al., 2011). However, exercise training even in the absence of weight loss has also been 
shown to down regulate the expression of Chemerin mediated by the contraction induced 
increase in glucose uptake (Lambernd et al., 2012). The percent change in Chemerin was 
best predicted by the percent change in aerobic fitness (93.4%) in the aerobic intervention, 
the percent change in IL-13 (67.4%) in the ECC group and the percent change in LDL 
(73%) in the REG group. Taking all findings into consideration it is likely that the 
production of Chemerin is not simply regulated by one factor but rather is influenced by a 
combination of factors including fitness, body composition, insulin sensitivity, and the 
circulating concentrations of other biomarkers. 
 
The best predictor of the percent change in Omentin was the percent change in Chemerin 
and AUCG, which accounted for 61% of the variance in Omentin post intervention. This 
supports the previous finding that Chemerin and Omentin regulate the production of each 
other (El-Mesallamy et al., 2011). Both biomarkers are produced in fat mass so it is 
possible that changes in fat mass alter their expression, but the results also suggest a 
regulatory relationship between them. The literature reports that Omentin may have a role 
in improving insulin sensitivity. In fact administration of recombinant Omentin has been 
shown to increase insulin stimulated glucose uptake by 47% in adipose tissue and 30% in 
omental adipose tissue by enhancing insulin action and thus improving glucose uptake 
(Yang et al., 2006). The literature suggests that Omentin plays a role in the regulation of 
blood glucose levels but the results of this current study suggest that improvements in 
insulin sensitivity and glucose tolerance also regulate the production of Omentin, indicating 
a possible cyclical relationship between Omentin and Chemerin, in addition to Omentin 
and glucose tolerance. These findings support those of the aerobic and REG interventions 
which reported that the best predictor of the percent change in Omentin was the percent 
change in Stumvoll (44.3%) and AUCG (67.6%) respectively. Additionally, the ECC group 
identified the percent change in FGF21 (64.6%) to be the best predictor of the percent 
change in Omentin adding further support to the finding that Omentin is also regulated by 
other biomarkers of insulin resistance. 
 
The percent change in Visfatin was mostly predicted by the percent change in AUCG and 
HOMA-B, which accounted for 49.4% of the variance in Visfatin post intervention. 
Visfatin is a multi functioning protein that acts as a hormone, cytokine and enzyme. The 
enzyme version of Visfatin is known as Nampt and it is this enzyme that is essential for 
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beta cell functioning (Rongvaux et al., 2002). The results of the present study suggest that 
the reduction in fasting insulin secretion following exercise training may down regulate the 
production of Visfatin. Visfatin is reported to improve insulin sensitivity but its circulating 
concentration increases with greater levels of glucose intolerance (Dogru et al., 2007). This 
is possibly a compensatory response to diminished insulin function (Sun et al., 2007). Thus 
improvements in insulin sensitivity and glucose tolerance post training in the present study 
may have resulted in the suppression of Visfatin and thus a reduction in the circulating 
concentration of this hormone.  These findings support those of the ECC group which 
indicated that the percent change in AUCG predicted 67.6% of the variance in Visfatin. 
They also support the findings of the REG group which revealed that the percent change 
in RQ and RMR predicted 91% of the variance in Visfatin. The reduction in RQ represents 
improved fat metabolism which has important implications for insulin sensitivity and 
glucose tolerance. No variable best predicted the percent change in Visfatin in the aerobic 
group. Taken together, it appears that improvements in glucose tolerance and insulin 
sensitivity regulate the production of Visfatin. Since Visfatin functions to enhance insulin 
sensitivity it is likely that there is a cyclical relationship between insulin sensitivity and 
Visfatin. 
 
Backwards stepwise regression was run on FGF21 in the current analysis but surprisingly 
all combinations of variables were rejected and removed from the models with the 
exception of Chemerin which predicted 19.2% of the change in FGF21 post intervention. 
The percent change in FGF21 was best predicted by the percent change in LT and aerobic 
fitness (93%) in the aerobic group, the percent change in Omentin (70.2%) in the ECC 
group, and the percent change in Stumvoll (53.4%) in the REG group. Backwards 
regression was also run on IL-13 in the current analysis but similar to FGF21 all 
combinations of variables were rejected and removed from the models. The exception was 
the change in body weight which predicted 22% of the change in IL-13 post intervention. 
The percent change in IL-13 was best predicted by the percent change in LT (82.4%) in the 
aerobic group, the percent change in TG’s (92.4%) in the ECC group, and the percent 
change in body weight and aerobic fitness (86.3%) in the REG group. Taking all findings 
into account it appears that the production of FGF21 and IL-13 are not regulated by one 
factor but may be influenced by a combination of factors including fitness, body 
composition, insulin resistance and other biomarkers. 
 
Overall, the findings of the current analysis add support to those of chapters 3 and 
4 by suggesting that the regulation of the circulating concentration of the biomarkers is not 
simplistic. Their production seems to be influenced by each other in addition to 
improvements in body composition, insulin sensitivity and glucose tolerance. It also 
appears that they may be differentially regulated by different modes of intervention 
possibly mediated by the differential changes in body composition. 
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Figure 5.6 Schematic summarising the percent change in the independent variables 
that predict the percent change in each biomarker post intervention in the current 
analysis. This clearly shows the cyclical relationship between the biomarkers in 
addition to the influence of insulin sensitivity and glucose tolerance on the 
production of the biomarkers. 
 
5. 10. Limitations 
Fetuin-A was only measured in a subgroup of this population and so could not be included 
in the analysis using a larger sample size. There was a slight difference in intervention 
duration between groups with the aerobic exercise intervention consisting of 12 weeks of 
training but the ECC and REG interventions consisted of 10 weeks. This could not be 
avoided with the latter interventions due to end of term examinations but must be noted 
when considering this analysis. The mode of exercise in each group was slightly different 
but the interventions were broadly similar with regard to the number of training sessions 
per week, the intensity of the aerobic exercise, and the duration and energy expenditure of 
each training session.   
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5. 11. Summary and Conclusion 
This chapter clearly shows that 10-12 weeks of exercise training significantly reduces body 
weight, BMI, and body fat mass in obese subjects in addition to significantly increasing lean 
tissue mass and aerobic fitness. Exercise training also significantly improves insulin 
secretion and insulin sensitivity which is evident as a significant reduction in HOMA-B and 
AUCI and a significant increase in the AUCG/AUCI index. These physical and metabolic 
adaptations to exercise training are expected but were not all evident in all 3 individual 
exercise interventions possibly due to small sample size. The individual interventions also 
suggested that physical adaptations are specific to the mode of intervention undertaken.  
 
The Stumvoll and Matsuda indices of insulin sensitivity did not change following any of the 
3 individual exercise interventions or with the greater sample size in the current analysis. 
These findings suggest that these indices may not be the most comprehensive indicator of 
metabolic health in obese individuals and it is important to use other measures to support 
them including HOMA-B and the AUCG/AUCI index. The lipid profile of the subjects 
also did not change in the current analysis but the improvements in fat oxidation in the 
ECC and REG groups indicate that fat oxidation is an important measurement to obtain in 
exercise training interventions to get a true reflection of improvements in lipid metabolism 
and fuel utilization in this population.  
 
Finally, there was no change in the circulating concentration of the biomarkers in the 
current analysis. It appears that the regulation of the biomarkers is complex and can not be 
attributed to a change in any one variable. Many of novel biomarkers are derived from 
adipose tissue but they are also produced in various other tissues of metabolic importance 
and the relative contribution of these tissues to the circulating concentration of the 
biomarkers remains unknown. It is likely that their production is regulated by changes in a 
combination of variables post exercise training. The literature reports that the biomarkers 
have a regulatory role in metabolic health but the results of the 3 individual interventions in 
addition to the current analysis strongly indicate a cyclical relationship between metabolic 
health and the circulating concentrations of the biomarkers as opposed to a causative 
relationship. It also appears that the biomarkers play a role in the regulation of each other. 
The large individual variation in the response of the biomarkers to exercise training 
suggests that these may be important indicators of metabolic health in larger scale studies. 
Additional mechanistic studies are required to determine their regulation. 
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5. 12. Rationale 
Lifestyle interventions remain the primary therapy for the treatment of obesity. Both diet 
and exercise interventions have been reported to successfully produce weight loss in this 
population, but there is extensive variation in the design of these interventions, making it 
difficult to compare them and determine which might be the most successful. The purpose 
of this analysis was to compare the four isocaloric interventions discussed in Chapters 3 
and 4 and identify which intervention or combination of interventions was associated with 
the greatest improvements in body composition and metabolic health in obese subjects. 
Three of the interventions are those that are typically reported in the literature; diet, aerobic 
exercise, and aerobic exercise combined with resistance training. The final intervention 
takes a novel approach to exercise training and energy expenditure and consists of aerobic 
exercise combined with eccentric resistance training. 
 
5. 13. Aim 
The aim of this analysis was to identify the key physiological and biological adaptations to 
each type of intervention and use these to determine how to maximise the benefits gained 
by obese individuals from a lifestyle intervention. 
  
5. 14. Objective 
To compare the effects of 4 isocaloric interventions on body composition, insulin 
sensitivity, and the circulating concentrations of the novel biomarkers of insulin resistance.  
 
To compute the most effective combination of dietary restriction and physical activity 
based on improvements in body composition and changes in biomarker profile in obese 
subjects. 
 
5. 15. Hypothesis 
Dietary restriction and all modes of exercise training lead to distinctive physiological and 
biological profiles post intervention. 
 
A combination of dietary restriction, aerobic exercise and resistance training will be 
necessary to maximise the impact on physiological variables and biomarkers of insulin 
resistance. 
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5. 16. Study Design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Schematic representation of study design 
 
5. 17. Methods 
Please refer to chapters 3 and 4 for a detailed description of the tests and procedures and 
individual study designs outlined in Figure 5.1. 
 
 
 
 
Pre Tests 
VO2max + ECG 
Muscle Biopsy + OGTT 
DEXA Scan 
 
 
Chapter 3 
Aerobic Ex 
n = 10 
 
n =  10 
Chapter 3 
Diet 
n =  8 
Chapter 4 
Aerobic + RT 
n =  8 
Chapter 4 
Aerobic + ECC 
n = 7  
Post Tests 
VO2max + ECG 
Muscle Biopsy + OGTT 
DEXA Scan 
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5. 18. Statistical Analysis 
A mixed-between-within ANOVA was used to compare the impact of the four different 
interventions on all measured variables. A summary of these results is presented in Table 
5.3, Table 5.6 and Table 5.9.  
 
The first step of this analysis investigates the interaction effect between the type of 
intervention and time. In particular this analysis investigates whether the change in the 
dependent variable over time was the same in all four groups. If p>0.05 for the Wilks 
Lambda test, the change in the variable over time is the same in all four groups and so no 
difference exists between them. If p<0.05 for the Wilks Lambda test, the change that 
occurred in the variable over time is different between groups and further analysis is 
required to determine where the differences are, and thus which intervention is associated 
with the greatest change in that particular variable.  
 
If the change in the variable over time is significantly different between groups, the main 
effect for time examines the effect of time on the variable within each of the four 
interventions. If p<0.05 for the Wilks Lambda test for this step, this indicates that there is 
a significant change in the dependent variable post intervention. The partial eta squared 
value specified the effect size of this result, where .01=small effect, .06=moderate effect, 
.14=large effect, and any value greater than .14 indicates a very large effect size. A post 
Hoc test is then used to determine the intervention(s) that this result applies to.  
 
Finally, the between interventions analysis determines whether there is any difference 
between interventions with regard to their effect on a particular variable. If p<0.05 for the 
between intervention Wilks Lambda test, then there was a difference between 
interventions. The partial eta squared value confirmes the effect size of the change, and a 
post Hoc test establishes the intervention(s) that this result applies to.  
 
The effect of time on all of the measured variables has already been documented in detail 
in chapter 3 and 4 of this thesis. Therefore the current chapter will focus primarily on the 
main effect between interventions analysis in order to determine the intervention(s) that 
had the greatest favourable impact on body composition and metabolic health in these 
individuals. 
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5. 19. Results 
The findings of the individual interventions have been presented in detail in chapters 3 and 
4. The current results section focuses on a comparison between the 4 groups in the percent 
change that occurred to the physical characteristics, the metabolic characteristics, and the 
novel biomarkers of insulin resistance post intervention. The purpose of this analysis is to 
identify the key physiological and metabolic adaptations to each type of intervention so that 
this information may be used in the design of future interventions to maximise the benefits 
gains by obese individuals to a lifestyle intervention.  
 
5. 19. 1. Physical Characteristics 
The percent change that occurred to the physical characteristics post all 4 interventions is 
presented in Table 5.7. The mixed-between within analysis for these physical characteristics 
is presented in Table 5.8. There was a significant decrease in weight and BMI in the diet 
and aerobic exercise group post intervention, but there was no difference between groups 
in the amount of weight lost (p =0.36) or in the reduction in BMI (p=0.27). There was a 
significant decrease in fat mass in the diet, aerobic exercise, and REG groups, but there was 
no difference between groups in the amount of fat mass lost (p=0.85). Lean tissue mass 
increased significantly in the ECC group only but there was no difference between groups 
in the amount of lean tissue gained (p=0.42). Following exercise training there was a 
significant increase in fitness in the aerobic and ECC groups. The between intervention 
analysis revealed that there was a significant difference between these two groups (p=0.01) 
with quite a large effect size (partial eta squared .330). Post Hoc analysis identified the 
greatest improvement in fitness to be in the aerobic exercise group (p=0.012). 
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Table 5.7 Percent change in physical characteristics in all groups post intervention 
 Aerobic 
% change 
Diet 
% change 
ECC 
% change 
REG 
% change 
 (n=8) (n=10) (n=7) (n=8) 
Weight (kg) -2.6 ± 2.5 * -3.1 ± 2.9 * -0.6 ± 2.8 -3.1 ± 3.8 ٢ 
BMI (kg/m2) -2.62 ± 2.46 * -3.08 ± 2.89 * -0.60 ± 2.79 -3.09 ± 3.81 ٢ 
Fat mass (kg) -12.15 ± 11.04 * -5.82 ± 5.05 * -6.21 ± 8.08 -9.29 ± 8.4 * 
% body fat -9.8 ± 9.1 ٢ -3.7 ± 4.4  -5.8 ± 6.1 * -6.5 ± 5.47 * 
Lean tissue (kg) 8.62 ± 14.18  1.36 ± 6.34 4.21 ± 4.54 * 2.02 ± 3.16 ٢ 
% lean tissue 11.0 ± 12.6 ٢ 3.6 ± 5.1 4.9 ± 5.8 * 5.4 ± 4.6 * 
O2max 
(ml/kg/min) 
29.33 ± 20.70 * 10.14 ± 20.81 10.06 ± 5.54 * 9.02 ± 17.11 
O2max (L/min) 28.30 ± 18.28 * 8.26 ± 21.58 8.69 ± 6.21 * 7.06 ± 11.42 
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change in 
the variable post intervention. ٢p<0.09 represents a trend towards a significant change post 
intervention. 
 
Table 5.8 Summary of mixed-between-within analysis for the physical 
characteristics 
 Interaction Effect 
 
 
Main Effect for Time                   
Within Intervention      
Main Effect Between 
Interventions 
Variable P partial eta 
squared 
P partial eta 
squared 
P partial eta 
squared 
Weight 0.28 0.123 <0.001 * 0.402 0.36 0.104 
BMI 0.28 0.122 <0.001 * 0.395 0.27 0.126 
FM (kgs) 0.40 0.128 <0.001 * 0.526 0.85 0.037 
LT (kgs) 0.37 0.136 0.009 * 0.286 0.42 0.112 
O2max (ml) 0.06 0.226 <0.001 * 0.440 0.01 * 0.330 
O2max (l) 0.01 * 0.334 <0.001 * 0.429 0.39 0.097 
*p<0.05 is significant. partial eta squared 0.01=small effect size, 0.06 moderate effect size, 
0.14 large effect size, >0.14 very large effect size. Note: BMI = Body Mass Index, FM = Fat 
Mass, LT = Lean Tissue, O2max = aerobic fitness. 
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5. 19. 2. Metabolic Characteristics 
The percent change that occurred to the metabolic characteristics post all 4 interventions is 
presented in Table 5.9. Insulin sensitivity and insulin secretion improved significantly in the 
aerobic group only post intervention. This was evident as a significant decrease in AUCI 
and HOMA-B in addition to a significant increase in the ACUG/AUCI index of insulin 
sensitivity. The mixed-between-within analysis presented in Table 5.10 showed that there 
was a significant difference between groups in the change that occurred to AUCI post 
intervention (p<0.001), which had a large effect size (partial eta squared .522). Post hoc 
analysis revealed that the change in AUCI was greatest in the aerobic exercise group post 
intervention. However, since the interaction effect between group and time was significant 
for AUCI (p<0.001), these results must be interpreted with caution. This finding may be 
influenced by the fact that the baseline AUCI values were higher in this group than in any 
other group. However, the literature consistently reports that exercise training even in the 
absence of weight loss improves insulin sensitivity (Holloszy, 2005). There was no 
significant difference between groups in the change that occurred to the AUCG/AUCI 
index (p=0.13) or HOMA-B (p=0.10) post intervention.  
 
There was no change in AUCG, or the Stumvoll and Matsuda indices of insulin sensitivity 
in any group post intervention as outlined in chapters 3 and 4. The between groups analysis 
showed the change that occurred to AUCG (p=0.95), Stumvoll (p=0.51) or Matsuda 
(p=0.23) was similar between groups. 
  
There was no change in the lipid profile of the subjects. The main effect of time in the 
current analysis showed that there was that there was no change in FFA’s (p=0.46), TG’s 
(p=0.82), Total cholesterol (p=0.68), LDL cholesterol (p=0.84) or HDL cholesterol 
(p=0.48) in any group post intervention. The main effect between interventions analysis 
revealed that there was no difference between groups in the change that occured to FFA’s 
(p=0.32), TG’s (p=0.66), total cholesterol (p=0.95), LDL cholesterol (p=0.65) or HDL 
cholesterol (p=15) post intervention. 
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Table 5.9 Percent change in the metabolic characteristics in all 4 groups post 
intervention. 
 Aerobic 
% change 
Diet 
% change 
ECC 
% change 
REG 
% change 
 (n=8) (n=10) (n=7) (n=8) 
AUCG 1.08 ± 14.82 -0.92 ± 14.63 -0.43 ± 16.15 -3.30 ± 18.65 
AUCI -27.40 ± 21.26* -12.40 ± 25.95 -8.52 ± 14.28 -9.05 ± 23.53 
AUCG/AUCI 50.33 ± 46.29* 19.01 ± 25.23 10.46 ± 19.96 10.91 ± 24.75 
HOMA-B -14.12 ± 17.86* -14.91 ± 39.42 -6.40 ± 28.50 8.88 ± 97.56 
Stumvoll -7.02 ± 7.53 -0.67 ± 7.04 3.69 ± 13.68 1.72 ± 11.36 
Matsuda 34.79 ± 49.09 21.16 ± 44.31 14.33 ± 19.64 23.66 ± 52.79 
FFA’s 4.52 ± 19.42 4.51 ± 55.60 7.70 ± 77.93 -6.96 ± 32.30 
TG’s -10.09 ± 32.63 -6.60 ± 11.19 25.48 ± 32.46 -11.91 ± 46.75 
TC 1.96 ± 31.15 0.19 ± 6.56 4.39 ± 18.44 -8.89 ± 32.03 
LDL -1.39 ± 32.88 10.14 ± 18.74 2.87 ± 12.17 26.14 ± 57.73 
HDL 4.80 ± 26.75 -3.62 ± 15.29 1.06 ± 15.71 30.32 ± 76.50 
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change 
post intervention. Note: AUCG = Area Under the Glucose Curve, AUCI = Area Under the 
Insulin Curve, AUCG/AUCI = Area Under the Glucose Curve / Area Under the Insulin 
Curve (index of insulin sensitivity), HOMA-B is an index of fasting insulin secretion, 
Stumvoll and Matsuda are indexes of insulin sensitivity, FFA’s = Free Fatty Acids, TG’s = 
Triglycerides, TC = Total Cholesterol, LDL = Low Density Lipoprotein Cholesterol, HDL 
= High Density Lipoprotein Cholesterol.  
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Table 5.10 Summary of mixed-between-within analysis for the metabolic 
characteristics 
 Interaction Effect 
 
 
Main Effect for Time                   
Within Intervention 
Main Effect Between 
Interventions 
Variable P partial eta 
squared 
P partial eta 
squared 
P partial eta 
squared 
AUCG 0.95 0.013 0.45 0.022 0.95 0.013 
AUCI <0.001 * 0.642 0.05 * 0.132 <0.001 * 0.522 
AUCG/I 0.94 0.015 0.002 * 0.307 0.13 0.188 
HOMA-B 0.86 0.025 0.01 * 0.194 0.10 0.193 
Matsuda 0.69 0.052 0.16 0.072 0.23 0.144 
Stumvoll 0.14 0.173 0.42 0.023 0.51 0.079 
FFA’s 0.88 0.024 0.46 0.021 0.32 0.119 
TG’s 0.26 0.163 0.82 0.002 0.66 0.069 
TC 0.93 0.020 0.68 0.008 0.95 0.015 
LDL 0.77 0.049 0.84 0.002 0.65 0.070 
HDL 0.53 0.094 0.48 0.023 0.15 0.210 
*p<0.05 is significant. partial eta squared 0.01=small effect size, 0.06 moderate effect size, 
0.14 large effect size, >0.14 very large effect size. Note: AUCG = Area Under the Glucose 
Curve, AUCI = Area Under the Insulin Curve, AUCG/AUCI = Area Under the Glucose 
Curve / Area Under the Insulin Curve (index of insulin sensitivity), HOMA-B is an index 
of fasting insulin secretion, Stumvoll and Matsuda are indexes of insulin sensitivity, FFA’s 
= Free Fatty Acids, TG’s = Triglycerides, TC = Total Cholesterol, LDL = Low Density 
Lipoprotein Cholesterol, HDL = High Density Lipoprotein Cholesterol.  
 
 
5. 19. 3. Novel biomarkers of insulin resistance 
The percent change in the circulating concentration of the novel biomarkers post 
intervention is presented in Table 5.11. A summary of the mixed between within analysis 
for these characteristics is presented in Table 5.12. The main effect for time analysis 
demonstrated that there was no change in any group in the circulating concentration of 
FGF21 (p=0.22), IL-13 (p=0.96), Omentin (p=0.77), or Visfatin (p=0.49) post 
intervention, but Fetuin-A was trending towards a change (p=0.08) in the aerobic group. 
There was a significant change for Chemerin over time (p=0.04) in the diet group. The 
main effect between interventions analysis revealed that there was no difference between 
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groups in the change that occurred to FGF21 (p=0.14), IL-13 (p=0.07), Chemerin 
(p=0.17), Omentin (p=0.11), Fetuin-A (p=0.61) or Visfatin (p=0.66) post intervention. 
 
Table 5.11 Percent change in biomarkers in all groups post intervention 
 Aerobic 
% change 
Diet 
% change 
ECC 
% change 
REG 
% change 
 (n=8) (n=10) (n=7) (n=8) 
FGF21 28.46 ± 85.85 -1.10 ± 81.38 12.32 ± 68.12 -9.83 ± 39.56 
IL-13 3.06 ± 23.82 -3.22 ± 9.43 7.85 ± 30.84 5.20 ± 22.72 
Chemerin -3.23 ± 11.88 -19.22 ± 16.23 -11.44 ± 40.73 2.94 ± 41.60 
Omentin 7.06 ± 36.98 -12.42 ± 13.85 21.02 ± 55.87 25.67 ± 56.13 
Visfatin 0.21 ± 3.37 6.04 ± 23.65 -8.12 ± 8.17 -2.94 ± 22.89 
Fetuin-A -19.79 ± 13.08* -4.05 ± 32.11   
Data is presented as mean ± standard deviation. *p<0.05 represents a significant change 
post intervention.  
 
 
Table 5.12 Summary of mixed-between-within analysis for the biomarkers 
 Interaction Effect Main Effect for Time                   
Within Intervention      
Main Effect Between 
Interventions 
Variable P partial eta 
squared 
P partial eta 
squared 
P partial eta 
squared 
FGF21 0.42 0.094 0.22 0.052 0.14 0.176 
IL-13 0.99 0.005 0.96 0.000 0.07 0.224 
Chemerin 0.46 0.094 0.04 * 0.158 0.17 0.173 
Omentin 0.39 0.104 0.77 0.003 0.11 0.200 
Visfatin 0.64 0.065 0.49 0.019 0.66 0.062 
Fetuin-A 0.30 0.077 0.08 ٢ 0.205 0.61 0.019 
*p<0.05 is significant. ٢ represents a trend towards significance. partial eta squared 
0.01=small effect size, 0.06 moderate effect size, 0.14 large effect size, >0.14 very large effect 
size.  
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5. 20. Discussion 
There are two elements to this discussion. Firstly, the key findings of the diet, aerobic 
exercise, REG and ECC interventions will be briefly reviewed. Secondly, the key 
characteristics identified in each intervention will be compared to investigate the 
intervention or combination of interventions associated with the most favourable changes 
in body composition and metabolic health in an obese population.  
 
5. 20. 1. Review of key findings from the aerobic, diet, ECC and REG 
interventions 
Chapters 3 and 4 have discussed in detail all of the unique physical and metabolic 
adaptations that occur following each of the four interventions and so to follow is a brief 
review of the key findings of these interventions. Isocaloric aerobic exercise and diet 
interventions yield significant and similar reductions in body weight and BMI in an obese 
population, but aerobic exercise training is associated with greater reductions in fat mass 
and greater increases in lean tissue mass in these subjects although the difference between 
groups did not reach statistical significance. All exercise interventions improve body 
composition but the adaptations that occur to fat mass and lean tissue mass are specific to 
the mode of training undertaken. There are greater reductions in fat mass when aerobic 
exercise is the predominant mode of training (aerobic and REG groups). Conversely there 
are greater increases in lean tissue mass when resistance training is incorporated into the 
programme, particularly eccentric resistance training (ECC group). Body weight did not 
decrease significantly in the ECC and REG groups after 10 weeks of exercise training but 
the changes that occurred to body composition, which have important implications for 
metabolic health of obese individuals, support the recommendation that body composition 
must be a primary outcome measure in lifestyle interventions as opposed to body weight.  
 
 Insulin secretion and insulin sensitivity improved significantly following 12 weeks 
of aerobic exercise training but not caloric restriction despite significant reductions in body 
weight and body fat mass in this group. In the aerobic groups this was evident as a 
significant decrease in AUCI and HOMA-B in addition to a significant increase in the 
AUCG/AUCI index of insulin sensitivity. Importantly, the increase in aerobic fitness post 
intervention was the single best predictor of the improvements in metabolic status of these 
obese subjects. Insulin secretion and insulin sensitivity did not improve significantly in the 
ECC and REG groups post intervention which was a surprising finding since the literature 
consistently shows that exercise training improves insulin sensitivity even after a single 
bout (Wahren, Felig et al. 1971) and in the absence of weight loss (Duncan, Perri et al. 
2003). However, the favourable changes that did occur to AUCI, HOMA-B and the 
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AUCG/AUCI index after training were predicted by the favourable change in body 
composition and the circulating concentrations of the novel biomarkers of insulin 
resistance. The improvements in these biomarkers suggest amelioration of insulin 
resistance in these groups. Both groups also demonstrated significant improvements in fat 
oxidation at rest after exercise training. This is a key finding with clinical significance 
because there is substantial evidence to show that elevated concentrations of intracellular 
lipids in obese individuals contribute to the development of insulin resistance by inhibiting 
insulin stimulated glucose transport into target tissues (Petersen and Shulman, 2002, 
Shulman, 2000, Yu et al., 2002). Increased fat oxidation post intervention may lead to 
improved metabolic health in this population in the longer term. Fat oxidation was not 
measured in the aerobic exercise or diet group but the results of the concurrent 
interventions suggest that this measure should be taken in obese individuals to assess 
changes in metabolic flexibility post intervention. Finally, although RMR did not change 
post ECC or REG intervention, it is clinically important to note that RMR increased by an 
average of 100kcal per day in the ECC group. An increase in energy expenditure of 100kcal 
per day in these obese subjects equates to 700kcal per week or approximately 1lb 
(3500kcal) of body fat in 35 days. Over time, and with continued training, this could 
accumulate to significant fat loss in this population. The results of the 4 interventions 
suggest that the adaptations that occur to the metabolic characteristics of obese subjects 
post intervention are specific to the mode of intervention undertaken. The small numbers 
in the exercise interventions may mask some of the metabolic adaptations that occurred 
but the results of the individual studies in addition to chapter 5 where all exercise data was 
combined, clearly indicate that exercise training improves insulin secretion and insulin 
sensitivity in obese subjects. 
  
 Finally, it appears that the regulation of the biomarkers is complex and not 
attributed to a change in any single variable post intervention. Their production seems to 
be differentially regulated by each of the 4 interventions which is evident by the fact that 
the circulating concentration of Fetuin-A, Omentin and Visfatin only significantly 
decreased in the aerobic, diet and ECC groups respectively. In the aerobic group the 
changes that occurred to the biomarkers post intervention were mostly predicted by 
increases in fitness and lean tissue mass. In the diet, ECC and REG groups, the change that 
occurred to the circulating concentration of the biomarkers was best predicted by the 
improvements in insulin sensitivity in addition to improvements in the circulating 
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concentration of other biomarkers of insulin resistance.  The findings of all 4 interventions 
indicate that there is a cyclical, as opposed to a causative, relationship between metabolic 
health and the circulating concentration of the biomarkers. Also, the production of the 
biomarkers appears to be regulated by each other. The small numbers of subjects in these 
interventions in addition to the large variation in the baseline values of the biomarkers, and 
the large variation in their individual response to exercise training indicates that the 
response of these biomarkers to exercise could be highly specific to an individual. It is 
possible that a much greater number of subjects are required to determine the effects of 
exercise training on their circulating concentrations, but even with greater numbers it may 
still be difficult to identify for certain the factors that are responsible for regulating the 
biomarkers. Additional mechanistic studies are required to determine their regulation. 
 
5. 20. 2. A comparison of the physiological and metabolic adaptations 
to each of the four interventions 
This section of the discussion focuses on the mixed-between-within analysis presented in 
Tables 5.8, 5.10 and 5.12.  The primary aim of this analysis was to compare the changes 
that occurred in all variables following each intervention and identify the intervention or 
combination of interventions associated with the most favourable changes to body 
composition, insulin secretion, insulin sensitivity, and the novel biomarkers of insulin 
resistance. There was no difference between interventions in their ability to reduce body 
weight (p=0.28), BMI (p=0.28) or body fat mass (p=0.40), or increase lean tissue mass 
(p=0.37).  The clinically significant changes that were evident indicate that the diet and 
REG group were matched for weight loss with both groups achieving a 3.1% reduction in 
body weight compared to 2.6% in the aerobic group and 0.6% in the ECC group. Aerobic 
exercise training was associated with the greatest reduction in fat mass. This group achieve 
a 12% reduction compared to a 9.3%, 6.2% and 5.8% reduction in the REG, ECC, and diet 
group respectively. The aerobic group also achieved greater gains in lean tissue mass which 
increased by 8.6%, compared to 4.2%, 2%, 1.4% in the ECC, REG and diet group 
respectively. It was expected that the greatest gains in lean tissue mass would be evident in 
the ECC group but the average body weight of this group at baseline (83.3+12.1kgs) was 
lower that all other groups (98.6+20.7kgs, 99.3+15.5kgs, and 97.7+22.1kgs in the aerobic, 
diet and REG groups respectively), as was the average lean tissue mass of the ECC group 
at baseline (41.42 ± 5.93kgs compared to 47.58±12.58kgs, 52.08±13.09kgs and 
49.48±12.84kgs in the aerobic, diet and REG groups respectively). This may possibly have 
contributed to the findings that the percent increase in lean tissue mass was greatest in the 
aerobic group post intervention. Taking all findings into consideration it appears that 12 
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weeks of aerobic exercise lead to the greatest improvements in body composition in this 
population, although this did not reach statistical significance.  
 
 There was a significant interaction effect for fitness ( O2max l/min) (p=0.01) and 
the effect size was quite large (partial eta squared = 0.334). This indicates that the change in 
fitness over time was different in the four groups. A change was identified in the aerobic 
and ECC group over time but further analysis revealed that there was no difference 
between groups in the percent change in fitness (p=0.39). The actual percent increase in 
fitness was 29% in the aerobic group, 10.1% in the diet and ECC groups, and 9% in the 
REG group, demonstrating that aerobic exercise training is associated with the best 
clinically significant increase in fitness. This is an important finding given the positive 
relationship between fitness and metabolic health that has been established in this thesis 
and in the literature (O'Leary, Marchetti et al. 2006; Kadoglou, Vrabas et al. 2012). The 
10% increase in fitness in the diet group could be attributed to familiarisation of the O2max 
test but also indicates that these subjects subconsciously increased their daily activity levels since 
they did not take part in structured exercise sessions.  
 
 There was no difference between groups in the change that occurred metabolic 
variables including AUCG (p=0.95), AUCG/AUCI (p=0.94), HOMA-B (p=0.86), 
Stumvoll (p=0.14) and Matsuda (p=0.69). There was a significant interaction effect for 
AUCI (p<0.001) with a large effect size (partial eta squared 0.642). The post hoc analysis 
revealed that the greatest reduction in AUCI occurred in the aerobic exercise group 
(p<0.001) which also had a large effect size (partial eta squared 0.522). This is reflected by a 
27.4% reduction in AUCI following aerobic exercise training compared to a 12.4%, 9.05%, 
8.5% reduction following the diet, REG and ECC interventions respectively. These 
findings suggest that aerobic exercise training is associated with the best improvements in 
insulin secretion and insulin resistance in an obese population but this conclusion must be 
interpreted with caution since it may be influenced by the fact that the baseline values for 
insulin in this group were significantly greater than the baseline values in any other group. 
However, the literature consistently reports that both acute exercise (Wahren, Felig et al. 
1971) and chronic aerobic exercise training (Nassis, Papantakou et al. 2005) improves 
insulin sensitivity in this population, even in the absence of weight loss (Duncan, Perri et al. 
2003). These findings also indicate that although insulin secretion and insulin sensitivity did 
not improve significantly in the diet, ECC and REG groups post intervention, the percent 
change that did occur suggest important clinical implications for the metabolic health of 
these subjects. 
  
There was no difference between interventions in the change that occurred to the 
circulating concentration of FGF21 (p=0.42), IL-13 (p=0.99), Chemerin (p=0.46), 
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Omentin (p=0.39), Visfatin (p=0.64), or Fetuin-A (p=0.30). The analysis from the previous 
two chapters of this thesis suggests that the biomarkers respond differently to different 
modes of intervention and are influenced by improvements in fitness, body composition 
and the circulating concentration of other biomarkers. Possible explanations for the non 
significant changes in the biomarkers include the smaller than anticipated sample size in 
each group, the individual variation in baseline values of the biomarkers, and the wide 
variation in the individual response to each intervention. It is clear that the production of 
the biomarkers is complex and not regulated by one variable but respond to an integration 
of physical and metabolic adaptations to lifestyle intervention. The biomarkers may be 
more useful independent predictors of metabolic health in larger scale studies.   
 
5. 21. Limitations 
The small sample sizes in each group may limit the dept of statistical analysis. Also, this 
analysis could only compare variables that were measured in all 4 groups, which meant that 
fat oxidation, resting metabolic rate and Fetuin-A could not be included in the analysis. 
One final limitation was the difference between groups in intervention duration, 12 weeks 
for the aerobic and diet groups compared to 10 weeks for the ECC and REG groups. 
 
5. 22. Conclusion 
In obese subjects, the physical characteristics, metabolic characteristics and novel 
biomarkers of insulin resistance are differentially regulated by aerobic exercise training, 
caloric restriction, concurrent training and concurrent training with an eccentric 
component. All 4 groups display unique positive adaptations post intervention. When the 
effectiveness of all interventions is compared there is no difference between groups in their 
ability to improve body weight or body composition in the obese subjects. One key finding 
is that aerobic exercise leads to the greatest increase in aerobic fitness and is associated with 
improvements in insulin secretion, insulin sensitivity and the circulating concentration of 
the novel biomarkers of insulin resistance. The subjects in the aerobic exercise group were 
also identified as having the greatest improvement in insulin secretion and insulin 
sensitivity which was reflected by the greatest reduction in AUCI post intervention. 
However, this may be due to the fact that the baseline insulin values were significantly 
higher in this group than in all other groups and so this outcome must be interpreted with 
caution. There was no difference between groups in the change that occurred to the lipid 
profile of the subjects post intervention or the other models of insulin sensitivity. This 
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finding was also true for the circulating concentration of the novel biomarkers of insulin 
resistance but this may be due to the small numbers of subjects in each group in addition 
to the large variation in the baseline values of the biomarkers and the large variation in their 
individual response to diet and different modes of exercise training.  It is possible that a 
much greater number of subjects are required to determine the effects of caloric restriction 
and exercise training on their circulating concentrations, but even with greater numbers it 
may still be difficult to identify for certain the factors that are responsible for regulating the 
biomarkers. Additional mechanistic studies are required to determine their regulation. The 
key findings to date suggest that obese subjects would obtain maximum physiological and 
biological benefit from a combined lifestyle intervention. 
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Chapter 6. Thesis Summary, Conclusion 
and Future Recommendations  
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6. 1. Thesis Summary and Main Findings 
When all exercise interventions are considered in isolation, the different modes of training 
differentially affect body composition, insulin sensitivity and the novel biomarkers of 
insulin resistance as discussed above. However, when all exercise data is combined 
(Chapter 5) it is clear that exercise training improves body weight, BMI, and all elements of 
body composition, insulin secretion, and insulin sensitivity. The improvements in 
metabolic health are solely attributed to increased aerobic fitness.  
 
When the effectiveness of the 4 isocaloric interventions is compared (Chapter 5) there is 
no difference between groups in their ability to improve physical or metabolic 
characteristics with the exception of aerobic fitness which improved the most in the 
subjects in the aerobic exercise group. Additionally, the aerobic exercise group was 
identified as having the greatest improvements in insulin sensitivity and insulin secretion 
measured by AUCI. However, this may be due to the fact that the baseline insulin values 
were significantly higher in this group than in all other groups and so this outcome must be 
interpreted with caution. 
 
The novel biomarkers of insulin resistance are differentially regulated by diet and exercise 
and also with different modes of exercise training. The pearson correlation and backwards 
regression analysis consistently indicate that there is a cyclical, as opposed to a causative, 
relationship between metabolic health and the circulating concentration of the biomarkers. 
It also appears that the production of these biomarkers is regulated in some part by each 
other. The wide inter individual variation in baseline concentrations of the biomarkers in 
addition and their response to intervention means that these biomarkers might be better 
indicators of metabolic health in larger scale studies. 
 
 
6. 2. Recommendations for revised lifestyle intervention  
The key characteristics of each of the 4 interventions suggest that obese individuals could 
obtain maximal physiological and biological benefit from a combined intervention. The 
findings so far indicate that aerobic exercise training leads to the most clinically significant 
improvements in body fat mass and fitness. The improvement in fitness is the best 
predictor of improvements in metabolic health in this population, and when combined 
with reductions in fat mass favourably influences the production of the novel biomarkers 
of insulin resistance, particularly those that are derived from adipose tissue. Thus aerobic 
exercise should form the foundation of exercise prescription for this population. The 
addition of resistance training is important for the development of lean tissue mass and 
improving fat oxidation and resting metabolic rate. These adaptations may enhance weight 
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loss and insulin sensitivity in the longer term and may also improve the circulating 
concentration of the myokines. The improvement in fat oxidation and resting metabolic 
rate may be augmented with eccentric resistance training, however since no statistically 
significant difference was found between the REG group and the ECC group in the change 
that occurred to these variable, from a practical perspective regular resistance training is 
recommended but of greater volume and intensity than that used in the REG intervention. 
Finally, the addition of moderate caloric restriction (500kcal/day) to the exercise 
prescription may augment fat mass loss and weight loss in these individuals which in turn 
may augment the metabolic benefits associated with lifestyle intervention. Augmented 
weight loss may increase motivation and improve adherence to the programme thus 
ameliorating one of major difficulties with these types of interventions (Franz, VanWormer 
et al. 2007).  
 
Weekly Lifestyle
Prescription
Exercise
• 3 * 60mins aerobic exercise @ 70% VO2max
+
• 2 * 30mins aerobic ex @ 70% VO2max + 3*10 reps @ 70-80% 1RM * 6 
exercises using large muscle groups (30mins total for resistance training)  
Diet
Deficit of 500kcal/day
(3,500kcal/wk)
 
Figure 6.1 Recommended weekly prescription for lifestyle intervention for obese 
population. 
 
6. 3. Practical application of these recommendations for free living 
adults / population based obesity interventions  
Short term interventions are reported to successfully reduce obesity but one of the well 
documented difficulties in weight loss programmes is poor long term adherence to the 
programme and in many cases weight regain (Figure 6.2) (Foster, Wadden et al. 1997). 
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Figure 6.2 Average weight loss of subjects completing a minimum 1 year weight 
management intervention; based on a review of 80 studies (n=26,455; 18,199 
completers (69%), Taken from (Franz, VanWormer et al. 2007). 
 
 There is an urgent need to devise a lifestyle intervention that is effective and can be 
sustained in the long term. To follow, in no particular order, are a number of 
recommendations that must be considered when implementing population based weight 
loss programmes which may help to improve adherence and success of outcome measures. 
These recommendations are presented in Figure 6.3. 
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Figure 6.3 Practical elements to consider when devising and delivering community 
based lifestyle intervention programmes.  
  
6. 3. 1. Realistic Expectations 
To improve adherence it is necessary to understand the factors that contribute to poor 
attrition rates. One explanation that has been proposed is the mismatch between 
participants expected weight loss and actual weight loss outcomes (Foster, Wadden et al. 
1997).  The 2001/2002 National Health and Nutrition Examination Survey reported that 
almost 50% of adults were trying to lose weight in the previous 12 months (Weiss, Galuska 
et al. 2006). It is likely that this figure has increased over the past 10 years with the growing 
epidemic of obesity. Yet a review of various types of diet and exercise weight loss 
interventions has reported that the attrition rate across all interventions was approximately 
31% regardless of the length of intervention (Franz, VanWormer et al. 2007). Many of 
these individuals reported disappointment with their weight loss outcomes (Foster, 
Wadden et al. 1997). Women taking part in a weight loss programme reported a desired 
reduction in body weight of 32%. Forty seven percent of women were disappointed with a 
16kg weight loss in 48 weeks and deemed the intervention to be unsuccessful (Foster, 
Wadden et al. 1997). This perception may be affecting attrition rates. To improve perceived 
success and thus adherence it is necessary to educate participants to set realistic weight loss 
outcomes. In relation to exercise training interventions it is essential to highlight the energy 
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expenditure derived from an exercise training session and the energy expenditure actually 
required to cause substantial weight loss. Many participants engaging in a research based 
lifestyle programme are required to complete up to 5 training session (5 hours of exercise) 
per week. This a substantial increase in physical activity for a previously sedentary 
individual but only equates to a maximum of ~3,500kcal per week, which would yield a 
reduction in body fat mass of 1lb per week if energy intake is controlled at pre intervention 
values. Individuals aiming to augment these results must undertake greater volumes of 
activity and/ or restrict energy intake. It is important to educate participants so that they 
understand the energy equivalent of exercise training and the effort that is required to 
achieve substantial weight loss thorough exercise training. 
  
6. 3. 2. Focus on body composition as a primary outcome measure as 
opposed to body weight 
Significant changes occur to body composition in response to exercise training. Previously 
inactive muscles undergo hypertrophy with training and so the weight of lean tissue mass in 
kilograms increases. This occurs alongside significant reductions in fat mass but the net 
weight loss is often minimal. Participants must be educated with regard to these changes 
and the effect that these adaptations have on net weight change. It is important to quantify 
improvements in fat mass and lean tissue in order to give a true indication of intervention 
success so that participants do not become discouraged with small changes in body weight. 
This may help to improve adherence. The primary outcome measure of obesity 
interventions must be body composition as opposed to body weight. Participants should be 
given body fat targets to achieve and the health benefits associated with these changes must 
be communicated to the participant.  
 
6. 3. 3. Focus on fitness as a primary outcome measure 
There is a strong, independent, graded, and inverse relationship between physical fitness 
and all cause mortality (Blair, Kohl et al. 1989; Kampert, Blair et al. 1996). Low fitness 
confers the same risk of mortality to an individual as that of actually having diabetes or 
cardiovascular disease (Wei, Kampert et al. 1999). In contrast, individuals with high fitness 
are protected against mortality regardless of their BMI, waist circumference and percent 
body fat. In support of this one of the key findings of Chapter 6 of this thesis was that 
improved fitness was solely responsible for the improvements in metabolic health in this 
obese population. For this reason fitness must be a primary outcome measure of 
intervention for the obese population (McAuley, Artero et al. 2012) and this can only be 
achieved through exercise training. 
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6. 3. 4. Incorporate mild caloric restriction and dietary education 
Obesity programmes must incorporate education relating to the nutrient composition and 
caloric content of convenience foods compared to healthy food. Food diary analysis 
frequently reveals that obese individuals consume high fat, high sugar, high processed, 
calorie dense foods. Daily calorie intake is often significantly greater than that actually 
required by the individual to meet energy needs. It is impossible for moderate amounts of 
exercise training to compensate for this type of dietary intake. Also, any exercise training 
that is carried out is very quickly compensated for by poor food choices after the exercise 
bout. Sixty minutes of moderate intensity exercise yields an energy expenditure of 
approximately 500-600kcal. However, consumption of as little as 5-6 chocolate biscuits or 
2 standard chocolate bars or a slice of pizza above daily energy requirements is sufficient to 
counteract the energy expended in the training session. The best approach is to combine 
exercise training with a mild caloric deficit (500kcal per day) and education with regard to 
appropriate food choices. A combined approach will lead to greater reductions in body fat 
mass in a shorter period of time which may improve motivation and enhance adherence to 
the programme. 
 
6. 3. 5. Injury prevention - phased approach to training  
It is often the case the previously sedentary individuals progress from doing no exercise in 
their typical week to completing 4-5 training sessions per week as part of a weight loss 
programme without a transition phase. This type of approach places extensive overload on 
a deconditioned individual and may result in musculoskeletal injury. An injury at an early 
stage of training is an unnecessary obstacle and if severe enough, or perceived to be severe 
enough, could potentially stop the individual participation in exercise. It is necessary to 
adopt a phased approach to exercise training starting with 2 sessions per week and 
progressing to 4-5 or daily if possible. During the initial few weeks when the volume of 
exercise training is low, particular attention and time should be given to changing dietary 
habits so that weight loss occurs during this time. Dietary modification should also occur in 
a progressive manner. 
 
 
6. 3. 6. Document the health benefits associated with exercise training 
and lifestyle intervention (possible collaboration between exercise 
specialists and physicians) 
Effort should be made to facilitate the participants understanding of the health benefits 
associated with exercise training and a healthy lifestyle including the favourable metabolic 
and cardiovascular adaptations that occur. This could simply be in the form of education, 
but could be more comprehensive with collaboration between exercise specialists and 
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physicians. It would be progressive to have blood samples taken at the beginning a lifestyle 
programme in addition to various time points throughout the year to evaluate changes in 
parameters such as glucose levels, insulin, lipids, and blood pressure. Favourable changes to 
these parameters may assist with adherence rates particularly during times of less than 
desired weight loss or weight plateau. There are of course time, resource and financial 
implications to this approach but it would be interesting to observe the effects of 
incorporating a clinical element to weight loss programmes run outside of the research 
setting. 
 
6. 3. 7. Reduce sedentary time  
Daily energy expenditure can be categorised into exercise or non exercise activity 
thermogenesis (NEAT). NEAT encompasses energy expended in the day excluding 
structured exercise sessions and significantly contributes to total daily energy expenditure 
since we are awake for approximately 16 hours per day (Matthews, Chen et al. 2008). 
Mathews et al (2008) reported that American adults spend on average 7.7 hours of their 
waking day engaging in sedentary behaviours such as TV watching (Matthews, Chen et al. 
2008). Reducing sedentary time or substituting it with more active tasks throughout the day 
would augment total energy expenditure. Over time this may accumulate to substantial 
energy deficits and enhanced weight loss. This may also reduce the time required for 
structured exercise training. 
 
6. 3. 8. Awareness of compensation  
Even within tightly controlled weight loss interventions there is wide variation between 
subjects in the amount of weight lost. One possible explanation is that either consciously 
or subconsciously the subjects compensate for energy expenditure and negate the energy 
deficit caused by exercise training (King, Hopkins et al. 2008). Compensatory responses 
include increased energy intake (Stubbs, Hughes et al. 2004) and / or reduced daily physical 
activity and energy expenditure in non exercising time (Donnelly, Hill et al. 2003). The 
latter may be in an attempt to recover from fatigue associated with exercise training. It is 
crucial to highlight this issue so that participants are aware of compensation and the 
implications this has for the effectiveness of a lifestyle intervention. 
 
6. 3. 9. Time efficient but energy expensive exercise training modes 
It is essential to promote time efficient but energy expensive modes of exercise training. An 
example of this is home based functional circuit training. Home based activities eliminate 
travel time associated with GYM based exercise training. The exercises chosen for the 
circuit should alternate between aerobic and resistance. The results of this PhD suggest that 
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the mixture of training modes would facilitate reductions in fat mass and simultaneous 
increases in lean tissue mass.  The resistance exercises should be functional and incorporate 
a number of muscles simultaneously e.g. squat, plank, press ups, as opposed to exercises 
that isolate a muscle group e.g. bicep curl. There are three key advantages to this type of 
training (i) every exercise recruits a large number of muscles in the body simultaneously 
which may improve functionality in every day living (ii) energy expenditure in a given time 
period may be greater than that achieved by traditional resistance training in a GYM which 
isolates particular muscles per exercise, (iii) functional training engages the core muscles to 
stabilise the body as it performs the exercise in contrast to machine based resistance 
training which support the body during the exercise thus reducing the requirements on the 
core stabilisers. Finally, high intensity interval training is another type of training that could 
be investigated for use in this population. 
 
6. 3. 10. Dynamic approach to lifestyle intervention and the treatment of 
obesity 
In order to study the response of obese individuals to a lifestyle intervention in a research 
setting, these interventions must be tightly controlled, monitored and supervised for their 
duration. For the participant who has enrolled in the study, the intervention is a priority for 
that time period and they have signed a consent form committing to completing the 
intervention and not deviating from the experimental design. The reality of long term 
weight loss in free living adults is quite different. They are not as intensely monitored, their 
lifestyles are not as controlled, and lifestyle change in not their only priority. The 
practicality of long term weight loss is that obstacles arise every day that must be overcome 
in order to prevent weight regain and drop out. Examples of these obstacles include lack of 
social support, will power, planning, organisation, general knowledge of food, general 
knowledge of effective exercise training, acquiring minor injuries due to continuous heavy 
loading on a deconditioned musculoskeletal system, stressful periods in their lives when 
healthy food preparation and exercise training are not a priority, and plateaus in weight loss 
despite continued exercise training, which significantly diminishes motivation. The reality 
of long term population based weight loss interventions is that they require a very dynamic 
approach. The professional delivering the programme must be knowledgeable, skilled and 
flexible enough to adapt to all of these obstacles including injury and illness, and alter 
lifestyle prescription accordingly. With the increasing prevalence of clinical conditions, they 
must be able to adapt lifestyle interventions for special populations including individuals 
with CVD, T2DM and a range of other clinical conditions. They must be able to 
continuously apply sufficient overload and recovery so that the participant continues to 
adapt and progress over a long period of time. A varied programme is also essential to 
avoid boredom. They must have excellent communication skills so that they can adapt to 
all of the different personalities that they come in contact with. It is essential for the 
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participant to trust the professional so that they will adhere to the programme and stick 
with it through tough times. Participants must be treated individually even within a group 
setting. There is a need for these experts to deliver such programmes in order for them to 
be effective in the long term.  
 
6. 4. Thesis Limitations 
With regard to intervention 1, the original study was a cross-over design but the 
complexity of the analysis and the interaction effects led us to exclude the second phase 
of the intervention. The complex nature of this original design also resulted in a smaller 
sample size than originally anticipated. For intervention 2, the original study design was 
a 12 week intervention. However, due to the time required to conduct the extensive 
baseline testing, the intervention was reduced to 10 weeks to ensure that the post tests 
could be completed prior to end of semester. This meant that intervention 1 and 2 
were not exactly matched for intervention duration which must be taken into account 
when comparing the effectiveness of each of them. The time commitment required for 
the extensive testing procedures and training in the ECC and REG interventions also 
resulted in a smaller sample size than originally recruited. The small sample size 
affected the dept of statistical analysis. The final limitations was that the DEXA scan 
was damaged by flooding in year one of data collection which means that body 
composition analysis is only available for subjects recruited in year 2 of data collection. 
This also limits the dept of statistical analysis. 
 
6. 5. Thesis Conclusion 
The physiological and biological adaptations that occur in response to lifestyle intervention 
are specific to the mode of intervention undertaken. Diet, aerobic exercise, concurrent 
training and concurrent training incorporating eccentric exercise all display unique 
characteristics which when combined could maximise physiological and biological benefits 
for obese individuals. The key findings of this thesis suggest that body composition as 
opposed to body weight must be a primary outcome measure for lifestyle intervention due 
to its relationship with metabolic health in this population. Also obese previously sedentary 
individuals who undertake an exercise training programme often display significant changes 
in body composition despite modest changes in body weight which when measured may 
help to improve adherence to lifestyle intervention. Aerobic fitness must also be a key 
outcome measure as it has been shown to best predict the improvements in insulin 
secretion and insulin sensitivity in obese individuals (chapters 3 and 5). The biomarkers 
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may be useful indicators of metabolic health as they have also been shown to predict the 
improvements in insulin secretion and insulin sensitivity (chapters 3 and 4). A consistent 
finding throughout this thesis is that the regulation of the biomarkers is complex and 
influenced by a combination of variables including changes to body composition, 
metabolic status and each other. They in turn influence metabolic health demonstrating a 
cyclical relationship between the circulating concentration of the biomarkers and insulin 
sensitivity. The large variability in individual response to intervention indicates that larger 
scale mechanistic studies are required to determine the true impact of lifestyle intervention 
on their production. 
 
Translating research findings into effective public health programmes has not been 
successful and changes in the scientific approach to lifestyle intervention is required. A 
combination of aerobic exercise, resistance training and caloric restriction with education 
will maximise the physiological and biological benefits for obese individuals as outlined in 
Figure 6.1. This combined intervention will lead to augmented weight loss and fat loss in 
addition to gains in lean tissue mass and aerobic fitness. These adaptations in turn will 
influence metabolic health and the circulating concentration of the novel biomarkers of 
insulin resistance. Other considerations that must also be taken into account to improve 
adherence and success include greater volumes of exercise training or reducing sedentary 
time, taking a dynamic approach to intervention, educating the individual to set realistic 
goals, and broadening the participants focus from physical changes to health benefits 
associated with lifestyle intervention.   
 
6. 6. Recommendations for Future Research 
Each of the 4 interventions of this thesis displayed key adaptations that were specific to the 
mode of intervention undertaken. It would be interesting to administer the revised lifestyle 
intervention outlined in Figure 6.1 to investigate if the combined intervention would yield 
all of the physiological and biological benefits associated with the individual interventions. 
The energy expenditure derived from the exercise training in the combined intervention 
should equate to ~3,500kcal per week, in addition to a caloric deficit of 3,500kcal per week. 
In comparison to the individual interventions outline in this thesis, this is almost a 3 fold 
increase in energy deficit per week which should augment the changes to the physical and 
metabolic characteristics of the obese subjects which may have a greater impact on the 
circulating concentration of the novel biomarkers of insulin resistance.  
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It would also be interesting to conduct a community based weight loss intervention 
incorporating the considerations outlined in Figure 6.3. This could be used for 
comparison to the controlled study design recommended in Figure 6.1 to determine 
how effectively research studies translate to population based interventions. Finally, 
other modes of novel exercise could be studies to determine their effectiveness in 
reducing obesity including (i) functional training and (ii) high intensity interval training.  
. 
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Appendix A2: Published Abstract  
 
Agneiszka Pazderska2, Diane Cooper 1, Declan O’Hanlon2, Noelle Collura2, Shah Syed2, 
Krzysztof Wanic2, Fiona Lithander2, Prof. John Nolan2, Donal O’Gorman1. 12 weeks 
aerobic exercise improves intrinsic muscle mitochondrial function in patients with type 2 
diabetes. Irish Endocrine Society Meeting, Dublin, Ireland, September 2010. 
Dublin City University, Dublin1, St. James Hospital, Dublin2 
 
Title 
12 weeks aerobic exercise improves intrinsic muscle mitochondrial function in patients 
with type 2 diabetes. 
 
Abstract  
Exercise is known to increase maximal oxygen uptake (VO2 max) and improve insulin 
resistance in patients with type 2 diabetes. Several recent studies have shown that exercise 
enhances in vivo mitochondrial function. However, it remains unclear whether this 
improvement is due to an increase in skeletal muscle mitochondrial mass or in intrinsic 
mitochondrial function. The aim of this study was to assess changes in electron transport 
capacity in mitochondria isolated from muscle biopsies from patients after an exercise 
programme. 
 
Six sedentary men with type 2 diabetes (age 41+/-11.5; HbA1c 8.3+/-1.7%; BMI 34.4+/-
6.7) participated in a 12 weeks aerobic exercise programme consisting of four supervised 
sessions/week at 70%VO2 max. Muscle biopsies from vastus lateralis were obtained before 
and after the intervention. High resolution respirometry was used to measure oxygen flux 
capacity in isolated skeletal muscle mitochondria.  
T-test was used for statistical analysis.  
 
VO2 max improved following the intervention (baseline VO2 max: 2.65 L/min, post 
exercise: 2.99 L/min; p=0.012). Following training, significant increases were observed in 
oxygen fluxes, expressed per milligram of mitochondrial protein (pmolO2/s/mg protein), 
stimulated by parallel electron input from complexes I and II in the presence of 
pyruvate+malate and succinate (188.21 vs. 420.96; p=0.024). Similarly, significant increases 
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were observed in oxygen fluxes in the presence of ADP (506.61 vs. 1527.15; p=0.007), as 
well as in response to uncoupling by FCCP (572.40 protein vs. 1645.18; p=0.013).  
 
12 weeks aerobic exercise training leads to improvements in several components of 
intrinsic mitochondrial function in patients with type 2 diabetes 
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Appendix A3: Recruitment email for intervention 1 (Chapter 3) 
 
Hello all, 
The School of Health and Human Performance at DCU are conducting a research study in 
January 2010 to investigate how an exercise programme and a dietary programme 
influences body weight, body fat and the use of energy by the muscles. This project is in 
conjunction with Prof. John Nolan at St. James’s Hospital, Dublin who is looking at 
similar changes in patients with type 2 diabetes. 
 
This is a 6-month study divided into a 3-month exercise programme and a 3-month dietary 
programme. The order of these will be randomly assigned. A number of measurements will 
be made before the study and at the end of each 3-month phase. These include fitness 
testing on a bicycle, a test for diabetes and a muscle biopsy. 
 
We are looking for males and females aged 18-30 and aged 50-70 years who are overweight 
and interested in participating in a weight loss programme. 
 
If you would like to hear more about this study or would consider participating, please 
contact Diane Cooper (Tel: 7008472; e-mail: (diane.cooper2@mail.dcu.ie) 
 
Looking forward to hearing from you. 
 
Kind regards, 
Diane. 
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Appendix A4: Plain Language Statement for intervention 1 (Chapter 3) 
 
Cellular mechanisms of insulin resistance and exercise resistance in early onset 
type 2 diabetes. 
 
Principal investigator: 
Prof. John Nolan -  jnolan@stjames.ie  01-4162488 
Dr. Donal O’Gorman - donal.ogorman@dcu.ie  01-7008060 
 
Metabolic Research Unit, St. James’s Hospital Dublin and School of Health and Human 
Performance, Dublin City University. 
 
 This leaflet is intended to explain what the study involves. A number of different 
procedures will be carried out over a period of about 6 months; from the time consent is 
taken up until the last tests are carried out. This study will involve three months diet 
intervention and three months exercise intervention. 
 
 The first visit will involve a full medical history and physical examination by a 
doctor. You will need to be fasting from the night before this visit. Please bring any 
medications that you are currently taking, to this first visit. We will ask for information 
about allergies, family medical history and your past medical history, if any. We will weigh 
you, check your height and then estimate your total body fat composition. Waist, thigh and 
hip measurements will be taken. An ECG (electrocardiogram, a painless test that takes a 
few minutes) will be performed to check your heart. You will be asked to give a urine 
sample to check your kidney function. A 3-hour oral glucose tolerance test will be 
performed to test your glucose, insulin and lipid levels. A blood sample will also be taken 
for DNA analysis for the purpose of identifying specific genes that may be associated with 
diabetes or obesity. 
 
 At Visit 2 an MRI scan will be performed. This scan, which is painless, is based on 
magnetic excitation resulting in signals that can be computed into graphs or images. This 
will allow us to calculate your body composition, as well as the distribution of muscle and 
fat. On the same day, you will have an exercise test known as a VO2max measurement. 
This test usually takes no more than half an hour. We measure your breathing, and how 
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your heart rate and blood pressure change while you exercise on an exercise bicycle in our 
exercise laboratory. You will wear a comfortable facemask and a blood pressure cuff on 
your arm. The test gives us important information about how well your heart and lungs are 
working, and estimates your level of physical fitness before your exercise program begins. 
 
At Visit 3 a muscle biopsy will be performed. This procedure involves giving a 
small injection of local anaesthetic initially, which will anesthesize and numb the area that is 
to be biopsied. A very small tissue sample from your leg, on the outside of the thigh, will 
then be taken. The biopsied area may feel slightly uncomfortable for a short period of time 
after the biopsy. We will clean and dress the site afterwards with a small plaster. There is a 
very small (< 1:200) risk of local bleeding and infection associated with this procedure, but 
by using appropriate techniques during this procedure the risk is minimised. The muscle 
sample will be analysed in various ways to calculate how glucose and other fuels are being 
used to produce energy in your body.  
 
Following these experimental procedures, you will initially be randomised (by 
chance) to begin the study either with 3 months of monitored dietary intervention or 
monitored exercise intervention: 
 
Dietary intervention 
If you are randomised initially to the dietary intervention, this will involve a low fat diet at 
2500 calories less than your usual daily diet each week. You will be instructed to maintain a 
food diary and will be reviewed by a dietician on a 2 weekly basis.  
 
Exercise intervention 
If you are randomised initially to the exercise intervention, you will exercise for 1 hour, 4 
times per week in the GYM at DCU. This exercise programme will be equivalent to 2500 
kcal of energy used per week. It is very important that you attend all of the exercise 
sessions. The exercise session will be divided into five minutes warm- up, sixty minutes of 
aerobic exercise and then a five-minute warm down. During the exercise training, we will 
monitor your heart rate, and blood pressure as before. This will enable us to calculate the 
correct level of exercise intensity for you. We will also check your fitness level every 4 
weeks and change the exercise programme to reflect your improvement in fitness. 
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We cannot emphasise enough that attendance for the exercise training and compliance with 
diet is crucial as this is what the study is all about – to see if exercise and diet helps insulin 
to work better in your body, and to try to find out how it does so. This is the part of the 
study that requires the most commitment from you and from us, the investigators. 
 
At the end of the first 3 months of intervention (either dietary or exercise), you will have your body weight 
and blood pressure measured and VO2 max test repeated. On the following days, you will have the MRI 
scan, oral glucose tolerance test and muscle biopsy repeated to reassess your response to the above 
intervention. Similarly, in the following final 3 months, you will be changed over to the other intervention 
programme (either dietary or exercise). You will have the same measurements and procedures repeated at the 
end of the study (body weight, blood pressure, MRI scan, VO2 max test, oral glucose tolerance test and 
muscle biopsy). 
 
Thank you for reading this information leaflet, please note that it is intended to 
complement the other information you have received, and we would be delighted to 
discuss any queries you might have at any time. 
 
Risks to Participants: Exercise does carry a risk of injury, such as a pulled muscle, muscle 
soreness or in extreme cases abnormal heart rhythm, heart attack or death.  
 
Benefits of participation: After completing the study you will be given a report of your 
results which will include feedback on the changes, if any, that occur during the research 
study. 
 
Your confidentiality will be guarded: 
 All information we gather will be stored in a secure filing cabinet.  The results of the 
study will be used for a postgraduate project and may be published in academic 
journals. You will not be identified, as your information will be presented as part of a 
group.  Confidentiality of information provided can only be protected within the 
limitations of the law.  It is possible for data to be subject to subpoena, freedom of 
information claim or mandated reporting by some professions.   
 You may withdraw from the research study at any point. There will be no penalty for 
withdrawing before all stages of the Research Study have been completed. 
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Project funding 
This project is funded by a grant awarded by the European Foundation for the 
Study of Diabetes. 
 
If you have concerns about this study and wish to contact an independent person, please 
contact: The Secretary, Dublin City University Research Ethics Committee, c/o Office of 
the Vice-President for Research, Dublin City University, Dublin 9. Tel 01-7008000 
 
If you require further information or are interested in taking part in the study please 
contact Diane Cooper on 01 7008472, 087 2388748 or email 
diane.cooper2@mail.dcu.ie 
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Appendix A 5: Informed Consent Form for Intervention 1 (Chapter 3) 
 
INFORMED CONSENT FORM FOR CLINICAL RESEARCH STUDY 
 
Title of project :  Cellular mechanisms of insulin resistance and exercise 
resistance in early onset type 2 diabetes. 
 
Principal Investigators: 
 Prof. John J. Nolan, Metabolic Research Unit, St. James’s Hospital, Dublin 
 Dr. Donal O’Gorman, School of Health and Human Performance, Dublin City 
University. 
 
I,  _________________________ understand that I have been asked to participate in a 
study at the Department of Endocrinology at St James’s Hospital and at the School of 
Health and Human Performance at Dublin City University to determine the influence of 
exercise and dietary intervention on insulin resistance and muscle metabolism. To 
determine if I am eligible to participate in the study, I will visit the Metabolic Research Unit 
in the Department of Endocrinology for screening, including having an oral glucose 
tolerance test performed. On my second visit, I will have an MRI scan performed to assess 
my intra-abdominal fat content. I will also have an exercise test called a VO2 max test to 
assess my fitness level. Following that, on a different day, I will come in for a muscle 
biopsy performed by the study physicians. In the next 6 months, I will be randomly 
assigned to a 3 monthly period of: 
 
1) Supervised dietary intervention; which will involve a low fat diet (at 2500 calories less 
than my usual diet each week). 
 
AND 
 
2)  Supervised exercise intervention; which will involve 4 sessions a week, equivalent to 
2500 kcal of energy used. 
 
During the exercise element I will have my fitness measured every 4 weeks and my blood 
pressure and heart rate will be monitored during exercise. After each 3 monthly period I 
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will have each of the baseline tests (oral glucose tolerance test, MRI scan, VO2 max test, 
and muscle biopsy) repeated. 
 
Benefits: At the conclusion of the project, I may obtain information about my own 
exercise capacity. I will also benefit from having a specialised dietary input in this 
programme. Involvement in this project is designed to improve my physical fitness and to 
help me lose weight.  
 
Discomforts and Risks: 
Blood Draw : The insertion and placement of the catheter should be minimally painful, a 
slight ache may be felt and a small bruise may appear on the arm. There is also a small risk 
of infection, but by using the appropriate techniques, this risk is minimal. 
 
V02 Max test : Some risks are associated with this test. As subjects approach a maximal 
effort, they may experience episodes of transient light-headedness, chest discomfort, leg 
cramps, occasional irregular heartbeats, and abnormal blood pressure response. The risk of 
coronary event although minor (approximately one occurrence per 15,000 tests) does exist. 
Even though a regular exercise session may involve some hyperventilation; the aim of the 
test is to achieve a maximum effort.  
 
Exercise training : Exercise training may lead to muscle tightness, soreness, fatigue, and 
rarely a pulled muscle. An exercise physiologist and physician will closely monitor the 
exercise training session.  
 
Muscle biopsy: There will be some minor discomfort during the muscle biopsy procedure, 
which will be performed under local anaesthesia. There is a small (< 1:200) risk of local 
bleeding and infection. Due to the local anaesthesia administered, temporary numbness of 
the skin near the biopsy site may occur. By using appropriate techniques during these 
procedures the risks outlined above are minimised.   
 
MRI scan of the abdomen: This scan involves a very powerful magnetic field, and therefore 
any participants with implanted metal devices (such as a pacemaker or prosthetic device) 
will be excluded from having the scan performed. All jewellery (including dentures and 
reading glasses) will need to be removed prior to the scan. The scan is painless, however 
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some people experience a slight claustrophobic sensation while the scan is being performed 
(which may last for 15 minutes). 
 
Exclusion from participation: I understand that my doctors have told me that I cannot 
participate in this study if I have had any evidence of heart, liver, gastrointestinal or kidney 
disease, or if my blood sugar or blood pressure is not well controlled. If I suffer from 
claustrophobia, I can choose not to have the MRI scan performed.  
 
Alternative treatment:  I do not have to take part in this study to be treated. Other 
treatments are available and the research doctor has discussed this with me.  
 
Confidentiality and Right to Ask Questions: All records associated with my 
participation in the study will be subject to the usual confidentiality standards applicable to 
medical records, and in the event of any publication resulting from the research, no 
personally identifiable information will be disclosed. Confidentiality of information 
provided can only be protected within the limitations of the law.  It is possible for data to 
be subject to subpoena, freedom of information claim or mandated reporting by some 
professions.   
 
I have been given the opportunity to ask any questions I may have, and all such 
questions or enquiries have been answered to my satisfaction. I have been provided 
with a detailed patient information leaflet explaining each of the stages in the study. 
If I have any further questions about the study, or my participation in it, I may 
contact any of the study investigators on a 24 hour basis. 
 
St. James’s Hospital 
Prof John J. Nolan   01-4162488 W 
Nicole Burns   086-1942705 M 
Dr Shabahat Shah  086-6039220  M 
Dr Krzystof Wanic 
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Dublin City University 
Dr. Donal O’Gorman 01-7008060 
Ms. Diane Cooper 01-7008472 
Dr. Davide Susta  
 
Compensation: 
I understand that in the event of injury resulting form research, the doctors are covered by 
standard medical malpractice insurance. No other compensation is available. 
 
Voluntary Participation:  I understand that my participation in this study is voluntary, and 
that I may withdraw from this study at any time by notifying the investigator. My 
withdrawal from the study, or my refusal to participate, will in no way affect my care or 
access to medical services. I understand that the trial has ethical approval from St. James’s 
Hospital and Dublin City University and this is to certify that I consent to participate as a 
volunteer in this programme of investigation. I understand that I will receive a signed copy 
of this consent form. 
 
Project funding 
I understand that this project is funded by a grant awarded by the European 
Foundation for the Study of Diabetes. 
 
 
 
_________________     _______________ 
Volunteer’s signature     Date 
 
 
_________________ 
Name ( Print ) 
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I, the undersigned, have defined and explained the studies involved to the above volunteer. 
 
 
 
______________________    _________________ 
Investigator’s signature   Date 
 
 
 
______________________ 
Name ( Print ) 
 
 
 
______________________    __________________ 
Witness’ Signature     Date 
 
 
 
______________________ 
Name 
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Appendix A6: Medical Questionnaire 
 
 
Cellular Mechanisms of Insulin and Exercise Resistance in Early Onset Type 2 
Diabetes 
DATE    
CONTACT DETAILS) 
Last name: _____________________   
First name: _____________________ 
Date of birth:          _______________   Age _________   
Address:  _______________________________________________________ 
 
Mobile __________________  Work:_______________  
Home:________________ 
Email Address:   _______________________________ 
 
Next of kin 
Name        Contact tel:    
Relationship to you       
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MEDICAL HISTORY (PHYSICIAN ADMINISTERED) 
 
 
2.  Have you ever had any of the following (tick box)?  Yes  No 
 a) A heart attack      □  □ 
b) Heart surgery      □  □ 
c) An angiogram      □  □ 
d) Insertion of a stent      □  □ 
e) Treatment of an irregular heart beat   □  □ 
f) A blackout (loss of consciousness)   □  □ 
 
3. Please list any other medical conditions you suffer from  
at present or have suffered from in the past 
1.            
2.            
3.            
4.            
 
 
4.  List any medications which you are now taking 
 
1.  Do you suffer from any of the following (tick box)?  Yes No 
 a) High blood pressure (hypertension)   □ □ 
 b) Angina       □ □ 
  i.e  chest pain, neck pain, jaw pain, arm pain  
or undue breathless on exertion 
   (such as walking fast or walking up a hill) 
 c) Heart disease of any sort     □ □ 
  e.g.  heart attack 
blocked blood vessels to the heart 
abnormal heart rhythm 
 d) Peripheral vascular disease    □ □  
e.g.  intermittent claudication (calf pain on walking) 
stroke 
 e) Elevated blood cholesterol or triglycerides  □ □ 
 f) Diabetes       □ □ 
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5. Your family history 
 
Do any of your first degree relatives (parents, brothers, sisters) 
suffer from any of the following (tick box if yes)? 
       Yes  No 
a) heart disease   □  □    
b) high blood pressure  □  □ 
c) diabetes   □  □ 
 
Has any first degree relative of yours died from heart disease? Yes □  No   □ 
 
6. Alcohol / Cigarettes 
 
Do you consume alcohol regularly?  Yes  □    No  □  
 
If yes, how many units per week? ______________ 
 
 
Do you smoke?    Yes  □    No  □    
 
If yes, how many cigarettes a day? ______________ 
 
 
7.  Your Exercise Pattern 
 
Do you take part in regular exercise of physical activity ?   Yes  □   No  □  
 
 
If yes, give details (how often per week, duration per session) 
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PHYSICAL EXAMINATION 
 
 
Blood Pressure ___  / ____  Pulse____ 
  
 
GENERAL APPEARANCE 
 
Subject looks:  Healthy____ Not healthy___ Very ill____ 
 
 
SUMMARY FINDINGS 
    Nothing    Details if Abnormal 
    Abnormal    
    Found   
 
HEAD AND NECK     □         
 
             
 
CHEST AND LUNGS    □         
 
             
 
HEART      □         
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ABDOMEN      □          
 
             
 
EXTREMITIES     □         
 
             
 
NEUROMUSCULAR    □         
 
             
 
 
RESTING ECG 
 
Descriptive Analysis: 
 
Rate:    ______bpm  
Rhythm:  __________________________ 
Arrhythmias  __________________________ 
   __________________________ 
   __________________________ 
 
Clinical Impression: 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
_________ 
 
According to the medical history and physical exam, does subject qualify for this research study?  
 
Yes  
No  
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Comments: 
_____________________________________________________    
_____________________________________________________       
 
 
   ___________________________ ____________ 
Physician's signature             (Date) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 296 
 
Appendix A7: Informed Consent Form for DEXA Scan 
DUBLIN CITY UNIVERSITY 
Informed Consent Form for DEXA Scan 
 
Title: 
Cellular mechanisms of insulin resistance and exercise resistance in early onset type 2 
diabetes. 
 
Investigators: 
Dr. Donal O’Gorman   
Prof. John Nolan  
Ms. Diane Cooper 
 
This consent form is in addition to the detailed consent form that has already been signed 
by the participant for the above study. A DEXA scan was not included in the original 
consent form.  
Potential risks to participants from involvement in the Research Study: 
I understand that DEXA Scanning involves exposure to a small amount of x-ray radiation, 
~2% of that used in a traditional x-ray scan. This is a routine assessment.  
 
Participant – please complete the following (Circle Yes or No for each question) 
 
Do you understand all the information provided here?   Yes/No 
Have you had an opportunity to ask questions and discuss this study?  
 Yes/No 
Have you received satisfactory answers to all your questions?    Yes/No 
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Signature: 
I have read and understood the information in this form.  My questions and concerns have 
been answered by the researchers, and I have a copy of this consent form.  Therefore, I 
consent to undergo a DEXA scan. 
 
 Participants Signature:      __  
 Name in Block Capitals:        
 Witness:           
  
 Date:             
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Appendix A8: 6-20 Point Borg Scale 
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Appendix A9: Recruitment email for intervention 2 (Chapter 4)  
 
Hi All, 
The School of Health and Human Performance at DCU are conducting a research study in 
January 2010 to investigate how body weight, body fat and the use of energy by the 
muscles is influenced by different types of exercise training. We want to conduct a 3-
month exercise training programme using two different approaches. For the first 4-weeks 
all participants will exercise for 4x 1 hour sessions consisting of aerobic exercise, like 
walking and cycling, as well as approximately 15-minutes of strength exercises. For the last 
8 weeks some participants will continue with this programme while others will change the 
resistance exercise. Instead they will only perform half of the strength exercise, ie they will 
only let the weight down, but not lift it. 
 
A number of measurements will be made before the study and at the end of each 3-month 
phase. These include fitness testing, an MRI of the arm and leg, a measure of energy use by 
the body, a measure of how well the body reacts to insulin, measurement of body fat and a 
muscle biopsy. 
 
We are looking for males and females aged 18-50 years who are overweight and interested 
in participating in a weight loss programme. If you would like to hear more about this 
study or would consider participating, please contact Diane Cooper (Tel: 7008472; 
e-mail: (diane.cooper2@mail.dcu.ie) 
 
Kind regards, 
Diane. 
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Appendix A10: Plain Language Statement for Intervention 2 (Chapter 4) 
 
Plain Language Statement 
Title: The impact of eccentric exercise training on energy expenditure and metabolism in 
obese participants. 
 
Principal investigators: 
Dr. Donal O’Gorman  donal.ogorman@dcu.ie 01-7008060 
Dr. Davide Susta            davide.susta@dcu.ie 
 
Other investigator: 
Ms. Diane Cooper - diane.cooper2@mail.dcu.ie 01-7008472 
 
What is the study about? 
Regular exercise has many important benefits for health including weight loss as well as the 
prevention of diabetes and heart disease. One of the key roles of exercise is to increase the 
amount of energy we use during the day. This study compares a traditional exercise 
programme, combining some aerobic (walking) exercise with some strength exercises, to a 
programme that has a similar amount of aerobic exercise but modifies the strength 
exercises. We wish to determine if the modified exercise programme is a more effective 
way of increasing energy used by the body. 
 
What will be involved in the study? 
The training study will involve 4x1-hr sessions of exercise each week for 12-weeks. Each of 
these sessions will involve 45-mins of aerobic exercise (walking on a treadmill, cycling on a 
stationary bicycle, etc) and 15-mins of strength exercises (lifting a weight with your arms 
and legs). All participants in the study will follow the same exercise programme for the first 
4-weeks. At that time one group will continue with the same exercise programme and the 
other will have a modified programme for the strength exercises. This group will only 
perform half of the exercise. For example, if you were doing a bench press (see picture 
below), you will not lift the weight but you will have to lower it slowly back to your chest. 
Two people, standing next to you, will take the weight and lift it back up for you to lower it 
again. Otherwise the programme remains the same. 
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A number of tests will be carried out before and after the 12-week training programme. 
The energy your body uses at rest will be measured in the lab by lying down for 1-hr and 
having the air you breathe out analysed for oxygen and carbon dioxide. Your aerobic 
fitness and strength will be determined before you start and every 4-weeks during the 
programme. In order for us to examine the changes that have occurred in the muscle we 
will take a scan of your arm and leg to measure the amount of muscle you have. We will 
also take a sample of muscle from your leg so that we can measure the size and number of 
individual muscle fibres. The amount of fat in your body will be measured by scanning it 
with a DEXA analyser.  
 
Exercise does carry a risk of injury, such as a pulled muscle, muscle soreness or in extreme 
cases abnormal heart rhythm, heart attack or death.  The benefits of being involved in this 
study include a detailed assessment of your fitness, your response to exercise and your 
energy use.  All information we gather will be stored in a secure filing cabinet.  The results 
of the study will be used for a postgraduate thesis and may be published in academic 
journals.  You will not be identified, as your information will be presented as part of a 
group.  Confidentiality of information provided can only be protected within the 
limitations of the law.  It is possible for data to be subject to subpoena, freedom of 
information claim or mandated reporting by some professions.  All data will be destroyed 
after 5 years.  Your participation in this research project is voluntary and you may withdraw 
your consent at any time. 
 
This study is being funded by a research training grant for Ms. Diane Cooper from the 
Irish Research Council for Science, Engineering and Technology. 
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If you have concerns about this study and wish to contact an independent person, please 
contact: 
 
The Secretary, Dublin City University Research Ethics Committee, c/o Office of 
the Vice-President for Research, Dublin City University, Dublin 9.  Tel 01-7008000 
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Appendix A11: Informed Consent Form for Intervention 2 (Chapter 4) 
 
Informed Consent Form 
Title:  The impact of eccentric exercise training on energy expenditure and metabolism in 
obese participants 
 
Principal investigators:  Dr. Donal O’Gorman, Dr. Davide Susta 
School of Health and Human Performance 
 
Other investigators: Ms. Diane Cooper 
 
Purpose: The purpose of this study is to determine if the amount of weight and body fat 
lost in response to exercise training could be improved by including strength exercises that 
accelerate the changes in muscle. 
 
This is what will happen during the research study 
1. I will have the purpose of the study, each of the steps involved and the risks of 
participating in the study explained to me. I will have the opportunity to ask any 
questions and if I am happy with the answers I will:  
a. Provide written informed consent for participation in the research project.  
b. I will then complete a medical history form, which will ask questions about 
my general health, personal and family health history, smoking, exercise, 
and dietary habits.   
 
2. Pre- and Post test evaluation 
a. I will have a number of measurements of my body size and shape.  Firstly, 
my blood pressure will be measured.  I will have an electrocardiogram 
(ECG) done to check my heart.  This is a painless, 5 minute procedure that 
involves lying down and having adhesive pads attached to my arms, legs 
and chest.  My height and weight will be measured in light clothing, and 
without shoes.  
b.  I understand that any of these procedures or tests may be waived at the 
discretion of the doctor for the following reasons: (i) I have completed the 
same or similar step in the past 6 months as part of another research 
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protocol at the School of Health and Human Performance; (ii) It has been 
determined that I am not eligible to participate in this research project; and 
thus completion of the entire screening process will not be necessary. 
c. The amount of fat and muscle in my body will be measured in two ways. 
My body fat will be measured using a DEXA scanner. This involves lying 
on a flat table for about 10-mins. During this time my body will be scanned. 
The picture taken will be used to determine the amount of fat. I will also 
have an MRI of my arm and leg. This is also a painless procedure where an 
image is taken that can be used to measure the size of the muscle. These 
pictures will be used to see if the amount of muscle in my body increased 
and the amount of fat decreased following exercise. 
d. Resting metabolic rate. I will rest by lying down on a bed for 1-hr. The bed 
will be located in a well-ventilated private semi-darkened room. After 30-
mins I will have a clear plastic hood placed over my head.  I will still be able 
to breathe normally as 50 litres of air is drawn through every minute. The 
air I breathe will be analysed to determine the amount of energy I use at 
rest. 
e. On one morning I will come to the lab between 0800h and 0900h after an 
overnight fast, with only water taken for the previous 10 hours. After 
resting for 15 minutes, I will have a muscle biopsy taken from my thigh. 
For the biopsy I will have the area anaesthetised with local anaesthetic, then 
a small 0.5 cm incision will be made in the skin and a needle inserted briefly 
into the muscle.  A small piece of muscle, less that 0.15 of a gram, will be 
taken from my leg.  The incision is pulled close with sterile strips and my 
leg will be wrapped snugly with an elastic bandage to maintain pressure. 
Before I leave I will be given contact information and supplies to change 
the dressing around the biopsy sites. A muscle biopsy will be taken before 
the exercise training and following 12 weeks of exercise. 
f. After the biopsy my metabolism and the way my body uses glucose will be 
determined. I will have a small tube placed in a vein of my left and right 
arm. After some baseline blood samples are taken I will have be given some 
glucose through one tube over 1-min. Blood samples will be taken from the 
other tube every 2-mintues for the next 10-mins. During the next 10-mins 
two other blood samples are taken. Then I will be given a small amount of 
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insulin and blood samples will be taken at 10-,20-,30-, 50-,70- and 160-min 
after this. The test will take 3-hrs. 
 
3. Exercise capacity and determination of exercise intensity 
a. I will undergo an exercise test designed to measure my fitness, and to 
evaluate my current physical condition.  I understand that I will walk on a 
treadmill, with the speed or slope getting more difficult every 2 minutes 
until, fatigue, breathlessness, chest pain and/or symptoms that indicate to 
the doctor or myself that I should stop exercise.  To assess my fitness I will 
have a mouthpiece similar to a snorkel in my mouth to measure the amount 
of air I breathe in and out. 
b. For the strength exercises I will be asked to lift a comfortable weight 10 
times. The amount of weight will increase gradually every 5-mins until I 
cannot lift it 3-times. This maximum weight will be used to determine the 
weight I will lift during the exercise training. 
 
4. Exercise training 
a. I will undertake 4 exercise sessions each week in DCU Sport. Each of these 
sessions will involve 45-mins of aerobic exercise, like walking on a 
treadmill, and 15-mins of strength exercises. I understand that all 
participants will undertake the same programme for the first 4- weeks. 
b. At that time I will be asked to either (i) continue with the same programme 
or (ii) modify the strength exercises so that I am only lowering the weight 
and not lifting it. I understand that, if I am part of this group, the weight I 
lower will be slightly heavier that what I was previously lifting but two 
people will lift the weight for me and I will lower it slowly. 
c. My fitness on the treadmill and my strength tests will be measured every 4-
weeks during the exercise training programme to monitor my performance 
and to adjust the training programme. 
 
 
Sometimes there are side effects from performing exercise tests. These side effects 
are often called risks, and for this project, the risks are: 
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1. Exercise testing carries with it a very small risk of exercise induced asthma, 
abnormal heart rhythms, heart attack, or death in less than one in 30,000 patients.  
The risk of sudden death during exercise for healthy men is 1:15000-18000.  
Because I will be asked to give a maximum effort, I may experience some muscle 
soreness in my arms and legs or nausea following the maximal exercise test.  
2. I understand that taking the blood sample should be minimally painful but a slight 
ache may be felt and a small bruise may appear on my arm.  There is also a small 
risk of infection, but by using the appropriate techniques this risk is minimal. 
3. I understand that following the glucose injection I may feel flushed with slight 
nausea for a couple of minutes. 
4. I understand that lowering the weight is strenuous and my muscles may feel stiff 
and sore for a few days after the first few sessions. 
 
There may be benefits from my participation in this study.  These are: 
1. I will receive a copy of my personal results, body fat and fitness measurements and 
energy use during exercise. 
2. I understand that no other benefits have been promised me. 
 
Participant – please complete the following (Circle Yes or No for each question) 
I have read the Plain Language Statement    Yes/No 
I understand the information provided    Yes/No 
I have had an opportunity to ask questions and discuss this study  Yes/No 
I have received satisfactory answers to all my questions   Yes/No 
 
My confidentiality will be guarded: 
Dublin City University will protect all the information about me, and my part in this study, 
within the limitations of the law.  My identity or personal information will not be revealed 
or published. All records associated with my participation in the study will be subject to the 
usual confidentiality standards applicable to medical records.  In addition, the study 
findings may be presented at scientific meetings and published in a scientific journal and/or 
as part of a postgraduate thesis, but my identity will not be divulged and only presented as 
part of a group.   
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If I have questions about the research project, I am free to call Dr. Donal 
O’Gorman at 01-7008060.   
 
Taking part in this study is my decision.   
I understand that my participation in this study is voluntary and that I may withdraw my 
consent at any time by notifying any of the investigators.  I may also request that my data 
and samples be removed from the database or storage and destroyed.  My withdrawal from 
this study, or my refusal to participate, will in no way affect my relationship with Dublin 
City University or my entitlements as a student or staff member.  I understand that my 
participation in this research may be terminated by the investigator without regard to my 
consent if I am unable or unwilling to comply with the guidelines and procedures explained 
to me.  
 
This study is being funded by a research training grant for Ms. Diane Cooper from the 
Irish Research Council for Science, Engineering and Technology. 
 
Signature: 
I have read and understood the information in this form.  My questions and concerns have 
been answered by the researchers, and I have a copy of this consent form.  Therefore, I 
consent to take part in this research project 
 
Participants Signature:         
Name in Block Capitals:        
Witness:            
 
Date:                
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Appendix A12: Post-Biopsy Care and Treatment Instructions 
 
Information for subject: 
 
1. You will be given a supply kit containing some steri-strips, sterile gauze, cotton 
wool, alcohol wipes, bandage and tegaderm transparent dressing.  Inspect the 
biopsy site regularly. 
2. Keep the biopsy incision dry for at least one full day. Do not get it wet in a shower, 
bathtub, jacuzzi, whirlpool, or go swimming during this time.  Use the transparent 
dressing over the site if you are having a shower. 
3. Check the incision several times each day. Change the bandage when necessary 
with the bandages supplied. 
4. Do not permit sweat to get in the incision. This means no saunas, and no vigorous 
exercise for at least two full days. 
5. Do not perform heavy lifting with the legs for at least two full days. When you do 
return to lifting, begin the training session gradually with light weights. 
6. Be sure to have contact with the research team the day after the biopsy and report 
any unusual feelings or responses since the biopsy. 
7. If the incision is painful, take some paracetamol as directed by the manufacturer, 
apply an ice pack, and elevate the leg. It is not recommended to take Aspirin or 
Advil since these may allow unnecessary bleeding or bruising. 
8. Inspect the biopsy area for swelling, red appearance or infection.  If you notice 
anything unusual please contact the research team. 
 
 
